1	International	NNP	O	International	nn	2	SENT_1	[p1l934t465r1189b501],
2	Journal	NNP	O	Journal	_	0	SENT_1	[p1l1208t465r1356b501],
3	of	IN	O	of	_	0	SENT_1	[p1l1375t465r1421b501],
4	Cardiology	NNP	O	Cardiology	prep_of	2	SENT_1	[p1l1434t465r1661b512],
5	133	CD	NUMBER	133	number	6	SENT_1	[p1l1684t466r1751b501],
6	(	CD	NUMBER	(	dep	2	SENT_1	[p1l1773t465r1906b511],
7	2009	CD	DATE	2009	num	8	SENT_1	[p1l1773t465r1906b511],
8	)	NN	O	)	dep	6	SENT_1	[p1l1773t465r1906b511],
9	341	CD	NUMBER	341	num	10	SENT_1	[p1l1925t466r1994b501],
10	-345	CD	NUMBER	-345	dep	6	SENT_1	[p1l2008t466r2117b501],

1	Platelet	NN	O	platelet	nn	2	SENT_2	[p1l47t628r367b706],
2	reactivity	NN	O	reactivity	nsubj	6	SENT_2	[p1l403t628r807b728],
3	and	CC	O	and	_	0	SENT_2	[p1l848t628r1001b706],
4	clopidogrel	NN	O	clopidogrel	nn	5	SENT_2	[p1l1041t628r1527b728],
5	resistance	NN	O	resistance	nsubj	6	SENT_2	[p1l1565t628r1985b706],
6	are	VBP	O	be	_	0	SENT_2	[p1l2028t654r2152b706],

1	Il	NN	O	il	_	0	SENT_3	[p1l1104t1193r1625b1269],
2	:1	CD	NUMBER	:1	num	3	SENT_3	[p1l1104t1193r1625b1269],
3	l	NN	O	l	tmod	1	SENT_3	[p1l1104t1193r1625b1269],
4	§	CD	NUMBER	§	dep	1	SENT_3	[p1l1104t1193r1625b1269],
5	EI	NN	O	eus	dep	4	SENT_3	[p1l1104t1193r1625b1269],
6	'	''	O	'	_	0	SENT_3	[p1l1104t1193r1625b1269],
7	.	.	O	.	_	0	SENT_3	[p1l1104t1193r1625b1269],

1	I	PRP	O	I	nsubj	2	SENT_4	[p1l1104t1193r1625b1269],
2	‘	VBP	O	‘	_	0	SENT_4	[p1l1104t1193r1625b1269],
3	1at	CD	NUMBER	1at	number	4	SENT_4	[p1l1104t1193r1625b1269],
4	’	CD	NUMBER	’	num	6	SENT_4	[p1l1104t1193r1625b1269],
5	iE	NN	O	ie	nn	6	SENT_4	[p1l1104t1193r1625b1269],
6	}	NN	O	}	dobj	2	SENT_4	[p1l1104t1193r1625b1269],
7	I	PRP	O	I	nsubj	8	SENT_4	[p1l1104t1193r1625b1269],
8	’	VBP	O	’	rcmod	6	SENT_4	[p1l1104t1193r1625b1269],
9	1al	JJ	O	1al	amod	10	SENT_4	[p1l1104t1193r1625b1269],
10	Journal	NNP	O	Journal	dobj	8	SENT_4	[p1l1677t1198r1977b1283],
11	of	IN	O	of	_	0	SENT_4	[p1l2020t1193r2115b1273],
12	ar	NN	O	ar	nn	14	SENT_4	[p1l1214t1326r1422b1478],
13	iolo	NN	O	iolo	nn	14	SENT_4	[p1l1480t1321r1872b1483],
14	www.elsevier.com/locate/ijcard	NN	O	www.elsevier.com/locate/ijcard	prep_of	10	SENT_4	[p1l839t1814r2148b1911],
15	associated	VBN	O	associate	partmod	14	SENT_4	[p1l6t2149r908b2308],
16	with	IN	O	with	_	0	SENT_4	[p1l985t2149r1376b2308],
17	the	DT	O	the	det	18	SENT_4	[p1l1453t2149r1718b2308],
18	H2	NN	O	h2	prep_with	15	SENT_4	[p1l1801t2154r2061b2306],

1	haplotype	NN	O	haplotype	_	0	SENT_5	[p1l461t2341r736b2406],
2	of	IN	O	of	_	0	SENT_5	[p1l763t2341r827b2392],
3	the	DT	O	the	det	4	SENT_5	[p1l843t2341r926b2392],
4	P2Y12	NN	O	p2y12	prep_of	1	SENT_5	[p1l952t2342r1290b2403],
5	.	.	O	.	_	0	SENT_5	[p1l952t2342r1290b2403],

1	—	NN	O	—	_	0	SENT_6	[p1l952t2342r1290b2403],
2	.	.	O	.	_	0	SENT_6	[p1l952t2342r1290b2403],

1	ADP	NN	O	adp	_	0	SENT_7	[p1l952t2342r1290b2403],
2	receptor	NN	O	receptor	nn	3	SENT_7	[p1l1317t2348r1545b2406],
3	gene	NN	O	gene	dep	1	SENT_7	[p1l1569t2358r1698b2406],

1	Peter	NNP	PERSON	Peter	nn	2	SENT_8	[p1l310t2478r420b2515],
2	Staritz	NNP	PERSON	Staritz	_	0	SENT_8	[p1l440t2477r574b2515],
3	a	DT	O	a	dep	2	SENT_8	[p1l586t2474r616b2523],
4	,	,	O	,	_	0	SENT_8	[p1l586t2474r616b2523],
5	Kerstin	NNP	PERSON	Kerstin	nn	6	SENT_8	[p1l638t2477r793b2515],
6	Kurz	NNP	PERSON	Kurz	appos	3	SENT_8	[p1l812t2478r918b2515],
7	a	DT	O	a	dep	6	SENT_8	[p1l930t2474r960b2523],
8	,	,	O	,	_	0	SENT_8	[p1l930t2474r960b2523],
9	Monika	NNP	PERSON	Monika	nn	10	SENT_8	[p1l981t2477r1148b2515],
10	Stollb	NNP	PERSON	Stollb	appos	3	SENT_8	[p1l1169t2465r1310b2523],
11	,	,	O	,	_	0	SENT_8	[p1l1169t2465r1310b2523],
12	Evangelos	NNP	PERSON	Evangelos	nn	13	SENT_8	[p1l1332t2477r1552b2526],
13	Giannitsis	NNP	PERSON	Giannitsis	appos	10	SENT_8	[p1l1574t2477r1786b2515],
14	"	``	O	"	punct	13	SENT_8	[p1l1800t2474r1830b2523],
15	‘	NN	O	‘	dep	13	SENT_8	[p1l1800t2474r1830b2523],
16	,	,	O	,	_	0	SENT_8	[p1l1800t2474r1830b2523],

1	Hugo	NNP	PERSON	Hugo	nn	2	SENT_9	[p1l673t2540r791b2588],
2	A.	NN	PERSON	a.	_	0	SENT_9	[p1l811t2539r859b2577],
3	Katus	NNP	PERSON	Katus	dep	2	SENT_9	[p1l881t2540r1004b2577],
4	a	DT	O	a	dep	3	SENT_9	[p1l1017t2535r1047b2586],
5	,	,	O	,	_	0	SENT_9	[p1l1017t2535r1047b2586],
6	Boris	NNP	PERSON	Boris	nn	8	SENT_9	[p1l1068t2538r1182b2577],
7	T.	NNP	PERSON	T.	nn	8	SENT_9	[p1l1203t2540r1240b2577],
8	Ivandic	NNP	PERSON	Ivandic	appos	3	SENT_9	[p1l1263t2538r1420b2577],
9	a	DT	O	a	advmod	10	SENT_9	[p1l1433t2533r1484b2558],
10	’	NN	O	’	dep	8	SENT_9	[p1l1433t2533r1484b2558],
11	*	CD	NUMBER	*	num	10	SENT_9	[p1l1433t2533r1484b2558],
12	"	''	O	"	punct	10	SENT_9	[p1l510t2633r520b2643],

1	Department	NNP	O	Department	_	0	SENT_10	[p1l529t2636r688b2665],
2	of	IN	O	of	_	0	SENT_10	[p1l699t2635r731b2665],
3	Medicine	NNP	O	Medicine	nn	4	SENT_10	[p1l734t2635r857b2659],
4	III	NNP	O	III	prep_of	1	SENT_10	[p1l866t2636r904b2662],
5	,	,	O	,	_	0	SENT_10	[p1l866t2636r904b2662],
6	University	NNP	ORGANIZATION	University	appos	4	SENT_10	[p1l922t2636r1056b2665],
7	of	IN	ORGANIZATION	of	_	0	SENT_10	[p1l1067t2635r1099b2665],
8	Heidelberg	NNP	ORGANIZATION	Heidelberg	prep_of	6	SENT_10	[p1l1102t2635r1254b2665],
9	,	,	O	,	_	0	SENT_10	[p1l1102t2635r1254b2665],
10	69120	CD	NUMBER	69120	num	11	SENT_10	[p1l1271t2635r1352b2659],
11	Heidelberg	NNP	LOCATION	Heidelberg	appos	4	SENT_10	[p1l1362t2635r1514b2665],
12	,	,	O	,	_	0	SENT_10	[p1l1362t2635r1514b2665],
13	Germany	NNP	LOCATION	Germany	nn	16	SENT_10	[p1l1531t2635r1652b2665],
14	b	NN	O	b	nn	16	SENT_10	[p1l102t2668r114b2684],
15	Genetic	JJ	ORGANIZATION	genetic	amod	16	SENT_10	[p1l127t2676r226b2699],
16	Epidemiology	NN	ORGANIZATION	epidemiology	appos	4	SENT_10	[p1l237t2675r420b2706],
17	of	IN	ORGANIZATION	of	_	0	SENT_10	[p1l432t2675r464b2706],
18	Vascular	JJ	ORGANIZATION	vascular	amod	19	SENT_10	[p1l472t2675r584b2699],
19	Disorders	NNS	ORGANIZATION	disorder	prep_of	16	SENT_10	[p1l593t2675r729b2703],
20	,	,	O	,	_	0	SENT_10	[p1l593t2675r729b2703],
21	Leibniz	NNP	ORGANIZATION	Leibniz	nn	22	SENT_10	[p1l743t2675r841b2699],
22	Institute	NNP	ORGANIZATION	Institute	appos	4	SENT_10	[p1l850t2676r958b2699],
23	for	IN	ORGANIZATION	for	_	0	SENT_10	[p1l963t2675r1009b2706],
24	Arteriosclerosis	NNP	ORGANIZATION	Arteriosclerosis	nn	25	SENT_10	[p1l1017t2675r1226b2699],
25	Research	NNP	ORGANIZATION	Research	prep_for	22	SENT_10	[p1l1237t2675r1363b2703],
26	,	,	O	,	_	0	SENT_10	[p1l1237t2675r1363b2703],
27	University	NNP	ORGANIZATION	University	nn	28	SENT_10	[p1l1381t2676r1515b2706],
28	ofMuenstei	NNP	O	ofMuenstei	appos	25	SENT_10	[p1l1526t2675r1687b2706],
29	:	:	O	:	_	0	SENT_10	[p1l1526t2675r1687b2706],
30	48149	CD	NUMBER	48149	num	31	SENT_10	[p1l1703t2676r1784b2699],
31	Muenster	NNP	LOCATION	Muenster	dep	1	SENT_10	[p1l1795t2676r1920b2703],
32	;	:	O	;	_	0	SENT_10	[p1l1795t2676r1920b2703],
33	Germany	NNP	LOCATION	Germany	dep	31	SENT_10	[p1l1937t2676r2058b2706],

1	Received	VBN	O	receive	_	0	SENT_11	[p1l423t2742r545b2766],
2	3	CD	DATE	3	dobj	1	SENT_11	[p1l557t2742r570b2766],
3	May	NNP	DATE	May	tmod	1	SENT_11	[p1l584t2743r644b2772],
4	2007	CD	DATE	2007	num	3	SENT_11	[p1l655t2742r729b2770],
5	;	:	O	;	_	0	SENT_11	[p1l655t2742r729b2770],
6	received	VBN	O	receive	parataxis	1	SENT_11	[p1l741t2742r852b2766],
7	in	IN	O	in	_	0	SENT_11	[p1l864t2742r889b2765],
8	revised	JJ	O	revised	amod	9	SENT_11	[p1l900t2742r994b2766],
9	form	NN	O	form	prep_in	6	SENT_11	[p1l1006t2742r1069b2766],
10	20	CD	DATE	20	num	9	SENT_11	[p1l1080t2742r1112b2766],
11	December	NNP	DATE	December	tmod	9	SENT_11	[p1l1124t2742r1259b2766],
12	2007	CD	DATE	2007	num	11	SENT_11	[p1l1270t2742r1343b2771],
13	;	:	O	;	_	0	SENT_11	[p1l1270t2742r1343b2771],
14	accepted	VBN	O	accept	parataxis	1	SENT_11	[p1l1357t2742r1471b2772],
15	26	CD	DATE	26	dobj	14	SENT_11	[p1l1482t2742r1513b2766],
16	December	NNP	DATE	December	tmod	14	SENT_11	[p1l1526t2742r1661b2766],
17	2007	CD	DATE	2007	num	16	SENT_11	[p1l1672t2742r1736b2766],

1	Available	JJ	O	available	amod	2	SENT_12	[p1l875t2782r999b2806],
2	online	NN	O	online	_	0	SENT_12	[p1l1011t2782r1092b2806],
3	15	CD	DATE	15	dep	2	SENT_12	[p1l1108t2783r1135b2806],
4	May	NNP	DATE	May	tmod	3	SENT_12	[p1l1148t2783r1208b2813],
5	2008	CD	DATE	2008	num	4	SENT_12	[p1l1220t2783r1284b2806],

1	Abstract	JJ	O	abstract	_	0	SENT_13	[p1l36t2930r174b2956],

1	Background	NN	O	background	nsubj	13	SENT_14	[p1l33t3020r225b3055],
2	:	:	O	:	_	0	SENT_14	[p1l33t3020r225b3055],
3	Platelet	NN	O	platelet	nn	4	SENT_14	[p1l241t3020r351b3047],
4	hyperreactivity	NN	O	hyperreactivity	dep	1	SENT_14	[p1l364t3020r587b3055],
5	was	VBD	O	be	auxpass	6	SENT_14	[p1l602t3029r658b3047],
6	reported	VBN	O	report	rcmod	4	SENT_14	[p1l673t3020r796b3055],
7	in	IN	O	in	_	0	SENT_14	[p1l811t3020r838b3047],
8	clopidogrel	NN	O	clopidogrel	prep_in	6	SENT_14	[p1l853t3020r1116b3055],
9	—	CD	NUMBER	—	num	8	SENT_14	[p1l853t3020r1116b3055],
10	na	TO	O	na	xcomp	6	SENT_14	[p1l853t3020r1116b3055],
11	'	''	O	'	_	0	SENT_14	[p1l853t3020r1116b3055],
12	1	CD	NUMBER	1	dep	10	SENT_14	[p1l853t3020r1116b3055],
13	've	VBP	O	have	_	0	SENT_14	[p1l853t3020r1116b3055],
14	carriers	NNS	O	carrier	dobj	13	SENT_14	[p1l1131t3020r1239b3047],
15	of	IN	O	of	_	0	SENT_14	[p1l1255t3020r1289b3047],
16	the	DT	O	the	det	18	SENT_14	[p1l1298t3020r1343b3047],
17	H2	NN	O	h2	nn	18	SENT_14	[p1l1357t3021r1401b3047],
18	haplotype	NN	O	haplotype	prep_of	14	SENT_14	[p1l1416t3020r1562b3055],
19	of	IN	O	of	_	0	SENT_14	[p1l1577t3020r1611b3047],
20	the	DT	O	the	det	24	SENT_14	[p1l1621t3020r1665b3047],
21	P2Y12	NN	O	p2y12	nn	24	SENT_14	[p1l1680t3021r1773b3053],
22	platelet	NN	O	platelet	nn	24	SENT_14	[p1l1787t3020r1896b3055],
23	ADP	NN	O	adp	nn	24	SENT_14	[p1l1910t3021r1983b3047],
24	receptor	NN	O	receptor	prep_of	18	SENT_14	[p1l1998t3024r2123b3055],
25	.	.	O	.	_	0	SENT_14	[p1l1998t3024r2123b3055],

1	Here	RB	O	here	advmod	4	SENT_15	[p1l35t3067r113b3098],
2	,	,	O	,	_	0	SENT_15	[p1l35t3067r113b3098],
3	we	PRP	O	we	nsubj	4	SENT_15	[p1l127t3074r170b3092],
4	studied	VBD	O	study	_	0	SENT_15	[p1l185t3066r290b3092],
5	the	DT	O	the	det	6	SENT_15	[p1l303t3066r347b3092],
6	inﬂuence	NN	O	inﬂuence	dobj	4	SENT_15	[p1l361t3066r497b3092],
7	of	IN	O	of	_	0	SENT_15	[p1l511t3066r545b3092],
8	this	DT	O	this	det	10	SENT_15	[p1l553t3066r605b3092],
9	genetic	JJ	O	genetic	amod	10	SENT_15	[p1l620t3066r725b3100],
10	variant	NN	O	variant	prep_of	6	SENT_15	[p1l738t3066r840b3093],
11	on	IN	O	on	_	0	SENT_15	[p1l854t3074r890b3092],
12	clopidogrel	NN	O	clopidogrel	nn	13	SENT_15	[p1l904t3066r1070b3100],
13	responsiveness	NN	O	responsiveness	prep_on	4	SENT_15	[p1l1084t3066r1312b3100],
14	.	.	O	.	_	0	SENT_15	[p1l1084t3066r1312b3100],

1	Methods	NNS	O	method	_	0	SENT_16	[p1l33t3111r172b3138],
2	:	:	O	:	_	0	SENT_16	[p1l33t3111r172b3138],
3	ADP-mediated	JJ	O	adp-mediated	amod	9	SENT_16	[p1l187t3111r409b3138],
4	(	NN	O	(	nn	9	SENT_16	[p1l424t3111r450b3145],
5	5	CD	NUMBER	5	num	9	SENT_16	[p1l424t3111r450b3145],
6	umol/L	NN	O	umol/l	nn	9	SENT_16	[p1l468t3111r589b3145],
7	)	CD	NUMBER	)	num	9	SENT_16	[p1l468t3111r589b3145],
8	platelet	NN	O	platelet	nn	9	SENT_16	[p1l603t3111r711b3145],
9	aggregation	NN	O	aggregation	nsubjpass	11	SENT_16	[p1l726t3111r899b3145],
10	was	VBD	O	be	auxpass	11	SENT_16	[p1l913t3120r969b3138],
11	determined	VBN	O	determine	dep	1	SENT_16	[p1l985t3111r1150b3138],
12	by	IN	O	by	_	0	SENT_16	[p1l1163t3111r1200b3145],
13	impedance	NN	O	impedance	agent	11	SENT_16	[p1l1215t3111r1373b3145],
14	(	CD	NUMBER	(	num	13	SENT_16	[p1l1388t3110r1441b3145],
15	(	NN	O	(	nn	18	SENT_16	[p1l1388t3110r1441b3145],
16	1	CD	NUMBER	1	num	18	SENT_16	[p1l1388t3110r1441b3145],
17	)	NN	O	)	nn	18	SENT_16	[p1l1388t3110r1441b3145],
18	aggregometry	NN	O	aggregometry	dobj	11	SENT_16	[p1l1457t3115r1661b3145],
19	in	IN	O	in	_	0	SENT_16	[p1l1675t3111r1703b3137],
20	43	CD	NUMBER	43	num	23	SENT_16	[p1l1717t3112r1751b3138],
21	clopidogrel-naive	JJ	O	clopidogrel-naive	amod	23	SENT_16	[p1l1768t3111r2027b3145],
22	blood	NN	O	blood	nn	23	SENT_16	[p1l2041t3111r2126b3138],
23	donors	NNS	O	donor	prep_in	18	SENT_16	[p1l35t3155r134b3182],
24	and	CC	O	and	_	0	SENT_16	[p1l149t3155r201b3182],
25	557	CD	NUMBER	557	num	26	SENT_16	[p1l215t3156r268b3182],
26	patients	NNS	O	patient	conj_and	23	SENT_16	[p1l281t3155r395b3190],
27	treated	VBN	O	treat	partmod	26	SENT_16	[p1l409t3155r509b3182],
28	with	IN	O	with	_	0	SENT_16	[p1l521t3155r586b3182],
29	aspirin	NN	O	aspirin	prep_with	27	SENT_16	[p1l600t3155r699b3190],
30	and	CC	O	and	_	0	SENT_16	[p1l713t3155r765b3182],
31	clopidogrel	NN	O	clopidogrel	prep_with	27	SENT_16	[p1l779t3155r945b3190],
32	after	IN	O	after	_	0	SENT_16	[p1l959t3155r1026b3182],
33	percutaneous	JJ	O	percutaneous	amod	36	SENT_16	[p1l1037t3159r1231b3190],
34	coronary	JJ	O	coronary	amod	36	SENT_16	[p1l1246t3164r1376b3190],
35	stent	NN	O	stent	nn	36	SENT_16	[p1l1390t3159r1458b3182],
36	implantation	NN	O	implantation	prep_after	27	SENT_16	[p1l1471t3155r1664b3190],
37	.	.	O	.	_	0	SENT_16	[p1l1471t3155r1664b3190],

1	A	DT	O	a	det	5	SENT_17	[p1l1679t3156r1705b3182],
2	cut-off	JJ	O	cut-off	amod	5	SENT_17	[p1l1719t3155r1822b3182],
3	of	IN	O	of	_	0	SENT_17	[p1l1831t3155r1865b3182],
4	5	CD	NUMBER	5	prep_of	2	SENT_17	[p1l1874t3156r1889b3182],
5	Q	NNP	O	Q	nsubjpass	7	SENT_17	[p1l1905t3154r1933b3182],
6	was	VBD	O	be	auxpass	7	SENT_17	[p1l1947t3164r2003b3182],
7	used	VBN	O	use	_	0	SENT_17	[p1l2017t3155r2085b3182],
8	to	TO	O	to	aux	9	SENT_17	[p1l2097t3159r2125b3182],
9	classify	VB	O	classify	xcomp	7	SENT_17	[p1l35t3201r146b3235],
10	the	DT	O	the	det	12	SENT_17	[p1l159t3201r203b3227],
11	aggregation	NN	O	aggregation	nn	12	SENT_17	[p1l218t3201r391b3235],
12	response	NN	O	response	dobj	9	SENT_17	[p1l404t3209r540b3235],
13	.	.	O	.	_	0	SENT_17	[p1l404t3209r540b3235],

1	Haplotype	NN	O	haplotype	nsubjpass	8	SENT_18	[p1l556t3201r709b3235],
2	tagging	VBG	O	tag	partmod	1	SENT_18	[p1l722t3201r833b3235],
3	single	JJ	O	single	amod	6	SENT_18	[p1l847t3201r933b3235],
4	nucleotide	NN	O	nucleotide	nn	6	SENT_18	[p1l947t3201r1100b3228],
5	polymorphism	NN	O	polymorphism	nn	6	SENT_18	[p1l1113t3201r1330b3235],
6	G52T	NN	O	g52t	dobj	2	SENT_18	[p1l1343t3201r1428b3228],
7	was	VBD	O	be	auxpass	8	SENT_18	[p1l1439t3209r1495b3227],
8	genotyped	VBN	O	genotype	_	0	SENT_18	[p1l1510t3201r1664b3235],
9	using	VBG	O	use	xcomp	8	SENT_18	[p1l1676t3201r1756b3235],
10	a	DT	O	a	det	12	SENT_18	[p1l1770t3209r1786b3227],
11	TaqMan	NN	O	taqman	nn	12	SENT_18	[p1l1799t3202r1921b3235],
12	assay	NN	O	assay	dobj	9	SENT_18	[p1l1935t3209r2018b3235],
13	.	.	O	.	_	0	SENT_18	[p1l1935t3209r2018b3235],

1	Results	NNS	O	result	_	0	SENT_19	[p1l33t3246r151b3272],
2	:	:	O	:	_	0	SENT_19	[p1l33t3246r151b3272],
3	The	DT	O	the	det	4	SENT_19	[p1l165t3246r220b3272],
4	number	NN	O	number	nsubj	8	SENT_19	[p1l233t3246r345b3272],
5	of	IN	O	of	_	0	SENT_19	[p1l356t3246r390b3272],
6	H2	NN	O	h2	nn	7	SENT_19	[p1l397t3246r441b3272],
7	alleles	NNS	O	allele	prep_of	4	SENT_19	[p1l454t3246r544b3272],
8	correlated	VBD	O	correlate	dep	1	SENT_19	[p1l557t3246r700b3272],
9	with	IN	O	with	_	0	SENT_19	[p1l711t3246r776b3273],
10	aggregation	NN	O	aggregation	prep_with	8	SENT_19	[p1l788t3246r958b3280],
11	in	IN	O	in	_	0	SENT_19	[p1l971t3246r998b3272],
12	clopidogrel-naive	JJ	O	clopidogrel-naive	amod	13	SENT_19	[p1l1010t3246r1263b3280],
13	subjects	NNS	O	subject	prep_in	10	SENT_19	[p1l1277t3246r1390b3280],
14	in	IN	O	in	_	0	SENT_19	[p1l1404t3246r1432b3272],
15	healthy	JJ	O	healthy	amod	16	SENT_19	[p1l1443t3246r1549b3280],
16	subjects	NNS	O	subject	prep_in	13	SENT_19	[p1l1562t3246r1676b3280],
17	(	JJ	O	(	amod	18	SENT_19	[p1l1689t3246r1849b3280],
18	p	NN	O	p	dobj	8	SENT_19	[p1l1689t3246r1849b3280],
19	=	JJ	O	=	amod	18	SENT_19	[p1l1689t3246r1849b3280],
20	0.041	CD	NUMBER	0.041	number	21	SENT_19	[p1l1689t3246r1849b3280],
21	)	CD	NUMBER	)	dep	19	SENT_19	[p1l1689t3246r1849b3280],
22	:	:	O	:	_	0	SENT_19	[p1l1689t3246r1849b3280],
23	impedance	NN	O	impedance	nn	24	SENT_19	[p1l1864t3246r2020b3280],
24	results	NNS	O	result	dep	21	SENT_19	[p1l2032t3246r2125b3272],
25	were	VBD	O	be	cop	27	SENT_19	[p1l34t3299r104b3317],
26	8.4	CD	NUMBER	8.4	number	27	SENT_19	[p1l118t3291r161b3317],
27	3.6	CD	NUMBER	3.6	rcmod	24	SENT_19	[p1l192t3291r243b3323],
28	,	,	O	,	_	0	SENT_19	[p1l192t3291r243b3323],
29	10.5	CD	NUMBER	10.5	appos	24	SENT_19	[p1l261t3291r318b3317],

1	1.6	CD	NUMBER	1.6	_	0	SENT_20	[p1l353t3291r394b3317],
2	and	CC	O	and	_	0	SENT_20	[p1l407t3290r459b3317],
3	12.5	CD	NUMBER	12.5	conj_and	1	SENT_20	[p1l475t3291r548b3317],
4	:	:	O	:	_	0	SENT_20	[p1l475t3291r548b3317],

1	:2.1	CD	NUMBER	:2.1	_	0	SENT_21	[p1l549t3291r605b3317],
2	Q	NNP	O	Q	dep	1	SENT_21	[p1l622t3289r649b3317],
3	in	IN	O	in	_	0	SENT_21	[p1l663t3290r691b3317],
4	carriers	NNS	O	carrier	prep_in	2	SENT_21	[p1l703t3290r808b3317],
5	of	IN	O	of	_	0	SENT_21	[p1l821t3290r855b3317],
6	the	DT	O	the	det	9	SENT_21	[p1l862t3290r905b3317],
7	H1/Hl	NN	O	h1/hl	nn	9	SENT_21	[p1l918t3290r1012b3317],
8	(	NN	O	(	nn	9	SENT_21	[p1l1029t3290r1144b3325],
9	n	NN	O	n	prep_of	4	SENT_21	[p1l1029t3290r1144b3325],
10	=	JJ	O	=	amod	12	SENT_21	[p1l1029t3290r1144b3325],
11	30	CD	NUMBER	30	tmod	10	SENT_21	[p1l1029t3290r1144b3325],
12	)	NN	O	)	dep	1	SENT_21	[p1l1029t3290r1144b3325],
13	,	,	O	,	_	0	SENT_21	[p1l1029t3290r1144b3325],
14	H1/H2	NN	O	h1/h2	nn	16	SENT_21	[p1l1157t3290r1255b3317],
15	(	NN	O	(	nn	16	SENT_21	[p1l1269t3290r1373b3325],
16	n	NN	O	n	appos	12	SENT_21	[p1l1269t3290r1373b3325],
17	=	JJ	O	=	amod	19	SENT_21	[p1l1269t3290r1373b3325],
18	ll	NN	O	ll	nn	19	SENT_21	[p1l1269t3290r1373b3325],
19	)	NN	O	)	dep	1	SENT_21	[p1l1269t3290r1373b3325],
20	and	CC	O	and	_	0	SENT_21	[p1l1387t3290r1439b3317],
21	H2/H2	NN	O	h2/h2	conj_and	19	SENT_21	[p1l1450t3290r1548b3317],
22	(	CD	NUMBER	(	num	23	SENT_21	[p1l1562t3290r1649b3325],
23	n	NN	O	n	dep	1	SENT_21	[p1l1562t3290r1649b3325],
24	=	JJ	O	=	amod	27	SENT_21	[p1l1562t3290r1649b3325],
25	2	CD	NUMBER	2	num	27	SENT_21	[p1l1562t3290r1649b3325],
26	)	CD	NUMBER	)	num	27	SENT_21	[p1l1562t3290r1649b3325],
27	haplotypes	NNS	O	haplotype	dep	23	SENT_21	[p1l1662t3290r1826b3325],
28	,	,	O	,	_	0	SENT_21	[p1l1662t3290r1826b3325],
29	respectively	RB	O	respectively	advmod	23	SENT_21	[p1l1839t3290r2017b3325],
30	.	.	O	.	_	0	SENT_21	[p1l1839t3290r2017b3325],

1	87.1	CD	PERCENT	87.1	num	2	SENT_22	[p1l2033t3291r2125b3318],
2	%	NN	PERCENT	%	_	0	SENT_22	[p1l2033t3291r2125b3318],
3	(	CD	NUMBER	(	num	4	SENT_22	[p1l35t3336r160b3370],
4	n	NN	O	n	npadvmod	5	SENT_22	[p1l35t3336r160b3370],
5	=	JJ	O	=	amod	2	SENT_22	[p1l35t3336r160b3370],
6	485	CD	NUMBER	485	num	7	SENT_22	[p1l35t3336r160b3370],
7	)	NN	O	)	dep	15	SENT_22	[p1l35t3336r160b3370],
8	and	CC	O	and	_	0	SENT_22	[p1l174t3336r226b3363],
9	12.9	CD	PERCENT	12.9	num	10	SENT_22	[p1l242t3336r332b3363],
10	%	NN	PERCENT	%	dep	15	SENT_22	[p1l242t3336r332b3363],
11	(	CD	NUMBER	(	num	12	SENT_22	[p1l346t3336r452b3370],
12	n	NN	O	n	dep	15	SENT_22	[p1l346t3336r452b3370],
13	=	JJ	O	=	amod	15	SENT_22	[p1l346t3336r452b3370],
14	72	CD	NUMBER	72	tmod	13	SENT_22	[p1l346t3336r452b3370],
15	)	NN	O	)	dep	21	SENT_22	[p1l346t3336r452b3370],
16	of	IN	O	of	_	0	SENT_22	[p1l466t3336r500b3362],
17	clopidogrel	NN	O	clopidogrel	prep_of	15	SENT_22	[p1l509t3336r672b3370],
18	treated	JJ	O	treated	amod	19	SENT_22	[p1l685t3336r782b3362],
19	patients	NNS	O	patient	nsubj	21	SENT_22	[p1l794t3336r906b3370],
20	were	VBD	O	be	cop	21	SENT_22	[p1l919t3344r989b3362],
21	responders	NNS	O	responder	ccomp	5	SENT_22	[p1l1001t3336r1157b3370],
22	and	CC	O	and	_	0	SENT_22	[p1l1171t3336r1223b3362],
23	nonresponders	NNS	O	nonresponder	conj_and	21	SENT_22	[p1l1236t3336r1454b3370],
24	,	,	O	,	_	0	SENT_22	[p1l1236t3336r1454b3370],
25	respectively	RB	O	respectively	advmod	21	SENT_22	[p1l1468t3336r1647b3370],
26	.	.	O	.	_	0	SENT_22	[p1l1468t3336r1647b3370],

1	Women	NNS	O	woman	nsubj	4	SENT_23	[p1l1661t3337r1774b3362],
2	were	VBD	O	be	cop	4	SENT_23	[p1l1787t3344r1857b3362],
3	more	RBR	O	more	advmod	4	SENT_23	[p1l1869t3344r1944b3362],
4	likely	JJ	O	likely	_	0	SENT_23	[p1l1957t3336r2038b3370],
5	to	TO	O	to	aux	7	SENT_23	[p1l2051t3339r2078b3362],
6	be	VB	O	be	cop	7	SENT_23	[p1l2091t3336r2125b3362],
7	nonresponders	NNS	O	nonresponder	xcomp	4	SENT_23	[p1l34t3381r245b3415],
8	(	CD	NUMBER	(	num	9	SENT_23	[p1l256t3381r333b3415],
9	O.R.	NNP	O	O.R.	dep	7	SENT_23	[p1l256t3381r333b3415],
10	3.90	CD	PERCENT	3.90	num	9	SENT_23	[p1l346t3381r408b3408],
11	[	CD	PERCENT	[	num	14	SENT_23	[p1l421t3381r496b3414],
12	95	CD	PERCENT	95	number	13	SENT_23	[p1l421t3381r496b3414],
13	%	NN	PERCENT	%	amod	14	SENT_23	[p1l421t3381r496b3414],
14	CI	NN	O	ci	dep	9	SENT_23	[p1l507t3381r542b3408],
15	2.34	CD	NUMBER	2.34	number	16	SENT_23	[p1l552t3381r731b3415],
16	—	CD	NUMBER	—	dep	9	SENT_23	[p1l552t3381r731b3415],
17	6.50	CD	NUMBER	6.50	num	19	SENT_23	[p1l552t3381r731b3415],
18	]	CD	NUMBER	]	num	19	SENT_23	[p1l552t3381r731b3415],
19	)	NN	O	)	dep	16	SENT_23	[p1l552t3381r731b3415],
20	.	.	O	.	_	0	SENT_23	[p1l552t3381r731b3415],

1	Carriers	NNS	O	carrier	nsubj	11	SENT_24	[p1l743t3381r857b3408],
2	of	IN	O	of	_	0	SENT_24	[p1l867t3381r901b3407],
3	a	DT	O	a	det	7	SENT_24	[p1l907t3389r922b3407],
4	H2/H2	NN	O	h2/h2	nn	7	SENT_24	[p1l931t3381r1029b3408],
5	haplotype	NN	O	haplotype	nn	7	SENT_24	[p1l1040t3381r1182b3415],
6	(	CD	NUMBER	(	num	7	SENT_24	[p1l1193t3381r1246b3415],
7	n	NN	O	n	prep_of	1	SENT_24	[p1l1193t3381r1246b3415],
8	=	JJ	O	=	amod	7	SENT_24	[p1l1193t3381r1246b3415],
9	14	CD	NUMBER	14	number	10	SENT_24	[p1l1255t3381r1299b3415],
10	)	CD	NUMBER	)	dep	8	SENT_24	[p1l1255t3381r1299b3415],
11	exhibited	VBD	O	exhibit	_	0	SENT_24	[p1l1310t3381r1443b3407],
12	stronger	JJR	O	stronger	amod	13	SENT_24	[p1l1454t3385r1571b3415],
13	aggregation	NN	O	aggregation	dobj	11	SENT_24	[p1l1580t3381r1750b3415],
14	than	IN	O	than	_	0	SENT_24	[p1l1760t3381r1822b3407],
15	patients	NNS	O	patient	prep_than	11	SENT_24	[p1l1830t3381r1942b3415],
16	with	IN	O	with	_	0	SENT_24	[p1l1952t3381r2016b3407],
17	at	IN	O	at	quantmod	19	SENT_24	[p1l2026t3384r2051b3407],
18	least	JJS	O	least	mwe	17	SENT_24	[p1l2061t3381r2126b3407],
19	one	CD	NUMBER	one	prep_with	11	SENT_24	[p1l35t3434r86b3452],
20	H1	NN	O	h1	nn	21	SENT_24	[p1l99t3426r140b3452],
21	allele	NN	O	allele	dep	19	SENT_24	[p1l157t3425r234b3452],
22	(	CD	NUMBER	(	number	23	SENT_24	[p1l247t3425r317b3459],
23	6.3	CD	NUMBER	6.3	dep	21	SENT_24	[p1l247t3425r317b3459],
24	:	:	O	:	_	0	SENT_24	[p1l247t3425r317b3459],

1	27.5	CD	NUMBER	27.5	num	2	SENT_25	[p1l318t3426r376b3452],
2	VS.	NNP	O	VS.	_	0	SENT_25	[p1l391t3434r430b3452],
3	1.8	CD	NUMBER	1.8	num	2	SENT_25	[p1l448t3426r503b3452],
4	:	:	O	:	_	0	SENT_25	[p1l448t3426r503b3452],

1	23.3	CD	NUMBER	23.3	num	2	SENT_26	[p1l505t3426r561b3452],
2	(	NN	O	(	nsubj	17	SENT_26	[p1l578t3424r615b3458],
3	2	CD	NUMBER	2	dep	2	SENT_26	[p1l578t3424r615b3458],
4	,	,	O	,	_	0	SENT_26	[p1l578t3424r615b3458],
5	p	NN	O	p	appos	2	SENT_26	[p1l624t3425r788b3460],
6	=	JJ	O	=	_	0	SENT_26	[p1l624t3425r788b3460],
7	0.02	CD	NUMBER	0.02	num	9	SENT_26	[p1l624t3425r788b3460],
8	l2	NN	O	l2	nn	9	SENT_26	[p1l624t3425r788b3460],
9	)	NN	O	)	dobj	6	SENT_26	[p1l624t3425r788b3460],
10	and	CC	O	and	_	0	SENT_26	[p1l802t3425r854b3452],
11	were	VBD	O	be	cop	17	SENT_26	[p1l866t3434r936b3452],
12	more	RBR	O	more	advmod	13	SENT_26	[p1l949t3434r1023b3452],
13	frequently	RB	O	frequently	advmod	17	SENT_26	[p1l1037t3425r1184b3460],
14	nonresponders	NNS	O	nonresponder	dep	13	SENT_26	[p1l1196t3425r1407b3460],
15	(	CD	NUMBER	(	num	16	SENT_26	[p1l1421t3425r1580b3460],
16	p	NN	O	p	dep	13	SENT_26	[p1l1421t3425r1580b3460],
17	=	JJ	O	=	conj_and	6	SENT_26	[p1l1421t3425r1580b3460],
18	0.004	CD	NUMBER	0.004	num	19	SENT_26	[p1l1421t3425r1580b3460],
19	)	NN	O	)	dep	17	SENT_26	[p1l1421t3425r1580b3460],
20	.	.	O	.	_	0	SENT_26	[p1l1421t3425r1580b3460],

1	Consequently	RB	O	consequently	advmod	7	SENT_27	[p1l1596t3425r1800b3460],
2	,	,	O	,	_	0	SENT_27	[p1l1596t3425r1800b3460],
3	the	DT	O	the	det	5	SENT_27	[p1l1814t3425r1858b3452],
4	H2/H2	NN	O	h2/h2	nn	5	SENT_27	[p1l1871t3425r1969b3452],
5	haplotype	NN	O	haplotype	nsubjpass	7	SENT_27	[p1l1982t3425r2125b3460],
6	was	VBD	O	be	auxpass	7	SENT_27	[p1l34t3479r90b3497],
7	associated	VBN	O	associate	_	0	SENT_27	[p1l104t3471r251b3497],
8	with	IN	O	with	_	0	SENT_27	[p1l263t3471r328b3497],
9	clopidogrel	NN	O	clopidogrel	prep_with	7	SENT_27	[p1l341t3471r504b3505],
10	resistance	NN	O	resistance	nn	12	SENT_27	[p1l517t3471r658b3497],
11	(	CD	NUMBER	(	num	12	SENT_27	[p1l672t3471r749b3505],
12	O.R.	NNP	O	O.R.	dep	21	SENT_27	[p1l672t3471r749b3505],
13	5.42	CD	PERCENT	5.42	number	14	SENT_27	[p1l765t3471r827b3497],
14	[	CD	PERCENT	[	dep	12	SENT_27	[p1l843t3471r918b3504],
15	95	CD	PERCENT	95	num	16	SENT_27	[p1l843t3471r918b3504],
16	%	NN	PERCENT	%	dep	14	SENT_27	[p1l843t3471r918b3504],
17	CI	NN	O	ci	dep	21	SENT_27	[p1l932t3471r968b3498],
18	1.82	CD	NUMBER	1.82	num	17	SENT_27	[p1l984t3471r1177b3505],
19	—	CD	NUMBER	—	num	21	SENT_27	[p1l984t3471r1177b3505],
20	16.1	CD	NUMBER	16.1	num	21	SENT_27	[p1l984t3471r1177b3505],
21	l	NN	O	l	dep	9	SENT_27	[p1l984t3471r1177b3505],
22	]	CD	NUMBER	]	num	23	SENT_27	[p1l984t3471r1177b3505],
23	)	NN	O	)	dep	21	SENT_27	[p1l984t3471r1177b3505],
24	.	.	O	.	_	0	SENT_27	[p1l984t3471r1177b3505],

1	This	DT	O	this	det	3	SENT_28	[p1l1192t3471r1255b3497],
2	risk	NN	O	risk	nn	3	SENT_28	[p1l1268t3471r1323b3497],
3	factor	NN	O	factor	nsubj	5	SENT_28	[p1l1335t3471r1419b3497],
4	was	VBD	O	be	cop	5	SENT_28	[p1l1430t3479r1486b3497],
5	independent	JJ	O	independent	_	0	SENT_28	[p1l1500t3471r1677b3505],
6	of	IN	O	of	_	0	SENT_28	[p1l1690t3471r1724b3497],
7	the	DT	O	the	det	9	SENT_28	[p1l1732t3471r1775b3497],
8	gender	NN	O	gender	nn	9	SENT_28	[p1l1789t3471r1887b3505],
9	effect	NN	O	effect	prep_of	5	SENT_28	[p1l1900t3471r1986b3497],
10	.	.	O	.	_	0	SENT_28	[p1l1900t3471r1986b3497],

1	Conclusions	NNS	O	conclusion	_	0	SENT_29	[p1l36t3516r227b3543],
2	:	:	O	:	_	0	SENT_29	[p1l36t3516r227b3543],
3	This	DT	O	this	nsubj	8	SENT_29	[p1l240t3516r304b3542],
4	is	VBZ	O	be	cop	8	SENT_29	[p1l315t3516r338b3542],
5	the	DT	O	the	det	8	SENT_29	[p1l349t3516r393b3542],
6	ﬁrst	NN	O	ﬁrst	nn	8	SENT_29	[p1l404t3516r462b3542],
7	large	JJ	O	large	amod	8	SENT_29	[p1l472t3516r543b3550],
8	study	NN	O	study	dep	1	SENT_29	[p1l555t3516r634b3550],
9	in	IN	O	in	_	0	SENT_29	[p1l645t3516r672b3542],
10	clopidogrel	NN	O	clopidogrel	nn	12	SENT_29	[p1l683t3516r850b3550],
11	treated	JJ	O	treated	amod	12	SENT_29	[p1l860t3516r959b3542],
12	patients	NNS	O	patient	prep_in	8	SENT_29	[p1l969t3516r1082b3550],
13	suggesting	VBG	O	suggest	partmod	12	SENT_29	[p1l1095t3516r1251b3550],
14	that	IN	O	that	complm	19	SENT_29	[p1l1262t3516r1317b3542],
15	a	DT	O	a	det	18	SENT_29	[p1l1327t3524r1343b3542],
16	homozygote	NN	O	homozygote	nn	18	SENT_29	[p1l1352t3516r1535b3550],
17	H2	NN	O	h2	nn	18	SENT_29	[p1l1545t3516r1589b3542],
18	genotype	NN	O	genotype	nsubj	19	SENT_29	[p1l1601t3520r1735b3550],
19	contributes	VBZ	O	contribute	ccomp	13	SENT_29	[p1l1746t3516r1908b3542],
20	to	TO	O	to	_	0	SENT_29	[p1l1919t3519r1947b3542],
21	clopidogrel	NN	O	clopidogrel	nn	22	SENT_29	[p1l1958t3516r2125b3550],
22	resistance	NN	O	resistance	prep_to	19	SENT_29	[p1l34t3560r186b3587],
23	.	.	O	.	_	0	SENT_29	[p1l34t3560r186b3587],

1	The	DT	O	the	det	3	SENT_30	[p1l202t3560r258b3587],
2	clinical	JJ	O	clinical	amod	3	SENT_30	[p1l272t3560r378b3587],
3	signiﬁcance	NN	O	signiﬁcance	nsubj	7	SENT_30	[p1l393t3560r569b3595],
4	of	IN	O	of	_	0	SENT_30	[p1l583t3560r617b3587],
5	this	DT	O	this	det	6	SENT_30	[p1l626t3560r678b3587],
6	ﬁnding	NN	O	ﬁnding	prep_of	3	SENT_30	[p1l692t3560r797b3595],
7	remains	VBZ	O	remain	_	0	SENT_30	[p1l811t3560r926b3587],
8	to	TO	O	to	aux	10	SENT_30	[p1l940t3564r967b3587],
9	be	VB	O	be	auxpass	10	SENT_30	[p1l981t3560r1015b3587],
10	demonstrated	VBN	O	demonstrate	xcomp	7	SENT_30	[p1l1029t3560r1234b3587],
11	.	.	O	.	_	0	SENT_30	[p1l1029t3560r1234b3587],

1	©	RB	O	©	advmod	2	SENT_31	[p1l35t3606r61b3633],
2	2008	CD	DATE	2008	_	0	SENT_31	[p1l75t3606r147b3632],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	5	SENT_31	[p1l162t3606r283b3632],
4	Ireland	NNP	ORGANIZATION	Ireland	nn	5	SENT_31	[p1l295t3606r399b3632],
5	Ltd.	NNP	ORGANIZATION	Ltd.	dep	2	SENT_31	[p1l412t3606r470b3633],
6	.	.	O	.	_	0	SENT_31	[p1l412t3606r470b3633],

1	All	DT	O	all	det	2	SENT_32	[p1l484t3606r531b3632],
2	rights	NNS	O	rights	nsubj	3	SENT_32	[p1l544t3606r627b3640],
3	reserved	VBN	O	reserve	_	0	SENT_32	[p1l641t3606r772b3632],
4	.	.	O	.	_	0	SENT_32	[p1l641t3606r772b3632],

1	Keywords	NNPS	O	Keywords	_	0	SENT_33	[p1l33t3700r174b3731],
2	:	:	O	:	_	0	SENT_33	[p1l33t3700r174b3731],
3	Platelet	NN	O	platelet	nn	4	SENT_33	[p1l187t3700r285b3724],
4	aggregation	NN	O	aggregation	dep	1	SENT_33	[p1l296t3700r457b3731],
5	;	:	O	;	_	0	SENT_33	[p1l296t3700r457b3731],
6	Drug	NN	O	drug	nn	7	SENT_33	[p1l471t3701r537b3731],
7	resistance	NN	O	resistance	dep	4	SENT_33	[p1l549t3700r685b3729],
8	;	:	O	;	_	0	SENT_33	[p1l549t3700r685b3729],
9	ADP	NN	O	adp	nn	10	SENT_33	[p1l698t3701r763b3724],
10	receptor	NN	O	receptor	dep	4	SENT_33	[p1l775t3703r889b3731],
11	;	:	O	;	_	0	SENT_33	[p1l775t3703r889b3731],
12	Clopidogrel	NNP	O	Clopidogrel	dep	10	SENT_33	[p1l903t3700r1066b3731],
13	;	:	O	;	_	0	SENT_33	[p1l903t3700r1066b3731],
14	Pharrnacogenetics	NNP	O	Pharrnacogenetics	dep	4	SENT_33	[p1l1079t3700r1324b3731],
15	;	:	O	;	_	0	SENT_33	[p1l1079t3700r1324b3731],
16	Single	JJ	O	single	amod	18	SENT_33	[p1l1339t3700r1420b3731],
17	nucleotide	NN	O	nucleotide	nn	18	SENT_33	[p1l1432t3700r1568b3724],
18	polymorphism	NN	O	polymorphism	dep	14	SENT_33	[p1l1579t3700r1771b3731],

1	1	LS	NUMBER	1	_	0	SENT_34	[p2l13t143r70b203],
2	.	.	O	.	_	0	SENT_34	[p2l13t143r70b203],

1	Introduction	NN	O	introduction	_	0	SENT_35	[p2l105t143r553b202],

1	Platelet	NN	O	platelet	nn	2	SENT_36	[p2l109t343r356b403],
2	activation	NN	O	activation	nsubj	5	SENT_36	[p2l386t343r710b403],
3	and	CC	O	and	_	0	SENT_36	[p2l740t343r858b403],
4	aggregation	NN	O	aggregation	conj_and	2	SENT_36	[p2l888t343r1277b420],
5	play	VBP	O	play	_	0	SENT_36	[p2l1305t343r1448b420],
6	a	DT	O	a	det	8	SENT_36	[p2l1479t363r1514b403],
7	pivotal	JJ	O	pivotal	amod	8	SENT_36	[p2l1540t343r1770b420],
8	role	NN	O	role	dobj	5	SENT_36	[p2l1799t343r1925b403],
9	in	IN	O	in	_	0	SENT_36	[p2l1957t343r2019b402],
10	cardiovascular	JJ	O	cardiovascular	amod	11	SENT_36	[p2l10t443r492b503],
11	disease	NN	O	disease	prep_in	8	SENT_36	[p2l535t443r790b515],
12	,	,	O	,	_	0	SENT_36	[p2l535t443r790b515],
13	triggering	VBG	O	trigger	partmod	5	SENT_36	[p2l836t443r1161b520],
14	adverse	JJ	O	adverse	amod	15	SENT_36	[p2l1208t443r1457b503],
15	events	NNS	O	event	dobj	13	SENT_36	[p2l1504t451r1710b503],
16	such	JJ	O	such	_	0	SENT_36	[p2l1759t443r1907b503],
17	as	IN	O	as	_	0	SENT_36	[p2l1953t463r2017b503],
18	acute	JJ	O	acute	amod	20	SENT_36	[p2l10t551r180b603],
19	coronary	JJ	O	coronary	amod	20	SENT_36	[p2l221t562r513b619],
20	syndrome	NN	O	syndrome	prep_such_as	15	SENT_36	[p2l554t543r877b619],
21	(	CD	NUMBER	(	num	23	SENT_36	[p2l919t543r1129b619],
22	ACS	NN	O	ac	nn	23	SENT_36	[p2l919t543r1129b619],
23	)	NN	O	)	dep	20	SENT_36	[p2l919t543r1129b619],
24	and	CC	O	and	_	0	SENT_36	[p2l1171t543r1289b603],
25	stroke	NN	O	stroke	prep_such_as	15	SENT_36	[p2l1329t543r1543b603],
26	.	.	O	.	_	0	SENT_36	[p2l1329t543r1543b603],

1	Inhibition	NN	O	inhibition	nsubj	9	SENT_37	[p2l1587t543r1913b603],
2	of	IN	O	of	_	0	SENT_37	[p2l1953t543r2029b603],
3	platelet	NN	O	platelet	nn	4	SENT_37	[p2l7t642r250b719],
4	aggregation	NN	O	aggregation	prep_of	1	SENT_37	[p2l274t642r664b719],
5	is	VBZ	O	be	cop	9	SENT_37	[p2l687t643r737b702],
6	therefore	RB	O	therefore	advmod	9	SENT_37	[p2l761t642r1056b702],
7	a	DT	O	a	det	9	SENT_37	[p2l1082t662r1117b702],
8	major	JJ	O	major	amod	9	SENT_37	[p2l1137t642r1331b719],
9	goal	NN	O	goal	_	0	SENT_37	[p2l1352t642r1492b719],
10	of	IN	O	of	_	0	SENT_37	[p2l1516t643r1592b702],
11	therapy	NN	O	therapy	prep_of	9	SENT_37	[p2l1604t642r1863b719],
12	.	.	O	.	_	0	SENT_37	[p2l1604t642r1863b719],

1	The	DT	O	the	_	0	SENT_38	[p2l1892t642r2017b702],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_39	[p2l105t908r496b956],
2	:	:	O	:	_	0	SENT_39	[p2l105t908r496b956],
3	ADP	NN	ORGANIZATION	adp	dep	1	SENT_39	[p2l536t909r676b966],
4	,	,	O	,	_	0	SENT_39	[p2l536t909r676b966],
5	adenosine-di-phosphate	NN	O	adenosine-di-phosphate	appos	3	SENT_39	[p2l718t908r1360b970],
6	;	:	O	;	_	0	SENT_39	[p2l718t908r1360b970],
7	CAD	NNP	O	CAD	dep	1	SENT_39	[p2l1402t909r1554b966],
8	,	,	O	,	_	0	SENT_39	[p2l1402t909r1554b966],
9	coronary	JJ	O	coronary	amod	11	SENT_39	[p2l1596t924r1830b970],
10	artery	NN	O	artery	nn	11	SENT_39	[p2l1868t915r2019b970],
11	disease	NN	O	disease	appos	7	SENT_39	[p2l9t991r213b1049],
12	;	:	O	;	_	0	SENT_39	[p2l9t991r213b1049],
13	MeSAMP	NNP	O	MeSAMP	dep	1	SENT_39	[p2l259t992r534b1049],
14	,	,	O	,	_	0	SENT_39	[p2l259t992r534b1049],
15	Methyl-S-adenosine-mono-phosphate	NNP	O	Methyl-S-adenosine-mono-phosphate	appos	13	SENT_39	[p2l581t991r1596b1053],
16	;	:	O	;	_	0	SENT_39	[p2l581t991r1596b1053],
17	PCI	NNP	O	PCI	dep	1	SENT_39	[p2l1642t992r1758b1049],
18	,	,	O	,	_	0	SENT_39	[p2l1642t992r1758b1049],
19	percutaneous	JJ	O	percutaneous	amod	21	SENT_39	[p2l1803t998r2018b1053, p2l8t1090r161b1123],
20	coronary	JJ	O	coronary	amod	21	SENT_39	[p2l185t1090r418b1136],
21	intervention	NN	O	intervention	appos	17	SENT_39	[p2l440t1074r770b1123],
22	.	.	O	.	_	0	SENT_39	[p2l440t1074r770b1123],

1	*	NN	O	*	_	0	SENT_40	[p2l46t1157r71b1184],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_40	[p2l107t1157r499b1219],
3	author	NN	O	author	dobj	2	SENT_40	[p2l533t1158r709b1206],
4	.	.	O	.	_	0	SENT_40	[p2l533t1158r709b1206],

1	Innere	NNP	O	Innere	nn	2	SENT_41	[p2l745t1160r912b1206],
2	Abt	NNP	O	Abt	_	0	SENT_41	[p2l943t1158r1055b1206],
3	.	.	O	.	_	0	SENT_41	[p2l943t1158r1055b1206],

1	III	NNP	O	III	_	0	SENT_42	[p2l1092t1160r1169b1216],
2	,	,	O	,	_	0	SENT_42	[p2l1092t1160r1169b1216],
3	Universitaetsklinikum	NNP	ORGANIZATION	Universitaetsklinikum	nn	4	SENT_42	[p2l1203t1158r1792b1206],
4	Heidelberg	NNP	ORGANIZATION	Heidelberg	appos	1	SENT_42	[p2l1822t1158r2018b1206, p2l7t1240r138b1302],
5	,	,	O	,	_	0	SENT_42	[p2l1822t1158r2018b1206, p2l7t1240r138b1302],
6	Im	NNP	O	Im	nn	7	SENT_42	[p2l171t1242r243b1288],
7	Neuenheimer	NNP	PERSON	Neuenheimer	appos	1	SENT_42	[p2l269t1240r629b1288],
8	Feld	NNP	PERSON	Feld	dep	7	SENT_42	[p2l656t1240r774b1288],
9	410	CD	NUMBER	410	num	8	SENT_42	[p2l802t1241r916b1298],
10	,	,	O	,	_	0	SENT_42	[p2l802t1241r916b1298],
11	69120	CD	NUMBER	69120	num	8	SENT_42	[p2l950t1241r1113b1288],
12	Heidelberg	NNP	LOCATION	Heidelberg	dep	1	SENT_42	[p2l1143t1240r1449b1302],
13	,	,	O	,	_	0	SENT_42	[p2l1143t1240r1449b1302],
14	Germany	NNP	LOCATION	Germany	appos	12	SENT_42	[p2l1483t1241r1736b1302],
15	.	.	O	.	_	0	SENT_42	[p2l1483t1241r1736b1302],

1	Tel.	NNP	O	Tel.	_	0	SENT_43	[p2l1770t1240r1882b1288],
2	:	:	O	:	_	0	SENT_43	[p2l1770t1240r1882b1288],
3	+49	CD	NUMBER	+49	number	4	SENT_43	[p2l1916t1241r2017b1288],
4	6221	CD	NUMBER	6221	dep	1	SENT_43	[p2l10t1325r133b1371],
5	56	CD	NUMBER	56	num	6	SENT_43	[p2l164t1325r226b1371],
6	39119	CD	NUMBER	39119	dep	4	SENT_43	[p2l251t1325r428b1382],
7	;	:	O	;	_	0	SENT_43	[p2l251t1325r428b1382],
8	fax	NN	O	fax	dep	1	SENT_43	[p2l453t1323r549b1371],
9	:	:	O	:	_	0	SENT_43	[p2l453t1323r549b1371],
10	+49	CD	NUMBER	+49	number	11	SENT_43	[p2l575t1325r676b1372],
11	6221	CD	NUMBER	6221	num	13	SENT_43	[p2l701t1325r825b1371],
12	56	CD	NUMBER	56	number	13	SENT_43	[p2l855t1325r917b1371],
13	4866	CD	NUMBER	4866	dep	8	SENT_43	[p2l940t1325r1086b1371],
14	.	.	O	.	_	0	SENT_43	[p2l940t1325r1086b1371],

1	E-mail	NN	O	e-mail	nn	2	SENT_44	[p2l107t1407r290b1455],
2	address	NN	O	address	_	0	SENT_44	[p2l309t1407r530b1455],
3	:	:	O	:	_	0	SENT_44	[p2l309t1407r530b1455],
4	Boris.Ivandic@med.uni-heidelberg.de	NN	O	boris.ivandic@med.uni-heidelberg.de	dep	2	SENT_44	[p2l555t1407r1569b1468],
5	(	CD	NUMBER	(	num	8	SENT_44	[p2l1593t1407r1721b1468],
6	B.T.	NNP	O	B.T.	nn	8	SENT_44	[p2l1593t1407r1721b1468],
7	Ivandic	NNP	O	Ivandic	nn	8	SENT_44	[p2l1747t1407r1978b1468],
8	)	NN	O	)	dep	4	SENT_44	[p2l1747t1407r1978b1468],
9	.	.	O	.	_	0	SENT_44	[p2l1747t1407r1978b1468],

1	beneﬁt	NN	O	beneﬁt	nsubj	17	SENT_45	[p2l75t1782r312b1843],
2	of	IN	O	of	_	0	SENT_45	[p2l342t1782r420b1843],
3	a	DT	O	a	det	6	SENT_45	[p2l441t1802r476b1843],
4	dual	JJ	O	dual	amod	6	SENT_45	[p2l506t1782r650b1844],
5	antiplatelet	JJ	O	antiplatelet	amod	6	SENT_45	[p2l681t1782r1056b1861],
6	therapy	NN	O	therapy	prep_of	1	SENT_45	[p2l1084t1782r1339b1861],
7	consisting	VBG	O	consist	partmod	6	SENT_45	[p2l1371t1782r1713b1861],
8	of	IN	O	of	_	0	SENT_45	[p2l1745t1782r1823b1843],
9	acetylsalicylic	JJ	O	acetylsalicylic	amod	13	SENT_45	[p2l1844t1782r2140b1861, p2l77t1885r285b1963],
10	acid	NN	O	acid	nn	13	SENT_45	[p2l318t1885r457b1946],
11	(	NN	O	(	nn	13	SENT_45	[p2l489t1885r710b1963],
12	ASA	NN	O	asa	nn	13	SENT_45	[p2l489t1885r710b1963],
13	)	NN	O	)	prep_of	7	SENT_45	[p2l489t1885r710b1963],
14	and	CC	O	and	_	0	SENT_45	[p2l744t1885r865b1946],
15	clopidogrel	NN	O	clopidogrel	prep_of	7	SENT_45	[p2l896t1885r1281b1963],
16	is	VBZ	O	be	cop	17	SENT_45	[p2l1313t1885r1365b1946],
17	uncontroversial	JJ	O	uncontroversial	_	0	SENT_45	[p2l1395t1885r1927b1946],
18	for	IN	O	for	_	0	SENT_45	[p2l1958t1885r2055b1946],
19	at	IN	DURATION	at	quantmod	21	SENT_45	[p2l2085t1893r2144b1946],
20	least	JJS	DURATION	least	mwe	19	SENT_45	[p2l77t1988r231b2050],
21	30	CD	DURATION	30	num	22	SENT_45	[p2l256t1990r336b2050],
22	days	NNS	NUMBER	day	prep_for	17	SENT_45	[p2l364t1988r517b2067],
23	after	IN	O	after	_	0	SENT_45	[p2l545t1989r698b2050],
24	percutaneous	JJ	O	percutaneous	amod	26	SENT_45	[p2l718t1997r1167b2067],
25	coronary	JJ	O	coronary	amod	26	SENT_45	[p2l1196t2009r1497b2067],
26	intervention	NN	O	intervention	prep_after	17	SENT_45	[p2l1521t1988r1931b2050],
27	(	CD	NUMBER	(	num	29	SENT_45	[p2l1958t1989r2140b2067],
28	PCI	NN	O	pcus	nn	29	SENT_45	[p2l1958t1989r2140b2067],
29	)	NN	O	)	dep	26	SENT_45	[p2l1958t1989r2140b2067],
30	and	CC	O	and	_	0	SENT_45	[p2l78t2091r204b2153],
31	stent	NN	O	stent	nn	32	SENT_45	[p2l266t2100r433b2153],
32	implantation	NN	O	implantation	conj_and	26	SENT_45	[p2l494t2091r948b2170],
33	[	CD	NUMBER	[	number	34	SENT_45	[p2l1014t2093r1198b2169],
34	1,2	CD	NUMBER	1,2	num	35	SENT_45	[p2l1014t2093r1198b2169],
35	]	NN	O	]	dep	32	SENT_45	[p2l1014t2093r1198b2169],
36	.	.	O	.	_	0	SENT_45	[p2l1014t2093r1198b2169],

1	Improved	JJ	O	improved	amod	2	SENT_46	[p2l1264t2091r1611b2170],
2	reduction	NN	O	reduction	nsubjpass	8	SENT_46	[p2l1670t2091r2011b2153],
3	of	IN	O	of	_	0	SENT_46	[p2l2072t2091r2153b2153],
4	cardiovascular	JJ	O	cardiovascular	amod	5	SENT_46	[p2l78t2194r574b2255],
5	risk	NN	O	risk	prep_of	2	SENT_46	[p2l619t2194r747b2255],
6	may	MD	O	may	aux	8	SENT_46	[p2l794t2214r940b2273],
7	be	VB	O	be	auxpass	8	SENT_46	[p2l987t2194r1066b2255],
8	achieved	VBN	O	achieve	_	0	SENT_46	[p2l1117t2194r1418b2255],
9	by	IN	O	by	_	0	SENT_46	[p2l1465t2194r1551b2273],
10	continuation	NN	O	continuation	agent	8	SENT_46	[p2l1600t2194r2025b2255],
11	of	IN	O	of	_	0	SENT_46	[p2l2075t2194r2153b2255],
12	clopidogrel	NN	O	clopidogrel	nn	13	SENT_46	[p2l78t2297r463b2375],
13	treatment	NN	O	treatment	prep_of	10	SENT_46	[p2l491t2305r812b2358],
14	for	IN	O	for	_	0	SENT_46	[p2l841t2297r938b2358],
15	up	RB	DURATION	up	advmod	18	SENT_46	[p2l962t2317r1046b2375],
16	to	TO	DURATION	to	_	0	SENT_46	[p2l1075t2305r1138b2358],
17	one	CD	DURATION	one	prep_to	15	SENT_46	[p2l1169t2317r1289b2358],
18	year	NN	NUMBER	year	prep_for	8	SENT_46	[p2l1317t2317r1465b2375],
19	[	CD	NUMBER	[	number	20	SENT_46	[p2l1496t2298r1669b2374],
20	2,3	CD	NUMBER	2,3	num	21	SENT_46	[p2l1496t2298r1669b2374],
21	]	NN	O	]	dep	18	SENT_46	[p2l1496t2298r1669b2374],
22	.	.	O	.	_	0	SENT_46	[p2l1496t2298r1669b2374],

1	In	IN	O	in	_	0	SENT_47	[p2l180t2402r249b2460],
2	recent	JJ	DURATION	recent	amod	3	SENT_47	[p2l272t2408r479b2461],
3	years	NNS	DURATION	year	prep_in	24	SENT_47	[p2l500t2420r697b2479],
4	,	,	O	,	_	0	SENT_47	[p2l500t2420r697b2479],
5	evidence	NN	O	evidence	nsubj	24	SENT_47	[p2l726t2400r1025b2461],
6	accumulated	VBN	O	accumulate	partmod	5	SENT_47	[p2l1051t2400r1480b2461],
7	suggesting	VBG	O	suggest	xcomp	6	SENT_47	[p2l1505t2400r1867b2479],
8	that	IN	O	that	complm	19	SENT_47	[p2l1890t2400r2018b2461],
9	the	DT	O	the	det	10	SENT_47	[p2l2039t2400r2141b2461],
10	inhibition	NN	O	inhibition	nsubj	19	SENT_47	[p2l77t2503r407b2565],
11	of	IN	O	of	_	0	SENT_47	[p2l435t2504r513b2565],
12	platelet	NN	O	platelet	nn	13	SENT_47	[p2l528t2503r778b2582],
13	aggregation	NN	O	aggregation	prep_of	10	SENT_47	[p2l806t2503r1206b2582],
14	by	IN	O	by	_	0	SENT_47	[p2l1231t2503r1317b2582],
15	clopidogrel	NN	O	clopidogrel	prep_by	13	SENT_47	[p2l1345t2503r1730b2582],
16	may	MD	O	may	aux	19	SENT_47	[p2l1757t2524r1903b2582],
17	not	RB	O	not	neg	19	SENT_47	[p2l1929t2512r2038b2565],
18	be	VB	O	be	cop	19	SENT_47	[p2l2062t2503r2142b2565],
19	comparable	JJ	O	comparable	ccomp	7	SENT_47	[p2l78t2606r471b2685],
20	in	IN	O	in	_	0	SENT_47	[p2l499t2606r563b2667],
21	all	DT	O	all	det	23	SENT_47	[p2l588t2606r668b2667],
22	clopidogrel	NN	O	clopidogrel	nn	23	SENT_47	[p2l695t2606r1080b2685],
23	users	NNS	O	user	prep_in	19	SENT_47	[p2l1104t2626r1277b2668],
24	[	VBP	O	[	_	0	SENT_47	[p2l1309t2608r1417b2684],
25	4	CD	NUMBER	4	number	26	SENT_47	[p2l1309t2608r1417b2684],
26	]	CD	NUMBER	]	dobj	24	SENT_47	[p2l1309t2608r1417b2684],
27	.	.	O	.	_	0	SENT_47	[p2l1309t2608r1417b2684],

1	This	DT	O	this	det	2	SENT_48	[p2l1448t2606r1595b2668],
2	phenomenon	NN	O	phenomenon	nsubjpass	5	SENT_48	[p2l1619t2606r2064b2685],
3	is	VBZ	O	be	auxpass	5	SENT_48	[p2l2089t2606r2141b2668],
4	often	RB	O	often	advmod	5	SENT_48	[p2l78t2709r258b2770],
5	referred	VBN	O	refer	_	0	SENT_48	[p2l317t2709r598b2770],
6	to	TO	O	to	xcomp	5	SENT_48	[p2l657t2717r722b2770],
7	as	IN	O	as	_	0	SENT_48	[p2l786t2729r853b2770],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_48	[p2l917t2709r1322b2788],
9	resistance	NN	O	resistance	prep_as	5	SENT_48	[p2l1382t2709r1751b2770],
10	.	.	O	.	_	0	SENT_48	[p2l1382t2709r1751b2770],

1	Reported	VBN	O	report	_	0	SENT_49	[p2l1817t2709r2144b2787],
2	prevalence	NN	O	prevalence	nn	3	SENT_49	[p2l74t2812r443b2890],
3	ranges	NNS	O	range	dobj	1	SENT_49	[p2l472t2832r691b2890],
4	from	IN	O	from	_	0	SENT_49	[p2l725t2812r887b2873],
5	4	CD	NUMBER	4	number	7	SENT_49	[p2l915t2813r955b2872],
6	to	TO	O	to	dep	7	SENT_49	[p2l985t2820r1048b2873],
7	46	CD	PERCENT	46	num	8	SENT_49	[p2l1079t2813r1253b2886],
8	%	NN	PERCENT	%	prep_from	1	SENT_49	[p2l1079t2813r1253b2886],
9	,	,	O	,	_	0	SENT_49	[p2l1079t2813r1253b2886],
10	24	CD	NUMBER	24	num	11	SENT_49	[p2l1286t2813r1368b2872],
11	h	NN	O	h	appos	8	SENT_49	[p2l1398t2812r1441b2872],
12	after	IN	O	after	_	0	SENT_49	[p2l1471t2812r1624b2873],
13	administration	NN	O	administration	prep_after	1	SENT_49	[p2l1653t2812r2142b2873],
14	of	IN	O	of	_	0	SENT_49	[p2l78t2915r156b2977],
15	a	DT	O	a	det	16	SENT_49	[p2l202t2936r238b2976],
16	clopidogrel	NN	O	clopidogrel	prep_of	13	SENT_49	[p2l293t2915r679b2994],
17	loading	VBG	O	load	xcomp	1	SENT_49	[p2l736t2915r989b2994],
18	dose	NN	O	dose	nn	19	SENT_49	[p2l1047t2915r1200b2977],
19	[	NN	O	[	dobj	17	SENT_49	[p2l1262t2917r1484b2993],
20	5-10	CD	NUMBER	5-10	num	21	SENT_49	[p2l1262t2917r1484b2993],
21	]	NN	O	]	dep	19	SENT_49	[p2l1262t2917r1484b2993],
22	.	.	O	.	_	0	SENT_49	[p2l1262t2917r1484b2993],

1	There	EX	O	there	expl	2	SENT_50	[p2l1546t2915r1741b2977],
2	are	VBP	O	be	_	0	SENT_50	[p2l1799t2935r1897b2977],
3	many	JJ	O	many	amod	5	SENT_50	[p2l1953t2935r2143b2994],
4	potential	JJ	O	potential	amod	5	SENT_50	[p2l74t3018r373b3097],
5	explanations	NNS	O	explanation	nsubj	2	SENT_50	[p2l397t3018r823b3097],
6	of	IN	O	of	_	0	SENT_50	[p2l849t3018r927b3079],
7	clopidogrel	NN	O	clopidogrel	nn	8	SENT_50	[p2l940t3018r1326b3097],
8	resistance	NN	O	resistance	prep_of	5	SENT_50	[p2l1347t3018r1681b3079],
9	[	CD	NUMBER	[	number	10	SENT_50	[p2l1709t3019r1857b3095],
10	11	CD	NUMBER	11	num	11	SENT_50	[p2l1709t3019r1857b3095],
11	]	NN	O	]	dep	8	SENT_50	[p2l1709t3019r1857b3095],
12	.	.	O	.	_	0	SENT_50	[p2l1709t3019r1857b3095],

1	Little	JJ	O	little	nsubjpass	3	SENT_51	[p2l1885t3018r2065b3079],
2	is	VBZ	O	be	auxpass	3	SENT_51	[p2l2089t3018r2141b3079],
3	known	VBN	O	know	_	0	SENT_51	[p2l75t3121r310b3182],
4	about	IN	O	about	_	0	SENT_51	[p2l342t3121r530b3182],
5	the	DT	O	the	det	6	SENT_51	[p2l559t3121r661b3182],
6	contribution	NN	O	contribution	prep_about	3	SENT_51	[p2l694t3121r1110b3182],
7	of	IN	O	of	_	0	SENT_51	[p2l1141t3121r1220b3182],
8	genetic	JJ	O	genetic	amod	9	SENT_51	[p2l1241t3121r1483b3199],
9	polymorphisms	NNS	O	polymorphism	prep_of	6	SENT_51	[p2l1514t3121r2045b3199],
10	to	TO	O	to	prep	3	SENT_51	[p2l2077t3129r2140b3182],

1	0167-5273	CD	DURATION	0167-5273	nsubj	5	SENT_52	[p2l541t3238r708b3265],
2	/	:	O	/	punct	3	SENT_52	[p2l541t3238r708b3265],
3	$	$	MONEY	$	dep	1	SENT_52	[p2l541t3238r708b3265],
4	-	:	O	-	_	0	SENT_52	[p2l721t3253r730b3256],
5	see	VB	O	see	_	0	SENT_52	[p2l743t3246r783b3262],
6	front	JJ	O	front	amod	7	SENT_52	[p2l795t3239r858b3262],
7	matter	NN	O	matter	dobj	5	SENT_52	[p2l869t3242r953b3262],
8	©	CD	NUMBER	©	num	12	SENT_52	[p2l964t3239r987b3263],
9	2008	CD	DATE	2008	num	12	SENT_52	[p2l1000t3239r1064b3262],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	12	SENT_52	[p2l1077t3239r1184b3262],
11	Ireland	NNP	ORGANIZATION	Ireland	nn	12	SENT_52	[p2l1195t3239r1287b3262],
12	Ltd.	NNP	ORGANIZATION	Ltd.	dep	7	SENT_52	[p2l1298t3239r1350b3262],
13	.	.	O	.	_	0	SENT_52	[p2l1298t3239r1350b3262],

1	All	DT	O	all	det	2	SENT_53	[p2l1363t3239r1404b3262],
2	rights	NNS	O	rights	nsubj	3	SENT_53	[p2l1416t3239r1489b3269],
3	reserved	VBN	O	reserve	_	0	SENT_53	[p2l1501t3239r1618b3263],
4	.	.	O	.	_	0	SENT_53	[p2l1501t3239r1618b3263],

1	doi	FW	O	doi	_	0	SENT_54	[p2l541t3280r970b3311],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_54	[p2l541t3280r970b3311],
3	/	:	O	/	punct	5	SENT_54	[p2l541t3280r970b3311],
4	j.	NN	O	j.	nn	5	SENT_54	[p2l541t3280r970b3311],
5	ijcard	NN	O	ijcard	dep	2	SENT_54	[p2l541t3280r970b3311],
6	.2007.12.118	CD	NUMBER	.2007.12.118	dep	2	SENT_54	[p2l541t3280r970b3311],

1	342	CD	NUMBER	342	num	3	SENT_55	[p2l307t3387r354b3410],
2	P	NN	O	p	nn	3	SENT_55	[p2l851t3387r872b3410],
3	Staritz	NNP	O	Staritz	_	0	SENT_55	[p2l887t3387r973b3410],
4	et	FW	O	et	nn	5	SENT_55	[p2l984t3391r1008b3410],
5	al.	FW	O	al.	dep	3	SENT_55	[p2l1018t3386r1048b3410],
6	/	:	O	/	punct	3	SENT_55	[p2l1062t3386r1075b3410],
7	International	NNP	ORGANIZATION	International	nn	8	SENT_55	[p2l1082t3386r1257b3410],
8	Journal	NNP	ORGANIZATION	Journal	dep	3	SENT_55	[p2l1266t3386r1371b3410],
9	of	IN	ORGANIZATION	of	_	0	SENT_55	[p2l1381t3386r1413b3417],
10	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	8	SENT_55	[p2l1419t3386r1566b3417],
11	133	CD	NUMBER	133	number	12	SENT_55	[p2l1579t3387r1626b3410],
12	(	CD	NUMBER	(	dep	10	SENT_55	[p2l1640t3386r1724b3417],
13	2009	CD	DATE	2009	num	15	SENT_55	[p2l1640t3386r1724b3417],
14	)	CD	NUMBER	)	num	15	SENT_55	[p2l1640t3386r1724b3417],
15	34I	NN	O	34us	dep	12	SENT_55	[p2l1738t3387r1852b3410],
16	—	NN	O	—	dep	12	SENT_55	[p2l1738t3387r1852b3410],
17	345	CD	NUMBER	345	num	16	SENT_55	[p2l1738t3387r1852b3410],

1	platelet	NN	O	platelet	nn	2	SENT_56	[p2l7t3578r266b3658],
2	reactivity	NN	O	reactivity	_	0	SENT_56	[p2l315t3578r646b3659],
3	in	IN	O	in	_	0	SENT_56	[p2l699t3578r765b3640],
4	clopidogrel	NN	O	clopidogrel	nn	5	SENT_56	[p2l817t3578r1214b3659],
5	users	NNS	O	user	prep_in	2	SENT_56	[p2l1265t3598r1462b3641],
6	.	.	O	.	_	0	SENT_56	[p2l1265t3598r1462b3641],

1	Fontana	NNP	PERSON	Fontana	nsubj	10	SENT_57	[p2l1519t3580r1803b3641],
2	and	CC	O	and	_	0	SENT_57	[p2l1855t3578r1980b3641],
3	coworkers	NNS	O	coworker	nsubj	4	SENT_57	[p2l2033t3598r2139b3641, p2l8t3684r289b3747],
4	examined	VBN	O	examine	_	0	SENT_57	[p2l334t3684r674b3747],
5	healthy	JJ	O	healthy	amod	8	SENT_57	[p2l714t3684r986b3765],
6	,	,	O	,	_	0	SENT_57	[p2l714t3684r986b3765],
7	clopidogrel-naive	JJ	O	clopidogrel-naive	amod	8	SENT_57	[p2l1032t3684r1650b3765],
8	subjects	NNS	O	subject	dobj	4	SENT_57	[p2l1695t3684r1972b3765],
9	and	CC	O	and	_	0	SENT_57	[p2l2017t3684r2142b3747],
10	identiﬁed	VBD	O	identiﬁed	conj_and	4	SENT_57	[p3l10t19r345b82],
11	the	DT	O	the	det	13	SENT_57	[p3l373t19r478b82],
12	H2	NN	O	h2	nn	13	SENT_57	[p3l509t21r612b81],
13	haplotype	NN	O	haplotype	dobj	10	SENT_57	[p3l645t19r991b100],
14	as	IN	O	as	_	0	SENT_57	[p3l1024t40r1091b82],
15	a	DT	O	a	det	17	SENT_57	[p3l1124t40r1161b82],
16	gain-of-function	NN	O	gain-of-function	nn	17	SENT_57	[p3l1191t19r1765b100],
17	haplotype	NN	O	haplotype	prep_as	10	SENT_57	[p3l1794t19r2140b100],
18	of	IN	O	of	_	0	SENT_57	[p3l10t125r91b188],
19	the	DT	O	the	det	24	SENT_57	[p3l115t125r219b188],
20	P2Y12	NN	O	p2y12	nn	24	SENT_57	[p3l256t126r477b201],
21	platelet	NN	O	platelet	nn	24	SENT_57	[p3l512t125r770b205],
22	ADP	NN	O	adp	nn	24	SENT_57	[p3l804t126r978b187],
23	receptor	NN	O	receptor	nn	24	SENT_57	[p3l1014t134r1303b206],
24	gene	NN	O	gene	prep_of	17	SENT_57	[p3l1336t145r1518b206],
25	,	,	O	,	_	0	SENT_57	[p3l1336t145r1518b206],
26	the	DT	O	the	det	28	SENT_57	[p3l1556t125r1661b188],
27	pharmacological	JJ	O	pharmacological	amod	28	SENT_57	[p3l1696t125r2139b205, p3l10t231r177b312],
28	target	NN	O	target	appos	24	SENT_57	[p3l198t240r397b312],
29	of	IN	O	of	_	0	SENT_57	[p3l418t232r499b294],
30	clopidogrel	NN	O	clopidogrel	prep_of	28	SENT_57	[p3l510t231r908b312],
31	[	CD	NUMBER	[	num	30	SENT_57	[p3l936t233r1091b311],
32	12	CD	NUMBER	12	num	33	SENT_57	[p3l936t233r1091b311],
33	]	NN	O	]	dep	28	SENT_57	[p3l936t233r1091b311],
34	.	.	O	.	_	0	SENT_57	[p3l936t233r1091b311],

1	We	PRP	O	we	nsubj	2	SENT_58	[p3l1117t234r1231b295],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_58	[p3l1252t231r1718b312],
3	that	IN	O	that	complm	13	SENT_58	[p3l1738t231r1869b294],
4	genetic	JJ	O	genetic	amod	5	SENT_58	[p3l1890t231r2140b312],
5	testing	NN	O	testing	nsubj	13	SENT_58	[p3l8t337r241b418],
6	for	IN	O	for	_	0	SENT_58	[p3l273t337r374b400],
7	the	DT	O	the	det	9	SENT_58	[p3l400t337r505b400],
8	H2	NN	O	h2	nn	9	SENT_58	[p3l535t339r639b399],
9	haplotype	NN	O	haplotype	prep_for	5	SENT_58	[p3l670t337r1017b418],
10	might	MD	O	might	aux	13	SENT_58	[p3l1047t337r1253b418],
11	also	RB	O	also	advmod	13	SENT_58	[p3l1282t337r1418b400],
12	be	VB	O	be	cop	13	SENT_58	[p3l1449t337r1531b400],
13	useful	JJ	O	useful	ccomp	2	SENT_58	[p3l1559t337r1774b400],
14	to	TO	O	to	aux	15	SENT_58	[p3l1803t346r1868b400],
15	predict	VB	O	predict	xcomp	13	SENT_58	[p3l1897t337r2143b418],
16	the	DT	O	the	det	17	SENT_58	[p3l8t443r113b506],
17	response	NN	O	response	dobj	15	SENT_58	[p3l169t463r475b524],
18	to	TO	O	to	_	0	SENT_58	[p3l530t452r595b506],
19	clopidogrel	NN	O	clopidogrel	prep_to	15	SENT_58	[p3l654t443r1069b524],
20	.	.	O	.	_	0	SENT_58	[p3l654t443r1069b524],

1	This	DT	DATE	this	nsubj	3	SENT_59	[p3l1130t443r1282b506],
2	may	MD	DATE	may	aux	3	SENT_59	[p3l1338t464r1489b524],
3	help	VB	O	help	_	0	SENT_59	[p3l1543t443r1691b524],
4	to	TO	O	to	aux	5	SENT_59	[p3l1748t452r1813b506],
5	identify	VB	O	identify	xcomp	3	SENT_59	[p3l1871t443r2141b524],
6	patients	NNS	O	patient	dobj	5	SENT_59	[p3l7t549r300b629],
7	,	,	O	,	_	0	SENT_59	[p3l7t549r300b629],
8	who	WP	O	who	nsubj	9	SENT_59	[p3l331t549r481b612],
9	carry	VBP	O	carry	rcmod	6	SENT_59	[p3l513t569r690b629],
10	an	DT	O	a	det	13	SENT_59	[p3l720t569r801b611],
11	increased	VBN	O	increase	amod	13	SENT_59	[p3l830t549r1160b612],
12	cardiovascular	JJ	O	cardiovascular	amod	13	SENT_59	[p3l1190t549r1701b612],
13	risk	NN	O	risk	dobj	9	SENT_59	[p3l1727t549r1859b612],
14	[	CD	NUMBER	[	number	15	SENT_59	[p3l1892t550r2048b628],
15	13	CD	NUMBER	13	dep	6	SENT_59	[p3l1892t550r2048b628],
16	]	NN	O	]	dep	15	SENT_59	[p3l1892t550r2048b628],
17	.	.	O	.	_	0	SENT_59	[p3l1892t550r2048b628],

1	2	LS	NUMBER	2	_	0	SENT_60	[p3l10t762r75b824],
2	.	.	O	.	_	0	SENT_60	[p3l10t762r75b824],

1	Materials	NNPS	O	Materials	_	0	SENT_61	[p3l112t762r469b824],
2	and	CC	O	and	_	0	SENT_61	[p3l505t763r643b824],
3	methods	NNS	O	method	conj_and	1	SENT_61	[p3l677t763r990b824],

1	2	LS	NUMBER	2	_	0	SENT_62	[p3l9t975r131b1037],
2	.	.	O	.	_	0	SENT_62	[p3l9t975r131b1037],
3	]	SYM	O	]	dep	1	SENT_62	[p3l9t975r131b1037],

1	.	.	O	.	_	0	SENT_63	[p3l9t975r131b1037],

1	Patients	NNS	O	patient	_	0	SENT_64	[p3l169t976r458b1037],

1	At	IN	O	at	_	0	SENT_65	[p3l115t1189r203b1250],
2	our	PRP$	O	we	poss	3	SENT_65	[p3l243t1208r359b1250],
3	hospital	NN	O	hospital	prep_at	8	SENT_65	[p3l395t1187r692b1268],
4	,	,	O	,	_	0	SENT_65	[p3l395t1187r692b1268],
5	impedance	NN	O	impedance	nn	6	SENT_65	[p3l736t1187r1114b1268],
6	aggregometry	NN	O	aggregometry	nsubjpass	8	SENT_65	[p3l1156t1196r1643b1268],
7	is	VBZ	O	be	auxpass	8	SENT_65	[p3l1683t1187r1736b1250],
8	performed	VBN	O	perform	dep	41	SENT_65	[p3l1775t1187r2142b1268],
9	routinely	RB	O	routinely	advmod	8	SENT_65	[p3l8t1293r325b1374],
10	to	TO	O	to	aux	11	SENT_65	[p3l351t1302r416b1356],
11	assess	VB	O	assess	xcomp	8	SENT_65	[p3l445t1313r655b1356],
12	the	DT	O	the	det	13	SENT_65	[p3l683t1293r788b1356],
13	response	NN	O	response	dobj	11	SENT_65	[p3l814t1313r1120b1374],
14	to	TO	O	to	_	0	SENT_65	[p3l1147t1302r1212b1356],
15	clopidogrel	NN	O	clopidogrel	prep_to	11	SENT_65	[p3l1242t1293r1640b1374],
16	in	IN	O	in	_	0	SENT_65	[p3l1667t1293r1733b1355],
17	all	DT	O	all	det	18	SENT_65	[p3l1760t1293r1843b1356],
18	patients	NNS	O	patient	prep_in	11	SENT_65	[p3l1868t1293r2139b1374],
19	who	WP	O	who	nsubj	20	SENT_65	[p3l8t1399r158b1462],
20	underwent	VBD	O	undergo	rcmod	18	SENT_65	[p3l196t1399r570b1462],
21	PCI	NNP	O	PCI	dobj	20	SENT_65	[p3l606t1400r741b1462],
22	and	CC	O	and	_	0	SENT_65	[p3l780t1399r906b1462],
23	stent	JJ	O	stent	amod	27	SENT_65	[p3l945t1407r1107b1462],
24	implantation	NN	O	implantation	npadvmod	26	SENT_65	[p3l1145t1399r1588b1479],
25	(	CD	NUMBER	(	num	24	SENT_65	[p3l1626t1399r1801b1479],
26	bare	JJ	O	bare	amod	27	SENT_65	[p3l1626t1399r1801b1479],
27	metal	NN	O	metal	dobj	20	SENT_65	[p3l1839t1399r2032b1462],
28	or	CC	O	or	_	0	SENT_65	[p3l2072t1419r2144b1462],
29	drug	NN	O	drug	nn	30	SENT_65	[p3l10t1505r169b1586],
30	eluting	NN	O	eluting	conj_or	27	SENT_65	[p3l197t1505r485b1586],
31	)	CD	NUMBER	)	dep	27	SENT_65	[p3l197t1505r485b1586],
32	:	:	O	:	_	0	SENT_65	[p3l197t1505r485b1586],
33	the	DT	DATE	the	det	34	SENT_65	[p3l516t1505r621b1568],
34	day	NN	DATE	day	dobj	20	SENT_65	[p3l649t1505r773b1586],
35	after	IN	O	after	_	0	SENT_65	[p3l800t1505r959b1568],
36	PCI	NNP	O	PCI	prep_after	34	SENT_65	[p3l982t1506r1136b1581],
37	,	,	O	,	_	0	SENT_65	[p3l982t1506r1136b1581],
38	whole	JJ	O	whole	amod	39	SENT_65	[p3l1164t1505r1378b1568],
39	blood	NN	O	blood	appos	36	SENT_65	[p3l1403t1505r1606b1568],
40	was	VBD	O	be	auxpass	41	SENT_65	[p3l1629t1525r1763b1568],
41	drawn	VBN	O	draw	_	0	SENT_65	[p3l1793t1505r2011b1568],
42	Via	NNP	O	Via	nn	44	SENT_65	[p3l2035t1505r2142b1568],
43	a	DT	O	a	det	44	SENT_65	[p3l11t1631r48b1673],
44	butterﬂy	NN	O	butterﬂy	dobj	41	SENT_65	[p3l105t1611r416b1691],
45	canula	NN	O	canulum	nn	47	SENT_65	[p3l478t1611r712b1674],
46	(	CD	NUMBER	(	num	47	SENT_65	[p3l773t1611r982b1691],
47	21G	NN	O	21g	npadvmod	41	SENT_65	[p3l773t1611r982b1691],
48	)	CD	NUMBER	)	num	47	SENT_65	[p3l773t1611r982b1691],
49	into	IN	O	into	_	0	SENT_65	[p3l1046t1611r1181b1674],
50	10-mL	JJ	O	10-ml	amod	52	SENT_65	[p3l1253t1612r1486b1673],
51	plastic	NN	O	plastic	nn	52	SENT_65	[p3l1545t1611r1779b1691],
52	syringes	NNS	O	syringe	prep_into	41	SENT_65	[p3l1844t1611r2140b1691],
53	containing	VBG	O	contain	partmod	52	SENT_65	[p3l11t1717r379b1798],
54	1	CD	NUMBER	1	num	55	SENT_65	[p3l427t1719r450b1779],
55	mL	NN	O	ml	dobj	53	SENT_65	[p3l496t1720r617b1779],
56	of	IN	O	of	_	0	SENT_65	[p3l656t1717r737b1780],
57	0.106	CD	NUMBER	0.106	num	59	SENT_65	[p3l765t1719r959b1780],
58	mol/L	NN	O	mol/l	nn	59	SENT_65	[p3l999t1717r1211b1780],
59	trisodium	NN	O	trisodium	prep_of	55	SENT_65	[p3l1249t1717r1587b1780],
60	citrate	NN	O	citrate	nn	63	SENT_65	[p3l1624t1717r1837b1780],
61	(	CD	NUMBER	(	num	63	SENT_65	[p3l1878t1717r2140b1798],
62	Citrate	NNP	O	Citrate	nn	63	SENT_65	[p3l1878t1717r2140b1798],
63	Monovette	NNP	O	Monovette	nsubjpass	41	SENT_65	[p3l9t1826r409b1899],
64	,	,	O	,	_	0	SENT_65	[p3l9t1826r409b1899],
65	Sarstedt	NNP	ORGANIZATION	Sarstedt	nn	67	SENT_65	[p3l451t1823r729b1886],
66	AG	NNP	ORGANIZATION	AG	nn	67	SENT_65	[p3l761t1823r934b1903],
67	)	NNP	O	)	appos	63	SENT_65	[p3l761t1823r934b1903],
68	.	.	O	.	_	0	SENT_65	[p3l761t1823r934b1903],

1	Genetic	JJ	O	genetic	amod	2	SENT_66	[p3l976t1823r1244b1886],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_66	[p3l1281t1823r1575b1904],
3	were	VBD	O	be	auxpass	4	SENT_66	[p3l1610t1844r1779b1886],
4	approved	VBN	O	approve	_	0	SENT_66	[p3l1816t1823r2143b1904],
5	by	IN	O	by	_	0	SENT_66	[p3l8t1929r96b2009],
6	the	DT	O	the	det	8	SENT_66	[p3l120t1929r226b1992],
7	Institutional	JJ	ORGANIZATION	institutional	amod	8	SENT_66	[p3l253t1929r675b1992],
8	Ethics	NNS	ORGANIZATION	ethic	agent	4	SENT_66	[p3l700t1929r916b1992],
9	Review	NNP	ORGANIZATION	Review	nn	10	SENT_66	[p3l943t1929r1211b1992],
10	Board	NNP	ORGANIZATION	Board	dep	8	SENT_66	[p3l1236t1929r1451b1992],
11	in	IN	O	in	_	0	SENT_66	[p3l1477t1929r1543b1991],
12	accordance	NN	O	accordance	prep_in	10	SENT_66	[p3l1569t1929r1960b1992],
13	with	IN	O	with	_	0	SENT_66	[p3l1986t1929r2141b1992],
14	the	DT	O	the	det	15	SENT_66	[p3l8t2035r113b2098],
15	Declaration	NN	O	declaration	prep_with	4	SENT_66	[p3l162t2035r571b2098],
16	of	IN	O	of	_	0	SENT_66	[p3l619t2036r700b2098],
17	Helsinki	NNP	LOCATION	Helsinki	prep_of	15	SENT_66	[p3l737t2035r1051b2098],
18	.	.	O	.	_	0	SENT_66	[p3l737t2035r1051b2098],

1	After	IN	O	after	_	0	SENT_67	[p3l1103t2036r1289b2098],
2	informed	VBN	O	inform	amod	3	SENT_67	[p3l1335t2035r1656b2099],
3	consent	NN	O	consent	prep_after	6	SENT_67	[p3l1704t2044r1989b2112],
4	,	,	O	,	_	0	SENT_67	[p3l1704t2044r1989b2112],
5	we	PRP	O	we	nsubj	6	SENT_67	[p3l2039t2056r2140b2099],
6	included	VBD	O	include	_	0	SENT_67	[p3l10t2141r313b2204],
7	557	CD	NUMBER	557	num	8	SENT_67	[p3l352t2144r478b2204],
8	patients	NNS	O	patient	dobj	6	SENT_67	[p3l517t2141r788b2222],
9	with	IN	O	with	_	0	SENT_67	[p3l827t2141r982b2204],
10	coronary	JJ	O	coronary	amod	15	SENT_67	[p3l1021t2162r1331b2222],
11	artery	NN	O	artery	nn	15	SENT_67	[p3l1371t2150r1571b2222],
12	disease	NN	O	disease	nn	15	SENT_67	[p3l1610t2141r1860b2204],
13	(	CD	NUMBER	(	num	15	SENT_67	[p3l1900t2141r2139b2221],
14	CAD	NN	O	cad	nn	15	SENT_67	[p3l1900t2141r2139b2221],
15	)	NN	O	)	prep_with	6	SENT_67	[p3l1900t2141r2139b2221],
16	who	WP	O	who	nsubj	17	SENT_67	[p3l8t2247r158b2310],
17	received	VBD	O	receive	rcmod	15	SENT_67	[p3l196t2247r493b2310],
18	aspirin	NN	O	aspirin	dobj	17	SENT_67	[p3l531t2247r767b2327],
19	and	CC	O	and	_	0	SENT_67	[p3l804t2247r929b2310],
20	clopidogrel	NN	O	clopidogrel	dobj	17	SENT_67	[p3l967t2247r1365b2328],
21	but	CC	O	but	_	0	SENT_67	[p3l1400t2247r1514b2310],
22	not	RB	O	not	_	0	SENT_67	[p3l1549t2256r1662b2310],
23	glycoprotein	NN	O	glycoprotein	nn	24	SENT_67	[p3l1698t2247r2142b2328],
24	Ilb	NN	O	ilb	conj_negcc	18	SENT_67	[p3l10t2353r288b2416],
25	.	.	O	.	_	0	SENT_67	[p3l10t2353r288b2416],

1	—	NN	O	—	_	0	SENT_68	[p3l10t2353r288b2416],
2	.	.	O	.	_	0	SENT_68	[p3l10t2353r288b2416],

1	IIIa	NN	O	iium	_	0	SENT_69	[p3l10t2353r288b2416],
2	receptor	NN	O	receptor	nn	3	SENT_69	[p3l316t2362r605b2434],
3	inhibitors	NNS	O	inhibitor	dep	1	SENT_69	[p3l635t2353r985b2416],
4	.	.	O	.	_	0	SENT_69	[p3l635t2353r985b2416],

1	Patients	NNS	O	patient	nsubj	2	SENT_70	[p3l1021t2353r1296b2416],
2	received	VBD	O	receive	_	0	SENT_70	[p3l1326t2353r1624b2416],
3	loading	VBG	O	load	xcomp	2	SENT_70	[p3l1655t2353r1916b2434],
4	doses	NNS	O	dose	dobj	3	SENT_70	[p3l1948t2353r2139b2416],
5	of	IN	O	of	_	0	SENT_70	[p3l10t2459r91b2522],
6	300	CD	NUMBER	300	prep_of	4	SENT_70	[p3l109t2460r256b2535],
7	,	,	O	,	_	0	SENT_70	[p3l109t2460r256b2535],
8	450	CD	NUMBER	450	num	12	SENT_70	[p3l286t2460r415b2522],
9	or	CC	O	or	_	0	SENT_70	[p3l444t2479r517b2522],
10	600	CD	NUMBER	600	num	12	SENT_70	[p3l542t2460r669b2522],
11	mg	NN	O	mg	nn	12	SENT_70	[p3l697t2479r808b2540],
12	clopidogrel	NN	O	clopidogrel	npadvmod	13	SENT_70	[p3l836t2459r1233b2540],
13	immediately	RB	O	immediately	advmod	4	SENT_70	[p3l1262t2459r1699b2540],
14	after	IN	O	after	_	0	SENT_70	[p3l1726t2459r1883b2522],
15	PCI	NNP	O	PCI	prep_after	13	SENT_70	[p3l1907t2460r2061b2535],
16	,	,	O	,	_	0	SENT_70	[p3l1907t2460r2061b2535],
17	if	IN	O	if	mark	22	SENT_70	[p3l2092t2459r2152b2521],
18	they	PRP	O	they	nsubjpass	22	SENT_70	[p3l8t2565r159b2646],
19	were	VBD	O	be	auxpass	22	SENT_70	[p3l197t2586r365b2628],
20	not	RB	O	not	neg	22	SENT_70	[p3l403t2574r516b2628],
21	already	RB	O	already	advmod	22	SENT_70	[p3l555t2565r810b2646],
22	treated	VBN	O	treat	dep	13	SENT_70	[p3l847t2565r1086b2628],
23	with	IN	O	with	_	0	SENT_70	[p3l1122t2565r1278b2628],
24	a	DT	O	a	det	26	SENT_70	[p3l1317t2586r1354b2628],
25	maintenance	NN	O	maintenance	nn	26	SENT_70	[p3l1390t2565r1833b2628],
26	dose	NN	O	dose	prep_with	22	SENT_70	[p3l1873t2565r2031b2628],
27	of	IN	O	of	_	0	SENT_70	[p3l2072t2566r2152b2628],
28	75	CD	NUMBER	75	num	30	SENT_70	[p3l11t2674r91b2734],
29	mg	NN	O	mg	nn	30	SENT_70	[p3l117t2692r228b2752],
30	clopidogrel	NN	O	clopidogrel	prep_of	26	SENT_70	[p3l252t2671r667b2752],
31	.	.	O	.	_	0	SENT_70	[p3l252t2671r667b2752],

1	The	DT	O	the	det	2	SENT_71	[p3l696t2671r829b2734],
2	choice	NN	O	choice	nsubjpass	8	SENT_71	[p3l853t2671r1078b2734],
3	of	IN	O	of	_	0	SENT_71	[p3l1102t2671r1183b2734],
4	the	DT	O	the	det	6	SENT_71	[p3l1193t2671r1298b2734],
5	loading	VBG	O	load	amod	6	SENT_71	[p3l1322t2671r1583b2752],
6	dose	NN	O	dose	prep_of	2	SENT_71	[p3l1608t2671r1765b2734],
7	was	VBD	O	be	auxpass	8	SENT_71	[p3l1787t2692r1921b2734],
8	left	VBN	O	leave	_	0	SENT_71	[p3l1946t2671r2059b2734],
9	at	IN	O	at	_	0	SENT_71	[p3l2082t2680r2143b2734],
10	the	DT	O	the	det	11	SENT_71	[p3l8t2777r113b2840],
11	discretion	NN	O	discretion	prep_at	8	SENT_71	[p3l137t2777r480b2840],
12	of	IN	O	of	_	0	SENT_71	[p3l502t2777r582b2840],
13	the	DT	O	the	det	15	SENT_71	[p3l591t2777r696b2840],
14	interventional	JJ	O	interventional	amod	15	SENT_71	[p3l719t2777r1204b2840],
15	cardiologist	NN	O	cardiologist	prep_of	11	SENT_71	[p3l1226t2777r1655b2858],
16	.	.	O	.	_	0	SENT_71	[p3l1226t2777r1655b2858],

1	Furthermore	RB	O	furthermore	advmod	4	SENT_72	[p3l1681t2777r2138b2853],
2	,	,	O	,	_	0	SENT_72	[p3l1681t2777r2138b2853],
3	we	PRP	O	we	nsubj	4	SENT_72	[p3l8t2903r109b2946],
4	analysed	VBD	O	analyse	_	0	SENT_72	[p3l148t2883r454b2963],
5	blood	NN	O	blood	nn	6	SENT_72	[p3l488t2883r690b2946],
6	samples	NNS	O	sample	dobj	4	SENT_72	[p3l728t2883r1005b2963],
7	from	IN	O	from	_	0	SENT_72	[p3l1045t2883r1213b2946],
8	43	CD	NUMBER	43	num	11	SENT_72	[p3l1249t2884r1329b2945],
9	healthy	JJ	O	healthy	amod	11	SENT_72	[p3l1371t2883r1630b2963],
10	blood	NN	O	blood	nn	11	SENT_72	[p3l1664t2883r1867b2946],
11	donors	NNS	O	donor	prep_from	4	SENT_72	[p3l1903t2883r2139b2946],
12	who	WP	O	who	nsubj	13	SENT_72	[p3l8t2989r158b3052],
13	denied	VBD	O	deny	rcmod	11	SENT_72	[p3l190t2989r423b3052],
14	taking	VBG	O	take	xcomp	13	SENT_72	[p3l451t2989r669b3070],
15	any	DT	O	any	det	17	SENT_72	[p3l700t3010r825b3070],
16	antiplatelet	JJ	O	antiplatelet	amod	17	SENT_72	[p3l855t2989r1243b3070],
17	medication	NN	O	medication	dobj	14	SENT_72	[p3l1270t2989r1677b3052],
18	.	.	O	.	_	0	SENT_72	[p3l1270t2989r1677b3052],

1	2.2	CD	NUMBER	2.2	_	0	SENT_73	[p3l9t3203r131b3264],
2	.	.	O	.	_	0	SENT_73	[p3l9t3203r131b3264],

1	A	DT	O	a	det	2	SENT_74	[p3l167t3203r220b3263],
2	ggregometrjy	NN	O	ggregometrjy	_	0	SENT_74	[p3l223t3213r674b3282],

1	Impedance	NN	O	impedance	nn	2	SENT_75	[p3l116t3414r515b3494],
2	aggregometry	NN	O	aggregometry	nsubj	3	SENT_75	[p3l577t3422r1084b3494],
3	measures	VBZ	O	measure	_	0	SENT_75	[p3l1143t3434r1480b3477],
4	the	DT	O	the	det	5	SENT_75	[p3l1541t3414r1650b3477],
5	increase	NN	O	increase	dobj	3	SENT_75	[p3l1712t3414r2008b3477],
6	of	IN	O	of	_	0	SENT_75	[p3l2070t3414r2152b3477],
7	impedance	NN	O	impedance	prep_of	5	SENT_75	[p3l10t3520r389b3601],
8	between	IN	O	between	_	0	SENT_75	[p3l420t3520r714b3583],
9	a	DT	O	a	det	10	SENT_75	[p3l748t3541r784b3583],
10	pair	NN	O	pair	prep_between	7	SENT_75	[p3l814t3520r952b3601],
11	of	IN	O	of	_	0	SENT_75	[p3l983t3520r1064b3583],
12	metal	NN	O	metal	nn	13	SENT_75	[p3l1085t3520r1278b3583],
13	electrodes	NNS	O	electrode	prep_of	10	SENT_75	[p3l1313t3520r1663b3583],
14	immersed	VBN	O	immerse	partmod	13	SENT_75	[p3l1699t3520r2044b3583],
15	in	IN	O	in	_	0	SENT_75	[p3l2077t3520r2142b3582],
16	diluted	VBN	O	dilute	amod	19	SENT_75	[p3l10t3626r259b3689],
17	whole	JJ	O	whole	amod	19	SENT_75	[p3l314t3626r532b3689],
18	blood	NN	O	blood	nn	19	SENT_75	[p3l589t3626r795b3689],
19	[	NN	O	[	prep_in	14	SENT_75	[p3l858t3627r1017b3705],
20	14	CD	NUMBER	14	num	21	SENT_75	[p3l858t3627r1017b3705],
21	]	NN	O	]	dep	19	SENT_75	[p3l858t3627r1017b3705],
22	.	.	O	.	_	0	SENT_75	[p3l858t3627r1017b3705],

1	The	DT	O	the	det	2	SENT_76	[p3l1081t3626r1216b3689],
2	increase	NN	O	increase	nsubj	5	SENT_76	[p3l1276t3626r1565b3689],
3	of	IN	O	of	_	0	SENT_76	[p3l1625t3626r1707b3689],
4	impedance	NN	O	impedance	prep_of	2	SENT_76	[p3l1755t3626r2140b3707],
5	correlates	VBZ	O	correlate	_	0	SENT_76	[p3l11t3732r346b3795],
6	with	IN	O	with	_	0	SENT_76	[p3l376t3732r531b3795],
7	the	DT	O	the	det	8	SENT_76	[p3l559t3732r664b3795],
8	amount	NN	O	amount	prep_with	5	SENT_76	[p3l696t3740r959b3795],
9	of	IN	O	of	_	0	SENT_76	[p3l988t3732r1069b3795],
10	platelet	NN	O	platelet	nn	11	SENT_76	[p3l1085t3732r1343b3812],
11	aggregates	NNS	O	aggregate	prep_of	8	SENT_76	[p3l1373t3740r1744b3812],
12	depositing	VBG	O	deposit	partmod	11	SENT_76	[p3l1776t3732r2141b3812],
13	on	IN	O	on	_	0	SENT_76	[p4l10t43r96b85],
14	the	DT	O	the	det	15	SENT_76	[p4l121t22r226b85],
15	electrodes	NNS	O	electrode	prep_on	12	SENT_76	[p4l255t22r605b85],
16	after	IN	O	after	_	0	SENT_76	[p4l635t23r793b85],
17	the	DT	O	the	det	18	SENT_76	[p4l816t22r921b85],
18	addition	NN	O	addition	prep_after	12	SENT_76	[p4l950t22r1235b85],
19	of	IN	O	of	_	0	SENT_76	[p4l1263t23r1343b85],
20	ADP	NN	O	adp	prep_of	18	SENT_76	[p4l1357t24r1531b84],
21	(	CD	NUMBER	(	num	23	SENT_76	[p4l1561t22r1746b103],
22	ﬁnal	JJ	O	ﬁnal	amod	23	SENT_76	[p4l1561t22r1746b103],
23	concentration	NN	O	concentration	dobj	5	SENT_76	[p4l1774t31r2139b85, p4l8t128r144b191],
24	of	IN	O	of	_	0	SENT_76	[p4l173t128r253b191],
25	5	CD	NUMBER	5	num	27	SENT_76	[p4l272t131r306b191],
26	umol/L	NN	O	umol/l	nn	27	SENT_76	[p4l341t128r648b208],
27	)	NN	O	)	prep_of	23	SENT_76	[p4l341t128r648b208],
28	.	.	O	.	_	0	SENT_76	[p4l341t128r648b208],

1	Aggregation	NN	O	aggregation	nsubjpass	3	SENT_77	[p4l679t128r1120b209],
2	was	VBD	O	be	auxpass	3	SENT_77	[p4l1146t149r1280b191],
3	analysed	VBN	O	analyse	_	0	SENT_77	[p4l1310t128r1616b209],
4	using	VBG	O	use	xcomp	3	SENT_77	[p4l1641t128r1831b209],
5	a	DT	O	a	det	8	SENT_77	[p4l1861t149r1897b191],
6	model	NN	O	model	nn	8	SENT_77	[p4l1922t128r2140b191],
7	560-CA	NN	O	560-ca	nn	8	SENT_77	[p4l12t236r293b297],
8	lumi-aggregometer	NN	O	lumi-aggregometer	dobj	4	SENT_77	[p4l327t234r1000b315],
9	from	IN	O	from	_	0	SENT_77	[p4l1032t234r1200b297],
10	Chrono-Log	NNP	O	Chrono-Log	nn	12	SENT_77	[p4l1233t234r1666b315],
11	(	NNP	O	(	nn	12	SENT_77	[p4l1702t235r2137b314],
12	Havertown	NNP	LOCATION	Havertown	prep_from	4	SENT_77	[p4l1702t235r2137b314],
13	,	,	O	,	_	0	SENT_77	[p4l1702t235r2137b314],
14	PA	NN	ORGANIZATION	pa	appos	12	SENT_77	[p4l9t341r132b416],
15	,	,	O	,	_	0	SENT_77	[p4l9t341r132b416],
16	U.S.A.	NNP	LOCATION	U.S.A.	appos	14	SENT_77	[p4l152t340r422b420],
17	)	CD	NUMBER	)	num	16	SENT_77	[p4l152t340r422b420],
18	exactly	RB	O	exactly	advmod	3	SENT_77	[p4l444t340r695b421],
19	as	IN	O	as	mark	20	SENT_77	[p4l715t361r783b403],
20	described	VBN	O	describe	advcl	3	SENT_77	[p4l804t340r1139b403],
21	previously	RB	DATE	previously	advmod	20	SENT_77	[p4l1154t340r1527b421],
22	[	CD	NUMBER	[	num	24	SENT_77	[p4l1552t341r1707b419],
23	15	CD	NUMBER	15	num	24	SENT_77	[p4l1552t341r1707b419],
24	]	NN	O	]	dobj	20	SENT_77	[p4l1552t341r1707b419],
25	.	.	O	.	_	0	SENT_77	[p4l1552t341r1707b419],

1	All	DT	O	all	det	2	SENT_78	[p4l1730t340r1841b402],
2	samples	NNS	O	sample	nsubjpass	4	SENT_78	[p4l1862t340r2139b421],
3	were	VBD	O	be	auxpass	4	SENT_78	[p4l8t466r176b509],
4	analysed	VBN	O	analyse	_	0	SENT_78	[p4l201t446r507b526],
5	during	IN	O	during	_	0	SENT_78	[p4l530t446r756b526],
6	a	DT	O	a	det	7	SENT_78	[p4l780t466r817b508],
7	period	NN	O	period	prep_during	4	SENT_78	[p4l835t446r1062b526],
8	of	IN	O	of	_	0	SENT_78	[p4l1084t446r1164b509],
9	0.5-1	CD	NUMBER	0.5-1	number	10	SENT_78	[p4l1177t447r1372b509],
10	.5	CD	NUMBER	.5	num	11	SENT_78	[p4l1389t448r1443b509],
11	h	NN	O	h	prep_of	7	SENT_78	[p4l1469t446r1513b508],
12	after	IN	O	after	_	0	SENT_78	[p4l1536t446r1694b509],
13	sampling	NN	O	sampling	prep_after	4	SENT_78	[p4l1716t446r2053b526],
14	.	.	O	.	_	0	SENT_78	[p4l1716t446r2053b526],

1	A	DT	O	a	det	3	SENT_79	[p4l2079t447r2142b508],
2	6-minute	JJ	DURATION	6-minute	amod	3	SENT_79	[p4l11t553r324b616],
3	impedance	NN	O	impedance	nsubjpass	8	SENT_79	[p4l345t552r723b634],
4	3	CD	NUMBER	3	number	5	SENT_79	[p4l750t563r802b615],
5	5	CD	NUMBER	5	dep	3	SENT_79	[p4l822t555r857b616],
6	Q	NNP	O	Q	dep	3	SENT_79	[p4l884t550r950b615],
7	was	VBD	O	be	auxpass	8	SENT_79	[p4l971t574r1105b616],
8	deﬁned	VBN	O	deﬁned	_	0	SENT_79	[p4l1128t552r1390b616],
9	as	IN	O	as	_	0	SENT_79	[p4l1409t574r1477b616],
10	a	DT	O	a	det	12	SENT_79	[p4l1499t574r1536b616],
11	good	JJ	O	good	amod	12	SENT_79	[p4l1555t552r1731b634],
12	response	NN	O	response	prep_as	8	SENT_79	[p4l1748t573r2055b634],
13	to	TO	O	to	_	0	SENT_79	[p4l2074t562r2139b616],
14	clopidogrel	NN	O	clopidogrel	prep_to	8	SENT_79	[p4l11t659r426b741],
15	.	.	O	.	_	0	SENT_79	[p4l11t659r426b741],

1	Nonresponders	NNS	O	nonresponder	nsubj	2	SENT_80	[p4l476t659r1009b741],
2	exhibited	VBD	O	exhibit	_	0	SENT_80	[p4l1061t659r1386b723],
3	results	NNS	O	result	dep	4	SENT_80	[p4l1432t659r1658b723],
4	>	JJR	O	>	nsubj	6	SENT_80	[p4l1707t662r1803b723],
5	5	CD	NUMBER	5	num	6	SENT_80	[p4l1707t662r1803b723],
6	o	NN	O	o	xcomp	2	SENT_80	[p4l1858t657r1924b722],
7	[	CD	NUMBER	[	num	9	SENT_80	[p4l1980t661r2136b740],
8	15	CD	NUMBER	15	num	9	SENT_80	[p4l1980t661r2136b740],
9	]	NN	O	]	dep	6	SENT_80	[p4l1980t661r2136b740],
10	.	.	O	.	_	0	SENT_80	[p4l1980t661r2136b740],

1	Whole	JJ	O	whole	amod	3	SENT_81	[p4l8t766r247b829],
2	blood	NN	O	blood	nn	3	SENT_81	[p4l305t766r513b829],
3	samples	NNS	O	sample	nsubjpass	8	SENT_81	[p4l573t766r859b846],
4	from	IN	O	from	_	0	SENT_81	[p4l921t766r1092b829],
5	most	JJS	O	most	amod	6	SENT_81	[p4l1149t774r1325b829],
6	nonresponders	NNS	O	nonresponder	prep_from	3	SENT_81	[p4l1381t766r1910b846],
7	were	VBD	O	be	auxpass	8	SENT_81	[p4l1969t786r2141b829],
8	incubated	VBN	O	incubate	_	0	SENT_81	[p4l10t872r351b935],
9	in	IN	O	in	_	0	SENT_81	[p4l400t872r466b934],
10	Vitro	NNP	O	Vitro	prep_in	8	SENT_81	[p4l512t872r674b935],
11	with	IN	O	with	_	0	SENT_81	[p4l723t872r879b935],
12	0.1	CD	NUMBER	0.1	num	14	SENT_81	[p4l928t873r1026b935],
13	mmol/L	NN	O	mmol/l	nn	14	SENT_81	[p4l1084t872r1365b935],
14	methylSadenosinemonophosphate	NN	O	methylsadenosinemonophosphate	prep_with	10	SENT_81	[p4l1413t872r2139b952, p4l8t978r568b1059],
15	(	CD	NUMBER	(	num	16	SENT_81	[p4l607t979r1000b1058],
16	MeSAMP	NN	O	mesamp	dep	8	SENT_81	[p4l607t979r1000b1058],
17	,	,	O	,	_	0	SENT_81	[p4l607t979r1000b1058],
18	Sigma	NNP	O	Sigma	nn	19	SENT_81	[p4l1044t978r1311b1059],
19	)	NNP	O	)	appos	16	SENT_81	[p4l1044t978r1311b1059],
20	,	,	O	,	_	0	SENT_81	[p4l1044t978r1311b1059],
21	a	DT	O	a	det	23	SENT_81	[p4l1353t999r1389b1041],
22	speciﬁc	NN	O	speciﬁc	nn	23	SENT_81	[p4l1428t978r1694b1059],
23	inhibitor	NN	O	inhibitor	appos	16	SENT_81	[p4l1733t978r2036b1041],
24	of	IN	O	of	_	0	SENT_81	[p4l2072t978r2152b1041],
25	the	DT	O	the	det	26	SENT_81	[p4l8t1084r113b1147],
26	PZY12-receptor	NN	O	pzy12-receptor	prep_of	23	SENT_81	[p4l146t1086r698b1164],
27	.	.	O	.	_	0	SENT_81	[p4l146t1086r698b1164],

1	After	IN	O	after	_	0	SENT_82	[p4l733t1084r919b1147],
2	a	DT	O	a	det	4	SENT_82	[p4l950t1104r987b1146],
3	30-min	JJ	DURATION	30-min	amod	4	SENT_82	[p4l1019t1084r1270b1147],
4	incubation	NN	O	incubation	prep_after	8	SENT_82	[p4l1303t1084r1691b1160],
5	,	,	O	,	_	0	SENT_82	[p4l1303t1084r1691b1160],
6	aggregation	NN	O	aggregation	nsubjpass	8	SENT_82	[p4l1728t1084r2141b1165],
7	was	VBD	O	be	auxpass	8	SENT_82	[p4l8t1211r142b1253],
8	examined	VBN	O	examine	_	0	SENT_82	[p4l173t1190r514b1253],
9	again	RB	O	again	advmod	8	SENT_82	[p4l542t1190r729b1271],
10	in	IN	O	in	_	0	SENT_82	[p4l757t1190r824b1252],
11	these	DT	O	these	det	14	SENT_82	[p4l850t1190r1028b1253],
12	whole	JJ	O	whole	amod	14	SENT_82	[p4l1056t1190r1269b1253],
13	blood	NN	O	blood	nn	14	SENT_82	[p4l1296t1190r1499b1253],
14	samples	NNS	O	sample	prep_in	8	SENT_82	[p4l1528t1190r1805b1271],
15	to	TO	O	to	aux	16	SENT_82	[p4l1834t1199r1899b1253],
16	assess	VB	O	assess	xcomp	8	SENT_82	[p4l1930t1211r2139b1253],
17	the	DT	O	the	det	19	SENT_82	[p4l8t1296r113b1359],
18	achievable	JJ	O	achievable	amod	19	SENT_82	[p4l142t1296r514b1359],
19	maximum	NN	O	maximum	dobj	16	SENT_82	[p4l541t1296r899b1359],
20	of	IN	O	of	_	0	SENT_82	[p4l925t1296r1006b1359],
21	inhibition	NN	O	inhibition	prep_of	19	SENT_82	[p4l1023t1296r1380b1359],
22	.	.	O	.	_	0	SENT_82	[p4l1023t1296r1380b1359],

1	2.3	CD	NUMBER	2.3	_	0	SENT_83	[p4l9t1511r131b1572],
2	.	.	O	.	_	0	SENT_83	[p4l9t1511r131b1572],

1	Genotyping	VBG	O	genotype	_	0	SENT_84	[p4l177t1511r586b1590],

1	Genomic	JJ	O	genomic	amod	2	SENT_85	[p4l117t1722r436b1785],
2	DNA	NN	O	dna	nsubjpass	4	SENT_85	[p4l492t1723r682b1785],
3	was	VBD	O	be	auxpass	4	SENT_85	[p4l729t1742r863b1785],
4	isolated	VBN	O	isolate	dep	18	SENT_85	[p4l921t1722r1191b1785],
5	semi-automatically	RB	O	semi-automatically	advmod	4	SENT_85	[p4l1249t1722r1919b1803],
6	from	IN	O	from	_	0	SENT_85	[p4l1974t1722r2142b1785],
7	peripheral	JJ	O	peripheral	amod	9	SENT_85	[p4l7t1828r363b1908],
8	blood	NN	O	blood	nn	9	SENT_85	[p4l395t1828r597b1891],
9	cells	NNS	O	cell	prep_from	4	SENT_85	[p4l631t1828r786b1891],
10	by	IN	O	by	_	0	SENT_85	[p4l819t1828r908b1908],
11	the	DT	O	the	det	12	SENT_85	[p4l940t1828r1044b1891],
12	use	NN	O	use	agent	4	SENT_85	[p4l1077t1848r1193b1891],
13	of	IN	O	of	_	0	SENT_85	[p4l1229t1828r1310b1891],
14	a	DT	O	a	det	17	SENT_85	[p4l1333t1848r1370b1890],
15	previously	RB	DATE	previously	advmod	16	SENT_85	[p4l1400t1828r1773b1908],
16	described	VBN	O	describe	amod	17	SENT_85	[p4l1807t1828r2142b1891],
17	protocol	NN	O	protocol	prep_of	12	SENT_85	[p4l8t1934r301b2014],
18	adapted	VBD	O	adapt	_	0	SENT_85	[p4l361t1934r633b2014],
19	to	TO	O	to	_	0	SENT_85	[p4l689t1942r754b1997],
20	a	DT	O	a	det	26	SENT_85	[p4l816t1954r852b1996],
21	robotic	JJ	O	robotic	amod	26	SENT_85	[p4l908t1934r1154b1997],
22	liquid	JJ	O	liquid	amod	26	SENT_85	[p4l1215t1934r1418b2014],
23	handling	NN	O	handling	nn	26	SENT_85	[p4l1475t1934r1782b2015],
24	platform	NN	O	platform	nn	26	SENT_85	[p4l1839t1934r2142b2014],
25	(	CD	NUMBER	(	num	26	SENT_85	[p4l11t2040r432b2121],
26	Multiprobe	NN	O	multiprobe	prep_to	18	SENT_85	[p4l11t2040r432b2121],
27	II	CD	NUMBER	ii	nsubj	18	SENT_85	[p4l475t2043r549b2117],
28	,	,	O	,	_	0	SENT_85	[p4l475t2043r549b2117],
29	Perkin	NNP	PERSON	Perkin	nn	30	SENT_85	[p4l594t2040r822b2103],
30	Elmer	NNP	PERSON	Elmer	appos	27	SENT_85	[p4l863t2040r1102b2121],
31	)	CD	NUMBER	)	number	32	SENT_85	[p4l863t2040r1102b2121],
32	[	CD	NUMBER	[	dep	30	SENT_85	[p4l1151t2042r1307b2120],
33	16	CD	NUMBER	16	num	34	SENT_85	[p4l1151t2042r1307b2120],
34	]	NN	O	]	dep	32	SENT_85	[p4l1151t2042r1307b2120],
35	.	.	O	.	_	0	SENT_85	[p4l1151t2042r1307b2120],

1	A	DT	O	a	det	4	SENT_86	[p4l1353t2042r1416b2102],
2	TaqMan	JJ	O	taqman	amod	4	SENT_86	[p4l1449t2043r1740b2121],
3	‘	NN	O	‘	nn	4	SENT_86	[p4l1785t2042r2140b2121, p4l11t2146r310b2209],
4	assayondemand	NN	O	assayondemand	_	0	SENT_86	[p4l1785t2042r2140b2121, p4l11t2146r310b2209],
5	’	CD	NUMBER	’	number	6	SENT_86	[p4l1785t2042r2140b2121, p4l11t2146r310b2209],
6	(	CD	NUMBER	(	dep	4	SENT_86	[p4l358t2146r509b2227],
7	No.	NN	O	no.	dep	6	SENT_86	[p4l358t2146r509b2227],
8	.	.	O	.	_	0	SENT_86	[p4l358t2146r509b2227],

1	C_25640992_l0	NN	O	c_25640992_l0	nsubjpass	7	SENT_87	[p4l556t2148r1165b2223],
2	,	,	O	,	_	0	SENT_87	[p4l556t2148r1165b2223],
3	Applied	NNP	ORGANIZATION	Applied	nn	4	SENT_87	[p4l1208t2146r1492b2227],
4	Biosystems	NNP	ORGANIZATION	Biosystems	appos	1	SENT_87	[p4l1532t2146r1965b2227],
5	)	NN	O	)	dep	4	SENT_87	[p4l1532t2146r1965b2227],
6	was	VBD	O	be	auxpass	7	SENT_87	[p4l2005t2167r2140b2209],
7	used	VBN	O	use	_	0	SENT_87	[p4l8t2252r173b2315],
8	to	TO	O	to	_	0	SENT_87	[p4l232t2260r298b2315],
9	genotype	NN	O	genotype	nn	10	SENT_87	[p4l362t2260r689b2333],
10	haplotype	NN	O	haplotype	prep_to	7	SENT_87	[p4l750t2252r1103b2333],
11	tagging	VBG	O	tag	xcomp	7	SENT_87	[p4l1164t2252r1433b2333],
12	single	JJ	O	single	amod	18	SENT_87	[p4l1497t2252r1706b2333],
13	nucleotide	NN	O	nucleotide	nn	18	SENT_87	[p4l1767t2252r2140b2315],
14	polymorphism	NN	O	polymorphism	nn	18	SENT_87	[p4l7t2358r526b2438],
15	(	CD	NUMBER	(	num	18	SENT_87	[p4l586t2358r799b2438],
16	SNP	NN	ORGANIZATION	snp	nn	18	SENT_87	[p4l586t2358r799b2438],
17	)	CD	NUMBER	)	num	18	SENT_87	[p4l586t2358r799b2438],
18	G52T	NN	O	g52t	dobj	11	SENT_87	[p4l862t2359r1065b2421],
19	on	IN	O	on	_	0	SENT_87	[p4l1121t2378r1207b2421],
20	an	DT	O	a	det	23	SENT_87	[p4l1267t2378r1347b2420],
21	ABI	NNP	O	ABI	nn	23	SENT_87	[p4l1404t2359r1555b2420],
22	7000	CD	NUMBER	7000	num	23	SENT_87	[p4l1616t2359r1789b2421],
23	analyser	NN	O	analyser	prep_on	11	SENT_87	[p4l1852t2358r2144b2438],
24	(	CD	NUMBER	(	num	27	SENT_87	[p4l11t2464r322b2545],
25	Applied	NNP	O	Applied	nn	27	SENT_87	[p4l11t2464r322b2545],
26	Biosystems	NNP	O	Biosystems	nn	27	SENT_87	[p4l350t2464r801b2545],
27	)	NN	O	)	dep	23	SENT_87	[p4l350t2464r801b2545],
28	.	.	O	.	_	0	SENT_87	[p4l350t2464r801b2545],

1	2.4	CD	NUMBER	2.4	_	0	SENT_88	[p4l9t2678r131b2739],
2	.	.	O	.	_	0	SENT_88	[p4l9t2678r131b2739],

1	Statistical	JJ	O	statistical	amod	2	SENT_89	[p4l172t2677r526b2740],
2	analysis	NN	O	analysis	_	0	SENT_89	[p4l555t2677r840b2757],

1	Nominal	JJ	O	nominal	amod	2	SENT_90	[p4l113t2889r423b2952],
2	data	NNS	O	datum	nsubjpass	4	SENT_90	[p4l448t2889r593b2952],
3	were	VBD	O	be	auxpass	4	SENT_90	[p4l614t2909r783b2952],
4	compared	VBN	O	compare	_	0	SENT_90	[p4l809t2889r1155b2969],
5	by	IN	O	by	_	0	SENT_90	[p4l1177t2889r1265b2969],
6	the	DT	O	the	det	7	SENT_90	[p4l1288t2889r1393b2952],
7	use	NN	O	use	agent	4	SENT_90	[p4l1417t2909r1533b2952],
8	of	IN	O	of	_	0	SENT_90	[p4l1559t2889r1640b2952],
9	Fisher	NNP	PERSON	Fisher	prep_of	7	SENT_90	[p4l1653t2889r1932b2952],
10	’s	POS	O	’s	possessive	9	SENT_90	[p4l1653t2889r1932b2952],
11	exact	JJ	O	exact	amod	9	SENT_90	[p4l1960t2897r2143b2952],
12	and	CC	O	and	_	0	SENT_90	[p4l11t2995r136b3058],
13	Chi	NNP	O	Chi	nn	15	SENT_90	[p4l174t2995r297b3058],
14	square	JJ	O	square	amod	15	SENT_90	[p4l337t3016r561b3076],
15	tests	NNS	O	test	prep_of	7	SENT_90	[p4l599t3004r771b3058],
16	.	.	O	.	_	0	SENT_90	[p4l599t3004r771b3058],

1	Numerical	JJ	O	numerical	amod	2	SENT_91	[p4l810t2995r1181b3058],
2	data	NNS	O	datum	nsubjpass	10	SENT_91	[p4l1220t2995r1364b3058],
3	were	VBD	O	be	auxpass	4	SENT_91	[p4l1399t3016r1567b3058],
4	summarized	VBN	O	summarize	_	0	SENT_91	[p4l1608t2995r2034b3058],
5	as	IN	O	as	_	0	SENT_91	[p4l2072t3016r2139b3058],
6	meani	JJ	O	meani	amod	8	SENT_91	[p4l9t3109r257b3164],
7	standard	JJ	O	standard	amod	8	SENT_91	[p4l273t3101r567b3164],
8	deviation	NN	O	deviation	prep_as	4	SENT_91	[p4l606t3101r931b3164],
9	and	CC	O	and	_	0	SENT_91	[p4l969t3101r1095b3164],
10	compared	VBN	O	compare	conj_and	4	SENT_91	[p4l1132t3101r1478b3182],
11	using	VBG	O	use	xcomp	10	SENT_91	[p4l1512t3101r1703b3182],
12	the	DT	O	the	det	15	SENT_91	[p4l1741t3101r1846b3164],
13	MannWhitney	NNP	O	MannWhitney	nn	15	SENT_91	[p4l1883t3104r2139b3164, p4l9t3207r312b3287],
14	U	NNP	O	U	nn	15	SENT_91	[p4l346t3209r409b3270],
15	test	NN	O	test	dobj	11	SENT_91	[p4l426t3215r547b3270],
16	calculating	VBG	O	calculate	partmod	15	SENT_91	[p4l575t3207r956b3287],
17	p-values	NNS	O	p-value	dobj	16	SENT_91	[p4l972t3207r1279b3287],
18	corrected	VBN	O	correct	dep	17	SENT_91	[p4l1309t3207r1632b3270],
19	for	IN	O	for	_	0	SENT_91	[p4l1660t3207r1761b3270],
20	ties	NNS	O	tie	prep_for	18	SENT_91	[p4l1784t3207r1923b3283],
21	,	,	O	,	_	0	SENT_91	[p4l1784t3207r1923b3283],
22	if	IN	O	if	_	0	SENT_91	[p4l1954t3207r2015b3269],
23	not	RB	O	not	_	0	SENT_91	[p4l2030t3215r2143b3270],
24	stated	VBN	O	state	dep	17	SENT_91	[p4l12t3313r214b3376],
25	otherwise	RB	O	otherwise	advmod	24	SENT_91	[p4l248t3313r603b3376],
26	.	.	O	.	_	0	SENT_91	[p4l248t3313r603b3376],

1	Statistical	JJ	O	statistical	amod	2	SENT_92	[p4l647t3313r985b3377],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_92	[p4l1022t3313r1315b3394],
3	were	VBD	O	be	auxpass	4	SENT_92	[p4l1349t3334r1518b3376],
4	performed	VBN	O	perform	_	0	SENT_92	[p4l1551t3313r1918b3394],
5	using	VBG	O	use	xcomp	4	SENT_92	[p4l1950t3314r2140b3394],
6	StatView	NNP	O	StatView	nn	11	SENT_92	[p4l13t3419r330b3482],
7	5.0	CD	NUMBER	5.0	num	11	SENT_92	[p4l354t3421r458b3482],
8	(	CD	NUMBER	(	num	11	SENT_92	[p4l483t3419r666b3499],
9	SAS	NNP	ORGANIZATION	SAS	nn	11	SENT_92	[p4l483t3419r666b3499],
10	Institute	NNP	ORGANIZATION	Institute	nn	11	SENT_92	[p4l690t3419r974b3482],
11	Inc.	NNP	ORGANIZATION	Inc.	dobj	5	SENT_92	[p4l996t3419r1174b3499],
12	)	NN	O	)	dep	11	SENT_92	[p4l996t3419r1174b3499],
13	.	.	O	.	_	0	SENT_92	[p4l996t3419r1174b3499],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_93	[p4l1203t3419r1542b3482],
2	signiﬁcance	NN	O	signiﬁcance	nsubjpass	4	SENT_93	[p4l1566t3419r1985b3500],
3	was	VBD	O	be	auxpass	4	SENT_93	[p4l2006t3440r2140b3482],
4	assumed	VBN	O	assume	_	0	SENT_93	[p4l11t3525r313b3588],
5	at	IN	O	at	_	0	SENT_93	[p4l342t3534r403b3587],
6	p	NN	O	p	prep_at	4	SENT_93	[p4l419t3526r717b3605],
7	<	JJR	O	<	dep	8	SENT_93	[p4l419t3526r717b3605],
8	0.05	CD	NUMBER	0.05	advmod	4	SENT_93	[p4l419t3526r717b3605],
9	.	.	O	.	_	0	SENT_93	[p4l419t3526r717b3605],

1	3	LS	NUMBER	3	_	0	SENT_94	[p4l9t3738r75b3800],
2	.	.	O	.	_	0	SENT_94	[p4l9t3738r75b3800],

1	Results	NNS	O	result	_	0	SENT_95	[p4l111t3739r381b3800],

1	3.1	CD	NUMBER	3.1	_	0	SENT_96	[p5l11t142r131b203],
2	.	.	O	.	_	0	SENT_96	[p5l11t142r131b203],

1	The	DT	O	the	det	3	SENT_97	[p5l177t140r304b203],
2	H2	NN	O	h2	nn	3	SENT_97	[p5l332t142r440b202],
3	allele	NN	O	allele	nsubj	4	SENT_97	[p5l474t140r666b203],
4	enhanced	VBD	O	enhance	_	0	SENT_97	[p5l699t140r1040b203],
5	platelet	NN	O	platelet	nn	6	SENT_97	[p5l1057t140r1332b221],
6	aggregation	NN	O	aggregation	nsubj	11	SENT_97	[p5l1361t145r1786b221],
7	in	IN	O	in	_	0	SENT_97	[p5l1824t145r1885b203],
8	clopidogrel	NN	O	clopidogrel	nn	10	SENT_97	[p5l10t246r632b327],
9	—	CD	NUMBER	—	num	10	SENT_97	[p5l10t246r632b327],
10	nai	NNS	O	naus	prep_in	6	SENT_97	[p5l10t246r632b327],
11	've	VBP	O	have	ccomp	4	SENT_97	[p5l10t246r632b327],
12	subjects	NNS	O	subject	dobj	11	SENT_97	[p5l661t246r945b327],

1	Thirteen	CD	NUMBER	thirteen	nsubj	6	SENT_98	[p5l117t458r397b521],
2	of	IN	O	of	_	0	SENT_98	[p5l417t458r496b521],
3	43	CD	NUMBER	43	num	5	SENT_98	[p5l502t460r581b521],
4	blood	NN	O	blood	nn	5	SENT_98	[p5l604t458r798b521],
5	donors	NNS	O	donor	prep_of	1	SENT_98	[p5l817t458r1041b521],
6	(	VBP	O	(	ccomp	19	SENT_98	[p5l1063t458r1168b538],
7	28	CD	NUMBER	28	num	8	SENT_98	[p5l1063t458r1168b538],
8	men	NNS	O	man	dobj	6	SENT_98	[p5l1190t479r1337b521],
9	and	CC	O	and	_	0	SENT_98	[p5l1356t458r1477b521],
10	15	CD	NUMBER	15	num	11	SENT_98	[p5l1503t460r1574b521],
11	women	NNS	O	woman	conj_and	8	SENT_98	[p5l1596t479r1864b534],
12	,	,	O	,	_	0	SENT_98	[p5l1596t479r1864b534],
13	31	CD	NUMBER	31	num	16	SENT_98	[p5l1887t460r1960b521],
14	i9	NN	O	i9	nn	16	SENT_98	[p5l1979t460r2140b521],
15	.6	CD	DURATION	.6	num	16	SENT_98	[p5l1979t460r2140b521],
16	years	NNS	NUMBER	year	nsubj	19	SENT_98	[p5l8t584r182b645],
17	old	JJ	DURATION	old	amod	16	SENT_98	[p5l210t564r340b644],
18	)	CD	NUMBER	)	tmod	17	SENT_98	[p5l210t564r340b644],
19	exhibited	VBD	O	exhibit	_	0	SENT_98	[p5l369t564r677b627],
20	a	DT	O	a	det	22	SENT_98	[p5l703t584r740b626],
21	G52T	NN	O	g52t	nn	22	SENT_98	[p5l765t565r961b627],
22	transversion	NN	O	transversion	dobj	19	SENT_98	[p5l986t564r1391b627],
23	in	IN	O	in	_	0	SENT_98	[p5l1417t564r1480b626],
24	the	DT	O	the	det	26	SENT_98	[p5l1505t564r1605b627],
25	P2Y12-receptor	NN	O	p2y12-receptor	nn	26	SENT_98	[p5l1631t565r2144b644],
26	gene	NN	O	gene	prep_in	19	SENT_98	[p5l10t690r183b751],
27	.	.	O	.	_	0	SENT_98	[p5l10t690r183b751],

1	There	EX	O	there	expl	2	SENT_99	[p5l210t670r402b733],
2	were	VBD	O	be	_	0	SENT_99	[p5l424t690r586b733],
3	11	CD	NUMBER	11	num	4	SENT_99	[p5l618t671r681b732],
4	heterozygote	NN	O	heterozygote	nsubj	2	SENT_99	[p5l711t670r1140b751],
5	and	CC	O	and	_	0	SENT_99	[p5l1164t670r1285b733],
6	2	CD	NUMBER	2	num	8	SENT_99	[p5l1305t671r1345b732],
7	homozygote	NN	O	homozygote	nn	8	SENT_99	[p5l1368t670r1784b751],
8	carriers	NNS	O	carrier	nsubj	2	SENT_99	[p5l1808t670r2049b733],
9	of	IN	O	of	_	0	SENT_99	[p5l2074t670r2152b733],
10	the	DT	O	the	det	12	SENT_99	[p5l8t776r109b839],
11	H2	NN	O	h2	nn	12	SENT_99	[p5l129t778r231b838],
12	haplotype	NN	O	haplotype	prep_of	4	SENT_99	[p5l252t776r596b857],
13	.	.	O	.	_	0	SENT_99	[p5l252t776r596b857],

1	Aggregation	NN	O	aggregation	nsubj	2	SENT_100	[p5l620t776r1040b857],
2	correlated	VBD	O	correlate	ccomp	16	SENT_100	[p5l1060t776r1388b839],
3	with	IN	O	with	_	0	SENT_100	[p5l1406t776r1555b839],
4	the	DT	O	the	det	7	SENT_100	[p5l1574t776r1675b839],
5	number	NN	O	number	nn	7	SENT_100	[p5l1694t776r1955b839],
6	(	CD	NUMBER	(	num	7	SENT_100	[p5l1974t777r2057b857],
7	o	NN	O	o	prep_with	2	SENT_100	[p5l1974t777r2057b857],
8	,	,	O	,	_	0	SENT_100	[p5l1974t777r2057b857],
9	1	CD	NUMBER	1	appos	7	SENT_100	[p5l2089t778r2139b853],
10	,	,	O	,	_	0	SENT_100	[p5l2089t778r2139b853],
11	2	CD	NUMBER	2	num	12	SENT_100	[p5l9t882r77b963],
12	)	NN	O	)	nsubj	16	SENT_100	[p5l9t882r77b963],
13	of	IN	O	of	_	0	SENT_100	[p5l106t882r185b945],
14	H2	NN	O	h2	nn	15	SENT_100	[p5l200t884r302b944],
15	alleles	NNS	O	allele	prep_of	12	SENT_100	[p5l333t882r538b945],
16	(	VBP	O	(	_	0	SENT_100	[p5l568t883r907b963],
17	p	NN	O	p	dobj	16	SENT_100	[p5l568t883r907b963],
18	=	JJ	O	=	amod	17	SENT_100	[p5l568t883r907b963],
19	0.041	CD	NUMBER	0.041	tmod	18	SENT_100	[p5l568t883r907b963],
20	,	,	O	,	_	0	SENT_100	[p5l568t883r907b963],
21	Speannan	NNP	O	Speannan	nn	23	SENT_100	[p5l941t884r1273b963],
22	Rank	NNP	O	Rank	nn	23	SENT_100	[p5l1299t882r1520b963],
23	)	NNP	O	)	appos	17	SENT_100	[p5l1299t882r1520b963],
24	:	:	O	:	_	0	SENT_100	[p5l1299t882r1520b963],
25	6-min	JJ	DURATION	6-min	amod	27	SENT_100	[p5l1555t882r1753b945],
26	impedance	NN	O	impedance	nn	27	SENT_100	[p5l1781t882r2141b963],
27	results	NNS	O	result	nsubj	30	SENT_100	[p5l8t988r221b1051],
28	were	VBD	O	be	cop	30	SENT_100	[p5l250t1009r411b1051],
29	8.4	CD	NUMBER	8.4	num	30	SENT_100	[p5l444t989r734b1064],
30	i3	NN	O	i3	rcmod	17	SENT_100	[p5l444t989r734b1064],
31	.6	CD	NUMBER	.6	dep	30	SENT_100	[p5l444t989r734b1064],
32	,	,	O	,	_	0	SENT_100	[p5l444t989r734b1064],
33	10511.6	CD	NUMBER	10511.6	conj_and	30	SENT_100	[p5l774t989r1082b1051],
34	and	CC	O	and	_	0	SENT_100	[p5l1114t988r1235b1051],
35	12.5	CD	NUMBER	12.5	number	36	SENT_100	[p5l1271t989r1403b1051],
36	:21	CD	NUMBER	:21	conj_and	30	SENT_100	[p5l1418t990r1571b1051],
37	Q	NNP	O	Q	dep	36	SENT_100	[p5l1612t985r1678b1050],
38	in	IN	O	in	_	0	SENT_100	[p5l1710t988r1774b1050],
39	carriers	NNS	O	carrier	prep_in	30	SENT_100	[p5l1802t988r2043b1051],
40	of	IN	O	of	_	0	SENT_100	[p5l2074t988r2152b1051],
41	the	DT	O	the	det	47	SENT_100	[p5l8t1094r109b1157],
42	H1/H1	NN	O	h1/h1	nn	47	SENT_100	[p5l134t1094r381b1170],
43	,	,	O	,	_	0	SENT_100	[p5l134t1094r381b1170],
44	H1/H2	NN	O	h1/h2	nn	47	SENT_100	[p5l408t1094r636b1157],
45	and	CC	O	and	_	0	SENT_100	[p5l664t1094r785b1157],
46	H2/H2	NN	O	h2/h2	nn	47	SENT_100	[p5l808t1094r1036b1157],
47	haplotypes	NNS	O	haplotype	prep_of	39	SENT_100	[p5l1062t1094r1441b1174],
48	,	,	O	,	_	0	SENT_100	[p5l1062t1094r1441b1174],
49	respectively	RB	O	respectively	advmod	30	SENT_100	[p5l1467t1094r1876b1174],
50	.	.	O	.	_	0	SENT_100	[p5l1467t1094r1876b1174],

1	3.2	CD	NUMBER	3.2	_	0	SENT_101	[p5l11t1308r131b1369],
2	.	.	O	.	_	0	SENT_101	[p5l11t1308r131b1369],

1	The	DT	O	the	det	4	SENT_102	[p5l177t1306r304b1369],
2	homozygote	NN	O	homozygote	nn	4	SENT_102	[p5l336t1306r756b1387],
3	H2	NN	O	h2	nn	4	SENT_102	[p5l785t1308r893b1368],
4	haplotype	NN	O	haplotype	nsubjpass	6	SENT_102	[p5l927t1306r1274b1387],
5	was	VBD	O	be	auxpass	6	SENT_102	[p5l1305t1328r1440b1369],
6	associated	VBN	O	associate	_	0	SENT_102	[p5l1474t1306r1849b1369],
7	with	IN	O	with	_	0	SENT_102	[p5l1876t1306r2022b1369],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_102	[p5l10t1412r415b1492],
9	resistance	NN	O	resistance	prep_with	6	SENT_102	[p5l445t1417r796b1474],

1	In	IN	O	in	_	0	SENT_103	[p5l117t1626r188b1686],
2	our	PRP$	O	we	poss	3	SENT_103	[p5l223t1644r339b1687],
3	study	NN	O	study	prep_in	15	SENT_103	[p5l374t1624r575b1704],
4	,	,	O	,	_	0	SENT_103	[p5l374t1624r575b1704],
5	H1	NN	O	h1	nn	9	SENT_103	[p5l612t1625r709b1686],
6	and	CC	O	and	_	0	SENT_103	[p5l754t1624r879b1687],
7	H2	NN	O	h2	nn	9	SENT_103	[p5l912t1625r1016b1686],
8	allele	NN	O	allele	nn	9	SENT_103	[p5l1055t1624r1238b1687],
9	frequencies	NNS	O	frequency	nsubj	15	SENT_103	[p5l1276t1624r1676b1704],
10	were	VBD	O	be	cop	15	SENT_103	[p5l1711t1644r1879b1687],
11	84.6	CD	PERCENT	84.6	number	15	SENT_103	[p5l1918t1625r2140b1688],
12	%	NN	PERCENT	%	dep	15	SENT_103	[p5l1918t1625r2140b1688],
13	and	CC	O	and	_	0	SENT_103	[p5l11t1730r136b1793],
14	15.4	CD	PERCENT	15.4	conj_and	15	SENT_103	[p5l199t1732r435b1807],
15	%	NN	PERCENT	%	_	0	SENT_103	[p5l199t1732r435b1807],
16	,	,	O	,	_	0	SENT_103	[p5l199t1732r435b1807],
17	respectively	RB	O	respectively	advmod	15	SENT_103	[p5l493t1730r930b1811],
18	,	,	O	,	_	0	SENT_103	[p5l493t1730r930b1811],
19	which	WDT	O	which	nsubj	20	SENT_103	[p5l987t1730r1202b1793],
20	was	VBD	O	be	rcmod	15	SENT_103	[p5l1256t1751r1390b1793],
21	in	IN	O	in	_	0	SENT_103	[p5l1448t1730r1514b1792],
22	agreement	NN	O	agreement	prep_in	20	SENT_103	[p5l1569t1739r1934b1811],
23	with	IN	O	with	_	0	SENT_103	[p5l1986t1730r2141b1793],
24	Hardy	NNP	PERSON	Hardy	prep_with	22	SENT_103	[p5l9t1836r622b1917],
25	.	.	O	.	_	0	SENT_103	[p5l9t1836r622b1917],

1	—	NN	O	—	_	0	SENT_104	[p5l9t1836r622b1917],
2	.	.	O	.	_	0	SENT_104	[p5l9t1836r622b1917],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_105	[p5l9t1836r622b1917],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_105	[p5l658t1836r1082b1917],
3	.	.	O	.	_	0	SENT_105	[p5l658t1836r1082b1917],

1	Among	IN	O	among	_	0	SENT_106	[p5l1121t1837r1385b1917],
2	557	CD	NUMBER	557	num	3	SENT_106	[p5l1423t1839r1549b1899],
3	patients	NNS	O	patient	prep_among	24	SENT_106	[p5l1584t1836r1876b1917],
4	,	,	O	,	_	0	SENT_106	[p5l1584t1836r1876b1917],
5	25.9	CD	PERCENT	25.9	num	6	SENT_106	[p5l1915t1837r2140b1900],
6	%	NN	PERCENT	%	dep	11	SENT_106	[p5l1915t1837r2140b1900],
7	(	CD	NUMBER	(	num	8	SENT_106	[p5l11t1942r313b2022],
8	n	NN	O	n	dep	6	SENT_106	[p5l11t1942r313b2022],
9	=	JJ	O	=	dep	11	SENT_106	[p5l11t1942r313b2022],
10	144	CD	NUMBER	144	num	11	SENT_106	[p5l11t1942r313b2022],
11	)	NN	O	)	dep	16	SENT_106	[p5l11t1942r313b2022],
12	and	CC	O	and	_	0	SENT_106	[p5l356t1942r481b2005],
13	2.5	CD	PERCENT	2.5	num	14	SENT_106	[p5l521t1943r702b2006],
14	%	NN	PERCENT	%	conj_and	11	SENT_106	[p5l521t1943r702b2006],
15	(	CD	NUMBER	(	num	16	SENT_106	[p5l745t1942r874b2022],
16	n	NN	O	n	dep	24	SENT_106	[p5l745t1942r874b2022],
17	=	JJ	O	=	amod	19	SENT_106	[p5l745t1942r874b2022],
18	14	CD	NUMBER	14	num	19	SENT_106	[p5l897t1942r1002b2022],
19	)	NN	O	)	nsubj	24	SENT_106	[p5l897t1942r1002b2022],
20	were	VBD	O	be	cop	24	SENT_106	[p5l1043t1962r1212b2005],
21	heterozygote	NN	O	heterozygote	nn	24	SENT_106	[p5l1252t1942r1705b2022],
22	and	CC	O	and	_	0	SENT_106	[p5l1748t1942r1873b2005],
23	homozygote	NN	O	homozygote	nn	24	SENT_106	[p5l1912t1942r2139b2005, p5l9t2057r242b2129],
24	carriers	NNS	O	carrier	_	0	SENT_106	[p5l266t2048r523b2111],
25	of	IN	O	of	_	0	SENT_106	[p5l548t2049r628b2111],
26	the	DT	O	the	det	28	SENT_106	[p5l639t2048r744b2111],
27	H2	NN	O	h2	nn	28	SENT_106	[p5l767t2050r870b2110],
28	haplotype	NN	O	haplotype	prep_of	24	SENT_106	[p5l895t2048r1260b2129],
29	,	,	O	,	_	0	SENT_106	[p5l895t2048r1260b2129],
30	respectively	RB	O	respectively	advmod	24	SENT_106	[p5l1285t2048r1720b2129],
31	.	.	O	.	_	0	SENT_106	[p5l1285t2048r1720b2129],

1	There	EX	O	there	expl	2	SENT_107	[p5l1749t2048r1950b2111],
2	were	VBD	O	be	_	0	SENT_107	[p5l1972t2069r2140b2111],
3	almost	RB	O	almost	advmod	4	SENT_107	[p5l11t2154r243b2217],
4	twice	RB	O	twice	advmod	2	SENT_107	[p5l278t2154r466b2217],
5	as	IN	O	as	mark	8	SENT_107	[p5l506t2175r574b2217],
6	many	JJ	O	many	amod	7	SENT_107	[p5l612t2175r807b2235],
7	women	NNS	O	woman	nsubj	8	SENT_107	[p5l843t2174r1103b2217],
8	(	VBP	O	(	ccomp	4	SENT_107	[p5l1142t2154r1554b2235],
9	p	NN	O	p	dobj	8	SENT_107	[p5l1142t2154r1554b2235],
10	=	JJ	O	=	amod	9	SENT_107	[p5l1142t2154r1554b2235],
11	0.0387	CD	NUMBER	0.0387	tmod	10	SENT_107	[p5l1142t2154r1554b2235],
12	)	NN	O	)	dep	19	SENT_107	[p5l1142t2154r1554b2235],
13	among	IN	O	among	_	0	SENT_107	[p5l1595t2175r1832b2235],
14	patients	NNS	O	patient	prep_among	12	SENT_107	[p5l1868t2154r2139b2235],
15	with	IN	O	with	_	0	SENT_107	[p5l8t2260r165b2323],
16	(	NN	O	(	prep_with	14	SENT_107	[p5l215t2260r496b2340],
17	57.1	CD	PERCENT	57.1	num	18	SENT_107	[p5l215t2260r496b2340],
18	%	NN	PERCENT	%	dep	19	SENT_107	[p5l215t2260r496b2340],
19	)	CD	NUMBER	)	dep	25	SENT_107	[p5l215t2260r496b2340],
20	than	IN	O	than	prep	19	SENT_107	[p5l547t2260r697b2322],
21	without	IN	O	without	pcomp	20	SENT_107	[p5l746t2260r1015b2323],
22	(	CD	PERCENT	(	pobj	21	SENT_107	[p5l1066t2260r1347b2340],
23	29.8	CD	PERCENT	29.8	number	24	SENT_107	[p5l1066t2260r1347b2340],
24	%	NN	PERCENT	%	amod	22	SENT_107	[p5l1066t2260r1347b2340],
25	)	CD	NUMBER	)	dep	28	SENT_107	[p5l1066t2260r1347b2340],
26	a	DT	O	a	det	28	SENT_107	[p5l1399t2280r1436b2322],
27	H2/H2	NN	O	h2/h2	nn	28	SENT_107	[p5l1483t2260r1720b2323],
28	haplotype	NN	O	haplotype	dep	8	SENT_107	[p5l1771t2260r2136b2341],
29	.	.	O	.	_	0	SENT_107	[p5l1771t2260r2136b2341],

1	Otherwise	RB	O	otherwise	advmod	12	SENT_108	[p5l11t2366r387b2442],
2	,	,	O	,	_	0	SENT_108	[p5l11t2366r387b2442],
3	the	DT	O	the	det	4	SENT_108	[p5l412t2366r517b2429],
4	characteristics	NNS	O	characteristic	nsubj	12	SENT_108	[p5l540t2366r1036b2429],
5	of	IN	O	of	_	0	SENT_108	[p5l1060t2366r1141b2429],
6	homozygote	NN	O	homozygote	nn	8	SENT_108	[p5l1150t2366r1586b2447],
7	H2	NN	O	h2	nn	8	SENT_108	[p5l1608t2368r1711b2428],
8	carriers	NNS	O	carrier	prep_of	4	SENT_108	[p5l1737t2366r1992b2429],
9	and	CC	O	and	_	0	SENT_108	[p5l2017t2366r2142b2429],
10	noncarriers	NNS	O	noncarrier	prep_of	4	SENT_108	[p5l8t2472r400b2535],
11	were	VBD	O	be	cop	12	SENT_108	[p5l427t2492r595b2535],
12	comparable	JJ	O	comparable	_	0	SENT_108	[p5l623t2472r1029b2552],
13	for	IN	O	for	_	0	SENT_108	[p5l1057t2472r1157b2535],
14	age	NN	O	age	nn	18	SENT_108	[p5l1181t2492r1299b2553],
15	and	CC	O	and	_	0	SENT_108	[p5l1327t2472r1452b2535],
16	cardiovascular	JJ	O	cardiovascular	nn	18	SENT_108	[p5l1478t2472r1989b2535],
17	risk	NN	O	risk	nn	18	SENT_108	[p5l2011t2472r2143b2535],
18	factors	NNS	O	factor	prep_for	12	SENT_108	[p5l11t2578r244b2641],
19	such	JJ	O	such	_	0	SENT_108	[p5l278t2578r436b2641],
20	as	IN	O	as	_	0	SENT_108	[p5l466t2599r534b2641],
21	diabetes	NN	O	diabetes	prep_such_as	18	SENT_108	[p5l566t2578r870b2655],
22	,	,	O	,	_	0	SENT_108	[p5l566t2578r870b2655],
23	current	JJ	DATE	current	amod	25	SENT_108	[p5l905t2587r1151b2641],
24	smoking	NN	O	smoking	nn	25	SENT_108	[p5l1182t2578r1481b2659],
25	status	NN	O	status	appos	21	SENT_108	[p5l1514t2587r1708b2641],
26	and	CC	O	and	_	0	SENT_108	[p5l1740t2578r1866b2641],
27	plasma	NN	O	plasma	nn	28	SENT_108	[p5l1892t2578r2142b2659],
28	lipoprotein	NN	O	lipoprotein	appos	21	SENT_108	[p5l10t2684r394b2765],
29	cholesterol	NN	O	cholesterol	nn	31	SENT_108	[p5l419t2684r801b2747],
30	(	CD	NUMBER	(	num	31	SENT_108	[p5l826t2684r1044b2765],
31	Table	NNP	O	Table	dep	25	SENT_108	[p5l826t2684r1044b2765],
32	1	CD	NUMBER	1	number	33	SENT_108	[p5l1078t2684r1157b2765],
33	)	CD	NUMBER	)	dep	31	SENT_108	[p5l1078t2684r1157b2765],
34	.	.	O	.	_	0	SENT_108	[p5l1078t2684r1157b2765],

1	No	DT	O	no	det	2	SENT_109	[p5l1182t2687r1289b2747],
2	difference	NN	O	difference	nsubjpass	4	SENT_109	[p5l1315t2684r1666b2747],
3	was	VBD	O	be	auxpass	4	SENT_109	[p5l1688t2705r1822b2747],
4	found	VBN	O	find	_	0	SENT_109	[p5l1849t2684r2052b2747],
5	in	IN	O	in	_	0	SENT_109	[p5l2076t2684r2142b2746],
6	blood	NN	O	blood	nn	8	SENT_109	[p5l8t2790r210b2853],
7	cell	NN	O	cell	nn	8	SENT_109	[p5l235t2790r358b2853],
8	counts	NNS	O	count	prep_in	4	SENT_109	[p5l384t2799r631b2866],
9	,	,	O	,	_	0	SENT_109	[p5l384t2799r631b2866],
10	indications	NNS	O	indication	prep_in	4	SENT_109	[p5l660t2790r1042b2853],
11	for	IN	O	for	_	0	SENT_109	[p5l1070t2790r1171b2853],
12	PCI	NN	O	pcus	nn	14	SENT_109	[p5l1193t2791r1327b2853],
13	(	CD	NUMBER	(	num	14	SENT_109	[p5l1355t2790r1548b2870],
14	ACS	NN	ORGANIZATION	ac	prep_for	10	SENT_109	[p5l1355t2790r1548b2870],
15	vs.	CC	O	vs.	prep	14	SENT_109	[p5l1575t2810r1670b2853],
16	stable	JJ	O	stable	amod	18	SENT_109	[p5l1703t2790r1901b2853],
17	CAD	NN	O	cad	nn	18	SENT_109	[p5l1929t2790r2139b2870],
18	)	NN	O	)	dep	15	SENT_109	[p5l1929t2790r2139b2870],
19	and	CC	O	and	_	0	SENT_109	[p5l11t2896r137b2959],
20	interventional	JJ	O	interventional	amod	21	SENT_109	[p5l196t2896r683b2959],
21	parameters	NNS	O	parameter	conj_and	8	SENT_109	[p5l741t2904r1125b2976],
22	including	VBG	O	include	_	0	SENT_109	[p5l1187t2896r1518b2976],
23	the	DT	O	the	det	24	SENT_109	[p5l1577t2896r1683b2959],
24	number	NN	O	number	prep_including	21	SENT_109	[p5l1742t2896r2014b2959],
25	of	IN	O	of	_	0	SENT_109	[p5l2072t2896r2152b2959],
26	stents	NNS	O	stent	prep_of	24	SENT_109	[p5l12t3011r227b3078],
27	,	,	O	,	_	0	SENT_109	[p5l12t3011r227b3078],
28	maximal	JJ	O	maximal	amod	30	SENT_109	[p5l275t3002r581b3065],
29	stent	NN	O	stent	nn	30	SENT_109	[p5l630t3011r792b3065],
30	length	NN	O	length	conj_and	26	SENT_109	[p5l838t3002r1055b3083],
31	and	CC	O	and	_	0	SENT_109	[p5l1103t3002r1228b3065],
32	minimal	JJ	O	minimal	amod	34	SENT_109	[p5l1272t3002r1564b3065],
33	stent	NN	O	stent	nn	34	SENT_109	[p5l1612t3011r1774b3065],
34	diameter	NN	O	diameter	prep_of	24	SENT_109	[p5l1820t3002r2136b3065],
35	.	.	O	.	_	0	SENT_109	[p5l1820t3002r2136b3065],

1	Notably	RB	O	notably	advmod	8	SENT_110	[p5l7t3108r305b3189],
2	,	,	O	,	_	0	SENT_110	[p5l7t3108r305b3189],
3	clopidogrel	NN	O	clopidogrel	nn	5	SENT_110	[p5l338t3108r736b3189],
4	loading	NN	O	loading	nn	5	SENT_110	[p5l765t3108r1025b3189],
5	doses	NNS	O	dose	nsubj	8	SENT_110	[p5l1055t3108r1247b3171],
6	were	VBD	O	be	cop	8	SENT_110	[p5l1275t3128r1443b3171],
7	also	RB	O	also	advmod	8	SENT_110	[p5l1473t3108r1609b3171],
8	comparable	JJ	O	comparable	dep	12	SENT_110	[p5l1640t3108r2046b3189],
9	in	IN	O	in	_	0	SENT_110	[p5l2076t3108r2142b3170],
10	both	DT	O	both	det	11	SENT_110	[p5l8t3214r165b3277],
11	groups	NNS	O	group	prep_in	8	SENT_110	[p5l195t3235r431b3295],
12	(	VBP	O	(	_	0	SENT_110	[p5l464t3214r682b3295],
13	Table	NNP	O	Table	dobj	12	SENT_110	[p5l464t3214r682b3295],
14	1	CD	NUMBER	1	num	13	SENT_110	[p5l721t3214r800b3295],
15	)	CD	NUMBER	)	nsubj	12	SENT_110	[p5l721t3214r800b3295],
16	.	.	O	.	_	0	SENT_110	[p5l721t3214r800b3295],

1	Impedance	NN	O	impedance	nn	2	SENT_111	[p5l117t3320r493b3401],
2	results	NNS	O	result	nsubj	6	SENT_111	[p5l520t3320r741b3384],
3	were	VBD	O	be	cop	6	SENT_111	[p5l768t3341r934b3384],
4	1.8	CD	NUMBER	1.8	num	6	SENT_111	[p5l971t3322r1266b3397],
5	i3	NN	O	i3	nn	6	SENT_111	[p5l971t3322r1266b3397],
6	.2	NN	NUMBER	.2	ccomp	23	SENT_111	[p5l971t3322r1266b3397],
7	,	,	O	,	_	0	SENT_111	[p5l971t3322r1266b3397],
8	1.9	CD	NUMBER	1.9	num	9	SENT_111	[p5l1304t3322r1578b3384],
9	i3	NN	O	i3	nsubj	23	SENT_111	[p5l1304t3322r1578b3384],
10	.6	CD	NUMBER	.6	dep	9	SENT_111	[p5l1304t3322r1578b3384],
11	and	CC	O	and	_	0	SENT_111	[p5l1608t3320r1732b3384],
12	6.3	CD	NUMBER	6.3	dep	9	SENT_111	[p5l1760t3321r2037b3384],
13	i7	NN	O	i7	nn	15	SENT_111	[p5l1760t3321r2037b3384],
14	.5	CD	NUMBER	.5	num	15	SENT_111	[p5l1760t3321r2037b3384],
15	Q	NNP	O	Q	dep	9	SENT_111	[p5l2073t3318r2138b3383],
16	in	IN	O	in	_	0	SENT_111	[p5l10t3427r77b3489],
17	carriers	NNS	O	carrier	prep_in	15	SENT_111	[p5l97t3427r348b3490],
18	of	IN	O	of	_	0	SENT_111	[p5l371t3427r452b3490],
19	the	DT	O	the	det	22	SENT_111	[p5l461t3427r564b3490],
20	H1/H1	NN	O	h1/h1	nn	22	SENT_111	[p5l586t3427r812b3490],
21	(	NN	O	(	nn	22	SENT_111	[p5l844t3427r909b3507],
22	n	NN	O	n	prep_of	17	SENT_111	[p5l844t3427r909b3507],
23	=	JJ	O	=	_	0	SENT_111	[p5l924t3427r1160b3507],
24	399	CD	NUMBER	399	num	25	SENT_111	[p5l924t3427r1160b3507],
25	)	NN	O	)	dobj	23	SENT_111	[p5l924t3427r1160b3507],
26	,	,	O	,	_	0	SENT_111	[p5l924t3427r1160b3507],
27	H1/H2	NN	O	h1/h2	nn	29	SENT_111	[p5l1184t3427r1417b3490],
28	(	NN	O	(	nn	29	SENT_111	[p5l1443t3427r1508b3507],
29	n	NN	O	n	dobj	23	SENT_111	[p5l1443t3427r1508b3507],
30	=	JJ	O	=	amod	32	SENT_111	[p5l1523t3450r1570b3468],
31	144	CD	NUMBER	144	tmod	30	SENT_111	[p5l1592t3427r1739b3507],
32	)	NN	O	)	dep	29	SENT_111	[p5l1592t3427r1739b3507],
33	and	CC	O	and	_	0	SENT_111	[p5l1763t3427r1886b3490],
34	H2/H2	NN	O	h2/h2	nn	36	SENT_111	[p5l1906t3427r2138b3490],
35	(	CD	NUMBER	(	num	36	SENT_111	[p5l11t3534r268b3614],
36	n	NN	O	n	conj_and	25	SENT_111	[p5l11t3534r268b3614],
37	=	JJ	O	=	amod	40	SENT_111	[p5l11t3534r268b3614],
38	14	CD	NUMBER	14	num	40	SENT_111	[p5l11t3534r268b3614],
39	)	CD	NUMBER	)	num	40	SENT_111	[p5l11t3534r268b3614],
40	haplotypes	NNS	O	haplotype	dep	36	SENT_111	[p5l327t3533r725b3614],
41	,	,	O	,	_	0	SENT_111	[p5l327t3533r725b3614],
42	respectively	RB	O	respectively	advmod	36	SENT_111	[p5l786t3533r1218b3614],
43	.	.	O	.	_	0	SENT_111	[p5l786t3533r1218b3614],

1	Thus	RB	O	thus	advmod	6	SENT_112	[p5l1283t3533r1475b3610],
2	,	,	O	,	_	0	SENT_112	[p5l1283t3533r1475b3610],
3	aggregation	NN	O	aggregation	nsubjpass	6	SENT_112	[p5l1539t3533r1949b3614],
4	was	VBD	O	be	auxpass	6	SENT_112	[p5l2006t3554r2140b3596],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_112	[p5l12t3639r437b3720],
6	enhanced	VBN	O	enhance	_	0	SENT_112	[p5l474t3639r800b3702],
7	(	NN	O	(	nn	8	SENT_112	[p5l835t3639r1240b3720],
8	p	NN	O	p	dobj	6	SENT_112	[p5l835t3639r1240b3720],
9	=	JJ	O	=	dep	15	SENT_112	[p5l835t3639r1240b3720],
10	0.0212	CD	NUMBER	0.0212	num	11	SENT_112	[p5l835t3639r1240b3720],
11	)	NN	O	)	nsubj	15	SENT_112	[p5l835t3639r1240b3720],
12	in	IN	O	in	_	0	SENT_112	[p5l1278t3639r1343b3701],
13	H2/H2	NN	O	h2/h2	nn	14	SENT_112	[p5l1378t3639r1611b3702],
14	carriers	NNS	O	carrier	prep_in	11	SENT_112	[p5l1650t3639r1901b3702],
15	(	VBP	O	(	dep	6	SENT_112	[p5l1940t3639r2131b3719],
16	6.3	CD	NUMBER	6.3	dobj	15	SENT_112	[p5l1940t3639r2131b3719],
17	i	FW	O	i	dep	16	SENT_112	[p5l1940t3639r2131b3719],

1	7.5	CD	NUMBER	7.5	num	2	SENT_113	[p6l11t24r112b85],
2	Q	NNP	O	Q	nsubj	14	SENT_113	[p6l141t18r236b102],
3	)	CD	NUMBER	)	num	2	SENT_113	[p6l141t18r236b102],
4	compared	VBN	O	compare	_	0	SENT_113	[p6l260t21r600b102],
5	to	TO	O	to	prepc_compared_to	2	SENT_113	[p6l618t30r683b85],
6	the	DT	O	the	det	8	SENT_113	[p6l704t21r808b85],
7	combined	JJ	O	combined	amod	8	SENT_113	[p6l831t21r1172b85],
8	group	NN	O	group	pobj	2	SENT_113	[p6l1193t42r1390b103],
9	of	IN	O	of	_	0	SENT_113	[p6l1415t21r1495b85],
10	H1/H1	NN	O	h1/h1	nn	13	SENT_113	[p6l1505t21r1730b85],
11	and	CC	O	and	_	0	SENT_113	[p6l1763t21r1886b85],
12	H1/H2	NN	O	h1/h2	conj_and	10	SENT_113	[p6l1906t21r2138b85],
13	carriers	NNS	O	carrier	prep_of	8	SENT_113	[p6l11t129r262b192],
14	(	VBP	O	(	_	0	SENT_113	[p6l287t129r591b210],
15	1.8	CD	NUMBER	1.8	num	17	SENT_113	[p6l287t129r591b210],
16	i3	NN	O	i3	nn	17	SENT_113	[p6l287t129r591b210],
17	.3	NN	NUMBER	.3	nsubj	19	SENT_113	[p6l287t129r591b210],
18	9	CD	NUMBER	9	num	19	SENT_113	[p6l622t126r736b210],
19	)	NN	O	)	xcomp	14	SENT_113	[p6l622t126r736b210],
20	.	.	O	.	_	0	SENT_113	[p6l622t126r736b210],

1	Applying	VBG	O	apply	partmod	12	SENT_114	[p6l761t128r1089b210],
2	a	DT	O	a	det	4	SENT_114	[p6l1113t150r1149b192],
3	cut	NN	O	cut	nn	4	SENT_114	[p6l1171t129r1410b192],
4	—	NN	O	—	dobj	1	SENT_114	[p6l1171t129r1410b192],
5	off	IN	O	off	_	0	SENT_114	[p6l1171t129r1410b192],
6	of	IN	O	of	_	0	SENT_114	[p6l1423t129r1503b192],
7	5	CD	NUMBER	5	number	8	SENT_114	[p6l1516t131r1551b192],
8	(	CD	NUMBER	(	num	9	SENT_114	[p6l1581t126r1668b206],
9	Z	NN	O	z	prep_off_of	1	SENT_114	[p6l1581t126r1668b206],
10	,	,	O	,	_	0	SENT_114	[p6l1581t126r1668b206],
11	we	PRP	O	we	nsubj	12	SENT_114	[p6l1692t150r1792b192],
12	identiﬁed	VBD	O	identiﬁed	_	0	SENT_114	[p6l1816t128r2143b192],
13	87.1	CD	PERCENT	87.1	num	14	SENT_114	[p6l13t237r246b299],
14	%	NN	PERCENT	%	dep	24	SENT_114	[p6l13t237r246b299],
15	(	CD	NUMBER	(	num	16	SENT_114	[p6l314t235r386b316],
16	n	NN	O	n	dep	14	SENT_114	[p6l314t235r386b316],
17	=	JJ	O	=	quantmod	18	SENT_114	[p6l404t235r634b316],
18	485	CD	NUMBER	485	num	19	SENT_114	[p6l404t235r634b316],
19	)	NN	O	)	dep	16	SENT_114	[p6l404t235r634b316],
20	and	CC	O	and	_	0	SENT_114	[p6l703t235r833b298],
21	12.9	CD	PERCENT	12.9	num	22	SENT_114	[p6l906t237r1133b299],
22	%	NN	PERCENT	%	dobj	12	SENT_114	[p6l906t237r1133b299],
23	(	CD	NUMBER	(	num	24	SENT_114	[p6l1201t236r1274b315],
24	n	NN	O	n	dobj	12	SENT_114	[p6l1201t236r1274b315],
25	=	JJ	O	=	prep	24	SENT_114	[p6l1292t258r1340b277],
26	72	CD	NUMBER	72	num	28	SENT_114	[p6l1358t236r1475b315],
27	)	CD	NUMBER	)	num	28	SENT_114	[p6l1358t236r1475b315],
28	responders	NNS	O	responder	dep	25	SENT_114	[p6l1541t235r1944b316],
29	and	CC	O	and	_	0	SENT_114	[p6l2012t235r2142b298],

1	P	NN	O	p	nn	2	SENT_115	[p6l307t392r328b415],
2	Staritz	NNP	O	Staritz	_	0	SENT_115	[p6l343t392r429b415],
3	et	FW	O	et	nn	4	SENT_115	[p6l440t396r464b415],
4	al.	FW	O	al.	dep	2	SENT_115	[p6l474t391r504b415],
5	/	:	O	/	punct	2	SENT_115	[p6l518t391r531b415],
6	International	NNP	ORGANIZATION	International	nn	7	SENT_115	[p6l538t391r713b415],
7	Journal	NNP	ORGANIZATION	Journal	dep	2	SENT_115	[p6l722t391r827b415],
8	of	IN	ORGANIZATION	of	_	0	SENT_115	[p6l837t391r869b422],
9	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	7	SENT_115	[p6l875t391r1023b422],
10	133	CD	NUMBER	133	number	11	SENT_115	[p6l1035t392r1082b415],
11	(	CD	NUMBER	(	num	12	SENT_115	[p6l1096t391r1180b422],
12	2009	CD	DATE	2009	dep	9	SENT_115	[p6l1096t391r1180b422],
13	)	CD	NUMBER	)	num	15	SENT_115	[p6l1096t391r1180b422],
14	34I	NN	O	34us	nn	15	SENT_115	[p6l1194t392r1308b415],
15	—	NN	O	—	dep	9	SENT_115	[p6l1194t392r1308b415],
16	345	CD	NUMBER	345	number	17	SENT_115	[p6l1194t392r1308b415],
17	343	CD	NUMBER	343	dep	15	SENT_115	[p6l1806t392r1852b415],

1	Table	NNP	O	Table	nsubj	4	SENT_116	[p6l9t584r162b635],
2	1	CD	NUMBER	1	num	4	SENT_116	[p6l193t585r212b634],
3	Potential	JJ	O	potential	amod	4	SENT_116	[p6l8t673r257b724],
4	determinants	NNS	O	determinant	_	0	SENT_116	[p6l289t673r649b724],
5	of	IN	O	of	_	0	SENT_116	[p6l682t673r747b724],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_116	[p6l770t673r1088b739],
7	response	NN	O	response	prep_of	4	SENT_116	[p6l1119t689r1365b739],
8	in	IN	O	in	_	0	SENT_116	[p6l1397t673r1450b723],
9	CAD	NN	O	cad	nn	10	SENT_116	[p6l1482t674r1628b724],
10	patients	NNS	O	patient	prep_in	7	SENT_116	[p6l1658t673r1876b739],
11	(	CD	NUMBER	(	num	12	SENT_116	[p6l1909t673r2151b738],
12	n	NN	O	n	npadvmod	13	SENT_116	[p6l1909t673r2151b738],
13	=	JJ	O	=	amod	10	SENT_116	[p6l1909t673r2151b738],
14	557	CD	NUMBER	557	num	15	SENT_116	[p6l1909t673r2151b738],
15	)	NN	O	)	nsubj	19	SENT_116	[p6l1909t673r2151b738],
16	with	IN	O	with	_	0	SENT_116	[p6l7t761r133b812],
17	(	NN	O	(	nn	18	SENT_116	[p6l157t761r408b826],
18	carriers	NNS	O	carrier	prep_with	15	SENT_116	[p6l157t761r408b826],
19	)	VBP	O	)	rcmod	4	SENT_116	[p6l157t761r408b826],
20	and	CC	O	and	dep	21	SENT_116	[p6l433t761r534b812],
21	without	IN	O	without	dep	4	SENT_116	[p6l555t761r772b812],
22	(	CD	NUMBER	(	num	23	SENT_116	[p6l795t761r1154b826],
23	noncarriers	NNS	O	noncarrier	pobj	21	SENT_116	[p6l795t761r1154b826],
24	)	CD	NUMBER	)	num	27	SENT_116	[p6l795t761r1154b826],
25	homozygote	NN	O	homozygote	nn	27	SENT_116	[p6l1177t761r1527b827],
26	H2	NN	O	h2	nn	27	SENT_116	[p6l1550t762r1633b812],
27	haplotypes	NNS	O	haplotype	dep	23	SENT_116	[p6l1657t761r1978b827],
28	.	.	O	.	_	0	SENT_116	[p6l1657t761r1978b827],

1	Non-carriers	NNS	O	non-carrier	_	0	SENT_117	[p6l1036t889r1390b940],
2	3	CD	NUMBER	3	number	3	SENT_117	[p6l1404t884r1426b907],
3	‘	CD	NUMBER	‘	num	4	SENT_117	[p6l1404t884r1426b907],
4	Carriers	NNS	O	carrier	dep	1	SENT_117	[p6l1514t889r1736b940],
5	p-Value	JJ	O	p-value	amod	6	SENT_117	[p6l1895t889r2114b954],
6	b	NN	O	b	dep	4	SENT_117	[p6l2126t873r2151b908],

1	Mean	NN	O	mean	nn	2	SENT_118	[p6l8t1018r169b1067],
2	age	NN	O	age	_	0	SENT_118	[p6l192t1032r302b1081],
3	,	,	O	,	_	0	SENT_118	[p6l192t1032r302b1081],
4	years	NNS	DURATION	year	appos	2	SENT_118	[p6l328t1032r474b1081],
5	70.03	CD	NUMBER	70.03	num	4	SENT_118	[p6l1039t1017r1208b1067],
6	:	:	O	:	_	0	SENT_118	[p6l1039t1017r1208b1067],
7	10.7	CD	NUMBER	10.7	number	8	SENT_118	[p6l1226t1017r1340b1067],
8	66.9	CD	NUMBER	66.9	num	9	SENT_118	[p6l1514t1017r1776b1067],
9	d	NN	O	d	dep	2	SENT_118	[p6l1514t1017r1776b1067],
10	:9.3	CD	NUMBER	:9.3	num	12	SENT_118	[p6l1514t1017r1776b1067],
11	N.S.	NNP	ORGANIZATION	N.S.	nn	12	SENT_118	[p6l1902t1017r2025b1067],
12	Sex	NN	ORGANIZATION	sex	dep	9	SENT_118	[p6l11t1105r128b1166],
13	,	,	O	,	_	0	SENT_118	[p6l11t1105r128b1166],
14	n	NN	O	n	appos	9	SENT_118	[p6l154t1122r186b1155],
15	(	CD	PERCENT	(	num	16	SENT_118	[p6l213t1104r313b1169],
16	%	NN	PERCENT	%	dep	14	SENT_118	[p6l213t1104r313b1169],
17	)	CD	NUMBER	)	number	18	SENT_118	[p6l213t1104r313b1169],
18	0.0387	CD	NUMBER	0.0387	num	16	SENT_118	[p6l1906t1105r2097b1155],

1	Men	NN	O	man	dep	10	SENT_119	[p6l80t1196r209b1245],
2	381	CD	NUMBER	381	num	1	SENT_119	[p6l1039t1195r1136b1245],
3	(	CD	NUMBER	(	number	4	SENT_119	[p6l1168t1194r1334b1259],
4	70.2	CD	NUMBER	70.2	dep	1	SENT_119	[p6l1168t1194r1334b1259],
5	)	NN	O	)	dep	4	SENT_119	[p6l1168t1194r1334b1259],
6	6	CD	NUMBER	6	num	5	SENT_119	[p6l1514t1195r1545b1245],
7	(	NN	O	(	dep	10	SENT_119	[p6l1571t1194r1738b1259],
8	42.8	CD	NUMBER	42.8	num	7	SENT_119	[p6l1571t1194r1738b1259],
9	)	CD	NUMBER	)	num	10	SENT_119	[p6l1571t1194r1738b1259],
10	Women	NNS	O	woman	dep	14	SENT_119	[p6l80t1285r298b1334],
11	162	CD	NUMBER	162	num	12	SENT_119	[p6l1045t1284r1141b1334],
12	(	CD	NUMBER	(	dep	10	SENT_119	[p6l1168t1283r1334b1348],
13	29.8	CD	NUMBER	29.8	num	14	SENT_119	[p6l1168t1283r1334b1348],
14	)	NN	O	)	dep	16	SENT_119	[p6l1168t1283r1334b1348],
15	8	CD	NUMBER	8	num	16	SENT_119	[p6l1516t1284r1544b1334],
16	(	NN	O	(	dep	18	SENT_119	[p6l1571t1283r1738b1348],
17	57.1	CD	NUMBER	57.1	num	18	SENT_119	[p6l1571t1283r1738b1348],
18	)	NN	O	)	_	0	SENT_119	[p6l1571t1283r1738b1348],

1	Acute	JJ	O	acute	dep	140	SENT_120	[p6l7t1373r175b1423],
2	coronary	JJ	O	coronary	dep	140	SENT_120	[p6l200t1388r449b1437],
3	syndrome	NN	O	syndrome	dep	140	SENT_120	[p6l473t1372r764b1437],
4	,	,	O	,	_	0	SENT_120	[p6l473t1372r764b1437],
5	n	NN	O	n	dep	140	SENT_120	[p6l790t1390r821b1423],
6	(	CD	PERCENT	(	dep	140	SENT_120	[p6l848t1372r948b1437],
7	%	NN	PERCENT	%	dep	140	SENT_120	[p6l848t1372r948b1437],
8	)	CD	NUMBER	)	dep	140	SENT_120	[p6l848t1372r948b1437],
9	263	CD	NUMBER	263	dep	140	SENT_120	[p6l1038t1373r1138b1423],
10	(	NN	O	(	dep	140	SENT_120	[p6l1168t1372r1334b1437],
11	48.4	CD	NUMBER	48.4	dep	140	SENT_120	[p6l1168t1372r1334b1437],
12	)	CD	NUMBER	)	dep	140	SENT_120	[p6l1168t1372r1334b1437],
13	8	CD	NUMBER	8	dep	140	SENT_120	[p6l1516t1373r1544b1423],
14	(	NN	O	(	dep	140	SENT_120	[p6l1571t1372r1661b1437],
15	57	CD	NUMBER	57	dep	140	SENT_120	[p6l1571t1372r1661b1437],
16	.1	NN	NUMBER	.1	dep	140	SENT_120	[p6l1668t1372r1738b1437],
17	)	CD	NUMBER	)	dep	140	SENT_120	[p6l1668t1372r1738b1437],
18	N.S.	NNP	ORGANIZATION	N.S.	dep	140	SENT_120	[p6l1902t1373r2025b1423],
19	Diabetes	NNP	ORGANIZATION	Diabetes	dep	140	SENT_120	[p6l8t1461r269b1523],
20	,	,	O	,	_	0	SENT_120	[p6l8t1461r269b1523],
21	nn	NN	O	nn	dep	140	SENT_120	[p6l294t1477r365b1512],
22	(	CD	PERCENT	(	dep	140	SENT_120	[p6l388t1461r489b1526],
23	%	NN	PERCENT	%	dep	140	SENT_120	[p6l388t1461r489b1526],
24	)	CD	NUMBER	)	dep	140	SENT_120	[p6l388t1461r489b1526],
25	148	CD	NUMBER	148	dep	140	SENT_120	[p6l1045t1462r1140b1512],
26	(	NN	O	(	dep	140	SENT_120	[p6l1168t1461r1334b1526],
27	27.3	CD	NUMBER	27.3	dep	140	SENT_120	[p6l1168t1461r1334b1526],
28	)	CD	NUMBER	)	dep	140	SENT_120	[p6l1168t1461r1334b1526],
29	4	CD	NUMBER	4	dep	140	SENT_120	[p6l1513t1462r1546b1511],
30	(	NN	O	(	dep	140	SENT_120	[p6l1571t1461r1738b1526],
31	28.6	CD	NUMBER	28.6	dep	140	SENT_120	[p6l1571t1461r1738b1526],
32	)	CD	NUMBER	)	dep	140	SENT_120	[p6l1571t1461r1738b1526],
33	N.S.	NNP	MISC	N.S.	dep	140	SENT_120	[p6l1903t1462r2025b1512],
34	Current	NNP	DATE	Current	dep	140	SENT_120	[p6l10t1551r224b1601],
35	smoker	NN	O	smoker	dep	140	SENT_120	[p6l247t1550r465b1612],
36	,	,	O	,	_	0	SENT_120	[p6l247t1550r465b1612],
37	nn	NN	O	nn	dep	140	SENT_120	[p6l490t1567r561b1601],
38	(	CD	PERCENT	(	dep	140	SENT_120	[p6l585t1550r685b1615],
39	%	NN	PERCENT	%	dep	140	SENT_120	[p6l585t1550r685b1615],
40	)	CD	NUMBER	)	dep	140	SENT_120	[p6l585t1550r685b1615],
41	95	CD	NUMBER	95	dep	140	SENT_120	[p6l1040t1551r1104b1601],
42	(	NN	O	(	dep	140	SENT_120	[p6l1132t1550r1299b1615],
43	17.5	CD	NUMBER	17.5	dep	140	SENT_120	[p6l1132t1550r1299b1615],
44	)	NN	O	)	dep	140	SENT_120	[p6l1132t1550r1299b1615],
45	1	CD	NUMBER	1	dep	140	SENT_120	[p6l1521t1551r1539b1600],
46	(	NN	O	(	dep	140	SENT_120	[p6l1572t1550r1703b1615],
47	7.1	CD	NUMBER	7.1	dep	140	SENT_120	[p6l1572t1550r1703b1615],
48	)	CD	NUMBER	)	dep	140	SENT_120	[p6l1572t1550r1703b1615],
49	N.S.	NNP	ORGANIZATION	N.S.	dep	140	SENT_120	[p6l1903t1551r2026b1601],
50	LDL-cholesterol	NNP	ORGANIZATION	LDL-cholesterol	dep	140	SENT_120	[p6l8t1638r492b1700],
51	,	,	O	,	_	0	SENT_120	[p6l8t1638r492b1700],
52	mg/dL	NNP	O	mg/dL	dep	140	SENT_120	[p6l517t1638r704b1704],
53	109.6	CD	NUMBER	109.6	dep	140	SENT_120	[p6l1046t1639r1375b1689],
54	i42	NN	O	i42	dep	140	SENT_120	[p6l1046t1639r1375b1689],
55	.9	CD	NUMBER	.9	dep	140	SENT_120	[p6l1046t1639r1375b1689],
56	78.94	CD	NUMBER	78.94	dep	140	SENT_120	[p6l1514t1639r1684b1689],
57	_	NN	O	_	dep	140	SENT_120	[p6l1514t1639r1684b1689],
58	r	NN	O	r	dep	140	SENT_120	[p6l1514t1639r1684b1689],
59	17.1	CD	NUMBER	17.1	dep	140	SENT_120	[p6l1701t1639r1809b1689],
60	N.S.	NNP	ORGANIZATION	N.S.	dep	140	SENT_120	[p6l1902t1639r2025b1690],
61	HDL	NNP	ORGANIZATION	HDL	dep	140	SENT_120	[p6l8t1730r152b1778],
62	cholesterol	NN	O	cholesterol	dep	140	SENT_120	[p6l176t1728r498b1790],
63	,	,	O	,	_	0	SENT_120	[p6l176t1728r498b1790],
64	mg/dL	NN	O	mg/dl	dep	140	SENT_120	[p6l523t1728r711b1793],
65	44.1	CD	NUMBER	44.1	dep	140	SENT_120	[p6l1037t1729r1154b1779],
66	at	IN	O	at	dep	140	SENT_120	[p6l1170t1735r1208b1773],
67	11.6	CD	NUMBER	11.6	dep	140	SENT_120	[p6l1226t1729r1337b1779],
68	47.0	CD	NUMBER	47.0	dep	140	SENT_120	[p6l1513t1729r1684b1779],
69	i	FW	O	i	dep	140	SENT_120	[p6l1513t1729r1684b1779],
70	10.4	CD	NUMBER	10.4	dep	140	SENT_120	[p6l1701t1729r1815b1779],
71	N.S.	NNP	O	N.S.	dep	140	SENT_120	[p6l1902t1729r2025b1779],
72	Platelet	NN	O	platelet	dep	140	SENT_120	[p6l8t1817r218b1867],
73	count	NN	O	count	dep	140	SENT_120	[p6l241t1824r397b1868],
74	X	NN	O	x	dep	140	SENT_120	[p6l436t1834r470b1867],
75	109/L	NN	O	109/l	dep	140	SENT_120	[p6l509t1803r675b1878],
76	,	,	O	,	_	0	SENT_120	[p6l509t1803r675b1878],
77	n	NN	O	n	dep	140	SENT_120	[p6l700t1835r732b1867],
78	247	CD	NUMBER	247	dep	140	SENT_120	[p6l1038t1818r1141b1868],
79	3:83	CD	NUMBER	3:83	dep	140	SENT_120	[p6l1152t1818r1265b1867],
80	261	CD	NUMBER	261	dep	140	SENT_120	[p6l1513t1818r1611b1867],
81	i	FW	O	i	dep	140	SENT_120	[p6l1627t1824r1666b1862],
82	103	CD	NUMBER	103	dep	140	SENT_120	[p6l1683t1818r1776b1867],
83	N.S.	NNP	PERSON	N.S.	dep	140	SENT_120	[p6l1902t1818r2025b1868],
84	Hemoglobin	NN	PERSON	hemoglobin	dep	140	SENT_120	[p6l8t1904r376b1970],
85	,	,	O	,	_	0	SENT_120	[p6l8t1904r376b1970],
86	g/dL	NN	O	g/dl	dep	140	SENT_120	[p6l403t1904r534b1970],
87	13.4	CD	NUMBER	13.4	dep	140	SENT_120	[p6l1045t1905r1208b1955],
88	:	:	O	:	_	0	SENT_120	[p6l1045t1905r1208b1955],
89	t	NN	O	t	dep	140	SENT_120	[p6l1045t1905r1208b1955],
90	1.7	CD	NUMBER	1.7	dep	140	SENT_120	[p6l1226t1905r1304b1955],
91	13.24	CD	NUMBER	13.24	dep	140	SENT_120	[p6l1520t1905r1684b1955],
92	_	NN	O	_	dep	140	SENT_120	[p6l1520t1905r1684b1955],
93	r	NN	O	r	dep	140	SENT_120	[p6l1520t1905r1684b1955],
94	1.3	CD	NUMBER	1.3	dep	140	SENT_120	[p6l1701t1905r1776b1955],
95	N.S.	NNP	O	N.S.	dep	140	SENT_120	[p6l1902t1905r2025b1956],
96	Number	NNP	O	Number	dep	140	SENT_120	[p6l6t1994r241b2044],
97	of	IN	O	of	dep	140	SENT_120	[p6l263t1994r328b2044],
98	stents	NNS	O	stent	dep	140	SENT_120	[p6l344t2001r516b2055],
99	,	,	O	,	_	0	SENT_120	[p6l344t2001r516b2055],
100	nn	NN	O	nn	dep	140	SENT_120	[p6l542t2010r612b2044],
101	1.51	CD	NUMBER	1.51	dep	140	SENT_120	[p6l1045t1995r1154b2044],
102	i0	NN	O	i0	dep	140	SENT_120	[p6l1170t1995r1340b2044],
103	.70	CD	NUMBER	.70	dep	140	SENT_120	[p6l1170t1995r1340b2044],
104	1.13	CD	NUMBER	1.13	dep	140	SENT_120	[p6l1520t1995r1813b2044],
105	i0	NN	O	i0	dep	140	SENT_120	[p6l1520t1995r1813b2044],
106	.35	CD	NUMBER	.35	dep	140	SENT_120	[p6l1520t1995r1813b2044],
107	N.S.	NNP	O	N.S.	dep	140	SENT_120	[p6l1902t1995r2025b2044],
108	Maximal	JJ	O	maximal	dep	140	SENT_120	[p6l8t2082r262b2133],
109	stent	NN	O	stent	dep	140	SENT_120	[p6l287t2089r417b2133],
110	length	NN	O	length	dep	140	SENT_120	[p6l440t2082r630b2148],
111	,	,	O	,	_	0	SENT_120	[p6l440t2082r630b2148],
112	mm	NN	O	mm	dep	140	SENT_120	[p6l654t2099r764b2132],
113	17.3	CD	NUMBER	17.3	dep	140	SENT_120	[p6l1045t2083r1303b2133],
114	i6	NN	O	i6	dep	140	SENT_120	[p6l1045t2083r1303b2133],
115	.8	CD	NUMBER	.8	dep	140	SENT_120	[p6l1045t2083r1303b2133],
116	17.6	CD	NUMBER	17.6	dep	140	SENT_120	[p6l1520t2083r1779b2133],
117	i7	NN	O	i7	dep	140	SENT_120	[p6l1520t2083r1779b2133],
118	.2	NN	NUMBER	.2	dep	140	SENT_120	[p6l1520t2083r1779b2133],
119	N.S.	NNP	O	N.S.	dep	140	SENT_120	[p6l1902t2083r2025b2133],
120	Minimal	JJ	O	minimal	dep	140	SENT_120	[p6l8t2170r250b2220],
121	stent	NN	O	stent	dep	140	SENT_120	[p6l275t2177r406b2221],
122	diameter	NN	O	diameter	dep	140	SENT_120	[p6l428t2170r684b2231],
123	,	,	O	,	_	0	SENT_120	[p6l428t2170r684b2231],
124	mm	NN	O	mm	dep	140	SENT_120	[p6l710t2187r819b2220],
125	2.93	CD	NUMBER	2.93	dep	140	SENT_120	[p6l1038t2171r1340b2221],
126	i0	NN	O	i0	dep	140	SENT_120	[p6l1038t2171r1340b2221],
127	.54	CD	NUMBER	.54	dep	140	SENT_120	[p6l1038t2171r1340b2221],
128	2.96	CD	NUMBER	2.96	dep	140	SENT_120	[p6l1513t2171r1809b2221],
129	i0	NN	O	i0	dep	140	SENT_120	[p6l1513t2171r1809b2221],
130	.51	CD	NUMBER	.51	dep	140	SENT_120	[p6l1513t2171r1809b2221],
131	N.S.	NNP	ORGANIZATION	N.S.	dep	140	SENT_120	[p6l1902t2171r2025b2221],
132	Clopidogrel	NNP	ORGANIZATION	Clopidogrel	dep	140	SENT_120	[p6l10t2258r344b2324],
133	loading	VBG	O	load	dep	140	SENT_120	[p6l369t2258r579b2324],
134	dose	NN	O	dose	dep	140	SENT_120	[p6l602t2258r745b2320],
135	,	,	O	,	_	0	SENT_120	[p6l602t2258r745b2320],
136	n	NN	O	n	dep	140	SENT_120	[p6l771t2276r803b2309],
137	(	CD	PERCENT	(	dep	140	SENT_120	[p6l830t2258r930b2324],
138	%	NN	PERCENT	%	dep	140	SENT_120	[p6l830t2258r930b2324],
139	)	CD	NUMBER	)	dep	140	SENT_120	[p6l830t2258r930b2324],
140	N.S.	NNP	ORGANIZATION	N.S.	_	0	SENT_120	[p6l1903t2259r2025b2310],

1	300	CD	NUMBER	300	num	2	SENT_121	[p6l82t2349r184b2399],
2	mg	NN	O	mg	dep	14	SENT_121	[p6l207t2365r296b2414],
3	90	CD	NUMBER	90	number	4	SENT_121	[p6l1039t2349r1106b2399],
4	(	CD	NUMBER	(	dep	2	SENT_121	[p6l1132t2348r1298b2413],
5	16.6	CD	NUMBER	16.6	num	6	SENT_121	[p6l1132t2348r1298b2413],
6	)	NN	O	)	dep	4	SENT_121	[p6l1132t2348r1298b2413],
7	2	CD	NUMBER	2	number	8	SENT_121	[p6l1513t2349r1545b2398],
8	(	CD	NUMBER	(	dep	4	SENT_121	[p6l1571t2348r1738b2413],
9	14.3	CD	NUMBER	14.3	num	10	SENT_121	[p6l1571t2348r1738b2413],
10	)	NN	O	)	dep	8	SENT_121	[p6l1571t2348r1738b2413],
11	450	CD	NUMBER	450	num	12	SENT_121	[p6l80t2437r184b2487],
12	mg	NN	O	mg	dep	14	SENT_121	[p6l207t2453r296b2502],
13	21	CD	NUMBER	21	num	14	SENT_121	[p6l1038t2437r1100b2487],
14	(	NN	O	(	dep	20	SENT_121	[p6l1132t2436r1263b2501],
15	3.9	CD	NUMBER	3.9	num	16	SENT_121	[p6l1132t2436r1263b2501],
16	)	NN	O	)	dep	14	SENT_121	[p6l1132t2436r1263b2501],
17	2	CD	NUMBER	2	number	18	SENT_121	[p6l1513t2437r1545b2487],
18	(	CD	NUMBER	(	dep	16	SENT_121	[p6l1571t2436r1738b2501],
19	14.3	CD	NUMBER	14.3	num	20	SENT_121	[p6l1571t2436r1738b2501],
20	)	NN	O	)	dep	22	SENT_121	[p6l1571t2436r1738b2501],
21	600	CD	NUMBER	600	num	22	SENT_121	[p6l82t2526r184b2576],
22	mg	NN	O	mg	dep	24	SENT_121	[p6l207t2542r296b2591],
23	357	CD	NUMBER	357	num	24	SENT_121	[p6l1039t2526r1141b2576],
24	(	NN	O	(	dep	28	SENT_121	[p6l1168t2525r1335b2590],
25	65.7	CD	NUMBER	65.7	number	26	SENT_121	[p6l1168t2525r1335b2590],
26	)	CD	NUMBER	)	dep	24	SENT_121	[p6l1168t2525r1335b2590],
27	9	CD	NUMBER	9	dep	26	SENT_121	[p6l1514t2526r1545b2576],
28	(	NN	O	(	dep	32	SENT_121	[p6l1571t2525r1738b2590],
29	64.3	CD	NUMBER	64.3	num	28	SENT_121	[p6l1571t2525r1738b2590],
30	)	CD	NUMBER	)	num	32	SENT_121	[p6l1571t2525r1738b2590],
31	Steady	JJ	O	steady	amod	32	SENT_121	[p6l83t2613r272b2679],
32	state	NN	O	state	dep	39	SENT_121	[p6l296t2609r454b2665],
33	‘’	CD	NUMBER	‘’	number	34	SENT_121	[p6l296t2609r454b2665],
34	75	CD	NUMBER	75	num	35	SENT_121	[p6l1039t2616r1103b2665],
35	(	NN	O	(	dep	32	SENT_121	[p6l1132t2614r1298b2679],
36	13.8	CD	NUMBER	13.8	num	37	SENT_121	[p6l1132t2614r1298b2679],
37	)	NN	O	)	dep	35	SENT_121	[p6l1132t2614r1298b2679],
38	1	CD	NUMBER	1	num	39	SENT_121	[p6l1521t2615r1539b2664],
39	(	NN	O	(	dep	41	SENT_121	[p6l1571t2614r1702b2679],
40	7.1	CD	NUMBER	7.1	num	41	SENT_121	[p6l1571t2614r1702b2679],
41	)	NN	O	)	_	0	SENT_121	[p6l1571t2614r1702b2679],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_122	[p6l10t2702r344b2768],
2	response	NN	O	response	_	0	SENT_122	[p6l367t2719r628b2768],
3	,	,	O	,	_	0	SENT_122	[p6l367t2719r628b2768],
4	n	NN	O	n	appos	2	SENT_122	[p6l655t2720r686b2753],
5	(	CD	PERCENT	(	num	6	SENT_122	[p6l713t2702r813b2767],
6	%	NN	PERCENT	%	dep	4	SENT_122	[p6l713t2702r813b2767],
7	)	CD	NUMBER	)	num	8	SENT_122	[p6l713t2702r813b2767],
8	<	JJR	O	<	dep	2	SENT_122	[p6l1905t2703r2107b2753],
9	0.005	CD	NUMBER	0.005	dep	8	SENT_122	[p6l1905t2703r2107b2753],

1	Responder	NN	O	responder	dep	9	SENT_123	[p6l80t2791r383b2857],
2	477	CD	NUMBER	477	number	3	SENT_123	[p6l1037t2792r1141b2842],
3	(	CD	NUMBER	(	dep	1	SENT_123	[p6l1168t2791r1334b2856],
4	87.8	CD	NUMBER	87.8	num	5	SENT_123	[p6l1168t2791r1334b2856],
5	)	NN	O	)	dep	3	SENT_123	[p6l1168t2791r1334b2856],
6	8	CD	NUMBER	8	num	7	SENT_123	[p6l1516t2792r1544b2842],
7	(	NN	O	(	dep	9	SENT_123	[p6l1571t2791r1738b2856],
8	57.1	CD	NUMBER	57.1	num	9	SENT_123	[p6l1571t2791r1738b2856],
9	)	CD	NUMBER	)	dep	16	SENT_123	[p6l1571t2791r1738b2856],
10	NonResponder	NNP	O	NonResponder	dep	9	SENT_123	[p6l78t2880r506b2946],
11	66	CD	NUMBER	66	num	10	SENT_123	[p6l1040t2882r1106b2931],
12	(	CD	NUMBER	(	number	13	SENT_123	[p6l1132t2881r1298b2946],
13	12.2	CD	NUMBER	12.2	num	14	SENT_123	[p6l1132t2881r1298b2946],
14	)	NN	O	)	dep	10	SENT_123	[p6l1132t2881r1298b2946],
15	6	CD	NUMBER	6	num	16	SENT_123	[p6l1515t2882r1545b2931],
16	(	NN	O	(	dep	18	SENT_123	[p6l1571t2881r1738b2946],
17	42.8	CD	NUMBER	42.8	num	18	SENT_123	[p6l1571t2881r1738b2946],
18	)	NN	O	)	_	0	SENT_123	[p6l1571t2881r1738b2946],

1	a	DT	O	a	predet	3	SENT_124	[p6l58t3003r80b3026],
2	This	DT	O	this	det	3	SENT_124	[p6l118t3007r240b3058],
3	group	NN	O	group	_	0	SENT_124	[p6l289t3024r452b3072],
4	comprised	VBN	O	comprise	partmod	3	SENT_124	[p6l501t3007r795b3072],
5	patients	NNS	O	patient	dep	11	SENT_124	[p6l840t3007r1059b3072],
6	with	IN	O	with	_	0	SENT_124	[p6l1107t3007r1232b3058],
7	H1/H1	NN	O	h1/h1	prep_with	5	SENT_124	[p6l1279t3007r1463b3058],
8	(	CD	NUMBER	(	num	9	SENT_124	[p6l1520t3007r1763b3072],
9	n	NN	O	n	dep	11	SENT_124	[p6l1520t3007r1763b3072],
10	=	JJ	O	=	amod	11	SENT_124	[p6l1520t3007r1763b3072],
11	399	CD	NUMBER	399	dep	15	SENT_124	[p6l1520t3007r1763b3072],
12	)	NN	O	)	dep	11	SENT_124	[p6l1520t3007r1763b3072],
13	and	CC	O	and	_	0	SENT_124	[p6l1813t3007r1913b3058],
14	H1ﬂ	NN	O	h1ﬂ	dep	11	SENT_124	[p6l1959t3007r2149b3058],
15	{	NN	O	{	dep	3	SENT_124	[p6l1959t3007r2149b3058],
16	2	CD	NUMBER	2	num	15	SENT_124	[p6l1959t3007r2149b3058],

1	haplotypes	NNS	O	haplotype	_	0	SENT_125	[p6l8t3096r313b3161],
2	(	CD	NUMBER	(	num	3	SENT_125	[p6l338t3096r442b3161],
3	n	NN	O	n	dep	1	SENT_125	[p6l338t3096r442b3161],
4	=	JJ	O	=	amod	6	SENT_125	[p6l338t3096r442b3161],
5	144	CD	NUMBER	144	tmod	4	SENT_125	[p6l460t3096r595b3161],
6	)	NN	O	)	dep	3	SENT_125	[p6l460t3096r595b3161],
7	.	.	O	.	_	0	SENT_125	[p6l460t3096r595b3161],

1	b	NN	O	b	nn	3	SENT_126	[p6l56t3170r82b3204],
2	Statistical	JJ	O	statistical	amod	3	SENT_126	[p6l123t3185r394b3236],
3	significance	NN	O	significance	nsubjpass	5	SENT_126	[p6l420t3185r755b3250],
4	was	VBD	O	be	auxpass	5	SENT_126	[p6l779t3201r887b3236],
5	assumed	VBN	O	assume	_	0	SENT_126	[p6l912t3185r1154b3236],
6	at	IN	O	at	_	0	SENT_126	[p6l1177t3192r1226b3236],
7	p	NN	O	p	prep_at	5	SENT_126	[p6l1239t3186r1478b3250],
8	<	JJR	O	<	dep	9	SENT_126	[p6l1239t3186r1478b3250],
9	0.05	CD	NUMBER	0.05	advmod	5	SENT_126	[p6l1239t3186r1478b3250],
10	.	.	O	.	_	0	SENT_126	[p6l1239t3186r1478b3250],

1	N.S.	NNP	PERSON	N.S.	_	0	SENT_127	[p6l1503t3186r1645b3247],
2	,	,	O	,	_	0	SENT_127	[p6l1503t3186r1645b3247],
3	not	RB	O	not	neg	4	SENT_127	[p6l1669t3192r1761b3236],
4	signiﬁcant	NN	O	signiﬁcant	appos	1	SENT_127	[p6l1785t3185r2092b3250],
5	.	.	O	.	_	0	SENT_127	[p6l1785t3185r2092b3250],

1	C	NN	O	c	nsubj	4	SENT_128	[p6l58t3269r78b3292],
2	These	DT	O	these	det	3	SENT_128	[p6l118t3273r283b3324],
3	patients	NNS	O	patient	dep	1	SENT_128	[p6l316t3273r534b3338],
4	received	VBD	O	receive	_	0	SENT_128	[p6l568t3273r807b3324],
5	no	DT	O	no	det	7	SENT_128	[p6l839t3290r908b3324],
6	loading	NN	O	loading	nn	7	SENT_128	[p6l944t3273r1154b3338],
7	dose	NN	O	dose	dobj	4	SENT_128	[p6l1189t3273r1331b3335],
8	,	,	O	,	_	0	SENT_128	[p6l1189t3273r1331b3335],
9	because	IN	O	because	mark	13	SENT_128	[p6l1367t3273r1589b3324],
10	they	PRP	O	they	nsubjpass	13	SENT_128	[p6l1623t3273r1744b3338],
11	were	VBD	O	be	auxpass	13	SENT_128	[p6l1777t3290r1912b3324],
12	already	RB	O	already	advmod	13	SENT_128	[p6l1948t3273r2153b3338],
13	treated	VBN	O	treat	advcl	4	SENT_128	[p6l8t3361r199b3413],
14	with	IN	O	with	_	0	SENT_128	[p6l217t3361r342b3413],
15	a	DT	O	a	det	17	SENT_128	[p6l362t3378r392b3412],
16	maintenance	NN	O	maintenance	nn	17	SENT_128	[p6l411t3361r764b3413],
17	dose	NN	O	dose	prep_with	13	SENT_128	[p6l787t3361r914b3413],
18	of	IN	O	of	_	0	SENT_128	[p6l935t3361r1000b3413],
19	75	CD	NUMBER	75	num	21	SENT_128	[p6l1012t3363r1076b3413],
20	mg	NN	O	mg	nn	21	SENT_128	[p6l1100t3378r1188b3427],
21	clopidogrel	NN	O	clopidogrel	prep_of	17	SENT_128	[p6l1210t3361r1528b3427],
22	once	RB	DATE	once	advmod	23	SENT_128	[p6l1550t3378r1680b3413],
23	daily	RB	SET	daily	advmod	13	SENT_128	[p6l1702t3361r1841b3427],
24	when	WRB	O	when	advmod	26	SENT_128	[p6l1859t3361r2013b3413],
25	they	PRP	O	they	nsubj	26	SENT_128	[p6l2031t3361r2152b3427],
26	had	VBD	O	have	dep	23	SENT_128	[p6l8t3451r110b3502],
27	PCI	NNP	O	PCI	dobj	26	SENT_128	[p6l132t3452r255b3502],
28	.	.	O	.	_	0	SENT_128	[p6l132t3452r255b3502],

1	nonresponders	NNS	O	nonresponder	_	0	SENT_129	[p6l8t3664r533b3746],
2	,	,	O	,	_	0	SENT_129	[p6l8t3664r533b3746],
3	respectively	RB	O	respectively	advmod	1	SENT_129	[p6l568t3664r996b3746],
4	,	,	O	,	_	0	SENT_129	[p6l568t3664r996b3746],
5	among	IN	O	among	_	0	SENT_129	[p6l1034t3685r1269b3746],
6	the	DT	O	the	det	8	SENT_129	[p6l1302t3664r1406b3728],
7	entire	JJ	O	entire	amod	8	SENT_129	[p6l1441t3664r1634b3728],
8	study	NN	O	study	prep_among	1	SENT_129	[p6l1669t3664r1855b3746],
9	population	NN	O	population	dep	1	SENT_129	[p6l1885t3664r2150b3746, p7l8t19r147b83],

1	of	IN	O	of	_	0	SENT_130	[p7l208t19r290b83],
2	557	CD	NUMBER	557	num	4	SENT_130	[p7l343t21r471b83],
3	CAD	NN	O	cad	nn	4	SENT_130	[p7l536t20r719b83],
4	patients	NNS	O	patient	pobj	1	SENT_130	[p7l781t19r1077b100],
5	.	.	O	.	_	0	SENT_130	[p7l781t19r1077b100],

1	Women	NNS	O	woman	nsubj	9	SENT_131	[p7l1143t21r1419b83],
2	were	VBD	O	be	cop	9	SENT_131	[p7l1479t40r1650b83],
3	much	RB	O	much	advmod	5	SENT_131	[p7l1711t19r1910b83],
4	more	RBR	O	more	advmod	5	SENT_131	[p7l1970t40r2151b83],
5	frequently	RB	O	frequently	advmod	9	SENT_131	[p7l10t126r362b207],
6	(	CD	NUMBER	(	num	9	SENT_131	[p7l401t126r809b207],
7	p	NN	O	p	nn	9	SENT_131	[p7l401t126r809b207],
8	gender	NN	O	gender	nn	9	SENT_131	[p7l1129t1838r1393b1920],
9	)	NN	O	)	_	0	SENT_131	[p7l1129t1838r1393b1920],
10	was	VBD	O	be	auxpass	11	SENT_131	[p7l1416t1859r1551b1902],
11	introduced	VBN	O	introduce	rcmod	9	SENT_131	[p7l1575t1838r1968b1902],
12	.	.	O	.	_	0	SENT_131	[p7l1575t1838r1968b1902],

1	This	DT	O	this	nsubj	2	SENT_132	[p7l1997t1838r2149b1902],
2	implied	VBD	O	imply	_	0	SENT_132	[p7l9t1945r278b2027],
3	that	IN	O	that	complm	5	SENT_132	[p7l308t1945r440b2009],
4	gender	NN	O	gender	nsubj	5	SENT_132	[p7l473t1945r713b2027],
5	was	VBD	O	be	ccomp	2	SENT_132	[p7l742t1966r877b2009],
6	neither	CC	O	neither	preconj	8	SENT_132	[p7l911t1945r1158b2009],
7	a	DT	O	a	det	8	SENT_132	[p7l1189t1966r1226b2009],
8	confounder	NN	O	confounder	nsubj	12	SENT_132	[p7l1258t1945r1662b2009],
9	nor	CC	O	nor	_	0	SENT_132	[p7l1691t1966r1810b2009],
10	an	DT	O	a	det	11	SENT_132	[p7l1842t1966r1923b2009],
11	effect	NN	O	effect	conj_nor	8	SENT_132	[p7l1957t1945r2153b2009],
12	modiﬁer	NN	O	modiﬁer	xcomp	5	SENT_132	[p7l8t2052r318b2116],
13	of	IN	O	of	_	0	SENT_132	[p7l378t2052r460b2116],
14	the	DT	O	the	det	16	SENT_132	[p7l509t2052r617b2116],
15	observed	VBN	O	observe	amod	16	SENT_132	[p7l679t2052r1004b2116],
16	association	NN	O	association	prep_of	12	SENT_132	[p7l1064t2052r1463b2116],
17	with	IN	O	with	_	0	SENT_132	[p7l1523t2052r1682b2116],
18	clopidogrel	NN	O	clopidogrel	nn	19	SENT_132	[p7l1743t2052r2151b2134],
19	resistance	NN	O	resistance	prep_with	16	SENT_132	[p7l7t2159r372b2223],
20	.	.	O	.	_	0	SENT_132	[p7l7t2159r372b2223],

1	The	DT	O	the	det	3	SENT_133	[p7l437t2159r571b2222],
2	independent	JJ	O	independent	amod	3	SENT_133	[p7l632t2159r1066b2240],
3	contribution	NN	O	contribution	nsubjpass	10	SENT_133	[p7l1125t2159r1556b2223],
4	of	IN	O	of	_	0	SENT_133	[p7l1616t2159r1697b2223],
5	the	DT	O	the	det	7	SENT_133	[p7l1745t2159r1850b2223],
6	H2/H2	NN	O	h2/h2	nn	7	SENT_133	[p7l1910t2159r2148b2223],
7	haplotype	NN	O	haplotype	prep_of	3	SENT_133	[p7l8t2266r356b2348],
8	was	VBD	O	be	auxpass	10	SENT_133	[p7l405t2287r540b2330],
9	also	RB	O	also	advmod	10	SENT_133	[p7l593t2266r730b2330],
10	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_133	[p7l783t2266r1143b2330],
11	by	IN	O	by	_	0	SENT_133	[p7l1190t2266r1281b2348],
12	a	DT	O	a	det	14	SENT_133	[p7l1330t2287r1367b2330],
13	separate	JJ	O	separate	amod	14	SENT_133	[p7l1418t2275r1701b2348],
14	analysis	NN	O	analysis	agent	10	SENT_133	[p7l1753t2266r2033b2348],
15	in	IN	O	in	_	0	SENT_133	[p7l2085t2266r2152b2329],
16	women	NNS	O	woman	nn	25	SENT_133	[p7l7t2394r273b2437],
17	only	RB	O	only	quantmod	18	SENT_133	[p7l334t2373r493b2455],
18	(	CD	NUMBER	(	num	24	SENT_133	[p7l555t2373r746b2454],
19	O.R.	NNP	O	O.R.	nn	24	SENT_133	[p7l555t2373r746b2454],
20	5.63	CD	PERCENT	5.63	num	24	SENT_133	[p7l815t2375r963b2437],
21	[	CD	PERCENT	[	number	22	SENT_133	[p7l1036t2374r1222b2453],
22	95	CD	PERCENT	95	dep	23	SENT_133	[p7l1036t2374r1222b2453],
23	%	NN	PERCENT	%	dep	24	SENT_133	[p7l1036t2374r1222b2453],
24	CI	NN	O	ci	dep	16	SENT_133	[p7l1285t2374r1370b2437],
25	l.	NN	O	l.	prep_in	14	SENT_133	[p7l1441t2373r1927b2454],
26	28	CD	NUMBER	28	number	27	SENT_133	[p7l1441t2373r1927b2454],
27	—	CD	NUMBER	—	dep	25	SENT_133	[p7l1441t2373r1927b2454],
28	24.68	CD	NUMBER	24.68	num	30	SENT_133	[p7l1441t2373r1927b2454],
29	]	CD	NUMBER	]	num	30	SENT_133	[p7l1441t2373r1927b2454],
30	)	NN	O	)	dep	27	SENT_133	[p7l1441t2373r1927b2454],
31	.	.	O	.	_	0	SENT_133	[p7l1441t2373r1927b2454],

1	This	DT	O	this	det	2	SENT_134	[p7l1994t2373r2150b2437],
2	contribution	NN	O	contribution	nsubj	4	SENT_134	[p7l10t2480r440b2544],
3	was	VBD	O	be	cop	4	SENT_134	[p7l469t2500r604b2544],
4	weaker	JJR	O	weaker	_	0	SENT_134	[p7l635t2480r891b2544],
5	in	IN	O	in	_	0	SENT_134	[p7l921t2480r987b2542],
6	men	NNS	O	man	prep_in	4	SENT_134	[p7l1016t2500r1167b2543],
7	(	CD	NUMBER	(	num	8	SENT_134	[p7l1199t2480r1387b2561],
8	O.R.	NNP	O	O.R.	dep	15	SENT_134	[p7l1199t2480r1387b2561],
9	2.43	CD	PERCENT	2.43	num	8	SENT_134	[p7l1423t2481r1570b2543],
10	[	CD	PERCENT	[	num	12	SENT_134	[p7l1613t2481r1796b2560],
11	95	CD	PERCENT	95	num	12	SENT_134	[p7l1613t2481r1796b2560],
12	%	NN	PERCENT	%	dep	8	SENT_134	[p7l1613t2481r1796b2560],
13	CI	NN	O	ci	dep	15	SENT_134	[p7l1829t2481r1913b2544],
14	0.272	CD	NUMBER	0.272	num	13	SENT_134	[p7l1945t2481r2149b2544, p7l9t2588r285b2669],
15	l.	NN	O	l.	dep	6	SENT_134	[p7l1945t2481r2149b2544, p7l9t2588r285b2669],
16	48	CD	NUMBER	48	num	15	SENT_134	[p7l1945t2481r2149b2544, p7l9t2588r285b2669],
17	]	CD	NUMBER	]	num	18	SENT_134	[p7l1945t2481r2149b2544, p7l9t2588r285b2669],
18	)	NN	O	)	dep	15	SENT_134	[p7l1945t2481r2149b2544, p7l9t2588r285b2669],
19	,	,	O	,	_	0	SENT_134	[p7l1945t2481r2149b2544, p7l9t2588r285b2669],
20	because	IN	O	because	mark	31	SENT_134	[p7l320t2587r598b2651],
21	only	RB	O	only	advmod	23	SENT_134	[p7l636t2587r791b2669],
22	one	CD	NUMBER	one	num	23	SENT_134	[p7l826t2608r950b2651],
23	man	NN	O	man	nsubj	31	SENT_134	[p7l984t2608r1136b2651],
24	was	VBD	O	be	cop	31	SENT_134	[p7l1168t2608r1302b2651],
25	a	DT	O	a	det	31	SENT_134	[p7l1340t2608r1377b2651],
26	nonresponder	JJ	O	nonresponder	amod	31	SENT_134	[p7l1408t2587r1893b2669],
27	with	IN	O	with	_	0	SENT_134	[p7l1924t2587r2081b2651],
28	a	DT	O	a	det	30	SENT_134	[p7l2116t2608r2153b2651],
29	homozygote	NN	O	homozygote	nn	30	SENT_134	[p7l8t2694r445b2776],
30	H2	NN	O	h2	prep_with	26	SENT_134	[p7l475t2696r579b2757],
31	haplotype	NN	O	haplotype	advcl	4	SENT_134	[p7l611t2694r976b2776],
32	.	.	O	.	_	0	SENT_134	[p7l611t2694r976b2776],

1	Whole	JJ	O	whole	amod	3	SENT_135	[p7l114t2801r347b2864],
2	blood	NN	O	blood	nn	3	SENT_135	[p7l377t2801r579b2864],
3	samples	NNS	O	sample	nsubjpass	16	SENT_135	[p7l611t2801r888b2882],
4	from	IN	O	from	_	0	SENT_135	[p7l922t2801r1090b2864],
5	64	CD	NUMBER	64	num	6	SENT_135	[p7l1121t2803r1204b2864],
6	nonresponders	NNS	O	nonresponder	prep_from	3	SENT_135	[p7l1234t2801r1748b2882],
7	(	CD	NUMBER	(	dep	6	SENT_135	[p7l1782t2801r2140b2882],
8	including	VBG	O	include	_	0	SENT_135	[p7l1782t2801r2140b2882],
9	5	CD	NUMBER	5	prep_including	7	SENT_135	[p7l10t2910r45b2970],
10	with	IN	O	with	_	0	SENT_135	[p7l71t2907r227b2970],
11	a	DT	O	a	det	14	SENT_135	[p7l250t2928r287b2970],
12	H2/H2	NN	O	h2/h2	nn	14	SENT_135	[p7l307t2907r543b2970],
13	genotype	NN	O	genotype	nn	14	SENT_135	[p7l570t2907r919b2988],
14	)	NN	O	)	prep_with	9	SENT_135	[p7l570t2907r919b2988],
15	were	VBD	O	be	auxpass	16	SENT_135	[p7l942t2928r1111b2970],
16	examined	VBN	O	examine	_	0	SENT_135	[p7l1136t2907r1476b2970],
17	again	RB	O	again	advmod	16	SENT_135	[p7l1499t2907r1686b2988],
18	after	IN	O	after	dep	16	SENT_135	[p7l1710t2907r1868b2970],
19	in	IN	O	in	_	0	SENT_135	[p7l1889t2907r1955b2969],
20	Vitro	NNP	O	Vitro	nn	21	SENT_135	[p7l1976t2907r2138b2970],
21	incubation	NN	O	incubation	prep_in	16	SENT_135	[p7l9t3013r395b3076],
22	with	IN	O	with	_	0	SENT_135	[p7l456t3013r617b3076],
23	MeSAMP	NN	O	mesamp	prep_with	21	SENT_135	[p7l679t3014r1055b3076],
24	.	.	O	.	_	0	SENT_135	[p7l679t3014r1055b3076],

1	Incubation	NN	O	incubation	nsubj	2	SENT_136	[p7l1123t3013r1514b3076],
2	reduced	VBD	O	reduce	dep	22	SENT_136	[p7l1575t3013r1864b3076],
3	6-min	JJ	DURATION	6-min	amod	4	SENT_136	[p7l1928t3013r2141b3075],
4	impedance	NN	O	impedance	dobj	2	SENT_136	[p7l9t3119r387b3201],
5	to	TO	O	to	_	0	SENT_136	[p7l411t3129r476b3183],
6	<	JJR	O	<	prep_to	2	SENT_136	[p7l502t3122r598b3183],
7	5	CD	NUMBER	5	number	8	SENT_136	[p7l502t3122r598b3183],
8	9	CD	NUMBER	9	amod	6	SENT_136	[p7l630t3117r695b3182],
9	in	IN	O	in	_	0	SENT_136	[p7l724t3120r790b3182],
10	61	CD	NUMBER	61	prep_in	2	SENT_136	[p7l815t3121r889b3183],
11	of	IN	O	of	_	0	SENT_136	[p7l925t3120r1006b3183],
12	64	CD	NUMBER	64	num	13	SENT_136	[p7l1021t3121r1103b3183],
13	samples	NNS	O	sample	prep_of	10	SENT_136	[p7l1131t3119r1409b3201],
14	(	CD	NUMBER	(	num	17	SENT_136	[p7l1436t3119r1617b3201],
15	total	JJ	O	total	amod	17	SENT_136	[p7l1436t3119r1617b3201],
16	group	NN	O	group	nn	17	SENT_136	[p7l1642t3141r1843b3201],
17	average	NN	O	average	nsubj	22	SENT_136	[p7l1871t3140r2139b3201],
18	was	VBD	O	be	cop	22	SENT_136	[p7l6t3247r141b3290],
19	0.62	CD	NUMBER	0.62	num	22	SENT_136	[p7l175t3228r501b3290],
20	i2	NN	O	i2	nn	22	SENT_136	[p7l175t3228r501b3290],
21	.3	NN	NUMBER	.3	nn	22	SENT_136	[p7l175t3228r501b3290],
22	(	NN	O	(	_	0	SENT_136	[p7l542t3224r657b3308],
23	2	CD	NUMBER	2	num	24	SENT_136	[p7l542t3224r657b3308],
24	)	NN	O	)	dep	22	SENT_136	[p7l542t3224r657b3308],
25	.	.	O	.	_	0	SENT_136	[p7l542t3224r657b3308],

1	Three	CD	NUMBER	three	num	2	SENT_137	[p7l694t3226r894b3290],
2	samples	NNS	O	sample	nsubj	14	SENT_137	[p7l929t3226r1206b3308],
3	including	VBG	O	include	_	0	SENT_137	[p7l1240t3226r1569b3308],
4	one	CD	NUMBER	one	prep_including	2	SENT_137	[p7l1602t3247r1726b3290],
5	with	IN	O	with	_	0	SENT_137	[p7l1756t3226r1912b3290],
6	a	DT	O	a	det	7	SENT_137	[p7l1944t3247r1981b3290],
7	H2	NN	O	h2	prep_with	4	SENT_137	[p7l2010t3226r2142b3290],
8	/	:	O	/	punct	10	SENT_137	[p7l2010t3226r2142b3290],
9	H2	NN	O	h2	nn	10	SENT_137	[p7l7t3334r111b3395],
10	genotype	NN	O	genotype	dep	7	SENT_137	[p7l165t3341r505b3414],
11	,	,	O	,	_	0	SENT_137	[p7l165t3341r505b3414],
12	did	VBD	O	do	aux	14	SENT_137	[p7l560t3333r670b3396],
13	not	RB	O	not	neg	14	SENT_137	[p7l718t3342r831b3396],
14	exhibit	VB	O	exhibit	_	0	SENT_137	[p7l882t3333r1124b3396],
15	the	DT	O	the	det	17	SENT_137	[p7l1171t3333r1276b3396],
16	expected	JJ	O	expected	amod	17	SENT_137	[p7l1330t3333r1640b3413],
17	reduction	NN	O	reduction	dobj	14	SENT_137	[p7l1688t3333r2020b3396],
18	of	IN	O	of	_	0	SENT_137	[p7l2071t3333r2151b3396],
19	impedance	NN	O	impedance	prep_of	17	SENT_137	[p7l9t3439r406b3519],
20	,	,	O	,	_	0	SENT_137	[p7l9t3439r406b3519],
21	consistent	JJ	O	consistent	amod	30	SENT_137	[p7l465t3439r814b3502],
22	with	IN	O	with	_	0	SENT_137	[p7l865t3439r1022b3502],
23	a	DT	O	a	det	25	SENT_137	[p7l1076t3459r1112b3501],
24	pharmacodynamic	JJ	O	pharmacodynamic	amod	25	SENT_137	[p7l1161t3439r1812b3519],
25	type	NN	O	type	prep_with	21	SENT_137	[p7l1867t3447r2016b3519],
26	of	IN	O	of	_	0	SENT_137	[p7l2071t3439r2151b3502],
27	resistance	NN	O	resistance	prep_of	25	SENT_137	[p7l7t3545r350b3608],
28	[	CD	NUMBER	[	num	27	SENT_137	[p7l386t3547r542b3625],
29	15	CD	NUMBER	15	tmod	21	SENT_137	[p7l386t3547r542b3625],
30	]	NN	O	]	appos	19	SENT_137	[p7l386t3547r542b3625],
31	.	.	O	.	_	0	SENT_137	[p7l386t3547r542b3625],

1	4	LS	NUMBER	4	_	0	SENT_138	[p8l8t74r73b136],
2	.	.	O	.	_	0	SENT_138	[p8l8t74r73b136],

1	Discussion	NN	O	discussion	_	0	SENT_139	[p8l109t74r504b135],

1	In	IN	O	in	_	0	SENT_140	[p8l115t287r186b346],
2	this	DT	O	this	det	4	SENT_140	[p8l222t284r346b347],
3	observational	JJ	O	observational	amod	4	SENT_140	[p8l387t284r859b347],
4	study	NN	O	study	prep_in	9	SENT_140	[p8l900t284r1087b365],
5	of	IN	O	of	_	0	SENT_140	[p8l1126t285r1207b347],
6	impedance	NN	O	impedance	nn	7	SENT_140	[p8l1236t284r1613b365],
7	aggregometry	NN	O	aggregometry	prep_of	4	SENT_140	[p8l1654t293r2141b365],
8	we	PRP	O	we	nsubj	9	SENT_140	[p8l6t411r107b453],
9	sought	VBD	O	seek	_	0	SENT_140	[p8l134t390r367b471],
10	to	TO	O	to	aux	11	SENT_140	[p8l388t399r453b453],
11	associate	VB	O	associate	xcomp	9	SENT_140	[p8l480t390r793b453],
12	platelet	NN	O	platelet	nn	13	SENT_140	[p8l816t390r1074b471],
13	reactivity	NN	O	reactivity	dobj	11	SENT_140	[p8l1096t390r1426b471],
14	in	IN	O	in	_	0	SENT_140	[p8l1450t390r1516b452],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_140	[p8l1540t390r1939b471],
16	users	NNS	O	user	prep_in	13	SENT_140	[p8l1960t411r2138b453],
17	with	IN	O	with	_	0	SENT_140	[p8l6t496r163b560],
18	genetic	JJ	O	genetic	amod	20	SENT_140	[p8l193t496r443b578],
19	P2Y12-receptor	NN	O	p2y12-receptor	nn	20	SENT_140	[p8l474t498r1017b577],
20	variants	NNS	O	variant	prep_with	11	SENT_140	[p8l1043t495r1337b559],
21	.	.	O	.	_	0	SENT_140	[p8l1043t495r1337b559],

1	We	PRP	O	we	nsubj	2	SENT_141	[p8l1372t498r1485b559],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_141	[p8l1515t495r1983b577],
3	that	IN	O	that	complm	7	SENT_141	[p8l2011t495r2142b559],
4	the	DT	O	the	det	6	SENT_141	[p8l7t603r112b666],
5	platelet	NN	O	platelet	nn	6	SENT_141	[p8l154t603r413b683],
6	hyperreactivity	NN	O	hyperreactivity	nsubj	7	SENT_141	[p8l453t603r985b684],
7	reported	VBD	O	report	ccomp	2	SENT_141	[p8l1026t603r1319b683],
8	previously	RB	DATE	previously	advmod	7	SENT_141	[p8l1359t603r1732b684],
9	in	IN	O	in	_	0	SENT_141	[p8l1776t603r1841b665],
10	healthy	JJ	O	healthy	prep_in	7	SENT_141	[p8l1882t603r2141b684],
11	and	CC	O	and	_	0	SENT_141	[p8l9t709r136b772],
12	clopidogrel-na	NN	O	clopidogrel-na	conj_and	10	SENT_141	[p8l196t709r820b789],
13	'	''	O	'	_	0	SENT_141	[p8l196t709r820b789],
14	1	CD	NUMBER	1	dobj	7	SENT_141	[p8l196t709r820b789],
15	've	VBP	O	have	rcmod	14	SENT_141	[p8l196t709r820b789],
16	H2	NN	O	h2	nn	17	SENT_141	[p8l880t710r985b771],
17	carriers	NNS	O	carrier	dobj	15	SENT_141	[p8l1048t709r1328b785],
18	,	,	O	,	_	0	SENT_141	[p8l1048t709r1328b785],
19	may	MD	O	may	aux	20	SENT_141	[p8l1391t729r1543b789],
20	persist	VB	O	persist	ccomp	7	SENT_141	[p8l1600t709r1833b789],
21	despite	IN	O	despite	_	0	SENT_141	[p8l1892t709r2140b789],
22	antiplatelet	JJ	O	antiplatelet	amod	23	SENT_141	[p8l9t815r410b895],
23	therapy	NN	O	therapy	prep_despite	20	SENT_141	[p8l469t815r740b896],
24	and	CC	O	and	_	0	SENT_141	[p8l802t815r930b878],
25	that	IN	O	that	complm	31	SENT_141	[p8l989t815r1124b877],
26	H2	NN	O	h2	nn	27	SENT_141	[p8l1184t816r1288b877],
27	alleles	NNS	O	allele	nsubjpass	31	SENT_141	[p8l1353t815r1579b878],
28	may	MD	O	may	aux	31	SENT_141	[p8l1641t835r1795b896],
29	also	RB	O	also	advmod	31	SENT_141	[p8l1857t815r1997b878],
30	be	VB	O	be	auxpass	31	SENT_141	[p8l2058t815r2140b878],
31	associated	VBN	O	associate	conj_and	20	SENT_141	[p8l9t921r368b984],
32	with	IN	O	with	_	0	SENT_141	[p8l406t921r562b984],
33	clopidogrel	NN	O	clopidogrel	nn	34	SENT_141	[p8l603t921r1001b1002],
34	resistance	NN	O	resistance	prep_with	31	SENT_141	[p8l1040t921r1402b984],
35	.	.	O	.	_	0	SENT_141	[p8l1040t921r1402b984],

1	To	TO	O	to	_	0	SENT_142	[p8l1448t924r1535b984],
2	our	PRP$	O	we	poss	3	SENT_142	[p8l1578t942r1694b984],
3	knowledge	NN	O	knowledge	prep_to	9	SENT_142	[p8l1731t921r2137b1002],
4	,	,	O	,	_	0	SENT_142	[p8l1731t921r2137b1002],
5	this	DT	O	this	nsubj	9	SENT_142	[p8l7t1027r131b1090],
6	is	VBZ	O	be	cop	9	SENT_142	[p8l171t1027r224b1090],
7	the	DT	O	the	det	9	SENT_142	[p8l262t1027r367b1090],
8	first	JJ	ORDINAL	first	amod	9	SENT_142	[p8l408t1027r545b1090],
9	study	NN	O	study	_	0	SENT_142	[p8l583t1027r771b1108],
10	that	WDT	O	that	nsubj	11	SENT_142	[p8l807t1027r939b1090],
11	examined	VBD	O	examine	rcmod	9	SENT_142	[p8l976t1027r1316b1090],
12	the	DT	O	the	det	13	SENT_142	[p8l1352t1027r1457b1090],
13	inﬂuence	NN	O	inﬂuence	dobj	11	SENT_142	[p8l1496t1027r1820b1090],
14	of	IN	O	of	_	0	SENT_142	[p8l1859t1027r1940b1090],
15	ADP	NN	ORGANIZATION	adp	nn	17	SENT_142	[p8l1965t1029r2139b1089],
16	receptor	NN	O	receptor	nn	17	SENT_142	[p8l7t1142r296b1214],
17	variants	NNS	O	variant	prep_of	13	SENT_142	[p8l324t1133r599b1196],
18	by	IN	O	by	_	0	SENT_142	[p8l631t1133r720b1214],
19	the	DT	O	the	det	20	SENT_142	[p8l751t1133r856b1196],
20	use	NN	O	use	prep_by	11	SENT_142	[p8l886t1154r1003b1196],
21	of	IN	O	of	_	0	SENT_142	[p8l1036t1133r1117b1196],
22	the	DT	O	the	det	28	SENT_142	[p8l1137t1133r1242b1196],
23	more	RBR	O	more	advmod	24	SENT_142	[p8l1274t1153r1452b1196],
24	physiologic	JJ	O	physiologic	amod	28	SENT_142	[p8l1483t1133r1894b1214],
25	whole	JJ	O	whole	amod	28	SENT_142	[p8l1926t1133r2140b1196],
26	blood	NN	O	blood	nn	28	SENT_142	[p8l6t1239r209b1302],
27	impedance	NN	O	impedance	nn	28	SENT_142	[p8l265t1239r643b1319],
28	aggregometry	NN	O	aggregometry	prep_of	20	SENT_142	[p8l701t1247r1199b1319],
29	.	.	O	.	_	0	SENT_142	[p8l701t1247r1199b1319],

1	This	DT	O	this	det	2	SENT_143	[p8l1261t1239r1413b1302],
2	approach	NN	O	approach	nsubj	3	SENT_143	[p8l1472t1239r1793b1319],
3	offers	VBZ	O	offer	_	0	SENT_143	[p8l1849t1239r2047b1302],
4	a	DT	O	a	det	6	SENT_143	[p8l2106t1259r2142b1301],
5	higher	JJR	O	higher	amod	6	SENT_143	[p8l7t1345r233b1426],
6	sensitivity	NN	O	sensitivity	dobj	3	SENT_143	[p8l275t1345r633b1426],
7	for	IN	O	for	_	0	SENT_143	[p8l676t1346r776b1408],
8	antiplatelet	JJ	O	antiplatelet	amod	10	SENT_143	[p8l817t1345r1205b1426],
9	drug	NN	O	drug	nn	10	SENT_143	[p8l1246t1345r1404b1426],
10	effects	NNS	O	effect	prep_for	6	SENT_143	[p8l1449t1345r1675b1408],
11	and	CC	O	and	_	0	SENT_143	[p8l1720t1345r1845b1408],
12	platelet	NN	O	platelet	nn	13	SENT_143	[p8l1883t1345r2142b1426],
13	hyperreactivity	NN	O	hyperreactivity	conj_and	10	SENT_143	[p8l7t1451r538b1532],
14	than	IN	O	than	_	0	SENT_143	[p8l581t1451r732b1514],
15	light	JJ	O	light	amod	17	SENT_143	[p8l776t1451r936b1532],
16	transmission	NN	O	transmission	nn	17	SENT_143	[p8l977t1451r1422b1514],
17	aggregometry	NN	O	aggregometry	prep_than	3	SENT_143	[p8l1466t1460r1966b1532],
18	,	,	O	,	_	0	SENT_143	[p8l1466t1460r1966b1532],
19	still	RB	O	still	advmod	17	SENT_143	[p8l2015t1451r2141b1514],
20	the	DT	O	the	det	25	SENT_143	[p8l7t1557r112b1620],
21	most	RBS	O	most	advmod	23	SENT_143	[p8l137t1566r308b1620],
22	widely	RB	O	widely	advmod	23	SENT_143	[p8l331t1557r571b1638],
23	used	VBN	O	use	amod	25	SENT_143	[p8l593t1557r756b1620],
24	method	NN	O	method	nn	25	SENT_143	[p8l780t1557r1045b1620],
25	[	NN	O	[	dep	17	SENT_143	[p8l1074t1558r1230b1636],
26	17	CD	NUMBER	17	num	27	SENT_143	[p8l1074t1558r1230b1636],
27	]	NN	O	]	dep	25	SENT_143	[p8l1074t1558r1230b1636],
28	.	.	O	.	_	0	SENT_143	[p8l1074t1558r1230b1636],

1	We	PRP	O	we	nsubj	2	SENT_144	[p8l1259t1559r1373b1620],
2	introduced	VBD	O	introduce	_	0	SENT_144	[p8l1400t1557r1774b1620],
3	recently	RB	DATE	recently	advmod	2	SENT_144	[p8l1798t1557r2080b1638],
4	a	DT	O	a	det	6	SENT_144	[p8l2106t1577r2142b1619],
5	novel	JJ	O	novel	amod	6	SENT_144	[p8l7t1663r203b1726],
6	protocol	NN	O	protocol	dobj	2	SENT_144	[p8l229t1663r522b1744],
7	for	IN	O	for	_	0	SENT_144	[p8l553t1663r653b1726],
8	impedance	NN	O	impedance	nn	9	SENT_144	[p8l680t1663r1059b1744],
9	aggregometry	NN	O	aggregometry	prep_for	2	SENT_144	[p8l1089t1672r1589b1744],
10	,	,	O	,	_	0	SENT_144	[p8l1089t1672r1589b1744],
11	which	WDT	O	which	nsubj	12	SENT_144	[p8l1620t1663r1836b1726],
12	allowed	VBD	O	allow	rcmod	9	SENT_144	[p8l1865t1663r2141b1726],
13	the	DT	O	the	det	14	SENT_144	[p8l7t1769r112b1832],
14	determination	NN	O	determination	dobj	12	SENT_144	[p8l143t1769r630b1832],
15	of	IN	O	of	_	0	SENT_144	[p8l659t1769r740b1832],
16	the	DT	O	the	det	17	SENT_144	[p8l757t1769r862b1832],
17	response	NN	O	response	prep_of	14	SENT_144	[p8l891t1789r1198b1849],
18	to	TO	O	to	_	0	SENT_144	[p8l1227t1777r1292b1832],
19	clopidogrel	NN	O	clopidogrel	prep_to	12	SENT_144	[p8l1324t1769r1722b1849],
20	by	IN	O	by	_	0	SENT_144	[p8l1750t1769r1839b1849],
21	a	DT	O	a	det	23	SENT_144	[p8l1869t1789r1905b1831],
22	single	JJ	O	single	amod	23	SENT_144	[p8l1935t1769r2140b1849],
23	examination	NN	O	examination	prep_by	2	SENT_144	[p8l9t1875r442b1938],
24	of	IN	O	of	_	0	SENT_144	[p8l475t1875r556b1938],
25	a	DT	O	a	det	26	SENT_144	[p8l578t1896r615b1938],
26	patient	NN	O	patient	prep_of	23	SENT_144	[p8l643t1875r900b1956],
27	,	,	O	,	_	0	SENT_144	[p8l643t1875r900b1956],
28	who	WP	O	who	nsubj	35	SENT_144	[p8l935t1875r1084b1938],
29	is	VBZ	O	be	cop	35	SENT_144	[p8l1120t1875r1173b1938],
30	already	RB	O	already	advmod	35	SENT_144	[p8l1208t1875r1464b1956],
31	on	IN	O	on	_	0	SENT_144	[p8l1496t1896r1583b1938],
32	treatment	NN	O	treatment	prep_on	30	SENT_144	[p8l1613t1884r1944b1938],
33	[	CD	NUMBER	[	number	34	SENT_144	[p8l1980t1877r2136b1955],
34	15	CD	NUMBER	15	num	35	SENT_144	[p8l1980t1877r2136b1955],
35	]	NN	O	]	rcmod	26	SENT_144	[p8l1980t1877r2136b1955],
36	.	.	O	.	_	0	SENT_144	[p8l1980t1877r2136b1955],

1	Aggregometry	NN	O	aggregometry	nsubj	12	SENT_145	[p8l7t1982r522b2062],
2	before	IN	O	before	_	0	SENT_145	[p8l575t1981r798b2044],
3	and	CC	O	and	_	0	SENT_145	[p8l857t1981r982b2044],
4	after	IN	O	after	_	0	SENT_145	[p8l1038t1981r1196b2044],
5	the	DT	O	the	det	6	SENT_145	[p8l1249t1981r1354b2044],
6	start	NN	O	start	prep_before	1	SENT_145	[p8l1413t1990r1560b2044],
7	of	IN	O	of	_	0	SENT_145	[p8l1616t1981r1697b2044],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_145	[p8l1743t1981r2140b2062],
9	therapy	NN	O	therapy	prep_of	6	SENT_145	[p8l7t2087r271b2168],
10	was	VBD	O	be	cop	12	SENT_145	[p8l290t2107r424b2150],
11	therefore	RB	O	therefore	advmod	12	SENT_145	[p8l447t2087r761b2150],
12	dispensable	JJ	O	dispensable	_	0	SENT_145	[p8l784t2087r1209b2168],
13	.	.	O	.	_	0	SENT_145	[p8l784t2087r1209b2168],

1	We	PRP	O	we	nsubj	3	SENT_146	[p8l1235t2089r1348b2150],
2	successfully	RB	O	successfully	advmod	3	SENT_146	[p8l1373t2087r1799b2168],
3	validated	VBD	O	validate	_	0	SENT_146	[p8l1819t2087r2141b2150],
4	our	PRP$	O	we	poss	5	SENT_146	[p8l9t2213r126b2256],
5	protocol	NN	O	protocol	dobj	3	SENT_146	[p8l144t2193r437b2273],
6	by	IN	O	by	_	0	SENT_146	[p8l458t2193r547b2273],
7	confirming	VBG	O	confirm	prepc_by	3	SENT_146	[p8l571t2193r958b2273],
8	the	DT	O	the	det	11	SENT_146	[p8l980t2193r1085b2256],
9	previously	RB	DATE	previously	advmod	10	SENT_146	[p8l1107t2193r1480b2273],
10	reported	VBN	O	report	amod	11	SENT_146	[p8l1501t2193r1793b2273],
11	inﬂuence	NN	O	inﬂuence	nsubj	23	SENT_146	[p8l1817t2193r2139b2256],
12	of	IN	O	of	_	0	SENT_146	[p8l9t2299r90b2362],
13	H2	NN	O	h2	nn	14	SENT_146	[p8l115t2301r219b2361],
14	alleles	NNS	O	allele	prep_of	11	SENT_146	[p8l260t2299r478b2362],
15	on	IN	O	on	_	0	SENT_146	[p8l518t2320r604b2362],
16	platelet	NN	O	platelet	nn	17	SENT_146	[p8l638t2299r897b2380],
17	reactivity	NN	O	reactivity	prep_on	14	SENT_146	[p8l932t2299r1262b2380],
18	in	IN	O	in	_	0	SENT_146	[p8l1299t2299r1365b2361],
19	healthy	JJ	O	healthy	amod	22	SENT_146	[p8l1400t2299r1672b2380],
20	,	,	O	,	_	0	SENT_146	[p8l1400t2299r1672b2380],
21	clopidogrelnatve	JJ	O	clopidogrelnatve	amod	22	SENT_146	[p8l1713t2299r2139b2380, p8l7t2412r204b2468],
22	subjects	NNS	O	subject	prep_in	11	SENT_146	[p8l237t2405r514b2486],
23	[	VBP	O	[	ccomp	7	SENT_146	[p8l551t2406r707b2484],
24	12	CD	NUMBER	12	num	25	SENT_146	[p8l551t2406r707b2484],
25	]	CD	NUMBER	]	dobj	23	SENT_146	[p8l551t2406r707b2484],
26	.	.	O	.	_	0	SENT_146	[p8l551t2406r707b2484],

1	There	EX	O	there	expl	6	SENT_147	[p8l115t2511r313b2574],
2	are	VBP	O	be	aux	6	SENT_147	[p8l336t2532r436b2574],
3	only	RB	O	only	advmod	6	SENT_147	[p8l459t2511r612b2592],
4	two	CD	NUMBER	two	num	5	SENT_147	[p8l630t2520r757b2574],
5	publications	NNS	O	publication	pobj	3	SENT_147	[p8l778t2511r1197b2592],
6	reporting	VBG	O	report	_	0	SENT_147	[p8l1218t2511r1530b2592],
7	platelet	NN	O	platelet	nn	8	SENT_147	[p8l1550t2511r1803b2592],
8	reactivity	NN	O	reactivity	dobj	6	SENT_147	[p8l1820t2511r2142b2592],
9	and	CC	O	and	_	0	SENT_147	[p8l9t2617r133b2680],
10	P2Y12-receptor	NN	O	p2y12-receptor	nn	11	SENT_147	[p8l172t2618r701b2697],
11	haplotypes	NNS	O	haplotype	conj_and	8	SENT_147	[p8l738t2616r1110b2697],
12	in	IN	O	in	_	0	SENT_147	[p8l1152t2617r1217b2678],
13	clopidogrel	NN	O	clopidogrel	prep_in	6	SENT_147	[p8l1258t2616r1647b2697],
14	treated	VBN	O	treat	partmod	13	SENT_147	[p8l1686t2616r1918b2679],
15	CAD	NN	O	cad	nn	16	SENT_147	[p8l1960t2618r2139b2680],
16	patients	NNS	O	patient	dobj	14	SENT_147	[p8l6t2723r288b2804],
17	.	.	O	.	_	0	SENT_147	[p8l6t2723r288b2804],

1	Both	DT	O	both	det	2	SENT_148	[p8l324t2723r492b2786],
2	authors	NNS	O	author	nsubj	3	SENT_148	[p8l524t2723r773b2786],
3	used	VBN	O	use	_	0	SENT_148	[p8l803t2723r964b2786],
4	light	JJ	O	light	amod	6	SENT_148	[p8l994t2723r1149b2804],
5	transmission	NN	O	transmission	nn	6	SENT_148	[p8l1178t2723r1612b2786],
6	aggregometry	NN	O	aggregometry	dobj	3	SENT_148	[p8l1643t2732r2136b2804],
7	:	:	O	:	_	0	SENT_148	[p8l1643t2732r2136b2804],
8	Angiolillo	NNP	O	Angiolillo	nsubj	9	SENT_148	[p8l7t2829r357b2910],
9	genotyped	VBD	O	genotype	parataxis	3	SENT_148	[p8l380t2829r740b2910],
10	another	DT	O	another	det	11	SENT_148	[p8l759t2829r1016b2892],
11	haplotype	NN	O	haplotype	dobj	9	SENT_148	[p8l1032t2829r1371b2910],
12	tagging	VBG	O	tag	partmod	11	SENT_148	[p8l1390t2829r1647b2910],
13	SNP	NN	O	snp	nn	16	SENT_148	[p8l1671t2830r1824b2892],
14	(	CD	NUMBER	(	num	16	SENT_148	[p8l1847t2829r2139b2909],
15	T744C	NN	O	t744c	nn	16	SENT_148	[p8l1847t2829r2139b2909],
16	)	NN	O	)	dobj	12	SENT_148	[p8l1847t2829r2139b2909],
17	in	IN	O	in	_	0	SENT_148	[p8l9t2935r75b2997],
18	119	CD	NUMBER	119	num	19	SENT_148	[p8l101t2936r217b2998],
19	clopidogrel	NN	O	clopidogrel	prep_in	16	SENT_148	[p8l239t2935r628b3015],
20	treated	VBN	O	treat	partmod	19	SENT_148	[p8l645t2935r876b2998],
21	CAD	NN	O	cad	nn	22	SENT_148	[p8l896t2936r1075b2998],
22	patients	NNS	O	patient	nsubj	25	SENT_148	[p8l1094t2935r1360b3015],
23	[	CD	NUMBER	[	number	24	SENT_148	[p8l1385t2936r1536b3014],
24	18	CD	NUMBER	18	num	25	SENT_148	[p8l1385t2936r1536b3014],
25	]	NN	O	]	xcomp	20	SENT_148	[p8l1385t2936r1536b3014],
26	.	.	O	.	_	0	SENT_148	[p8l1385t2936r1536b3014],

1	Only	RB	O	only	quantmod	2	SENT_149	[p8l1562t2935r1733b3015],
2	36	CD	NUMBER	36	num	3	SENT_149	[p8l1753t2936r1835b2997],
3	patients	NNS	O	patient	nsubj	10	SENT_149	[p8l1854t2935r2138b3015],
4	,	,	O	,	_	0	SENT_149	[p8l1854t2935r2138b3015],
5	however	RB	O	however	advmod	7	SENT_149	[p8l7t3041r319b3118],
6	,	,	O	,	_	0	SENT_149	[p8l7t3041r319b3118],
7	underwent	VBD	O	undergo	_	0	SENT_149	[p8l370t3041r735b3104],
8	PCI	NNP	O	PCI	dobj	7	SENT_149	[p8l783t3043r915b3104],
9	and	CC	O	and	_	0	SENT_149	[p8l966t3041r1089b3104],
10	received	VBD	O	receive	conj_and	7	SENT_149	[p8l1136t3041r1427b3104],
11	a	DT	O	a	det	13	SENT_149	[p8l1475t3062r1512b3104],
12	loading	VBG	O	load	amod	13	SENT_149	[p8l1561t3041r1817b3122],
13	dose	NN	O	dose	dobj	10	SENT_149	[p8l1867t3041r2021b3104],
14	of	IN	O	of	_	0	SENT_149	[p8l2072t3041r2153b3104],
15	300	CD	NUMBER	300	num	17	SENT_149	[p8l10t3149r135b3210],
16	mg	NN	O	mg	nn	17	SENT_149	[p8l162t3168r272b3228],
17	clopidogrel	NN	O	clopidogrel	prep_of	13	SENT_149	[p8l299t3147r704b3228],
18	.	.	O	.	_	0	SENT_149	[p8l299t3147r704b3228],

1	Platelet	NN	O	platelet	nn	2	SENT_150	[p8l733t3147r989b3210],
2	aggregation	NN	O	aggregation	nsubjpass	20	SENT_150	[p8l1013t3147r1435b3228],
3	,	,	O	,	_	0	SENT_150	[p8l1013t3147r1435b3228],
4	assessed	VBN	O	assess	partmod	2	SENT_150	[p8l1464t3147r1752b3210],
5	at	IN	O	at	_	0	SENT_150	[p8l1778t3156r1839b3210],
6	baseline	NN	O	baseline	prep_at	4	SENT_150	[p8l1860t3147r2140b3210],
7	as	RB	O	as	_	0	SENT_150	[p8l9t3273r77b3316],
8	well	RB	O	well	_	0	SENT_150	[p8l122t3253r269b3316],
9	as	IN	O	as	_	0	SENT_150	[p8l315t3273r382b3316],
10	4	CD	NUMBER	4	conj_and	6	SENT_150	[p8l427t3254r468b3315],
11	and	CC	O	and	_	0	SENT_150	[p8l516t3253r640b3316],
12	24	CD	NUMBER	24	num	13	SENT_150	[p8l683t3254r767b3315],
13	h	NN	O	h	conj_and	10	SENT_150	[p8l813t3253r856b3315],
14	after	IN	O	after	_	0	SENT_150	[p8l902t3253r1057b3316],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_150	[p8l1099t3253r1487b3333],
16	loading	NN	O	loading	prep_after	4	SENT_150	[p8l1533t3253r1806b3333],
17	,	,	O	,	_	0	SENT_150	[p8l1533t3253r1806b3333],
18	was	VBD	O	be	auxpass	20	SENT_150	[p8l1854t3273r1987b3316],
19	not	RB	O	not	neg	20	SENT_150	[p8l2031t3261r2142b3316],
20	associated	VBN	O	associate	_	0	SENT_150	[p8l9t3359r361b3422],
21	with	IN	O	with	_	0	SENT_150	[p8l398t3359r553b3422],
22	the	DT	O	the	det	24	SENT_150	[p8l592t3359r695b3422],
23	H2	NN	O	h2	nn	24	SENT_150	[p8l738t3361r840b3421],
24	haplotype	NN	O	haplotype	prep_with	20	SENT_150	[p8l884t3359r1223b3440],
25	in	IN	O	in	_	0	SENT_150	[p8l1266t3359r1332b3421],
26	this	DT	O	this	det	28	SENT_150	[p8l1371t3359r1492b3422],
27	small	JJ	O	small	amod	28	SENT_150	[p8l1538t3359r1720b3422],
28	study	NN	O	study	prep_in	24	SENT_150	[p8l1763t3359r1956b3440],
29	.	.	O	.	_	0	SENT_150	[p8l1763t3359r1956b3440],

1	Von	NNP	PERSON	Von	nn	2	SENT_151	[p8l2003t3362r2142b3422],
2	Beckerath	NNP	PERSON	Beckerath	nsubj	3	SENT_151	[p8l8t3465r356b3528],
3	examined	VBD	O	examine	_	0	SENT_151	[p8l389t3465r722b3528],
4	416	CD	NUMBER	416	num	6	SENT_151	[p8l754t3466r882b3527],
5	PCI	NN	O	pcus	nn	6	SENT_151	[p8l917t3466r1050b3528],
6	candidates	NNS	O	candidate	dobj	3	SENT_151	[p8l1085t3465r1442b3528],
7	2	CD	NUMBER	2	num	8	SENT_151	[p8l1477t3466r1516b3527],
8	h	NN	O	h	tmod	3	SENT_151	[p8l1551t3465r1595b3527],
9	after	IN	O	after	_	0	SENT_151	[p8l1629t3465r1783b3528],
10	a	DT	O	a	det	12	SENT_151	[p8l1816t3485r1852b3527],
11	loading	VBG	O	load	amod	12	SENT_151	[p8l1885t3465r2140b3545],
12	dose	NN	O	dose	prep_after	8	SENT_151	[p8l9t3571r165b3634],
13	of	IN	O	of	_	0	SENT_151	[p8l204t3571r285b3634],
14	600	CD	NUMBER	600	num	16	SENT_151	[p8l313t3573r438b3634],
15	mg	NN	O	mg	nn	16	SENT_151	[p8l477t3592r588b3652],
16	clopidogrel	NN	O	clopidogrel	prep_of	12	SENT_151	[p8l627t3571r1016b3652],
17	[	CD	NUMBER	[	num	19	SENT_151	[p8l1059t3573r1210b3651],
18	19	CD	NUMBER	19	num	19	SENT_151	[p8l1059t3573r1210b3651],
19	]	NN	O	]	dep	8	SENT_151	[p8l1059t3573r1210b3651],
20	.	.	O	.	_	0	SENT_151	[p8l1059t3573r1210b3651],

1	Two	CD	DURATION	two	num	2	SENT_152	[p8l1254t3574r1404b3634],
2	hours	NNS	DURATION	hour	npadvmod	14	SENT_152	[p8l1443t3571r1632b3634],
3	after	IN	O	after	_	0	SENT_152	[p8l1673t3572r1828b3634],
4	loading	VBG	O	load	prepc_after	14	SENT_152	[p8l1864t3571r2137b3652],
5	,	,	O	,	_	0	SENT_152	[p8l1864t3571r2137b3652],
6	however	RB	O	however	advmod	14	SENT_152	[p8l7t3677r319b3753],
7	,	,	O	,	_	0	SENT_152	[p8l7t3677r319b3753],
8	platelet	NN	O	platelet	nn	9	SENT_152	[p8l342t3677r595b3758],
9	inhibition	NN	O	inhibition	nsubj	21	SENT_152	[p8l616t3677r947b3740],
10	by	IN	O	by	_	0	SENT_152	[p8l967t3677r1056b3758],
11	clopidogrel	NN	O	clopidogrel	prep_by	9	SENT_152	[p8l1077t3677r1466b3758],
12	may	MD	O	may	aux	14	SENT_152	[p8l1486t3698r1635b3758],
13	be	VB	O	be	cop	14	SENT_152	[p8l1655t3677r1737b3740],
14	effective	JJ	O	effective	_	0	SENT_152	[p8l1761t3677r2053b3740],
15	in	IN	O	in	_	0	SENT_152	[p8l2077t3677r2142b3739],
16	most	JJS	O	most	prep_in	14	SENT_152	[p9l7t28r177b82],
17	but	CC	O	but	_	0	SENT_152	[p9l194t19r306b82],
18	may	MD	O	may	aux	21	SENT_152	[p9l324t39r474b100],
19	not	RB	O	not	neg	21	SENT_152	[p9l493t27r604b82],
20	have	VB	O	have	aux	21	SENT_152	[p9l622t19r785b82],
21	reached	VBN	O	reach	conj_but	14	SENT_152	[p9l805t19r1072b82],
22	the	DT	O	the	det	24	SENT_152	[p9l1091t19r1194b82],
23	achievable	JJ	O	achievable	amod	24	SENT_152	[p9l1217t19r1581b82],
24	maximum	NN	O	maximum	dobj	21	SENT_152	[p9l1601t19r1954b82],
25	in	IN	O	in	_	0	SENT_152	[p9l1974t19r2038b81],
26	all	DT	O	all	det	27	SENT_152	[p9l2060t19r2141b81],
27	patients	NNS	O	patient	prep_in	24	SENT_152	[p9l6t125r288b206],
28	.	.	O	.	_	0	SENT_152	[p9l6t125r288b206],

1	This	DT	O	this	det	3	SENT_153	[p9l316t125r465b188],
2	time	NN	O	time	nn	3	SENT_153	[p9l487t125r638b188],
3	point	NN	O	point	nsubj	6	SENT_153	[p9l657t125r836b206],
4	may	MD	O	may	aux	6	SENT_153	[p9l855t146r1005b206],
5	have	VB	O	have	aux	6	SENT_153	[p9l1024t125r1185b188],
6	been	VBN	O	be	_	0	SENT_153	[p9l1206t125r1370b188],
7	too	RB	O	too	advmod	8	SENT_153	[p9l1390t134r1498b188],
8	early	RB	O	early	advmod	6	SENT_153	[p9l1523t125r1691b206],
9	for	IN	O	for	_	0	SENT_153	[p9l1712t126r1811b188],
10	a	DT	O	a	det	12	SENT_153	[p9l1831t146r1868b188],
11	reliable	JJ	O	reliable	amod	12	SENT_153	[p9l1887t125r2140b188],
12	assessment	NN	O	assessment	prep_for	8	SENT_153	[p9l9t240r390b294],
13	of	IN	O	of	_	0	SENT_153	[p9l409t231r488b294],
14	the	DT	O	the	det	15	SENT_153	[p9l496t231r600b294],
15	response	NN	O	response	prep_of	12	SENT_153	[p9l618t252r918b312],
16	to	TO	O	to	_	0	SENT_153	[p9l936t240r1001b294],
17	clopidogrel	NN	O	clopidogrel	prep_to	8	SENT_153	[p9l1023t231r1429b312],
18	,	,	O	,	_	0	SENT_153	[p9l1023t231r1429b312],
19	which	WDT	O	which	nsubj	21	SENT_153	[p9l1450t231r1662b294],
20	could	MD	O	could	aux	21	SENT_153	[p9l1682t231r1872b294],
21	explain	VB	O	explain	rcmod	17	SENT_153	[p9l1891t231r2142b312],
22	their	PRP$	O	they	poss	23	SENT_153	[p9l7t337r165b400],
23	failure	NN	O	failure	dobj	21	SENT_153	[p9l193t337r410b400],
24	to	TO	O	to	aux	25	SENT_153	[p9l440t345r505b400],
25	find	VB	O	find	infmod	23	SENT_153	[p9l537t337r675b400],
26	an	DT	O	a	det	27	SENT_153	[p9l703t357r783b399],
27	association	NN	O	association	dobj	25	SENT_153	[p9l813t337r1191b400],
28	between	IN	O	between	_	0	SENT_153	[p9l1218t337r1506b400],
29	the	DT	O	the	det	31	SENT_153	[p9l1534t337r1638b400],
30	H2	NN	O	h2	nn	31	SENT_153	[p9l1668t338r1771b399],
31	haplotype	NN	O	haplotype	prep_between	27	SENT_153	[p9l1802t337r2140b418],
32	and	CC	O	and	_	0	SENT_153	[p9l9t443r133b506],
33	platelet	NN	O	platelet	nn	34	SENT_153	[p9l155t443r408b524],
34	aggregation	NN	O	aggregation	prep_between	27	SENT_153	[p9l432t443r851b524],
35	.	.	O	.	_	0	SENT_153	[p9l432t443r851b524],

1	Here	RB	O	here	advmod	4	SENT_154	[p9l114t551r305b625],
2	,	,	O	,	_	0	SENT_154	[p9l114t551r305b625],
3	we	PRP	O	we	nsubj	4	SENT_154	[p9l367t569r469b612],
4	report	VBP	O	report	_	0	SENT_154	[p9l530t558r744b630],
5	the	DT	O	the	det	8	SENT_154	[p9l802t549r908b612],
6	first	JJ	ORDINAL	first	amod	8	SENT_154	[p9l972t549r1112b612],
7	large	JJ	O	large	amod	8	SENT_154	[p9l1172t549r1345b630],
8	study	NN	O	study	dobj	4	SENT_154	[p9l1409t549r1600b630],
9	suggesting	VBG	O	suggest	partmod	8	SENT_154	[p9l1663t549r2044b630],
10	a	DT	O	a	det	11	SENT_154	[p9l2106t569r2142b611],
11	contribution	NN	O	contribution	dobj	9	SENT_154	[p9l9t655r438b718],
12	of	IN	O	of	_	0	SENT_154	[p9l463t656r544b718],
13	the	DT	O	the	det	16	SENT_154	[p9l557t655r662b718],
14	homozygote	NN	O	homozygote	nn	16	SENT_154	[p9l687t655r1122b736],
15	H2	NN	O	h2	nn	16	SENT_154	[p9l1148t657r1251b717],
16	haplotype	NN	O	haplotype	prep_of	11	SENT_154	[p9l1278t655r1625b736],
17	to	TO	O	to	_	0	SENT_154	[p9l1649t664r1714b718],
18	clopidogrel	NN	O	clopidogrel	nn	19	SENT_154	[p9l1742t655r2140b736],
19	resistance	NN	O	resistance	prep_to	9	SENT_154	[p9l7t761r351b824],
20	in	IN	O	in	_	0	SENT_154	[p9l377t761r443b823],
21	CAD	NN	O	cad	nn	22	SENT_154	[p9l467t763r648b824],
22	patients	NNS	O	patient	prep_in	19	SENT_154	[p9l672t761r961b842],
23	.	.	O	.	_	0	SENT_154	[p9l672t761r961b842],

1	The	DT	O	the	det	2	SENT_155	[p9l992t761r1125b824],
2	prevalence	NN	O	prevalence	nsubj	8	SENT_155	[p9l1147t761r1527b842],
3	of	IN	O	of	_	0	SENT_155	[p9l1553t761r1634b824],
4	this	DT	O	this	det	5	SENT_155	[p9l1645t761r1769b824],
5	haplotype	NN	O	haplotype	prep_of	2	SENT_155	[p9l1793t761r2140b842],
6	was	VBD	O	be	cop	8	SENT_155	[p9l7t888r141b930],
7	2.5	CD	PERCENT	2.5	num	8	SENT_155	[p9l187t868r388b943],
8	%	NN	PERCENT	%	_	0	SENT_155	[p9l187t868r388b943],
9	,	,	O	,	_	0	SENT_155	[p9l187t868r388b943],
10	comparable	JJ	O	comparable	dep	8	SENT_155	[p9l437t867r843b948],
11	to	TO	O	to	_	0	SENT_155	[p9l888t875r953b930],
12	3.1	CD	PERCENT	3.1	num	13	SENT_155	[p9l1000t868r1179b931],
13	%	NN	PERCENT	%	prep_to	10	SENT_155	[p9l1000t868r1179b931],
14	reported	VBN	O	report	partmod	13	SENT_155	[p9l1224t867r1516b948],
15	previously	RB	DATE	previously	advmod	14	SENT_155	[p9l1558t867r1931b948],
16	[	CD	NUMBER	[	number	17	SENT_155	[p9l1980t868r2136b946],
17	12	CD	NUMBER	12	num	18	SENT_155	[p9l1980t868r2136b946],
18	]	NN	O	]	dobj	14	SENT_155	[p9l1980t868r2136b946],
19	.	.	O	.	_	0	SENT_155	[p9l1980t868r2136b946],

1	Whole	JJ	O	whole	amod	3	SENT_156	[p9l7t973r241b1036],
2	blood	NN	O	blood	nn	3	SENT_156	[p9l282t973r484b1036],
3	aggregation	NN	O	aggregation	nsubj	6	SENT_156	[p9l527t973r940b1053],
4	was	VBD	O	be	cop	6	SENT_156	[p9l981t993r1115b1036],
5	nearly	RB	O	nearly	advmod	6	SENT_156	[p9l1158t973r1377b1053],
6	identical	JJ	O	identical	_	0	SENT_156	[p9l1420t973r1719b1036],
7	in	IN	O	in	_	0	SENT_156	[p9l1762t973r1828b1035],
8	patients	NNS	O	patient	prep_in	6	SENT_156	[p9l1867t973r2139b1053],
9	carrying	VBG	O	carry	partmod	8	SENT_156	[p9l9t1079r299b1160],
10	the	DT	O	the	det	14	SENT_156	[p9l335t1079r440b1142],
11	H1/Hl	NN	O	h1/hl	nn	14	SENT_156	[p9l477t1079r707b1142],
12	and	CC	O	and	_	0	SENT_156	[p9l755t1079r880b1142],
13	Hl/H2	NN	O	hl/h2	conj_and	11	SENT_156	[p9l916t1079r1152b1142],
14	haplotypes	NNS	O	haplotype	dobj	9	SENT_156	[p9l1191t1079r1589b1160],
15	.	.	O	.	_	0	SENT_156	[p9l1191t1079r1589b1160],

1	Therefore	RB	O	therefore	advmod	8	SENT_157	[p9l1633t1079r1995b1156],
2	,	,	O	,	_	0	SENT_157	[p9l1633t1079r1995b1156],
3	the	DT	O	the	det	7	SENT_157	[p9l2035t1079r2140b1142],
4	intermediate	JJ	O	intermediate	amod	7	SENT_157	[p9l9t1185r443b1248],
5	platelet	NN	O	platelet	nn	7	SENT_157	[p9l497t1185r755b1266],
6	hyperreactivity	NN	O	hyperreactivity	nn	7	SENT_157	[p9l808t1185r1340b1266],
7	Fontana	NNP	ORGANIZATION	Fontana	nsubj	8	SENT_157	[p9l1393t1188r1677b1248],
8	reported	VBD	O	report	_	0	SENT_157	[p9l1728t1185r2022b1266],
9	in	IN	O	in	prep	8	SENT_157	[p9l2076t1185r2141b1247],

1	344	CD	NUMBER	344	num	3	SENT_158	[p9l307t1342r355b1365],
2	R	NN	PERSON	r	nn	3	SENT_158	[p9l850t1342r872b1365],
3	Slaritz	NNP	PERSON	Slaritz	_	0	SENT_158	[p9l887t1342r973b1365],
4	el	FW	O	el	nn	5	SENT_158	[p9l984t1346r1008b1365],
5	al.	FW	O	al.	dep	3	SENT_158	[p9l1018t1341r1048b1365],
6	/	:	O	/	punct	3	SENT_158	[p9l1062t1341r1075b1366],
7	International	NNP	ORGANIZATION	International	nn	8	SENT_158	[p9l1081t1341r1257b1365],
8	Journal	NNP	ORGANIZATION	Journal	dep	3	SENT_158	[p9l1266t1341r1370b1365],
9	of	IN	ORGANIZATION	of	_	0	SENT_158	[p9l1381t1341r1413b1372],
10	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	8	SENT_158	[p9l1419t1341r1566b1372],
11	133	CD	NUMBER	133	number	12	SENT_158	[p9l1579t1342r1626b1365],
12	(	CD	NUMBER	(	num	13	SENT_158	[p9l1640t1341r1724b1372],
13	2009	CD	DATE	2009	dep	10	SENT_158	[p9l1640t1341r1724b1372],
14	)	CD	NUMBER	)	num	15	SENT_158	[p9l1640t1341r1724b1372],
15	341-345	CD	NUMBER	341-345	dep	13	SENT_158	[p9l1738t1342r1852b1365],

1	heterozygote	NN	O	heterozygote	nn	2	SENT_159	[p9l8t1533r461b1614],
2	clopidogrel-na	NN	O	clopidogrel-na	dep	5	SENT_159	[p9l491t1533r1117b1614],
3	'	''	O	'	_	0	SENT_159	[p9l491t1533r1117b1614],
4	t	NN	O	t	nsubj	5	SENT_159	[p9l491t1533r1117b1614],
5	've	VBP	O	have	_	0	SENT_159	[p9l491t1533r1117b1614],
6	subjects	NNS	O	subject	dobj	5	SENT_159	[p9l1149t1533r1446b1614],
7	,	,	O	,	_	0	SENT_159	[p9l1149t1533r1446b1614],
8	may	MD	O	may	aux	10	SENT_159	[p9l1477t1553r1628b1614],
9	be	VB	O	be	auxpass	10	SENT_159	[p9l1653t1533r1735b1596],
10	blunted	VBN	O	blunt	rcmod	6	SENT_159	[p9l1762t1533r2028b1596],
11	by	IN	O	by	_	0	SENT_159	[p9l2053t1533r2142b1614],
12	the	DT	O	the	det	15	SENT_159	[p9l8t1639r113b1702],
13	combined	JJ	O	combined	amod	15	SENT_159	[p9l146t1639r493b1702],
14	antiplatelet	JJ	O	antiplatelet	amod	15	SENT_159	[p9l523t1639r910b1720],
15	medication	NN	O	medication	agent	10	SENT_159	[p9l939t1639r1330b1702],
16	given	VBN	O	give	prep	6	SENT_159	[p9l1361t1639r1555b1720],
17	to	TO	O	to	pcomp	16	SENT_159	[p9l1584t1648r1649b1702],
18	patients	NNS	O	patient	pobj	17	SENT_159	[p9l1680t1640r1952b1720],
19	after	IN	O	after	_	0	SENT_159	[p9l1986t1640r2143b1702],
20	PCI	NN	O	pcus	prep_after	18	SENT_159	[p9l9t1747r161b1808],
21	.	.	O	.	_	0	SENT_159	[p9l9t1747r161b1808],

1	Patients	NNS	O	patient	nsubj	13	SENT_160	[p9l208t1745r483b1808],
2	with	IN	O	with	_	0	SENT_160	[p9l525t1745r681b1808],
3	a	DT	O	a	det	6	SENT_160	[p9l724t1766r760b1808],
4	homozygote	NN	O	homozygote	nn	6	SENT_160	[p9l800t1745r1236b1826],
5	H2	NN	O	h2	nn	6	SENT_160	[p9l1279t1747r1382b1807],
6	haplotype	NN	O	haplotype	prep_with	1	SENT_160	[p9l1426t1745r1773b1826],
7	exhibited	VBD	O	exhibit	dep	16	SENT_160	[p9l1816t1745r2142b1808],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_160	[p9l12t1851r447b1932],
9	enhanced	VBN	O	enhance	amod	11	SENT_160	[p9l485t1851r816b1914],
10	platelet	NN	O	platelet	nn	11	SENT_160	[p9l850t1851r1108b1931],
11	aggregation	NN	O	aggregation	dobj	7	SENT_160	[p9l1146t1851r1559b1932],
12	and	CC	O	and	_	0	SENT_160	[p9l1597t1851r1722b1914],
13	were	VBD	O	be	conj_and	7	SENT_160	[p9l1757t1871r1925b1914],
14	more	RBR	O	more	advmod	15	SENT_160	[p9l1962t1871r2140b1914],
15	frequently	RB	O	frequently	advmod	13	SENT_160	[p9l11t1957r369b2037],
16	clopidogrel	VBP	O	clopidogrel	_	0	SENT_160	[p9l410t1957r808b2037],
17	nonresponders	NNS	O	nonresponder	dobj	16	SENT_160	[p9l847t1957r1359b2037],
18	(	CD	NUMBER	(	num	19	SENT_160	[p9l1402t1957r1590b2037],
19	O.R.	NNP	O	O.R.	nsubj	16	SENT_160	[p9l1402t1957r1590b2037],
20	5.42	CD	PERCENT	5.42	number	21	SENT_160	[p9l1637t1958r1785b2020],
21	[	CD	PERCENT	[	amod	25	SENT_160	[p9l1833t1958r2014b2036],
22	95	CD	PERCENT	95	num	23	SENT_160	[p9l1833t1958r2014b2036],
23	%	NN	PERCENT	%	dep	21	SENT_160	[p9l1833t1958r2014b2036],
24	CI	NN	O	ci	nn	25	SENT_160	[p9l2057t1958r2141b2020],
25	l.	NN	O	l.	dep	19	SENT_160	[p9l18t2064r495b2143],
26	82	CD	NUMBER	82	number	27	SENT_160	[p9l18t2064r495b2143],
27	—	CD	NUMBER	—	num	28	SENT_160	[p9l18t2064r495b2143],
28	l6	NN	O	l6	dep	25	SENT_160	[p9l18t2064r495b2143],
29	.	.	O	.	_	0	SENT_160	[p9l18t2064r495b2143],

1	ll	NN	O	ll	_	0	SENT_161	[p9l18t2064r495b2143],
2	]	CD	NUMBER	]	num	3	SENT_161	[p9l18t2064r495b2143],
3	)	NN	O	)	dep	1	SENT_161	[p9l18t2064r495b2143],
4	.	.	O	.	_	0	SENT_161	[p9l18t2064r495b2143],

1	Improved	VBN	O	improve	csubj	13	SENT_162	[p9l560t2063r906b2144],
2	inhibition	NN	O	inhibition	dobj	1	SENT_162	[p9l966t2063r1312b2126],
3	of	IN	O	of	_	0	SENT_162	[p9l1372t2063r1453b2126],
4	aggregation	NN	O	aggregation	prep_of	2	SENT_162	[p9l1504t2063r1923b2144],
5	after	IN	O	after	_	0	SENT_162	[p9l1984t2063r2144b2126],
6	incubation	NN	O	incubation	prep_after	1	SENT_162	[p9l10t2169r394b2232],
7	with	IN	O	with	_	0	SENT_162	[p9l454t2169r615b2232],
8	the	DT	O	the	det	12	SENT_162	[p9l675t2169r784b2232],
9	ADP	NN	ORGANIZATION	adp	nn	12	SENT_162	[p9l846t2170r1023b2231],
10	receptor	NN	O	receptor	nn	12	SENT_162	[p9l1085t2178r1384b2250],
11	blocker	NN	O	blocker	nn	12	SENT_162	[p9l1442t2169r1717b2232],
12	MeSAMP	NN	O	mesamp	prep_with	1	SENT_162	[p9l1776t2170r2139b2232],
13	suggested	VBD	O	suggest	_	0	SENT_162	[p9l12t2275r357b2355],
14	that	IN	O	that	complm	20	SENT_162	[p9l385t2275r516b2337],
15	almost	RB	O	almost	advmod	17	SENT_162	[p9l547t2275r779b2338],
16	all	DT	O	all	det	17	SENT_162	[p9l809t2275r892b2337],
17	nonresponders	NNS	O	nonresponder	nsubj	20	SENT_162	[p9l922t2275r1434b2355],
18	may	MD	O	may	aux	20	SENT_162	[p9l1466t2295r1616b2355],
19	have	VB	O	have	aux	20	SENT_162	[p9l1645t2275r1810b2338],
20	gained	VBN	O	gain	ccomp	13	SENT_162	[p9l1842t2275r2075b2355],
21	a	DT	O	a	det	22	SENT_162	[p9l2106t2295r2143b2337],
22	benefit	NN	O	benefit	dobj	20	SENT_162	[p9l8t2381r253b2444],
23	from	IN	O	from	_	0	SENT_162	[p9l278t2381r445b2444],
24	higher	JJR	O	higher	amod	25	SENT_162	[p9l469t2381r695b2462],
25	doses	NNS	O	dose	prep_from	20	SENT_162	[p9l719t2381r911b2444],
26	of	IN	O	of	_	0	SENT_162	[p9l939t2381r1020b2444],
27	clopidogrel	NN	O	clopidogrel	prep_of	25	SENT_162	[p9l1035t2381r1450b2462],
28	.	.	O	.	_	0	SENT_162	[p9l1035t2381r1450b2462],

1	In	IN	O	in	_	0	SENT_163	[p9l1481t2383r1552b2443],
2	the	DT	DATE	the	det	3	SENT_163	[p9l1577t2381r1681b2444],
3	future	NN	DATE	future	prep_in	18	SENT_163	[p9l1709t2381r1934b2457],
4	,	,	O	,	_	0	SENT_163	[p9l1709t2381r1934b2457],
5	more	JJR	O	more	amod	9	SENT_163	[p9l1961t2401r2139b2444],
6	potent	JJ	O	potent	amod	9	SENT_163	[p9l7t2495r229b2567],
7	ADP	NN	O	adp	nn	9	SENT_163	[p9l251t2488r425b2549],
8	receptor	NN	O	receptor	nn	9	SENT_163	[p9l451t2495r739b2567],
9	blockers	NNS	O	blocker	nsubj	18	SENT_163	[p9l760t2487r1076b2563],
10	,	,	O	,	_	0	SENT_163	[p9l760t2487r1076b2563],
11	such	JJ	O	such	_	0	SENT_163	[p9l1107t2487r1265b2550],
12	as	IN	O	as	_	0	SENT_163	[p9l1290t2507r1358b2550],
13	prasugrel	NN	O	prasugrel	prep_such_as	9	SENT_163	[p9l1382t2487r1728b2567],
14	,	,	O	,	_	0	SENT_163	[p9l1382t2487r1728b2567],
15	may	MD	O	may	aux	18	SENT_163	[p9l1755t2507r1906b2567],
16	be	VB	O	be	cop	18	SENT_163	[p9l1928t2487r2010b2550],
17	the	DT	O	the	det	18	SENT_163	[p9l2035t2487r2140b2550],
18	drug	NN	O	drug	_	0	SENT_163	[p9l10t2593r168b2674],
19	of	IN	O	of	_	0	SENT_163	[p9l193t2593r273b2656],
20	choice	NN	O	choice	prep_of	18	SENT_163	[p9l286t2593r511b2656],
21	for	IN	O	for	_	0	SENT_163	[p9l536t2594r637b2656],
22	patients	NNS	O	patient	prep_for	20	SENT_163	[p9l655t2593r926b2674],
23	with	IN	O	with	_	0	SENT_163	[p9l949t2593r1105b2656],
24	a	DT	O	a	det	27	SENT_163	[p9l1128t2614r1165b2656],
25	homozygote	NN	O	homozygote	nn	27	SENT_163	[p9l1185t2593r1620b2674],
26	H2	NN	O	h2	nn	27	SENT_163	[p9l1643t2595r1746b2655],
27	haplotype	NN	O	haplotype	prep_with	22	SENT_163	[p9l1771t2593r2136b2674],
28	.	.	O	.	_	0	SENT_163	[p9l1771t2593r2136b2674],

1	Although	IN	O	although	mark	5	SENT_164	[p9l115t2699r449b2780],
2	women	NNS	O	woman	nsubj	5	SENT_164	[p9l480t2720r740b2762],
3	were	VBD	O	be	cop	5	SENT_164	[p9l771t2720r940b2762],
4	more	RBR	O	more	advmod	5	SENT_164	[p9l972t2720r1150b2762],
5	likely	JJ	O	likely	advcl	31	SENT_164	[p9l1185t2699r1383b2780],
6	to	TO	O	to	aux	8	SENT_164	[p9l1414t2708r1479b2762],
7	be	VB	O	be	cop	8	SENT_164	[p9l1512t2699r1594b2762],
8	nonresponders	NNS	O	nonresponder	xcomp	5	SENT_164	[p9l1627t2699r2139b2780],
9	(	CD	NUMBER	(	num	10	SENT_164	[p9l11t2805r198b2885],
10	O.R.	NNP	O	O.R.	dep	8	SENT_164	[p9l11t2805r198b2885],
11	3.90	CD	PERCENT	3.90	num	10	SENT_164	[p9l231t2806r380b2868],
12	[	CD	PERCENT	[	num	15	SENT_164	[p9l413t2806r595b2884],
13	95	CD	PERCENT	95	number	14	SENT_164	[p9l413t2806r595b2884],
14	%	NN	PERCENT	%	amod	15	SENT_164	[p9l413t2806r595b2884],
15	CI	NN	O	ci	dep	10	SENT_164	[p9l623t2806r707b2868],
16	2.34	CD	NUMBER	2.34	number	17	SENT_164	[p9l732t2805r1171b2885],
17	—	CD	NUMBER	—	dep	10	SENT_164	[p9l732t2805r1171b2885],
18	6.50	CD	NUMBER	6.50	num	20	SENT_164	[p9l732t2805r1171b2885],
19	]	CD	NUMBER	]	num	20	SENT_164	[p9l732t2805r1171b2885],
20	)	NN	O	)	dep	17	SENT_164	[p9l732t2805r1171b2885],
21	,	,	O	,	_	0	SENT_164	[p9l732t2805r1171b2885],
22	the	DT	O	the	det	23	SENT_164	[p9l1199t2805r1304b2868],
23	contribution	NN	O	contribution	nsubj	31	SENT_164	[p9l1331t2805r1759b2868],
24	of	IN	O	of	_	0	SENT_164	[p9l1786t2805r1866b2868],
25	the	DT	O	the	det	26	SENT_164	[p9l1880t2805r1985b2868],
26	H2	NN	O	h2	prep_of	23	SENT_164	[p9l2010t2805r2143b2868],
27	/	:	O	/	punct	29	SENT_164	[p9l2010t2805r2143b2868],
28	H2	NN	O	h2	nn	29	SENT_164	[p9l9t2913r112b2973],
29	haplotype	NN	O	haplotype	dep	26	SENT_164	[p9l148t2911r495b2992],
30	was	VBD	O	be	cop	31	SENT_164	[p9l529t2932r663b2974],
31	independent	JJ	O	independent	_	0	SENT_164	[p9l700t2911r1131b2992],
32	as	IN	O	as	mark	33	SENT_164	[p9l1165t2932r1233b2974],
33	evidenced	VBN	O	evidence	ccomp	31	SENT_164	[p9l1270t2911r1625b2974],
34	by	IN	O	by	_	0	SENT_164	[p9l1657t2911r1746b2992],
35	our	PRP$	O	we	poss	39	SENT_164	[p9l1780t2932r1897b2974],
36	multivariate	JJ	O	multivariate	amod	39	SENT_164	[p9l1928t2911r2139b2974, p9l8t3017r245b3080],
37	logistic	JJ	O	logistic	amod	39	SENT_164	[p9l304t3017r558b3098],
38	regression	NN	O	regression	nn	39	SENT_164	[p9l614t3017r976b3098],
39	analyses	NNS	O	analysis	prep_by	33	SENT_164	[p9l1033t3017r1346b3098],
40	.	.	O	.	_	0	SENT_164	[p9l1033t3017r1346b3098],

1	A	DT	O	a	det	4	SENT_165	[p9l1407t3019r1470b3079],
2	homozygous	JJ	O	homozygous	amod	4	SENT_165	[p9l1526t3017r1976b3098],
3	H2	NN	O	h2	nn	4	SENT_165	[p9l2035t3019r2138b3079],
4	haplotype	NN	O	haplotype	nsubj	10	SENT_165	[p9l8t3123r355b3204],
5	and	CC	O	and	_	0	SENT_165	[p9l403t3123r529b3186],
6	female	JJ	O	female	amod	7	SENT_165	[p9l576t3123r810b3186],
7	sex	NN	O	sex	conj_and	4	SENT_165	[p9l859t3143r972b3186],
8	are	VBP	O	be	cop	10	SENT_165	[p9l1020t3143r1122b3186],
9	independent	JJ	O	independent	amod	10	SENT_165	[p9l1171t3123r1601b3203],
10	predictors	NNS	O	predictor	_	0	SENT_165	[p9l1644t3123r1993b3203],
11	for	IN	O	for	_	0	SENT_165	[p9l2043t3123r2144b3186],
12	clopidogrel	NN	O	clopidogrel	nn	13	SENT_165	[p9l11t3229r413b3310],
13	resistance	NN	O	resistance	prep_for	10	SENT_165	[p9l472t3229r839b3292],
14	.	.	O	.	_	0	SENT_165	[p9l472t3229r839b3292],

1	Notably	RB	O	notably	advmod	9	SENT_166	[p9l901t3229r1203b3310],
2	,	,	O	,	_	0	SENT_166	[p9l901t3229r1203b3310],
3	the	DT	O	the	det	5	SENT_166	[p9l1266t3229r1372b3292],
4	gender	NN	O	gender	nn	5	SENT_166	[p9l1433t3229r1675b3310],
5	effect	NN	O	effect	nsubj	9	SENT_166	[p9l1734t3229r1932b3292],
6	may	MD	O	may	aux	9	SENT_166	[p9l1990t3249r2141b3310],
7	become	VB	O	become	cop	9	SENT_166	[p9l8t3335r281b3398],
8	more	RBR	O	more	advmod	9	SENT_166	[p9l315t3355r493b3398],
9	pronounced	JJ	O	pronounced	_	0	SENT_166	[p9l526t3335r946b3415],
10	in	IN	O	in	_	0	SENT_166	[p9l980t3335r1046b3397],
11	the	DT	O	the	det	12	SENT_166	[p9l1079t3335r1184b3398],
12	presence	NN	O	presence	prep_in	9	SENT_166	[p9l1217t3355r1524b3415],
13	of	IN	O	of	_	0	SENT_166	[p9l1560t3335r1641b3398],
14	a	DT	O	a	det	17	SENT_166	[p9l1665t3355r1702b3397],
15	rare	JJ	O	rare	amod	17	SENT_166	[p9l1734t3355r1867b3398],
16	H2/H2	NN	O	h2/h2	nn	17	SENT_166	[p9l1902t3335r2138b3398],
17	genotype	NN	O	genotype	prep_of	12	SENT_166	[p9l10t3450r331b3522],
18	contributing	VBG	O	contribute	partmod	17	SENT_166	[p9l362t3441r789b3522],
19	additional	JJ	O	additional	amod	20	SENT_166	[p9l821t3441r1170b3504],
20	risk	NN	O	risk	dobj	18	SENT_166	[p9l1198t3441r1346b3504],
21	.	.	O	.	_	0	SENT_166	[p9l1198t3441r1346b3504],

1	The	DT	O	the	det	3	SENT_167	[p9l1381t3441r1514b3504],
2	molecular	JJ	O	molecular	amod	3	SENT_167	[p9l1544t3441r1896b3504],
3	nature	NN	O	nature	nsubj	10	SENT_167	[p9l1922t3450r2140b3504],
4	of	IN	O	of	_	0	SENT_167	[p9l10t3547r91b3610],
5	the	DT	O	the	det	7	SENT_167	[p9l109t3547r214b3610],
6	gender	NN	O	gender	nn	7	SENT_167	[p9l246t3547r485b3628],
7	effect	NN	O	effect	prep_of	3	SENT_167	[p9l514t3547r709b3610],
8	is	VBZ	O	be	cop	10	SENT_167	[p9l739t3547r792b3610],
9	largely	RB	O	largely	advmod	10	SENT_167	[p9l825t3547r1064b3628],
10	unknown	JJ	O	unknown	_	0	SENT_167	[p9l1092t3547r1440b3610],
11	.	.	O	.	_	0	SENT_167	[p9l1092t3547r1440b3610],

1	It	PRP	O	it	nsubj	11	SENT_168	[p9l1476t3550r1527b3610],
2	may	MD	O	may	aux	5	SENT_168	[p9l1554t3568r1705b3628],
3	not	RB	O	not	neg	5	SENT_168	[p9l1734t3556r1847b3610],
4	directly	RB	O	directly	advmod	5	SENT_168	[p9l1877t3547r2141b3628],
5	inﬂuence	VB	O	inﬂuence	_	0	SENT_168	[p9l10t3653r333b3716],
6	the	DT	O	the	det	7	SENT_168	[p9l369t3653r474b3716],
7	P2Y12-receptor	NN	O	p2y12-receptor	dobj	5	SENT_168	[p9l510t3655r1053b3733],
8	but	CC	O	but	_	0	SENT_168	[p9l1084t3652r1198b3715],
9	may	MD	O	may	aux	11	SENT_168	[p9l1231t3673r1382b3733],
10	rather	RB	O	rather	advmod	11	SENT_168	[p9l1417t3652r1621b3715],
11	inﬂuence	VB	O	inﬂuence	conj_but	5	SENT_168	[p9l1656t3652r1978b3715],
12	any	DT	O	any	det	13	SENT_168	[p9l2017t3673r2142b3733],
13	pathway	NN	O	pathway	dobj	11	SENT_168	[p10l7t20r307b101],
14	involved	VBN	O	involve	partmod	13	SENT_168	[p10l334t20r641b83],
15	in	IN	O	in	_	0	SENT_168	[p10l668t20r734b82],
16	ADP-mediated	JJ	O	adp-mediated	amod	17	SENT_168	[p10l758t20r1286b83],
17	aggregation	NN	O	aggregation	prep_in	14	SENT_168	[p10l1313t20r1727b101],
18	or	CC	O	or	_	0	SENT_168	[p10l1754t41r1826b83],
19	clopidogrel	NN	O	clopidogrel	nn	20	SENT_168	[p10l1851t20r2140b101, p10l10t126r143b207],
20	metabolism	NN	O	metabolism	prep_in	14	SENT_168	[p10l172t126r598b189],
21	.	.	O	.	_	0	SENT_168	[p10l172t126r598b189],

1	Many	JJ	O	many	amod	3	SENT_169	[p10l116t234r321b312],
2	potential	JJ	O	potential	amod	3	SENT_169	[p10l375t232r683b312],
3	determinants	NNS	O	determinant	nsubjpass	8	SENT_169	[p10l742t232r1191b295],
4	of	IN	O	of	_	0	SENT_169	[p10l1251t232r1332b295],
5	clopidogrel	NN	O	clopidogrel	nn	6	SENT_169	[p10l1379t232r1777b312],
6	response	NN	O	response	prep_of	3	SENT_169	[p10l1834t252r2140b312],
7	were	VBD	O	be	auxpass	8	SENT_169	[p10l8t358r181b401],
8	eliminated	VBN	O	eliminate	_	0	SENT_169	[p10l245t338r627b401],
9	as	IN	O	as	_	0	SENT_169	[p10l689t358r758b401],
10	confounders	NNS	O	confounder	prep_as	8	SENT_169	[p10l823t338r1290b401],
11	.	.	O	.	_	0	SENT_169	[p10l823t338r1290b401],

1	We	PRP	O	we	nsubj	4	SENT_170	[p10l1356t340r1471b401],
2	can	MD	O	can	aux	4	SENT_170	[p10l1536t347r1776b401],
3	not	RB	O	not	neg	4	SENT_170	[p10l1536t347r1776b401],
4	exclude	VB	O	exclude	_	0	SENT_170	[p10l1838t338r2138b414],
5	,	,	O	,	_	0	SENT_170	[p10l1838t338r2138b414],
6	however	RB	O	however	advmod	4	SENT_170	[p10l8t444r343b520],
7	,	,	O	,	_	0	SENT_170	[p10l8t444r343b520],
8	that	IN	O	that	complm	15	SENT_170	[p10l409t444r547b506],
9	other	JJ	O	other	amod	11	SENT_170	[p10l610t444r799b507],
10	unknown	JJ	O	unknown	amod	11	SENT_170	[p10l858t444r1203b507],
11	factors	NNS	O	factor	nsubjpass	15	SENT_170	[p10l1267t444r1513b507],
12	were	VBD	O	be	auxpass	15	SENT_170	[p10l1577t464r1752b507],
13	not	RB	O	not	neg	15	SENT_170	[p10l1815t452r1933b507],
14	also	RB	O	also	advmod	15	SENT_170	[p10l1996t444r2139b507],
15	distributed	VBN	O	distribute	ccomp	4	SENT_170	[p10l10t550r405b613],
16	comparably	RB	O	comparably	dep	15	SENT_170	[p10l468t550r899b631],
17	among	IN	O	among	_	0	SENT_170	[p10l963t571r1208b631],
18	the	DT	O	the	det	20	SENT_170	[p10l1270t550r1380b613],
19	haplotype	NN	O	haplotype	nn	20	SENT_170	[p10l1442t550r1804b631],
20	groups	NNS	O	group	prep_among	16	SENT_170	[p10l1869t571r2136b631],
21	.	.	O	.	_	0	SENT_170	[p10l1869t571r2136b631],

1	Information	NN	O	information	nsubj	9	SENT_171	[p10l10t656r427b719],
2	on	IN	O	on	_	0	SENT_171	[p10l465t677r552b719],
3	the	DT	O	the	det	4	SENT_171	[p10l587t656r692b719],
4	use	NN	O	use	prep_on	1	SENT_171	[p10l728t677r844b719],
5	of	IN	O	of	_	0	SENT_171	[p10l883t656r964b719],
6	statins	NNS	O	statin	prep_of	4	SENT_171	[p10l992t656r1209b719],
7	was	VBD	O	be	cop	9	SENT_171	[p10l1248t677r1382b719],
8	not	RB	O	not	neg	9	SENT_171	[p10l1419t664r1533b719],
9	available	JJ	O	available	_	0	SENT_171	[p10l1569t656r1882b719],
10	for	IN	O	for	_	0	SENT_171	[p10l1922t656r2022b719],
11	all	DT	O	all	det	12	SENT_171	[p10l2058t656r2141b719],
12	patients	NNS	O	patient	prep_for	9	SENT_171	[p10l7t762r298b842],
13	.	.	O	.	_	0	SENT_171	[p10l7t762r298b842],

1	A	DT	O	a	det	3	SENT_172	[p10l339t763r402b824],
2	signiﬁcant	JJ	O	signiﬁcant	amod	3	SENT_172	[p10l441t762r808b842],
3	inﬂuence	NN	O	inﬂuence	nsubj	36	SENT_172	[p10l845t762r1168b825],
4	of	IN	O	of	_	0	SENT_172	[p10l1207t762r1287b825],
5	statins	NNS	O	statin	prep_of	3	SENT_172	[p10l1316t762r1533b825],
6	(	CD	NUMBER	(	num	7	SENT_172	[p10l1574t762r1715b842],
7	use	NN	O	use	nsubjpass	28	SENT_172	[p10l1574t762r1715b842],
8	of	IN	O	of	_	0	SENT_172	[p10l1754t762r1835b825],
9	atorvastatin/simvastatin	NN	O	atorvastatin/simvastatin	prep_of	7	SENT_172	[p10l1862t770r2139b825, p10l8t868r588b931],
10	vs.	IN	O	vs.	_	0	SENT_172	[p10l618t889r712b931],
11	no	DT	O	no	det	12	SENT_172	[p10l747t889r833b931],
12	statin/pravastatin	NN	O	statin/pravastatin	prep_vs.	9	SENT_172	[p10l868t868r1886b949],
13	/	:	O	/	punct	15	SENT_172	[p10l868t868r1886b949],
14	ﬂuvastatin	NN	O	ﬂuvastatin	nn	15	SENT_172	[p10l868t868r1886b949],
15	)	NN	O	)	dep	12	SENT_172	[p10l868t868r1886b949],
16	on	IN	O	on	_	0	SENT_172	[p10l1920t889r2006b931],
17	the	DT	O	the	det	18	SENT_172	[p10l2035t868r2140b931],
18	results	NNS	O	result	prep_on	15	SENT_172	[p10l8t974r240b1037],
19	of	IN	O	of	_	0	SENT_172	[p10l303t974r384b1037],
20	impedance	NN	O	impedance	prep_of	18	SENT_172	[p10l435t974r820b1055],
21	or	CC	O	or	_	0	SENT_172	[p10l883t995r956b1037],
22	the	DT	O	the	det	23	SENT_172	[p10l1013t974r1120b1037],
23	frequency	NN	O	frequency	conj_or	15	SENT_172	[p10l1183t974r1540b1055],
24	of	IN	O	of	_	0	SENT_172	[p10l1601t974r1683b1037],
25	clopidogrel	NN	O	clopidogrel	nn	26	SENT_172	[p10l1734t974r2141b1055],
26	resistance	NN	O	resistance	prep_of	23	SENT_172	[p10l8t1080r352b1143],
27	was	VBD	O	be	auxpass	28	SENT_172	[p10l380t1100r514b1143],
28	ruled	VBN	O	rule	rcmod	5	SENT_172	[p10l542t1080r723b1143],
29	out	RP	O	out	prt	28	SENT_172	[p10l750t1089r861b1143],
30	in	IN	O	in	_	0	SENT_172	[p10l889t1080r954b1142],
31	a	DT	O	a	det	32	SENT_172	[p10l983t1100r1019b1142],
32	subgroup	NN	O	subgroup	prep_in	28	SENT_172	[p10l1048t1080r1371b1161],
33	of	IN	O	of	_	0	SENT_172	[p10l1402t1080r1483b1143],
34	152	CD	NUMBER	152	prep_of	32	SENT_172	[p10l1508t1081r1628b1143],
35	consecutively	RB	O	consecutively	advmod	36	SENT_172	[p10l1659t1080r2142b1161],
36	enrolled	VBD	O	enrol	_	0	SENT_172	[p10l11t1186r296b1249],
37	patients	NNS	O	patient	dobj	36	SENT_172	[p10l330t1186r602b1267],
38	(	CD	NUMBER	(	num	39	SENT_172	[p10l642t1186r815b1266],
39	data	NNS	O	datum	npadvmod	40	SENT_172	[p10l642t1186r815b1266],
40	not	RB	O	not	neg	41	SENT_172	[p10l849t1194r963b1249],
41	shown	VBN	O	show	partmod	37	SENT_172	[p10l1000t1186r1273b1266],
42	)	NN	O	)	dobj	41	SENT_172	[p10l1000t1186r1273b1266],
43	.	.	O	.	_	0	SENT_172	[p10l1000t1186r1273b1266],

1	The	DT	O	the	det	2	SENT_173	[p10l1316t1186r1449b1249],
2	use	NN	O	use	nsubj	7	SENT_173	[p10l1485t1207r1601b1249],
3	of	IN	O	of	_	0	SENT_173	[p10l1641t1186r1721b1249],
4	statins	NNS	O	statin	prep_of	2	SENT_173	[p10l1749t1186r1968b1249],
5	was	VBD	O	be	cop	7	SENT_173	[p10l2005t1207r2139b1249],
6	also	RB	O	also	advmod	7	SENT_173	[p10l11t1292r146b1355],
7	comparable	JJ	O	comparable	_	0	SENT_173	[p10l193t1292r600b1372],
8	in	IN	O	in	_	0	SENT_173	[p10l645t1292r711b1354],
9	responders	NNS	O	responder	prep_in	7	SENT_173	[p10l752t1292r1132b1372],
10	and	CC	O	and	_	0	SENT_173	[p10l1178t1292r1303b1355],
11	nonresponders	NNS	O	nonresponder	prep_in	7	SENT_173	[p10l1345t1292r1857b1372],
12	among	IN	O	among	_	0	SENT_173	[p10l1904t1312r2140b1373],
13	carriers	NNS	O	carrier	prep_among	7	SENT_173	[p10l11t1398r266b1461],
14	of	IN	O	of	_	0	SENT_173	[p10l300t1399r381b1461],
15	the	DT	O	the	det	18	SENT_173	[p10l399t1398r504b1461],
16	homozygote	NN	O	homozygote	nn	18	SENT_173	[p10l535t1398r971b1479],
17	H2	NN	O	h2	nn	18	SENT_173	[p10l1002t1400r1105b1460],
18	haplotype	NN	O	haplotype	prep_of	13	SENT_173	[p10l1137t1398r1484b1479],
19	(	CD	NUMBER	(	num	20	SENT_173	[p10l1518t1398r1689b1479],
20	data	NNS	O	datum	npadvmod	21	SENT_173	[p10l1518t1398r1689b1479],
21	not	RB	O	not	neg	22	SENT_173	[p10l1718t1407r1831b1461],
22	shown	VBN	O	show	partmod	18	SENT_173	[p10l1863t1398r2136b1479],
23	)	NN	O	)	dobj	22	SENT_173	[p10l1863t1398r2136b1479],
24	.	.	O	.	_	0	SENT_173	[p10l1863t1398r2136b1479],

1	The	DT	O	the	det	2	SENT_174	[p10l10t1504r143b1567],
2	inﬂuence	NN	O	inﬂuence	nsubj	9	SENT_174	[p10l190t1504r512b1567],
3	of	IN	O	of	_	0	SENT_174	[p10l559t1504r640b1567],
4	statins	NNS	O	statin	prep_of	2	SENT_174	[p10l675t1504r893b1567],
5	on	IN	O	on	_	0	SENT_174	[p10l941t1525r1027b1567],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_174	[p10l1071t1504r1469b1585],
7	response	NN	O	response	prep_on	4	SENT_174	[p10l1513t1525r1820b1585],
8	remains	VBZ	O	remain	cop	9	SENT_174	[p10l1864t1504r2139b1567],
9	doubtful	JJ	O	doubtful	_	0	SENT_174	[p10l10t1610r307b1673],
10	in	IN	O	in	_	0	SENT_174	[p10l353t1610r418b1672],
11	our	PRP$	O	we	poss	12	SENT_174	[p10l463t1630r580b1673],
12	study	NN	O	study	prep_in	9	SENT_174	[p10l625t1610r824b1691],
13	.	.	O	.	_	0	SENT_174	[p10l625t1610r824b1691],

1	Even	RB	O	even	advmod	2	SENT_175	[p10l874t1612r1054b1673],
2	studies	NNS	O	study	nsubj	11	SENT_175	[p10l1101t1610r1359b1686],
3	,	,	O	,	_	0	SENT_175	[p10l1101t1610r1359b1686],
4	which	WDT	O	which	nsubj	7	SENT_175	[p10l1406t1610r1621b1673],
5	have	VBP	O	have	aux	7	SENT_175	[p10l1665t1610r1830b1673],
6	directly	RB	O	directly	advmod	7	SENT_175	[p10l1877t1610r2141b1691],
7	addressed	VBN	O	address	rcmod	2	SENT_175	[p10l11t1716r356b1779],
8	this	DT	O	this	det	9	SENT_175	[p10l383t1716r506b1779],
9	issue	NN	O	issue	dobj	7	SENT_175	[p10l539t1716r731b1792],
10	,	,	O	,	_	0	SENT_175	[p10l539t1716r731b1792],
11	came	VBD	O	come	_	0	SENT_175	[p10l765t1736r946b1779],
12	to	TO	O	to	_	0	SENT_175	[p10l975t1724r1040b1779],
13	a	DT	O	a	det	15	SENT_175	[p10l1073t1736r1109b1778],
14	similar	JJ	O	similar	amod	15	SENT_175	[p10l1139t1716r1380b1779],
15	conclusion	NN	O	conclusion	prep_to	11	SENT_175	[p10l1408t1716r1788b1779],
16	[	CD	NUMBER	[	number	17	SENT_175	[p10l1822t1717r2090b1795],
17	20,21	CD	NUMBER	20,21	num	18	SENT_175	[p10l1822t1717r2090b1795],
18	]	NN	O	]	dep	15	SENT_175	[p10l1822t1717r2090b1795],
19	.	.	O	.	_	0	SENT_175	[p10l1822t1717r2090b1795],

1	In	IN	O	in	_	0	SENT_176	[p10l116t1825r187b1884],
2	our	PRP$	O	we	poss	3	SENT_176	[p10l213t1843r328b1885],
3	study	NN	O	study	prep_in	18	SENT_176	[p10l353t1822r549b1903],
4	,	,	O	,	_	0	SENT_176	[p10l353t1822r549b1903],
5	the	DT	O	the	det	9	SENT_176	[p10l577t1822r681b1885],
6	G52T	NN	O	g52t	nn	9	SENT_176	[p10l708t1824r909b1885],
7	single	JJ	O	single	amod	9	SENT_176	[p10l931t1822r1132b1903],
8	nucleotide	NN	O	nucleotide	nn	9	SENT_176	[p10l1157t1822r1516b1885],
9	polymorphism	NN	O	polymorphism	nsubjpass	18	SENT_176	[p10l1539t1822r2047b1903],
10	of	IN	O	of	_	0	SENT_176	[p10l2072t1822r2152b1885],
11	the	DT	O	the	det	16	SENT_176	[p10l8t1928r112b1991],
12	P2Y12	NN	O	p2y12	nn	16	SENT_176	[p10l151t1930r369b2004],
13	platelet	NN	O	platelet	nn	16	SENT_176	[p10l406t1928r661b2008],
14	ADP	NN	ORGANIZATION	adp	nn	16	SENT_176	[p10l696t1929r869b1990],
15	receptor	NN	O	receptor	nn	16	SENT_176	[p10l908t1936r1192b2008],
16	gene	NN	O	gene	prep_of	9	SENT_176	[p10l1227t1948r1388b2008],
17	was	VBD	O	be	auxpass	18	SENT_176	[p10l1425t1948r1558b1991],
18	associated	VBN	O	associate	_	0	SENT_176	[p10l1600t1928r1953b1991],
19	with	IN	O	with	_	0	SENT_176	[p10l1988t1928r2142b1991],
20	clopidogrel	NN	O	clopidogrel	nn	21	SENT_176	[p10l11t2034r412b2115],
21	resistance	NN	O	resistance	prep_with	18	SENT_176	[p10l468t2034r833b2097],
22	.	.	O	.	_	0	SENT_176	[p10l468t2034r833b2097],

1	The	DT	O	the	det	3	SENT_177	[p10l896t2034r1029b2097],
2	clinical	JJ	O	clinical	amod	3	SENT_177	[p10l1090t2034r1346b2097],
3	signiﬁcance	NN	O	signiﬁcance	nsubj	7	SENT_177	[p10l1406t2034r1829b2115],
4	of	IN	O	of	_	0	SENT_177	[p10l1888t2034r1969b2097],
5	this	DT	O	this	det	6	SENT_177	[p10l2015t2034r2140b2097],
6	association	NN	O	association	prep_of	3	SENT_177	[p10l11t2140r391b2203],
7	remains	VBZ	O	remain	_	0	SENT_177	[p10l406t2140r677b2203],
8	to	TO	O	to	aux	10	SENT_177	[p10l694t2149r759b2203],
9	be	VB	O	be	auxpass	10	SENT_177	[p10l776t2140r858b2203],
10	demonstrated	VBN	O	demonstrate	xcomp	7	SENT_177	[p10l876t2140r1340b2203],
11	with	IN	O	with	_	0	SENT_177	[p10l1354t2140r1508b2203],
12	a	DT	O	a	det	15	SENT_177	[p10l1526t2161r1563b2203],
13	clinical	JJ	O	clinical	amod	15	SENT_177	[p10l1579t2140r1828b2203],
14	outcome	NN	O	outcome	nn	15	SENT_177	[p10l1845t2149r2141b2203],
15	study	NN	O	study	prep_with	10	SENT_177	[p10l12t2246r206b2327],
16	.	.	O	.	_	0	SENT_177	[p10l12t2246r206b2327],

1	In	IN	O	in	_	0	SENT_178	[p10l236t2249r307b2308],
2	the	DT	O	the	det	3	SENT_178	[p10l330t2246r433b2309],
3	meantime	NN	O	meantime	prep_in	11	SENT_178	[p10l458t2246r816b2323],
4	,	,	O	,	_	0	SENT_178	[p10l458t2246r816b2323],
5	routine	JJ	O	routine	amod	7	SENT_178	[p10l842t2246r1085b2309],
6	platelet	NN	O	platelet	nn	7	SENT_178	[p10l1108t2246r1362b2327],
7	aggregometry	NN	O	aggregometry	nsubj	11	SENT_178	[p10l1386t2255r1865b2327],
8	may	MD	O	may	aux	11	SENT_178	[p10l1887t2267r2037b2327],
9	be	VB	O	be	cop	11	SENT_178	[p10l2059t2246r2141b2309],
10	more	RBR	O	more	advmod	11	SENT_178	[p10l9t2372r185b2415],
11	useful	JJ	O	useful	_	0	SENT_178	[p10l209t2352r421b2415],
12	than	IN	O	than	_	0	SENT_178	[p10l445t2352r595b2414],
13	genotyping	NN	O	genotyping	prep_than	11	SENT_178	[p10l620t2352r1009b2433],
14	of	IN	O	of	_	0	SENT_178	[p10l1035t2352r1115b2415],
15	the	DT	O	the	det	17	SENT_178	[p10l1129t2352r1232b2415],
16	ADP	NN	ORGANIZATION	adp	nn	17	SENT_178	[p10l1258t2353r1431b2414],
17	receptor	NN	O	receptor	prep_of	13	SENT_178	[p10l1457t2360r1749b2432],
18	.	.	O	.	_	0	SENT_178	[p10l1457t2360r1749b2432],

1	5	CD	NUMBER	5	_	0	SENT_179	[p10l11t2567r75b2628],
2	.	.	O	.	_	0	SENT_179	[p10l11t2567r75b2628],

1	Limitations	NNPS	O	Limitations	_	0	SENT_180	[p10l111t2566r543b2627],

1	The	DT	O	the	det	3	SENT_181	[p10l117t2778r248b2841],
2	study	NN	O	study	nn	3	SENT_181	[p10l276t2778r460b2858],
3	population	NN	O	population	nsubj	6	SENT_181	[p10l481t2778r854b2858],
4	was	VBD	O	be	cop	6	SENT_181	[p10l876t2798r1008b2841],
5	not	RB	O	not	neg	6	SENT_181	[p10l1033t2786r1144b2841],
6	homogeneous	JJ	O	homogeneous	_	0	SENT_181	[p10l1166t2778r1666b2858],
7	.	.	O	.	_	0	SENT_181	[p10l1166t2778r1666b2858],

1	Patients	NNS	O	patient	nsubjpass	13	SENT_182	[p10l1694t2778r1964b2841],
2	with	IN	O	with	_	0	SENT_182	[p10l1988t2778r2142b2841],
3	both	DT	O	both	det	7	SENT_182	[p10l8t2884r165b2947],
4	stable	JJ	O	stable	amod	7	SENT_182	[p10l223t2884r422b2947],
5	coronary	JJ	O	coronary	amod	7	SENT_182	[p10l480t2904r790b2965],
6	artery	NN	O	artery	nn	7	SENT_182	[p10l847t2892r1047b2965],
7	disease	NN	O	disease	prep_with	1	SENT_182	[p10l1104t2884r1353b2947],
8	and	CC	O	and	_	0	SENT_182	[p10l1412t2884r1537b2947],
9	acute	JJ	O	acute	amod	11	SENT_182	[p10l1594t2893r1774b2947],
10	coronary	JJ	O	coronary	amod	11	SENT_182	[p10l1832t2904r2142b2965],
11	syndromes	NNS	O	syndrome	prep_with	1	SENT_182	[p10l12t2990r382b3071],
12	were	VBD	O	be	auxpass	13	SENT_182	[p10l410t3011r576b3053],
13	included	VBN	O	include	_	0	SENT_182	[p10l604t2990r916b3053],
14	.	.	O	.	_	0	SENT_182	[p10l604t2990r916b3053],

1	We	PRP	O	we	nsubj	4	SENT_183	[p10l947t2993r1059b3054],
2	did	VBD	O	do	aux	4	SENT_183	[p10l1088t2990r1197b3053],
3	not	RB	O	not	neg	4	SENT_183	[p10l1222t2999r1334b3053],
4	observe	VB	O	observe	_	0	SENT_183	[p10l1360t2990r1625b3053],
5	an	DT	O	a	det	6	SENT_183	[p10l1654t3011r1734b3053],
6	association	NN	O	association	dobj	4	SENT_183	[p10l1761t2990r2142b3053],
7	between	IN	O	between	_	0	SENT_183	[p10l8t3096r297b3159],
8	acute	JJ	O	acute	amod	10	SENT_183	[p10l323t3105r501b3159],
9	coronary	JJ	O	coronary	amod	10	SENT_183	[p10l529t3117r834b3177],
10	syndromes	NNS	O	syndrome	prep_between	6	SENT_183	[p10l862t3096r1232b3177],
11	and	CC	O	and	_	0	SENT_183	[p10l1260t3096r1384b3159],
12	platelet	NN	O	platelet	nn	13	SENT_183	[p10l1406t3096r1661b3177],
13	hyperreactivity	NN	O	hyperreactivity	conj_and	10	SENT_183	[p10l1683t3096r2139b3177, p10l10t3202r111b3283],
14	,	,	O	,	_	0	SENT_183	[p10l1683t3096r2139b3177, p10l10t3202r111b3283],
15	but	CC	O	but	_	0	SENT_183	[p10l133t3202r245b3265],
16	can	MD	O	can	aux	18	SENT_183	[p10l265t3210r496b3265],
17	not	RB	O	not	neg	18	SENT_183	[p10l265t3210r496b3265],
18	exclude	VB	O	exclude	conj_but	4	SENT_183	[p10l516t3202r781b3265],
19	an	DT	O	a	det	20	SENT_183	[p10l804t3222r884b3264],
20	effect	NN	O	effect	dobj	18	SENT_183	[p10l905t3202r1097b3265],
21	of	IN	O	of	_	0	SENT_183	[p10l1117t3202r1197b3265],
22	inﬂammation	NN	O	inﬂammation	prep_of	20	SENT_183	[p10l1208t3202r1671b3265],
23	and	CC	O	and	_	0	SENT_183	[p10l1691t3202r1816b3265],
24	coronary	JJ	O	coronary	amod	25	SENT_183	[p10l1836t3222r2142b3283],
25	thrombosis	NN	O	thrombosis	conj_and	20	SENT_183	[p10l8t3308r392b3371],
26	which	WDT	O	which	nsubj	28	SENT_183	[p10l416t3308r629b3371],
27	might	MD	O	might	aux	28	SENT_183	[p10l653t3308r856b3388],
28	persist	VB	O	persist	rcmod	25	SENT_183	[p10l878t3308r1104b3388],
29	even	RB	O	even	advmod	28	SENT_183	[p10l1130t3328r1292b3371],
30	beyond	IN	O	beyond	_	0	SENT_183	[p10l1315t3308r1573b3388],
31	this	DT	O	this	det	32	SENT_183	[p10l1596t3308r1718b3371],
32	time	NN	O	time	prep_beyond	28	SENT_183	[p10l1744t3308r1912b3371],
33	.	.	O	.	_	0	SENT_183	[p10l1744t3308r1912b3371],

1	Concomitant	JJ	O	concomitant	amod	2	SENT_184	[p10l117t3414r572b3478],
2	medication	NN	O	medication	nsubj	4	SENT_184	[p10l627t3414r1018b3477],
3	was	VBD	O	be	cop	4	SENT_184	[p10l1074t3435r1208b3477],
4	available	JJ	O	available	_	0	SENT_184	[p10l1269t3414r1581b3477],
5	only	RB	O	only	advmod	4	SENT_184	[p10l1641t3414r1795b3495],
6	for	IN	O	for	_	0	SENT_184	[p10l1854t3414r1955b3477],
7	152	CD	NUMBER	152	num	8	SENT_184	[p10l2019t3416r2138b3477],
8	patients	NNS	O	patient	prep_for	4	SENT_184	[p10l7t3520r298b3601],
9	.	.	O	.	_	0	SENT_184	[p10l7t3520r298b3601],

1	In	IN	O	in	_	0	SENT_185	[p10l346t3523r417b3582],
2	this	DT	O	this	det	3	SENT_185	[p10l458t3520r581b3583],
3	subgroup	NN	O	subgroup	prep_in	7	SENT_185	[p10l628t3520r952b3601],
4	we	PRP	O	we	nsubj	7	SENT_185	[p10l995t3541r1096b3583],
5	did	VBD	O	do	aux	7	SENT_185	[p10l1141t3520r1251b3583],
6	not	RB	O	not	neg	7	SENT_185	[p10l1292t3529r1405b3583],
7	ﬁnd	VB	O	ﬁnd	_	0	SENT_185	[p10l1448t3520r1586b3583],
8	an	DT	O	a	det	9	SENT_185	[p10l1629t3541r1710b3583],
9	association	NN	O	association	dobj	7	SENT_185	[p10l1753t3520r2142b3583],
10	between	IN	O	between	_	0	SENT_185	[p10l8t3626r301b3689],
11	medication	NN	O	medication	nn	14	SENT_185	[p10l329t3626r720b3689],
12	and	CC	O	and	_	0	SENT_185	[p10l750t3626r875b3689],
13	clopidogrel	NN	O	clopidogrel	conj_and	11	SENT_185	[p10l905t3626r1302b3707],
14	resistance	NN	O	resistance	prep_between	9	SENT_185	[p10l1331t3626r1693b3689],
15	.	.	O	.	_	0	SENT_185	[p10l1331t3626r1693b3689],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_186	[p11l9t23r740b103],

1	We	PRP	O	we	nsubj	2	SENT_187	[p11l114t238r227b298],
2	thank	VBP	O	thank	_	0	SENT_187	[p11l259t235r456b298],
3	Mrs.	NNP	O	Mrs.	nn	5	SENT_187	[p11l487t238r644b298],
4	Christa	NNP	PERSON	Christa	nn	5	SENT_187	[p11l684t235r936b298],
5	Dewald	NNP	PERSON	Dewald	dobj	2	SENT_187	[p11l967t235r1241b298],
6	and	CC	O	and	_	0	SENT_187	[p11l1274t235r1399b298],
7	Mrs.	NNP	O	Mrs.	nn	9	SENT_187	[p11l1430t238r1587b298],
8	Barbara	NNP	PERSON	Barbara	nn	9	SENT_187	[p11l1625t235r1902b298],
9	Calvo	NNP	PERSON	Calvo	conj_and	5	SENT_187	[p11l1935t235r2141b298],
10	for	IN	O	for	_	0	SENT_187	[p11l9t341r109b404],
11	their	PRP$	O	they	poss	14	SENT_187	[p11l142t341r304b404],
12	excellent	JJ	O	excellent	amod	14	SENT_187	[p11l339t341r655b404],
13	technical	JJ	O	technical	amod	14	SENT_187	[p11l688t341r1004b404],
14	assistance	NN	O	assistance	prep_for	5	SENT_187	[p11l1042t341r1407b404],
15	.	.	O	.	_	0	SENT_187	[p11l1042t341r1407b404],

1	We	PRP	O	we	nsubj	3	SENT_188	[p11l1448t344r1562b404],
2	are	VBP	O	be	cop	3	SENT_188	[p11l1600t362r1702b404],
3	indebted	JJ	O	indebted	_	0	SENT_188	[p11l1740t341r2042b404],
4	to	TO	O	to	_	0	SENT_188	[p11l2076t350r2141b404],
5	Dr.	NNP	O	Dr.	nn	7	SENT_188	[p11l7t449r111b510],
6	Albrecht	NNP	PERSON	Albrecht	nn	7	SENT_188	[p11l169t447r477b510],
7	Leo	NNP	PERSON	Leo	prep_to	3	SENT_188	[p11l531t449r664b510],
8	and	CC	O	and	_	0	SENT_188	[p11l722t447r848b510],
9	Dr.	NNP	O	Dr.	nn	11	SENT_188	[p11l901t449r1004b510],
10	Cornelia	NNP	PERSON	Cornelia	nn	11	SENT_188	[p11l1065t447r1367b510],
11	Wolf	NNP	PERSON	Wolf	prep_to	3	SENT_188	[p11l1419t447r1603b510],
12	for	IN	O	for	_	0	SENT_188	[p11l1647t447r1748b510],
13	access	NN	O	access	prep_for	7	SENT_188	[p11l1802t467r2021b510],
14	to	TO	O	to	_	0	SENT_188	[p11l2076t455r2141b510],
15	samples	NNS	O	sample	prep_to	3	SENT_188	[p11l10t553r288b635],
16	from	IN	O	from	_	0	SENT_188	[p11l323t554r491b617],
17	blood	NN	O	blood	nn	18	SENT_188	[p11l521t553r724b617],
18	donors	NNS	O	donor	prep_from	15	SENT_188	[p11l757t553r1011b617],
19	.	.	O	.	_	0	SENT_188	[p11l757t553r1011b617],

1	This	DT	O	this	det	2	SENT_189	[p11l115t660r269b724],
2	study	NN	O	study	nsubjpass	4	SENT_189	[p11l337t660r528b742],
3	was	VBD	O	be	auxpass	4	SENT_189	[p11l589t681r725b724],
4	supported	VBN	O	support	_	0	SENT_189	[p11l793t660r1144b742],
5	in	IN	O	in	_	0	SENT_189	[p11l1207t660r1273b723],
6	part	NN	O	part	prep_in	4	SENT_189	[p11l1334t669r1474b742],
7	by	IN	O	by	_	0	SENT_189	[p11l1534t660r1624b742],
8	the	DT	O	the	det	9	SENT_189	[p11l1686t660r1792b724],
9	Guidant	NNP	O	Guidant	agent	4	SENT_189	[p11l1858t660r2145b724],

1	Corporation	NNP	O	Corporation	nsubj	2	SENT_190	[p11l9t767r433b848],
2	(	RB	O	(	_	0	SENT_190	[p11l467t767r646b848],
3	now	RB	DATE	now	advmod	2	SENT_190	[p11l467t767r646b848],
4	Abbott	NNP	PERSON	Abbott	nn	5	SENT_190	[p11l676t767r967b848],
5	)	NNP	O	)	pobj	2	SENT_190	[p11l676t767r967b848],
6	.	.	O	.	_	0	SENT_190	[p11l676t767r967b848],

1	References	NNS	O	reference	_	0	SENT_191	[p11l7t1000r414b1062],

1	[	NN	O	[	_	0	SENT_192	[p11l47t1188r118b1251],
2	1	CD	NUMBER	1	num	1	SENT_192	[p11l47t1188r118b1251],
3	]	CD	NUMBER	]	num	5	SENT_192	[p11l47t1188r118b1251],
4	Silber	NNP	PERSON	Silber	nn	5	SENT_192	[p11l163t1187r327b1237],
5	S	NN	PERSON	s	dep	1	SENT_192	[p11l357t1188r406b1248],
6	,	,	O	,	_	0	SENT_192	[p11l357t1188r406b1248],
7	Albertsson	NN	PERSON	albertsson	nn	8	SENT_192	[p11l435t1187r740b1237],
8	P	NN	PERSON	p	appos	5	SENT_192	[p11l767t1189r812b1248],
9	,	,	O	,	_	0	SENT_192	[p11l767t1189r812b1248],
10	Aviles	NNP	PERSON	Aviles	nn	11	SENT_192	[p11l842t1187r1018b1237],
11	FF	NNP	O	FF	appos	5	SENT_192	[p11l1047t1189r1134b1248],
12	,	,	O	,	_	0	SENT_192	[p11l1047t1189r1134b1248],
13	et	FW	O	et	nn	14	SENT_192	[p11l1166t1194r1215b1237],
14	al.	FW	O	al.	appos	5	SENT_192	[p11l1242t1187r1303b1237],
15	.	.	O	.	_	0	SENT_192	[p11l1242t1187r1303b1237],

1	Guidelines	NNS	O	guideline	_	0	SENT_193	[p11l1336t1187r1638b1237],
2	for	IN	O	for	_	0	SENT_193	[p11l1668t1187r1748b1237],
3	percutaneous	JJ	O	percutaneous	amod	5	SENT_193	[p11l1772t1194r2143b1252],
4	coronary	JJ	O	coronary	amod	5	SENT_193	[p11l161t1290r409b1339],
5	interventions	NNS	O	intervention	prep_for	1	SENT_193	[p11l443t1274r821b1324],
6	.	.	O	.	_	0	SENT_193	[p11l443t1274r821b1324],

1	The	DT	O	the	det	3	SENT_194	[p11l860t1274r967b1324],
2	Task	NNP	O	Task	nn	3	SENT_194	[p11l1002t1274r1133b1324],
3	Force	NNP	O	Force	_	0	SENT_194	[p11l1165t1276r1323b1324],
4	for	IN	O	for	_	0	SENT_194	[p11l1359t1274r1440b1324],
5	Percutaneous	JJ	O	percutaneous	amod	7	SENT_194	[p11l1471t1276r1844b1324],
6	Coronary	JJ	O	coronary	amod	7	SENT_194	[p11l1880t1275r2145b1339],
7	Interventions	NNS	O	intervention	prep_for	3	SENT_194	[p11l160t1360r528b1410],
8	of	IN	O	of	_	0	SENT_194	[p11l567t1360r632b1410],
9	the	DT	O	the	det	11	SENT_194	[p11l658t1360r743b1410],
10	European	JJ	ORGANIZATION	european	amod	11	SENT_194	[p11l781t1362r1050b1425],
11	Society	NNP	ORGANIZATION	Society	prep_of	3	SENT_194	[p11l1089t1360r1296b1425],
12	of	IN	ORGANIZATION	of	_	0	SENT_194	[p11l1333t1360r1397b1410],
13	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	3	SENT_194	[p11l1426t1360r1750b1425],
14	.	.	O	.	_	0	SENT_194	[p11l1426t1360r1750b1425],

1	Eur	NNP	O	Eur	nn	3	SENT_195	[p11l1791t1362r1893b1410],
2	Heart	NNP	O	Heart	nn	3	SENT_195	[p11l1927t1362r2083b1410],
3	J	NNP	O	J	_	0	SENT_195	[p11l2118t1362r2145b1411],
4	2005	CD	DATE	2005	num	3	SENT_195	[p11l160t1450r644b1510],
5	;	:	O	;	_	0	SENT_195	[p11l160t1450r644b1510],
6	26:804	CD	NUMBER	26:804	number	7	SENT_195	[p11l160t1450r644b1510],
7	—	CD	NUMBER	—	dep	3	SENT_195	[p11l160t1450r644b1510],
8	47	CD	NUMBER	47	dep	7	SENT_195	[p11l160t1450r644b1510],
9	.	.	O	.	_	0	SENT_195	[p11l160t1450r644b1510],

1	[	NN	O	[	_	0	SENT_196	[p11l47t1537r118b1600],
2	2	CD	NUMBER	2	num	1	SENT_196	[p11l47t1537r118b1600],
3	]	CD	NUMBER	]	num	5	SENT_196	[p11l47t1537r118b1600],
4	Mehta	NNP	ORGANIZATION	Mehta	nn	5	SENT_196	[p11l159t1536r339b1586],
5	SR	NN	ORGANIZATION	sr	dep	1	SENT_196	[p11l376t1537r473b1597],
6	,	,	O	,	_	0	SENT_196	[p11l376t1537r473b1597],
7	Yusuf	NNP	PERSON	Yusuf	nn	8	SENT_196	[p11l509t1536r682b1586],
8	S	NNP	PERSON	S	appos	5	SENT_196	[p11l711t1537r761b1597],
9	,	,	O	,	_	0	SENT_196	[p11l711t1537r761b1597],
10	Peters	NNP	PERSON	Peters	nn	11	SENT_196	[p11l798t1538r967b1586],
11	RJ	NN	PERSON	rj	appos	5	SENT_196	[p11l1002t1538r1090b1597],
12	,	,	O	,	_	0	SENT_196	[p11l1002t1538r1090b1597],
13	et	FW	O	et	nn	14	SENT_196	[p11l1129t1543r1177b1586],
14	al.	FW	O	al.	appos	5	SENT_196	[p11l1212t1536r1273b1586],
15	.	.	O	.	_	0	SENT_196	[p11l1212t1536r1273b1586],

1	Effects	NNS	O	effect	nsubj	8	SENT_197	[p11l1312t1536r1507b1586],
2	of	IN	O	of	_	0	SENT_197	[p11l1543t1536r1608b1586],
3	pretreatment	NN	O	pretreatment	prep_of	1	SENT_197	[p11l1631t1543r1987b1601],
4	with	IN	O	with	_	0	SENT_197	[p11l2019t1536r2144b1586],
5	clopidogrel	NN	O	clopidogrel	prep_with	3	SENT_197	[p11l161t1622r478b1687],
6	and	CC	O	and	_	0	SENT_197	[p11l518t1622r618b1673],
7	aspirin	NN	O	aspirin	conj_and	5	SENT_197	[p11l656t1622r846b1687],
8	followed	VBN	O	follow	_	0	SENT_197	[p11l884t1622r1132b1672],
9	by	IN	O	by	_	0	SENT_197	[p11l1167t1622r1239b1687],
10	long-terrn	JJ	O	long-terrn	amod	11	SENT_197	[p11l1277t1622r1553b1687],
11	therapy	NN	O	therapy	prep_by	8	SENT_197	[p11l1588t1622r1799b1687],
12	in	IN	O	in	_	0	SENT_197	[p11l1837t1622r1890b1672],
13	patients	NNS	O	patient	prep_in	8	SENT_197	[p11l1926t1622r2143b1687],
14	undergoing	VBG	O	undergo	partmod	13	SENT_197	[p11l158t1709r479b1774],
15	percutaneous	JJ	O	percutaneous	amod	17	SENT_197	[p11l498t1716r869b1774],
16	coronary	JJ	O	coronary	amod	17	SENT_197	[p11l890t1726r1139b1774],
17	intervention	NN	O	intervention	dobj	14	SENT_197	[p11l1159t1709r1511b1760],
18	:	:	O	:	_	0	SENT_197	[p11l1159t1709r1511b1760],
19	the	DT	O	the	det	20	SENT_197	[p11l1534t1709r1619b1760],
20	PCI	NN	O	pcus	dep	17	SENT_197	[p11l1639t1710r1959b1760],
21	.	.	O	.	_	0	SENT_197	[p11l1639t1710r1959b1760],

1	—	NN	O	—	_	0	SENT_198	[p11l1639t1710r1959b1760],
2	.	.	O	.	_	0	SENT_198	[p11l1639t1710r1959b1760],

1	CURE	VB	O	cure	_	0	SENT_199	[p11l1639t1710r1959b1760],
2	study	NN	O	study	dobj	1	SENT_199	[p11l1981t1709r2140b1774],
3	.	.	O	.	_	0	SENT_199	[p11l1981t1709r2140b1774],

1	Lancet	NNP	O	Lancet	nn	2	SENT_200	[p11l159t1800r351b1848],
2	200l	NN	O	200l	_	0	SENT_200	[p11l372t1799r892b1859],
3	;	:	O	;	_	0	SENT_200	[p11l372t1799r892b1859],
4	358:527	CD	NUMBER	358:527	number	5	SENT_200	[p11l372t1799r892b1859],
5	—	CD	NUMBER	—	dep	2	SENT_200	[p11l372t1799r892b1859],
6	33	CD	NUMBER	33	dep	5	SENT_200	[p11l372t1799r892b1859],
7	.	.	O	.	_	0	SENT_200	[p11l372t1799r892b1859],

1	[	NN	O	[	nn	4	SENT_201	[p11l47t1885r118b1948],
2	3	CD	NUMBER	3	num	4	SENT_201	[p11l47t1885r118b1948],
3	]	NN	O	]	nn	4	SENT_201	[p11l47t1885r118b1948],
4	Steinhubl	NN	O	steinhubl	_	0	SENT_201	[p11l163t1884r429b1935],
5	SR	NN	O	sr	dep	4	SENT_201	[p11l453t1885r550b1945],
6	,	,	O	,	_	0	SENT_201	[p11l453t1885r550b1945],
7	Berger	NNP	PERSON	Berger	nn	8	SENT_201	[p11l575t1886r765b1949],
8	PB	NN	O	pb	appos	5	SENT_201	[p11l785t1886r885b1945],
9	,	,	O	,	_	0	SENT_201	[p11l785t1886r885b1945],
10	Mann	NNP	PERSON	Mann	nn	12	SENT_201	[p11l910t1886r1075b1934],
11	III	NNP	PERSON	III	nn	12	SENT_201	[p11l1096t1886r1163b1934],
12	JT	NNP	O	JT	appos	5	SENT_201	[p11l1185t1886r1263b1945],
13	,	,	O	,	_	0	SENT_201	[p11l1185t1886r1263b1945],
14	et	FW	O	et	nn	15	SENT_201	[p11l1289t1891r1338b1934],
15	al.	FW	O	al.	appos	5	SENT_201	[p11l1360t1884r1421b1934],
16	.	.	O	.	_	0	SENT_201	[p11l1360t1884r1421b1934],

1	Early	RB	O	early	advmod	3	SENT_202	[p11l1447t1884r1598b1949],
2	and	CC	O	and	cc	1	SENT_202	[p11l1620t1884r1721b1934],
3	sustained	VBD	O	sustain	_	0	SENT_202	[p11l1744t1884r2003b1935],
4	dual	JJ	O	dual	amod	7	SENT_202	[p11l2025t1884r2144b1934],
5	oral	JJ	O	oral	amod	7	SENT_202	[p11l160t1971r267b2022],
6	antiplatelet	JJ	O	antiplatelet	amod	7	SENT_202	[p11l286t1971r596b2036],
7	therapy	NN	O	therapy	dep	3	SENT_202	[p11l612t1971r823b2036],
8	following	VBG	O	follow	_	0	SENT_202	[p11l842t1971r1113b2036],
9	percutaneous	JJ	O	percutaneous	amod	11	SENT_202	[p11l1130t1978r1500b2036],
10	coronary	JJ	O	coronary	amod	11	SENT_202	[p11l1521t1988r1769b2036],
11	intervention	NN	O	intervention	prep_following	7	SENT_202	[p11l1788t1971r2139b2022],
12	:	:	O	:	_	0	SENT_202	[p11l1788t1971r2139b2022],
13	a	DT	O	a	nsubj	14	SENT_202	[p11l161t2076r190b2110],
14	randomized	VBN	O	randomize	parataxis	3	SENT_202	[p11l212t2059r544b2110],
15	controlled	JJ	O	controlled	amod	16	SENT_202	[p11l567t2060r851b2110],
16	trial	NN	O	trial	dobj	14	SENT_202	[p11l872t2060r997b2110],
17	.	.	O	.	_	0	SENT_202	[p11l872t2060r997b2110],

1	JAMA	NNP	O	JAMA	_	0	SENT_203	[p11l1024t2061r1215b2110],
2	2002	CD	DATE	2002	num	1	SENT_203	[p11l1237t2061r1623b2121],
3	;	:	O	;	_	0	SENT_203	[p11l1237t2061r1623b2121],
4	288:241	CD	NUMBER	288:241	number	5	SENT_203	[p11l1237t2061r1623b2121],
5	1-20	CD	NUMBER	1-20	dep	1	SENT_203	[p11l1637t2061r1790b2110],
6	.	.	O	.	_	0	SENT_203	[p11l1637t2061r1790b2110],

1	[	NN	O	[	_	0	SENT_204	[p11l47t2147r118b2210],
2	4	CD	NUMBER	4	num	1	SENT_204	[p11l47t2147r118b2210],
3	]	CD	NUMBER	]	num	5	SENT_204	[p11l47t2147r118b2210],
4	Gurbel	NNP	ORGANIZATION	Gurbel	nn	5	SENT_204	[p11l161t2146r362b2197],
5	PA	NN	ORGANIZATION	pa	dep	1	SENT_204	[p11l405t2147r507b2207],
6	,	,	O	,	_	0	SENT_204	[p11l405t2147r507b2207],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_204	[p11l552t2146r748b2196],
8	KP	NNP	O	KP	appos	5	SENT_204	[p11l790t2148r891b2207],
9	,	,	O	,	_	0	SENT_204	[p11l790t2148r891b2207],
10	Hiatt	NNP	PERSON	Hiatt	nn	11	SENT_204	[p11l936t2146r1083b2196],
11	BL	NN	O	bl	appos	5	SENT_204	[p11l1125t2148r1232b2207],
12	,	,	O	,	_	0	SENT_204	[p11l1125t2148r1232b2207],
13	O’Connor	NN	O	o’connor	nn	14	SENT_204	[p11l1279t2147r1578b2197],
14	CM	NN	O	cm	appos	5	SENT_204	[p11l1619t2147r1744b2197],
15	.	.	O	.	_	0	SENT_204	[p11l1619t2147r1744b2197],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_205	[p11l1792t2146r2144b2211],
2	for	IN	O	for	_	0	SENT_205	[p11l161t2233r245b2284],
3	coronary	JJ	O	coronary	amod	4	SENT_205	[p11l281t2250r542b2298],
4	stenting	NN	O	stenting	prep_for	1	SENT_205	[p11l580t2233r829b2298],
5	:	:	O	:	_	0	SENT_205	[p11l580t2233r829b2298],
6	response	NN	O	response	nn	7	SENT_205	[p11l870t2250r1128b2298],
7	variability	NN	O	variability	conj_and	1	SENT_205	[p11l1164t2233r1482b2298],
8	,	,	O	,	_	0	SENT_205	[p11l1164t2233r1482b2298],
9	drug	NN	O	drug	nn	10	SENT_205	[p11l1523t2233r1655b2298],
10	resistance	NN	O	resistance	appos	7	SENT_205	[p11l1691t2233r2000b2294],
11	,	,	O	,	_	0	SENT_205	[p11l1691t2233r2000b2294],
12	and	CC	O	and	_	0	SENT_205	[p11l2041t2233r2145b2284],
13	the	DT	O	the	det	14	SENT_205	[p11l159t2321r246b2371],
14	effect	NN	O	effect	conj_and	1	SENT_205	[p11l271t2321r436b2371],
15	of	IN	O	of	_	0	SENT_205	[p11l459t2321r524b2371],
16	pretreatment	NN	O	pretreatment	nn	18	SENT_205	[p11l537t2327r911b2385],
17	platelet	NN	O	platelet	nn	18	SENT_205	[p11l931t2321r1151b2385],
18	reactivity	NN	O	reactivity	prep_of	14	SENT_205	[p11l1172t2321r1462b2385],
19	.	.	O	.	_	0	SENT_205	[p11l1172t2321r1462b2385],

1	Circulation	NN	O	circulation	_	0	SENT_206	[p11l1490t2321r1822b2371],
2	2003	CD	DATE	2003	num	1	SENT_206	[p11l1844t2322r2139b2382],
3	;	:	O	;	_	0	SENT_206	[p11l1844t2322r2139b2382],
4	l07	CD	NUMBER	l07	num	6	SENT_206	[p11l1844t2322r2139b2382],
5	:	:	O	:	_	0	SENT_206	[p11l1844t2322r2139b2382],
6	2908-13	CD	NUMBER	2908-13	dep	1	SENT_206	[p11l159t2408r440b2457],
7	.	.	O	.	_	0	SENT_206	[p11l159t2408r440b2457],

1	[	NN	O	[	nn	5	SENT_207	[p11l47t2495r118b2558],
2	5	CD	NUMBER	5	num	5	SENT_207	[p11l47t2495r118b2558],
3	]	CD	NUMBER	]	num	5	SENT_207	[p11l47t2495r118b2558],
4	Angiolillo	NNP	O	Angiolillo	nn	5	SENT_207	[p11l159t2494r446b2559],
5	DJ	NNP	O	DJ	_	0	SENT_207	[p11l471t2496r563b2555],
6	,	,	O	,	_	0	SENT_207	[p11l471t2496r563b2555],
7	Fernandez-Ortiz	NNP	O	Fernandez-Ortiz	nn	8	SENT_207	[p11l588t2494r1047b2545],
8	A	NNP	O	A	appos	5	SENT_207	[p11l1069t2496r1134b2555],
9	,	,	O	,	_	0	SENT_207	[p11l1069t2496r1134b2555],
10	Bernardo	NNP	PERSON	Bernardo	nn	11	SENT_207	[p11l1160t2494r1420b2545],
11	E	NNP	PERSON	E	appos	5	SENT_207	[p11l1444t2496r1500b2555],
12	,	,	O	,	_	0	SENT_207	[p11l1444t2496r1500b2555],
13	et	FW	O	et	nn	14	SENT_207	[p11l1528t2501r1576b2545],
14	al.	FW	O	al.	appos	5	SENT_207	[p11l1599t2494r1660b2545],
15	.	.	O	.	_	0	SENT_207	[p11l1599t2494r1660b2545],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_208	[p11l1688t2494r2065b2545],
2	of	IN	O	of	_	0	SENT_208	[p11l2088t2494r2153b2545],
3	low	JJ	O	low	amod	4	SENT_208	[p11l160t2582r265b2632],
4	responders	NNS	O	responder	prep_of	1	SENT_208	[p11l302t2581r605b2646],
5	to	TO	O	to	_	0	SENT_208	[p11l644t2589r696b2632],
6	a	DT	O	a	det	8	SENT_208	[p11l738t2598r767b2632],
7	300-mg	JJ	O	300-mg	amod	8	SENT_208	[p11l806t2583r1023b2646],
8	clopidogrel	NN	O	clopidogrel	prep_to	4	SENT_208	[p11l1063t2581r1381b2646],
9	loading	VBG	O	load	partmod	1	SENT_208	[p11l1421t2582r1630b2646],
10	dose	NN	O	dose	dobj	9	SENT_208	[p11l1669t2582r1796b2632],
11	in	IN	O	in	_	0	SENT_208	[p11l1836t2582r1889b2631],
12	patients	NNS	O	patient	prep_in	9	SENT_208	[p11l1925t2582r2142b2646],
13	undergoing	VBG	O	undergo	partmod	12	SENT_208	[p11l158t2670r479b2734],
14	coronary	JJ	O	coronary	amod	15	SENT_208	[p11l503t2686r752b2734],
15	stenting	NN	O	stenting	dobj	13	SENT_208	[p11l776t2670r1009b2734],
16	.	.	O	.	_	0	SENT_208	[p11l776t2670r1009b2734],

1	Thromb	NNP	O	Thromb	nn	2	SENT_209	[p11l1037t2670r1261b2720],
2	Res	NNP	O	Res	_	0	SENT_209	[p11l1284t2672r1388b2720],
3	2005	CD	DATE	2005	num	2	SENT_209	[p11l1412t2671r1549b2720],
4	;	:	O	;	_	0	SENT_209	[p11l1558t2671r1894b2731],
5	ll5	CD	NUMBER	ll5	num	7	SENT_209	[p11l1558t2671r1894b2731],
6	:	:	O	:	_	0	SENT_209	[p11l1558t2671r1894b2731],
7	l0l	CD	NUMBER	l0l	dep	2	SENT_209	[p11l1558t2671r1894b2731],
8	—	CD	NUMBER	—	number	9	SENT_209	[p11l1558t2671r1894b2731],
9	8	CD	NUMBER	8	dep	7	SENT_209	[p11l1558t2671r1894b2731],
10	.	.	O	.	_	0	SENT_209	[p11l1558t2671r1894b2731],

1	[	NN	O	[	nn	3	SENT_210	[p11l47t2757r118b2820],
2	6	CD	NUMBER	6	num	3	SENT_210	[p11l47t2757r118b2820],
3	]	NN	O	]	_	0	SENT_210	[p11l47t2757r118b2820],
4	Angiolillo	NNP	O	Angiolillo	nn	5	SENT_210	[p11l159t2756r446b2821],
5	DJ	NNP	O	DJ	dep	3	SENT_210	[p11l468t2758r560b2818],
6	,	,	O	,	_	0	SENT_210	[p11l468t2758r560b2818],
7	Femandez-Ortiz	NNP	O	Femandez-Ortiz	nn	8	SENT_210	[p11l583t2756r1041b2807],
8	A	NNP	O	A	appos	5	SENT_210	[p11l1060t2757r1126b2818],
9	,	,	O	,	_	0	SENT_210	[p11l1060t2757r1126b2818],
10	Bernardo	NNP	PERSON	Bernardo	nn	11	SENT_210	[p11l1149t2756r1407b2807],
11	E	NNP	PERSON	E	appos	5	SENT_210	[p11l1429t2758r1486b2817],
12	,	,	O	,	_	0	SENT_210	[p11l1429t2758r1486b2817],
13	et	FW	O	et	nn	14	SENT_210	[p11l1511t2763r1559b2807],
14	al.	FW	O	al.	appos	5	SENT_210	[p11l1579t2756r1640b2807],
15	.	.	O	.	_	0	SENT_210	[p11l1579t2756r1640b2807],

1	High	JJ	O	high	amod	2	SENT_211	[p11l1665t2756r1805b2821],
2	clopidogrel	NN	O	clopidogrel	_	0	SENT_211	[p11l1826t2756r2143b2821],
3	loading	VBG	O	load	partmod	2	SENT_211	[p11l160t2844r370b2908],
4	dose	NN	O	dose	dobj	3	SENT_211	[p11l399t2844r525b2894],
5	during	IN	O	during	_	0	SENT_211	[p11l553t2844r735b2908],
6	coronary	JJ	O	coronary	amod	7	SENT_211	[p11l764t2860r1013b2908],
7	stenting	NN	O	stenting	prep_during	3	SENT_211	[p11l1042t2844r1276b2908],
8	:	:	O	:	_	0	SENT_211	[p11l1042t2844r1276b2908],
9	effects	NNS	O	effect	dep	2	SENT_211	[p11l1309t2844r1489b2894],
10	on	IN	O	on	_	0	SENT_211	[p11l1519t2860r1588b2894],
11	drug	NN	O	drug	nn	12	SENT_211	[p11l1617t2844r1743b2908],
12	response	NN	O	response	prep_on	9	SENT_211	[p11l1770t2860r2015b2908],
13	and	CC	O	and	_	0	SENT_211	[p11l2044t2843r2145b2894],
14	interindividual	JJ	O	interindividual	amod	15	SENT_211	[p11l160t2930r572b2981],
15	variability	NN	O	variability	conj_and	12	SENT_211	[p11l594t2931r891b2995],
16	.	.	O	.	_	0	SENT_211	[p11l594t2931r891b2995],

1	Eur	NNP	O	Eur	nn	3	SENT_212	[p11l918t2933r1020b2981],
2	Heart	NNP	O	Heart	nn	3	SENT_212	[p11l1040t2933r1196b2981],
3	J	NNP	O	J	_	0	SENT_212	[p11l1218t2933r1244b2981],
4	2004	CD	DATE	2004	num	3	SENT_212	[p11l1266t2932r1786b2992],
5	;	:	O	;	_	0	SENT_212	[p11l1266t2932r1786b2992],
6	25	CD	NUMBER	25	num	8	SENT_212	[p11l1266t2932r1786b2992],
7	:	:	O	:	_	0	SENT_212	[p11l1266t2932r1786b2992],
8	l903	CD	NUMBER	l903	dep	3	SENT_212	[p11l1266t2932r1786b2992],
9	—	CD	NUMBER	—	num	10	SENT_212	[p11l1266t2932r1786b2992],
10	l0	NN	O	l0	dep	8	SENT_212	[p11l1266t2932r1786b2992],
11	.	.	O	.	_	0	SENT_212	[p11l1266t2932r1786b2992],

1	[	NN	O	[	nn	3	SENT_213	[p11l47t3020r118b3082],
2	7	CD	NUMBER	7	num	3	SENT_213	[p11l47t3020r118b3082],
3	]	NN	O	]	_	0	SENT_213	[p11l47t3020r118b3082],
4	Gurbel	NNP	ORGANIZATION	Gurbel	nn	5	SENT_213	[p11l161t3019r354b3069],
5	PA	NN	ORGANIZATION	pa	dep	3	SENT_213	[p11l374t3020r473b3080],
6	,	,	O	,	_	0	SENT_213	[p11l374t3020r473b3080],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_213	[p11l496t3019r684b3069],
8	KP	NNP	O	KP	appos	5	SENT_213	[p11l703t3021r800b3080],
9	,	,	O	,	_	0	SENT_213	[p11l703t3021r800b3080],
10	Hayes	NNP	ORGANIZATION	Hayes	nn	11	SENT_213	[p11l824t3021r997b3083],
11	KM	NNP	ORGANIZATION	KM	appos	5	SENT_213	[p11l1019t3021r1147b3080],
12	,	,	O	,	_	0	SENT_213	[p11l1019t3021r1147b3080],
13	Yoho	NNP	LOCATION	Yoho	nn	14	SENT_213	[p11l1170t3019r1319b3069],
14	JA	NNP	LOCATION	JA	appos	5	SENT_213	[p11l1341t3020r1433b3080],
15	,	,	O	,	_	0	SENT_213	[p11l1341t3020r1433b3080],
16	Herzog	NNP	PERSON	Herzog	nn	17	SENT_213	[p11l1457t3021r1662b3083],
17	WR	NNP	O	WR	appos	5	SENT_213	[p11l1684t3021r1812b3080],
18	,	,	O	,	_	0	SENT_213	[p11l1684t3021r1812b3080],
19	Tantry	NNP	LOCATION	Tantry	nn	20	SENT_213	[p11l1836t3021r2017b3083],
20	US	NNP	LOCATION	US	appos	5	SENT_213	[p11l2037t3020r2140b3069],
21	.	.	O	.	_	0	SENT_213	[p11l2037t3020r2140b3069],

1	The	DT	O	the	det	2	SENT_214	[p11l160t3105r267b3156],
2	relation	NN	O	relation	_	0	SENT_214	[p11l286t3106r500b3156],
3	of	IN	O	of	_	0	SENT_214	[p11l520t3106r584b3156],
4	dosing	NN	O	dosing	prep_of	2	SENT_214	[p11l596t3106r782b3170],
5	to	TO	O	to	_	0	SENT_214	[p11l800t3112r853b3156],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_214	[p11l874t3105r1193b3170],
7	responsiveness	NN	O	responsiveness	prep_to	4	SENT_214	[p11l1211t3106r1632b3170],
8	and	CC	O	and	_	0	SENT_214	[p11l1654t3106r1754b3156],
9	the	DT	O	the	det	10	SENT_214	[p11l1772t3105r1856b3156],
10	incidence	NN	O	incidence	conj_and	4	SENT_214	[p11l1877t3106r2143b3156],
11	of	IN	O	of	_	0	SENT_214	[p11l160t3194r225b3244],
12	high	JJ	O	high	amod	17	SENT_214	[p11l255t3194r381b3258],
13	post	NN	O	post	nn	17	SENT_214	[p11l417t3201r824b3258],
14	—	NN	O	—	nn	17	SENT_214	[p11l417t3201r824b3258],
15	treatment	NN	O	treatment	nn	17	SENT_214	[p11l417t3201r824b3258],
16	platelet	NN	O	platelet	nn	17	SENT_214	[p11l860t3194r1068b3258],
17	aggregation	NN	O	aggregation	prep_of	10	SENT_214	[p11l1106t3194r1437b3258],
18	in	IN	O	in	_	0	SENT_214	[p11l1476t3194r1529b3243],
19	patients	NNS	O	patient	prep_in	17	SENT_214	[p11l1566t3194r1784b3258],
20	undergoing	VBG	O	undergo	partmod	2	SENT_214	[p11l1822t3194r2144b3258],
21	coronary	JJ	O	coronary	amod	22	SENT_214	[p11l160t3298r409b3346],
22	stenting	NN	O	stenting	dobj	20	SENT_214	[p11l433t3282r666b3346],
23	.	.	O	.	_	0	SENT_214	[p11l433t3282r666b3346],

1	J	NNP	O	J	nn	4	SENT_215	[p11l694t3284r720b3332],
2	Am	NNP	O	Am	nn	4	SENT_215	[p11l741t3283r848b3331],
3	Coll	NNP	O	Coll	nn	4	SENT_215	[p11l871t3282r990b3332],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_215	[p11l1013t3282r1222b3332],
5	2005	CD	DATE	2005	num	4	SENT_215	[p11l1245t3283r1729b3343],
6	;	:	O	;	_	0	SENT_215	[p11l1245t3283r1729b3343],
7	45	CD	NUMBER	45	num	9	SENT_215	[p11l1245t3283r1729b3343],
8	:	:	O	:	_	0	SENT_215	[p11l1245t3283r1729b3343],
9	l392	CD	NUMBER	l392	dep	4	SENT_215	[p11l1245t3283r1729b3343],
10	—	CD	NUMBER	—	number	11	SENT_215	[p11l1245t3283r1729b3343],
11	6	CD	NUMBER	6	dep	9	SENT_215	[p11l1245t3283r1729b3343],
12	.	.	O	.	_	0	SENT_215	[p11l1245t3283r1729b3343],

1	[	NN	O	[	nn	4	SENT_216	[p11l47t3371r118b3433],
2	8	CD	NUMBER	8	num	4	SENT_216	[p11l47t3371r118b3433],
3	]	NN	O	]	nn	4	SENT_216	[p11l47t3371r118b3433],
4	Jaremo	NN	O	jaremo	_	0	SENT_216	[p11l159t3372r359b3420],
5	P	NN	O	p	dep	4	SENT_216	[p11l377t3372r422b3431],
6	,	,	O	,	_	0	SENT_216	[p11l377t3372r422b3431],
7	Lindahl	NNP	PERSON	Lindahl	nn	8	SENT_216	[p11l442t3370r659b3420],
8	TL	NNP	O	TL	appos	4	SENT_216	[p11l676t3372r775b3431],
9	,	,	O	,	_	0	SENT_216	[p11l676t3372r775b3431],
10	Fransson	NNP	PERSON	Fransson	nn	11	SENT_216	[p11l794t3372r1048b3420],
11	SG	NNP	O	SG	appos	8	SENT_216	[p11l1066t3371r1167b3431],
12	,	,	O	,	_	0	SENT_216	[p11l1066t3371r1167b3431],
13	Richter	NNP	PERSON	Richter	nn	16	SENT_216	[p11l1186t3370r1393b3420],
14	A.	NNP	O	A.	nn	16	SENT_216	[p11l1407t3371r1470b3420],
15	Individual	NNP	O	Individual	nn	16	SENT_216	[p11l1491t3369r1779b3420],
16	variations	NNS	O	variation	appos	8	SENT_216	[p11l1795t3370r2070b3420],
17	of	IN	O	of	_	0	SENT_216	[p11l2088t3370r2153b3420],
18	platelet	NN	O	platelet	nn	19	SENT_216	[p11l158t3458r365b3522],
19	inhibition	NN	O	inhibition	prep_of	16	SENT_216	[p11l398t3458r671b3508],
20	after	IN	O	after	_	0	SENT_216	[p11l705t3458r831b3508],
21	loading	VBG	O	load	prepc_after	19	SENT_216	[p11l864t3458r1073b3522],
22	doses	NNS	O	dose	dobj	21	SENT_216	[p11l1108t3458r1261b3508],
23	of	IN	O	of	_	0	SENT_216	[p11l1297t3458r1362b3508],
24	clopidogrel	NN	O	clopidogrel	prep_of	22	SENT_216	[p11l1387t3458r1719b3522],
25	.	.	O	.	_	0	SENT_216	[p11l1387t3458r1719b3522],

1	J	NNP	O	J	nn	3	SENT_217	[p11l1757t3460r1784b3508],
2	Intern	NNP	O	Intern	nn	3	SENT_217	[p11l1817t3460r1983b3508],
3	Med	NNP	O	Med	_	0	SENT_217	[p11l2015t3458r2145b3508],
4	2002	CD	DATE	2002	num	3	SENT_217	[p11l159t3547r643b3607],
5	;	:	O	;	_	0	SENT_217	[p11l159t3547r643b3607],
6	252:233	CD	NUMBER	252:233	number	7	SENT_217	[p11l159t3547r643b3607],
7	—	CD	NUMBER	—	dep	3	SENT_217	[p11l159t3547r643b3607],
8	8	CD	NUMBER	8	dep	7	SENT_217	[p11l159t3547r643b3607],
9	.	.	O	.	_	0	SENT_217	[p11l159t3547r643b3607],

1	[	NN	O	[	nn	4	SENT_218	[p11l47t3634r118b3697],
2	9	CD	NUMBER	9	num	4	SENT_218	[p11l47t3634r118b3697],
3	]	NN	O	]	nn	4	SENT_218	[p11l47t3634r118b3697],
4	Muller	NN	O	muller	_	0	SENT_218	[p11l159t3633r351b3683],
5	I	PRP	O	I	dep	4	SENT_218	[p11l385t3635r422b3694],
6	,	,	O	,	_	0	SENT_218	[p11l385t3635r422b3694],
7	Besta	NNP	O	Besta	nn	8	SENT_218	[p11l460t3635r617b3683],
8	F	NN	O	f	appos	5	SENT_218	[p11l652t3635r699b3694],
9	,	,	O	,	_	0	SENT_218	[p11l652t3635r699b3694],
10	Schulz	NNP	PERSON	Schulz	nn	11	SENT_218	[p11l741t3633r929b3683],
11	C	NNP	O	C	appos	5	SENT_218	[p11l966t3634r1026b3694],
12	,	,	O	,	_	0	SENT_218	[p11l966t3634r1026b3694],
13	Massberg	NNP	LOCATION	Massberg	nn	14	SENT_218	[p11l1064t3633r1336b3698],
14	S	NNP	LOCATION	S	appos	5	SENT_218	[p11l1376t3634r1425b3694],
15	,	,	O	,	_	0	SENT_218	[p11l1376t3634r1425b3694],
16	Schonig	NNP	O	Schonig	nn	17	SENT_218	[p11l1468t3633r1695b3698],
17	A	NNP	O	A	appos	5	SENT_218	[p11l1730t3634r1796b3694],
18	,	,	O	,	_	0	SENT_218	[p11l1730t3634r1796b3694],
19	Gawaz	NNP	PERSON	Gawaz	nn	21	SENT_218	[p11l1836t3634r2029b3683],
20	M.	NNP	PERSON	M.	nn	21	SENT_218	[p11l2065t3635r2140b3683],
21	Prevalence	NN	PERSON	prevalence	appos	5	SENT_218	[p11l159t3721r466b3771],
22	of	IN	O	of	_	0	SENT_218	[p11l492t3721r557b3771],
23	clopidogrel	NN	O	clopidogrel	nn	24	SENT_218	[p11l574t3721r893b3785],
24	non-responders	NNS	O	non-responder	prep_of	21	SENT_218	[p11l916t3721r1349b3785],
25	among	IN	O	among	_	0	SENT_218	[p11l1376t3737r1566b3785],
26	patients	NNS	O	patient	prep_among	5	SENT_218	[p11l1589t3721r1807b3785],
27	with	IN	O	with	_	0	SENT_218	[p11l1832t3721r1957b3771],
28	stable	JJ	O	stable	prep_with	26	SENT_218	[p11l1984t3721r2143b3771],

1	[	NN	O	[	nn	5	SENT_219	[p12l35t2270r85b2300],
2	17	CD	NUMBER	17	num	5	SENT_219	[p12l35t2270r85b2300],
3	]	CD	NUMBER	]	num	5	SENT_219	[p12l35t2270r85b2300],
4	Dyszkiewicz-Korpanty	NNP	O	Dyszkiewicz-Korpanty	nn	5	SENT_219	[p12l104t2270r408b2300],
5	AM	NNP	O	AM	_	0	SENT_219	[p12l420t2271r480b2299],
6	,	,	O	,	_	0	SENT_219	[p12l420t2271r480b2299],
7	Frenkel	NNP	PERSON	Frenkel	nn	8	SENT_219	[p12l495t2270r594b2294],
8	EP	NNP	O	EP	appos	5	SENT_219	[p12l607t2271r649b2298],
9	,	,	O	,	_	0	SENT_219	[p12l607t2271r649b2298],
10	Sarode	NNP	PERSON	Sarode	nn	12	SENT_219	[p12l664t2270r753b2294],
11	R.	NNP	PERSON	R.	nn	12	SENT_219	[p12l766t2271r794b2294],
12	Approach	NNP	PERSON	Approach	appos	5	SENT_219	[p12l809t2270r939b2300],
13	to	TO	O	to	_	0	SENT_219	[p12l951t2273r975b2294],
14	the	DT	O	the	det	15	SENT_219	[p12l989t2270r1028b2294],
15	assessment	NN	O	assessment	prep_to	12	SENT_219	[p12l105t2314r250b2335],
16	of	IN	O	of	_	0	SENT_219	[p12l267t2311r297b2335],
17	platelet	NN	O	platelet	nn	18	SENT_219	[p12l310t2311r406b2342],
18	function	NN	O	function	prep_of	15	SENT_219	[p12l424t2311r539b2335],
19	:	:	O	:	_	0	SENT_219	[p12l424t2311r539b2335],
20	comparison	NN	O	comparison	dep	5	SENT_219	[p12l559t2311r711b2342],
21	between	IN	O	between	_	0	SENT_219	[p12l728t2311r838b2335],
22	optical	JJ	O	optical	amod	23	SENT_219	[p12l855t2311r1029b2342],
23	—	NN	O	—	prep_between	20	SENT_219	[p12l855t2311r1029b2342],
24	based	VBN	O	base	partmod	23	SENT_219	[p12l855t2311r1029b2342],
25	platelet	NN	O	platelet	nn	26	SENT_219	[p12l103t2352r265b2383],
26	—	NN	O	—	dobj	24	SENT_219	[p12l103t2352r265b2383],
27	rich	JJ	O	rich	amod	28	SENT_219	[p12l103t2352r265b2383],
28	plasma	NN	O	plasma	dep	20	SENT_219	[p12l287t2352r382b2383],
29	and	CC	O	and	_	0	SENT_219	[p12l404t2352r452b2376],
30	impedance	NN	O	impedance	nn	31	SENT_219	[p12l475t2352r706b2383],
31	—	NN	O	—	dep	20	SENT_219	[p12l475t2352r706b2383],
32	based	VBN	O	base	partmod	28	SENT_219	[p12l475t2352r706b2383],
33	whole	JJ	O	whole	amod	37	SENT_219	[p12l728t2352r809b2376],
34	blood	NN	O	blood	nn	37	SENT_219	[p12l832t2352r908b2376],
35	platelet	NN	O	platelet	nn	37	SENT_219	[p12l930t2352r1028b2383],
36	aggregation	NN	O	aggregation	nn	37	SENT_219	[p12l105t2393r258b2424],
37	methods	NNS	O	method	dobj	32	SENT_219	[p12l269t2393r386b2417],
38	.	.	O	.	_	0	SENT_219	[p12l269t2393r386b2417],

1	Clin	NNP	O	Clin	nn	4	SENT_220	[p12l399t2393r455b2417],
2	Appl	NNP	O	Appl	nn	4	SENT_220	[p12l465t2393r530b2424],
3	Thromb	NNP	O	Thromb	nn	4	SENT_220	[p12l541t2393r646b2417],
4	Hemost	NNP	O	Hemost	_	0	SENT_220	[p12l657t2394r759b2417],
5	2005	CD	DATE	2005	num	4	SENT_220	[p12l769t2394r977b2422],
6	;	:	O	;	_	0	SENT_220	[p12l769t2394r977b2422],
7	l1	NN	O	l1	dep	4	SENT_220	[p12l769t2394r977b2422],
8	:25	CD	NUMBER	:25	num	7	SENT_220	[p12l769t2394r977b2422],
9	—	CD	NUMBER	—	number	10	SENT_220	[p12l769t2394r977b2422],
10	35	CD	NUMBER	35	dep	7	SENT_220	[p12l769t2394r977b2422],
11	.	.	O	.	_	0	SENT_220	[p12l769t2394r977b2422],

1	[	NN	O	[	nn	5	SENT_221	[p12l35t2435r85b2465],
2	18	CD	NUMBER	18	num	5	SENT_221	[p12l35t2435r85b2465],
3	]	CD	NUMBER	]	num	5	SENT_221	[p12l35t2435r85b2465],
4	Angiolillo	NNP	O	Angiolillo	nn	5	SENT_221	[p12l105t2435r240b2466],
5	DJ	NNP	O	DJ	_	0	SENT_221	[p12l263t2436r306b2464],
6	,	,	O	,	_	0	SENT_221	[p12l263t2436r306b2464],
7	Femandez	NNP	PERSON	Femandez	appos	5	SENT_221	[p12l329t2435r545b2459],
8	.	.	O	.	_	0	SENT_221	[p12l329t2435r545b2459],

1	—	NN	O	—	_	0	SENT_222	[p12l329t2435r545b2459],
2	.	.	O	.	_	0	SENT_222	[p12l329t2435r545b2459],

1	Ortiz	NNP	PERSON	Ortiz	nn	2	SENT_223	[p12l329t2435r545b2459],
2	A	NNP	O	A	_	0	SENT_223	[p12l567t2436r598b2464],
3	,	,	O	,	_	0	SENT_223	[p12l567t2436r598b2464],
4	Bemardo	NNP	O	Bemardo	nn	5	SENT_223	[p12l621t2435r743b2459],
5	E	NNP	O	E	appos	2	SENT_223	[p12l766t2436r792b2464],
6	,	,	O	,	_	0	SENT_223	[p12l766t2436r792b2464],
7	et	FW	O	et	nn	8	SENT_223	[p12l816t2438r839b2459],
8	al.	FW	O	al.	appos	5	SENT_223	[p12l862t2435r890b2459],
9	.	.	O	.	_	0	SENT_223	[p12l862t2435r890b2459],

1	Lack	NN	O	lack	_	0	SENT_224	[p12l914t2435r980b2459],
2	of	IN	O	of	_	0	SENT_224	[p12l1002t2435r1032b2459],
3	association	NN	O	association	prep_of	1	SENT_224	[p12l105t2476r250b2500],
4	between	IN	O	between	_	0	SENT_224	[p12l268t2476r378b2500],
5	the	DT	O	the	det	9	SENT_224	[p12l397t2476r436b2500],
6	P2Yl2	NN	O	p2yl2	nn	9	SENT_224	[p12l455t2477r545b2500],
7	receptor	NN	O	receptor	nn	9	SENT_224	[p12l565t2480r673b2507],
8	gene	NN	O	gene	nn	9	SENT_224	[p12l691t2484r752b2507],
9	polymorphism	NN	O	polymorphism	prep_between	1	SENT_224	[p12l771t2476r963b2507],
10	and	CC	O	and	_	0	SENT_224	[p12l982t2476r1029b2500],
11	platelet	NN	O	platelet	nn	12	SENT_224	[p12l104t2517r201b2548],
12	response	NN	O	response	conj_and	9	SENT_224	[p12l221t2525r335b2548],
13	to	TO	O	to	_	0	SENT_224	[p12l355t2520r380b2541],
14	clopidogrel	NN	O	clopidogrel	prep_to	9	SENT_224	[p12l402t2517r550b2548],
15	in	IN	O	in	_	0	SENT_224	[p12l571t2517r596b2541],
16	patients	NNS	O	patient	prep_in	1	SENT_224	[p12l616t2517r717b2548],
17	with	IN	O	with	_	0	SENT_224	[p12l738t2517r796b2541],
18	coronary	JJ	O	coronary	amod	20	SENT_224	[p12l817t2525r933b2548],
19	artery	NN	O	artery	nn	20	SENT_224	[p12l954t2521r1029b2548],
20	disease	NN	O	disease	prep_with	16	SENT_224	[p12l105t2559r205b2583],
21	.	.	O	.	_	0	SENT_224	[p12l105t2559r205b2583],

1	Thromb	NNP	O	Thromb	nn	2	SENT_225	[p12l218t2559r322b2583],
2	Res	NNP	O	Res	_	0	SENT_225	[p12l334t2560r382b2583],
3	2005	CD	DATE	2005	num	2	SENT_225	[p12l393t2559r617b2588],
4	;	:	O	;	_	0	SENT_225	[p12l393t2559r617b2588],
5	ll6	CD	NUMBER	ll6	num	6	SENT_225	[p12l393t2559r617b2588],
6	:491	CD	NUMBER	:491	dep	2	SENT_225	[p12l393t2559r617b2588],
7	—	NN	O	—	dep	6	SENT_225	[p12l393t2559r617b2588],
8	7	CD	NUMBER	7	num	7	SENT_225	[p12l393t2559r617b2588],
9	.	.	O	.	_	0	SENT_225	[p12l393t2559r617b2588],

1	[	NN	O	[	nn	6	SENT_226	[p12l35t2601r85b2630],
2	19	CD	NUMBER	19	num	6	SENT_226	[p12l35t2601r85b2630],
3	]	CD	NUMBER	]	num	6	SENT_226	[p12l35t2601r85b2630],
4	Von	NNP	PERSON	Von	nn	6	SENT_226	[p12l104t2608r153b2624],
5	Beckerath	NNP	PERSON	Beckerath	nn	6	SENT_226	[p12l160t2600r293b2624],
6	N	NNP	PERSON	N	nsubjpass	29	SENT_226	[p12l299t2601r330b2629],
7	,	,	O	,	_	0	SENT_226	[p12l299t2601r330b2629],
8	Von	NNP	PERSON	Von	nn	10	SENT_226	[p12l339t2608r388b2624],
9	Beckerath	NNP	PERSON	Beckerath	nn	10	SENT_226	[p12l395t2600r528b2624],
10	O	NNP	PERSON	O	appos	6	SENT_226	[p12l535t2601r565b2629],
11	,	,	O	,	_	0	SENT_226	[p12l535t2601r565b2629],
12	Koch	NNP	PERSON	Koch	nn	13	SENT_226	[p12l574t2600r645b2624],
13	W	NNP	O	W	appos	6	SENT_226	[p12l652t2601r687b2629],
14	,	,	O	,	_	0	SENT_226	[p12l652t2601r687b2629],
15	Eichinger	NNP	PERSON	Eichinger	nn	16	SENT_226	[p12l695t2600r823b2631],
16	M	NNP	O	M	appos	6	SENT_226	[p12l829t2601r865b2629],
17	,	,	O	,	_	0	SENT_226	[p12l829t2601r865b2629],
18	Schomig	NNP	O	Schomig	nn	19	SENT_226	[p12l875t2600r990b2631],
19	A	NNP	O	A	appos	6	SENT_226	[p12l997t2601r1027b2629],
20	,	,	O	,	_	0	SENT_226	[p12l997t2601r1027b2629],
21	Kastrati	NNP	PERSON	Kastrati	nn	26	SENT_226	[p12l104t2641r206b2665],
22	A.	NNP	O	A.	nn	26	SENT_226	[p12l216t2642r245b2665],
23	P2Yl2	NNP	O	P2Yl2	nn	26	SENT_226	[p12l256t2642r347b2665],
24	gene	NN	O	gene	nn	26	SENT_226	[p12l357t2649r418b2672],
25	H2	NN	O	h2	nn	26	SENT_226	[p12l427t2642r466b2665],
26	haplotype	NN	O	haplotype	appos	6	SENT_226	[p12l476t2641r605b2672],
27	is	VBZ	O	be	auxpass	29	SENT_226	[p12l615t2641r635b2665],
28	not	RB	O	not	neg	29	SENT_226	[p12l645t2645r687b2665],
29	associated	VBN	O	associate	_	0	SENT_226	[p12l696t2641r830b2665],
30	with	IN	O	with	_	0	SENT_226	[p12l839t2641r897b2665],
31	increased	VBN	O	increase	amod	33	SENT_226	[p12l906t2641r1029b2665],
32	angina	NN	O	angina	nn	33	SENT_226	[p12l161t19r347b83],
33	pectoris	NNS	O	pectoris	prep_with	29	SENT_226	[p12l390t19r611b83],
34	scheduled	VBN	O	schedule	partmod	33	SENT_226	[p12l659t19r939b69],
35	for	IN	O	for	_	0	SENT_226	[p12l984t19r1065b69],
36	elective	JJ	O	elective	amod	39	SENT_226	[p12l1109t19r1323b69],
37	coronary	JJ	O	coronary	amod	39	SENT_226	[p12l1370t35r1618b83],
38	stent	NN	O	stent	nn	39	SENT_226	[p12l1665t26r1795b69],
39	placement	NN	O	placement	prep_for	34	SENT_226	[p12l1837t19r2140b83],
40	.	.	O	.	_	0	SENT_226	[p12l1837t19r2140b83],

1	Thromb	NNP	O	Thromb	nn	2	SENT_227	[p12l160t107r384b157],
2	Haemost	NNP	O	Haemost	_	0	SENT_227	[p12l408t109r659b157],
3	2003	CD	DATE	2003	num	2	SENT_227	[p12l680t108r1128b168],
4	;	:	O	;	_	0	SENT_227	[p12l680t108r1128b168],
5	89:783	CD	NUMBER	89:783	num	6	SENT_227	[p12l680t108r1128b168],
6	—	NN	O	—	dep	2	SENT_227	[p12l680t108r1128b168],
7	7	CD	NUMBER	7	dep	6	SENT_227	[p12l680t108r1128b168],
8	.	.	O	.	_	0	SENT_227	[p12l680t108r1128b168],

1	Serebruany	NNP	O	Serebruany	nn	2	SENT_228	[p12l163t193r480b258],
2	VL	NNP	O	VL	_	0	SENT_228	[p12l513t195r621b254],
3	,	,	O	,	_	0	SENT_228	[p12l513t195r621b254],
4	Steinhubl	NNP	O	Steinhubl	nn	5	SENT_228	[p12l663t193r928b244],
5	SR	NN	O	sr	appos	2	SENT_228	[p12l967t194r1064b254],
6	,	,	O	,	_	0	SENT_228	[p12l967t194r1064b254],
7	Berger	NNP	PERSON	Berger	nn	8	SENT_228	[p12l1102t195r1293b258],
8	PB	NN	O	pb	appos	5	SENT_228	[p12l1326t195r1426b254],
9	,	,	O	,	_	0	SENT_228	[p12l1326t195r1426b254],
10	Malinin	NNP	PERSON	Malinin	nn	11	SENT_228	[p12l1465t193r1687b243],
11	AI	NNP	O	AI	appos	5	SENT_228	[p12l1720t194r1809b254],
12	,	,	O	,	_	0	SENT_228	[p12l1720t194r1809b254],
13	Bhatt	NNP	PERSON	Bhatt	nn	14	SENT_228	[p12l1847t193r2000b243],
14	DL	NNP	O	DL	appos	5	SENT_228	[p12l2033t195r2141b254],
15	,	,	O	,	_	0	SENT_228	[p12l2033t195r2141b254],
16	Topol	NNP	PERSON	Topol	nn	17	SENT_228	[p12l160t282r323b346],
17	EJ	NNP	O	EJ	appos	5	SENT_228	[p12l347t284r429b332],
18	.	.	O	.	_	0	SENT_228	[p12l347t284r429b332],

1	Variability	NN	O	variability	_	0	SENT_229	[p12l458t282r754b346],
2	in	IN	O	in	_	0	SENT_229	[p12l779t282r832b331],
3	platelet	NN	O	platelet	nn	4	SENT_229	[p12l854t282r1061b346],
4	responsiveness	NN	O	responsiveness	prep_in	1	SENT_229	[p12l1084t282r1505b346],
5	to	TO	O	to	_	0	SENT_229	[p12l1531t289r1583b332],
6	clopidogrel	NN	O	clopidogrel	prep_to	1	SENT_229	[p12l1610t282r1929b346],
7	among	IN	O	among	_	0	SENT_229	[p12l1954t298r2144b346],
8	544	CD	NUMBER	544	num	9	SENT_229	[p12l161t371r263b420],
9	individuals	NNS	O	individual	prep_among	1	SENT_229	[p12l289t370r613b421],
10	.	.	O	.	_	0	SENT_229	[p12l289t370r613b421],

1	J	NNP	O	J	nn	4	SENT_230	[p12l640t372r666b421],
2	Am	NNP	O	Am	nn	4	SENT_230	[p12l688t371r794b420],
3	Coll	NNP	O	Coll	nn	4	SENT_230	[p12l817t370r936b421],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_230	[p12l960t370r1168b421],
5	2005	CD	DATE	2005	num	4	SENT_230	[p12l1192t371r1675b431],
6	;	:	O	;	_	0	SENT_230	[p12l1192t371r1675b431],
7	45:246	CD	NUMBER	45:246	number	8	SENT_230	[p12l1192t371r1675b431],
8	—	CD	NUMBER	—	dep	4	SENT_230	[p12l1192t371r1675b431],
9	51	CD	NUMBER	51	dep	8	SENT_230	[p12l1192t371r1675b431],
10	.	.	O	.	_	0	SENT_230	[p12l1192t371r1675b431],

1	Nguyen	NNP	ORGANIZATION	Nguyen	nn	2	SENT_231	[p12l155t458r381b521],
2	TA	NNP	ORGANIZATION	TA	_	0	SENT_231	[p12l419t457r520b517],
3	,	,	O	,	_	0	SENT_231	[p12l419t457r520b517],
4	Diodati	NNP	O	Diodati	nn	5	SENT_231	[p12l561t456r770b507],
5	JG	NNP	O	JG	appos	2	SENT_231	[p12l809t457r900b517],
6	,	,	O	,	_	0	SENT_231	[p12l809t457r900b517],
7	Pharand	NNP	O	Pharand	nn	9	SENT_231	[p12l941t456r1172b506],
8	C.	NNP	O	C.	nn	9	SENT_231	[p12l1209t457r1267b507],
9	Resistance	NNP	O	Resistance	appos	2	SENT_231	[p12l1310t456r1608b506],
10	to	TO	O	to	_	0	SENT_231	[p12l1646t463r1698b506],
11	clopidogrel	NN	O	clopidogrel	prep_to	9	SENT_231	[p12l1739t456r2071b521],
12	:	:	O	:	_	0	SENT_231	[p12l1739t456r2071b521],
13	a	DT	O	a	det	14	SENT_231	[p12l2115t473r2145b506],
14	review	NN	O	review	dep	2	SENT_231	[p12l156t545r347b595],
15	of	IN	O	of	_	0	SENT_231	[p12l371t545r435b595],
16	the	DT	O	the	det	17	SENT_231	[p12l449t545r533b595],
17	evidence	NN	O	evidence	prep_of	14	SENT_231	[p12l558t545r820b595],
18	.	.	O	.	_	0	SENT_231	[p12l558t545r820b595],

1	J	NNP	O	J	nn	4	SENT_232	[p12l847t547r873b595],
2	Am	NNP	O	Am	nn	4	SENT_232	[p12l894t546r1001b594],
3	Coll	NNP	O	Coll	nn	4	SENT_232	[p12l1024t545r1142b595],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_232	[p12l1166t545r1375b595],
5	2005	CD	DATE	2005	num	4	SENT_232	[p12l1398t546r1535b595],
6	;	:	O	;	_	0	SENT_232	[p12l1544t546r1915b606],
7	45	CD	NUMBER	45	num	9	SENT_232	[p12l1544t546r1915b606],
8	:	:	O	:	_	0	SENT_232	[p12l1544t546r1915b606],
9	ll57	CD	NUMBER	ll57	dep	4	SENT_232	[p12l1544t546r1915b606],
10	—	CD	NUMBER	—	number	11	SENT_232	[p12l1544t546r1915b606],
11	64	CD	NUMBER	64	dep	9	SENT_232	[p12l1544t546r1915b606],
12	.	.	O	.	_	0	SENT_232	[p12l1544t546r1915b606],

1	Fontana	NNP	PERSON	Fontana	nn	2	SENT_233	[p12l159t634r386b682],
2	P	NN	PERSON	p	_	0	SENT_233	[p12l422t634r468b693],
3	,	,	O	,	_	0	SENT_233	[p12l422t634r468b693],
4	Dupont	NNP	ORGANIZATION	Dupont	nn	5	SENT_233	[p12l507t634r720b697],
5	A	NNP	O	A	appos	2	SENT_233	[p12l755t633r820b693],
6	,	,	O	,	_	0	SENT_233	[p12l755t633r820b693],
7	Gandrille	NNP	LOCATION	Gandrille	nn	8	SENT_233	[p12l861t632r1123b682],
8	S	NNP	O	S	appos	2	SENT_233	[p12l1164t633r1214b693],
9	,	,	O	,	_	0	SENT_233	[p12l1164t633r1214b693],
10	et	FW	O	et	nn	11	SENT_233	[p12l1255t639r1304b682],
11	al.	FW	O	al.	appos	2	SENT_233	[p12l1341t632r1402b682],
12	.	.	O	.	_	0	SENT_233	[p12l1341t632r1402b682],

1	Adenosine	NN	LOCATION	adenosine	nn	3	SENT_234	[p12l1442t632r1744b682],
2	diphosphate	NN	O	diphosphate	nn	3	SENT_234	[p12l1782t632r2142b697],
3	—	NN	O	—	nsubj	4	SENT_234	[p12l1782t632r2142b697],
4	induced	VBD	O	induce	_	0	SENT_234	[p12l160t718r383b769],
5	platelet	NN	O	platelet	nn	6	SENT_234	[p12l403t718r610b783],
6	aggregation	NN	O	aggregation	nsubjpass	8	SENT_234	[p12l634t718r965b783],
7	is	VBZ	O	be	auxpass	8	SENT_234	[p12l988t718r1030b768],
8	associated	VBN	O	associate	ccomp	4	SENT_234	[p12l1057t718r1344b769],
9	with	IN	O	with	_	0	SENT_234	[p12l1365t718r1490b768],
10	P2Yl2	NN	O	p2yl2	nn	13	SENT_234	[p12l1513t719r1706b768],
11	gene	NN	O	gene	nn	13	SENT_234	[p12l1733t735r1863b783],
12	sequence	NN	O	sequence	nn	13	SENT_234	[p12l1889t735r2143b783],
13	variations	NNS	O	variation	prep_with	8	SENT_234	[p12l158t805r434b856],
14	in	IN	O	in	_	0	SENT_234	[p12l459t805r511b855],
15	healthy	JJ	O	healthy	amod	16	SENT_234	[p12l533t805r740b870],
16	subjects	NNS	O	subject	prep_in	8	SENT_234	[p12l765t805r1001b870],
17	.	.	O	.	_	0	SENT_234	[p12l765t805r1001b870],

1	Circulation	NN	O	circulation	_	0	SENT_235	[p12l1030t805r1343b856],
2	2003	CD	DATE	2003	num	1	SENT_235	[p12l1366t807r1886b867],
3	;	:	O	;	_	0	SENT_235	[p12l1366t807r1886b867],
4	108:989	CD	NUMBER	108:989	number	5	SENT_235	[p12l1366t807r1886b867],
5	—	CD	NUMBER	—	dep	1	SENT_235	[p12l1366t807r1886b867],
6	95	CD	NUMBER	95	dep	5	SENT_235	[p12l1366t807r1886b867],
7	.	.	O	.	_	0	SENT_235	[p12l1366t807r1886b867],

1	Matetzky	NNP	O	Matetzky	nn	2	SENT_236	[p12l159t893r425b958],
2	S	NNP	O	S	_	0	SENT_236	[p12l464t894r514b954],
3	,	,	O	,	_	0	SENT_236	[p12l464t894r514b954],
4	Shenkman	NNP	PERSON	Shenkman	nn	5	SENT_236	[p12l556t893r851b943],
5	B	NNP	O	B	appos	2	SENT_236	[p12l887t895r948b954],
6	,	,	O	,	_	0	SENT_236	[p12l887t895r948b954],
7	Guetta	NNP	PERSON	Guetta	nn	8	SENT_236	[p12l989t894r1175b943],
8	V	NNP	O	V	appos	2	SENT_236	[p12l1210t895r1266b954],
9	,	,	O	,	_	0	SENT_236	[p12l1210t895r1266b954],
10	et	FW	O	et	nn	11	SENT_236	[p12l1308t900r1357b943],
11	al.	FW	O	al.	appos	2	SENT_236	[p12l1394t893r1455b943],
12	.	.	O	.	_	0	SENT_236	[p12l1394t893r1455b943],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_237	[p12l1498t893r1832b958],
2	resistance	NN	O	resistance	nsubjpass	4	SENT_237	[p12l1868t893r2143b943],
3	is	VBZ	O	be	auxpass	4	SENT_237	[p12l160t979r204b1029],
4	associated	VBN	O	associate	_	0	SENT_237	[p12l254t979r547b1029],
5	with	IN	O	with	_	0	SENT_237	[p12l594t979r720b1029],
6	increased	VBN	O	increase	amod	7	SENT_237	[p12l770t979r1039b1029],
7	risk	NN	O	risk	prep_with	4	SENT_237	[p12l1085t979r1193b1029],
8	of	IN	O	of	_	0	SENT_237	[p12l1241t979r1305b1029],
9	recurrent	JJ	O	recurrent	amod	11	SENT_237	[p12l1344t986r1602b1029],
10	atherothrombotic	JJ	O	atherothrombotic	amod	11	SENT_237	[p12l1651t979r2142b1029],
11	events	NNS	O	event	prep_of	7	SENT_237	[p12l160t1073r338b1117],
12	in	IN	O	in	_	0	SENT_237	[p12l388t1066r441b1116],
13	patients	NNS	O	patient	prep_in	11	SENT_237	[p12l487t1066r705b1131],
14	with	IN	O	with	_	0	SENT_237	[p12l753t1066r879b1117],
15	acute	JJ	O	acute	amod	17	SENT_237	[p12l927t1073r1073b1117],
16	myocardial	JJ	O	myocardial	amod	17	SENT_237	[p12l1121t1066r1438b1131],
17	infarction	NN	O	infarction	prep_with	13	SENT_237	[p12l1487t1066r1774b1117],
18	.	.	O	.	_	0	SENT_237	[p12l1487t1066r1774b1117],

1	Circulation	NN	O	circulation	_	0	SENT_238	[p12l1827t1066r2144b1117],
2	2004	CD	DATE	2004	num	1	SENT_238	[p12l159t1156r678b1215],
3	;	:	O	;	_	0	SENT_238	[p12l159t1156r678b1215],
4	l09	CD	NUMBER	l09	num	6	SENT_238	[p12l159t1156r678b1215],
5	:3	CD	NUMBER	:3	num	6	SENT_238	[p12l159t1156r678b1215],
6	l7l	NN	O	l7l	dep	1	SENT_238	[p12l159t1156r678b1215],
7	—	CD	NUMBER	—	number	8	SENT_238	[p12l159t1156r678b1215],
8	5	CD	NUMBER	5	dep	6	SENT_238	[p12l159t1156r678b1215],
9	.	.	O	.	_	0	SENT_238	[p12l159t1156r678b1215],

1	Cardinal	NNP	O	Cardinal	nn	2	SENT_239	[p12l160t1241r400b1292],
2	DC	NNP	O	DC	_	0	SENT_239	[p12l420t1242r532b1302],
3	,	,	O	,	_	0	SENT_239	[p12l420t1242r532b1302],
4	Flower	NNP	PERSON	Flower	nn	5	SENT_239	[p12l555t1241r756b1291],
5	RJ	NN	PERSON	rj	appos	2	SENT_239	[p12l774t1243r861b1292],
6	.	.	O	.	_	0	SENT_239	[p12l774t1243r861b1292],

1	The	DT	O	the	det	3	SENT_240	[p12l887t1241r994b1291],
2	electronic	JJ	O	electronic	amod	3	SENT_240	[p12l1016t1241r1289b1291],
3	aggregometer	NN	O	aggregometer	_	0	SENT_240	[p12l1312t1248r1710b1306],
4	:	:	O	:	_	0	SENT_240	[p12l1312t1248r1710b1306],
5	a	DT	O	a	det	7	SENT_240	[p12l1736t1258r1766b1291],
6	novel	JJ	O	novel	amod	7	SENT_240	[p12l1785t1241r1942b1292],
7	device	NN	O	device	dep	3	SENT_240	[p12l1963t1241r2143b1291],
8	for	IN	O	for	_	0	SENT_240	[p12l160t1328r241b1379],
9	assessing	VBG	O	assess	prepc_for	7	SENT_240	[p12l285t1328r544b1393],
10	platelet	NN	O	platelet	nn	11	SENT_240	[p12l588t1328r795b1393],
11	behaviour	NN	O	behaviour	dobj	9	SENT_240	[p12l837t1328r1121b1379],
12	in	IN	O	in	_	0	SENT_240	[p12l1164t1328r1217b1378],
13	blood	NN	O	blood	prep_in	9	SENT_240	[p12l1260t1328r1435b1379],
14	.	.	O	.	_	0	SENT_240	[p12l1260t1328r1435b1379],

1	J	NNP	O	J	nn	4	SENT_241	[p12l1483t1330r1510b1379],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_241	[p12l1554t1328r1853b1379],
3	Methods	NNS	O	method	nn	4	SENT_241	[p12l1897t1328r2142b1379],
4	l980	NN	O	l980	_	0	SENT_241	[p12l167t1418r607b1477],
5	;	:	O	;	_	0	SENT_241	[p12l167t1418r607b1477],
6	3	CD	NUMBER	3	num	8	SENT_241	[p12l167t1418r607b1477],
7	:	:	O	:	_	0	SENT_241	[p12l167t1418r607b1477],
8	l350	CD	NUMBER	l350	dep	4	SENT_241	[p12l167t1418r607b1477],
9	—	CD	NUMBER	—	number	10	SENT_241	[p12l167t1418r607b1477],
10	8	CD	NUMBER	8	dep	8	SENT_241	[p12l167t1418r607b1477],
11	.	.	O	.	_	0	SENT_241	[p12l167t1418r607b1477],

1	lvandic	JJ	O	lvandic	amod	2	SENT_242	[p12l159t1504r368b1555],
2	BT	NNP	O	BT	dep	18	SENT_242	[p12l401t1507r500b1566],
3	,	,	O	,	_	0	SENT_242	[p12l401t1507r500b1566],
4	Schlick	NNP	PERSON	Schlick	nn	5	SENT_242	[p12l538t1505r746b1555],
5	P	NN	PERSON	p	appos	2	SENT_242	[p12l777t1507r822b1566],
6	,	,	O	,	_	0	SENT_242	[p12l777t1507r822b1566],
7	Staritz	NNP	ORGANIZATION	Staritz	nn	8	SENT_242	[p12l861t1505r1039b1555],
8	P	NN	ORGANIZATION	p	appos	2	SENT_242	[p12l1071t1507r1116b1566],
9	,	,	O	,	_	0	SENT_242	[p12l1071t1507r1116b1566],
10	Kurz	NNP	PERSON	Kurz	nn	11	SENT_242	[p12l1151t1507r1291b1555],
11	K	NNP	PERSON	K	appos	2	SENT_242	[p12l1322t1507r1387b1566],
12	,	,	O	,	_	0	SENT_242	[p12l1322t1507r1387b1566],
13	Katus	NNP	ORGANIZATION	Katus	nn	14	SENT_242	[p12l1422t1507r1584b1555],
14	HA	NNP	ORGANIZATION	HA	appos	2	SENT_242	[p12l1617t1506r1733b1566],
15	,	,	O	,	_	0	SENT_242	[p12l1617t1506r1733b1566],
16	Giannitsis	NNP	PERSON	Giannitsis	nn	17	SENT_242	[p12l1770t1505r2051b1555],
17	E.	NNP	O	E.	appos	2	SENT_242	[p12l2084t1507r2139b1555],
18	Determination	NN	O	determination	_	0	SENT_242	[p12l159t1591r564b1642],
19	of	IN	O	of	_	0	SENT_242	[p12l611t1591r676b1642],
20	clopidogrel	NN	O	clopidogrel	nn	21	SENT_242	[p12l714t1591r1032b1656],
21	resistance	NN	O	resistance	prep_of	18	SENT_242	[p12l1078t1591r1353b1642],
22	by	IN	O	by	_	0	SENT_242	[p12l1398t1591r1470b1656],
23	whole	JJ	O	whole	amod	26	SENT_242	[p12l1515t1591r1686b1642],
24	blood	NN	O	blood	nn	26	SENT_242	[p12l1731t1591r1894b1642],
25	platelet	NN	O	platelet	nn	26	SENT_242	[p12l1938t1591r2145b1656],
26	aggregometry	NN	O	aggregometry	prep_by	21	SENT_242	[p12l160t1685r550b1743],
27	and	CC	O	and	_	0	SENT_242	[p12l595t1678r695b1729],
28	inhibitors	NNS	O	inhibitor	conj_and	18	SENT_242	[p12l740t1678r1006b1729],
29	of	IN	O	of	_	0	SENT_242	[p12l1054t1678r1118b1729],
30	the	DT	O	the	det	32	SENT_242	[p12l1154t1678r1238b1729],
31	P2Yl2	NN	O	p2yl2	nn	32	SENT_242	[p12l1284t1680r1478b1728],
32	receptor	NN	O	receptor	prep_of	28	SENT_242	[p12l1524t1685r1762b1743],
33	.	.	O	.	_	0	SENT_242	[p12l1524t1685r1762b1743],

1	Clin	NNP	ORGANIZATION	Clin	nn	2	SENT_243	[p12l1813t1678r1932b1729],
2	Chem	NNP	ORGANIZATION	Chem	_	0	SENT_243	[p12l1978t1678r2145b1729],
3	2006	CD	DATE	2006	num	2	SENT_243	[p12l159t1768r607b1828],
4	;	:	O	;	_	0	SENT_243	[p12l159t1768r607b1828],
5	52:383	CD	NUMBER	52:383	number	6	SENT_243	[p12l159t1768r607b1828],
6	—	CD	NUMBER	—	dep	2	SENT_243	[p12l159t1768r607b1828],
7	8	CD	NUMBER	8	dep	6	SENT_243	[p12l159t1768r607b1828],
8	.	.	O	.	_	0	SENT_243	[p12l159t1768r607b1828],

1	Malferrari	NNP	O	Malferrari	nn	2	SENT_244	[p12l159t1853r444b1904],
2	G	NNP	O	G	_	0	SENT_244	[p12l475t1854r538b1914],
3	,	,	O	,	_	0	SENT_244	[p12l475t1854r538b1914],
4	Monferini	NNP	PERSON	Monferini	nn	5	SENT_244	[p12l570t1853r854b1904],
5	E	NNP	O	E	appos	2	SENT_244	[p12l884t1855r940b1914],
6	,	,	O	,	_	0	SENT_244	[p12l884t1855r940b1914],
7	DeBlasio	NNP	PERSON	DeBlasio	nn	8	SENT_244	[p12l972t1853r1232b1904],
8	P	NN	O	p	appos	2	SENT_244	[p12l1262t1855r1308b1914],
9	,	,	O	,	_	0	SENT_244	[p12l1262t1855r1308b1914],
10	et	FW	O	et	nn	11	SENT_244	[p12l1341t1860r1390b1904],
11	al.	FW	O	al.	appos	2	SENT_244	[p12l1420t1853r1481b1904],
12	.	.	O	.	_	0	SENT_244	[p12l1420t1853r1481b1904],

1	High-quality	JJ	O	high-quality	amod	3	SENT_245	[p12l1514t1853r1874b1918],
2	genomic	JJ	O	genomic	amod	3	SENT_245	[p12l1903t1853r2143b1918],
3	DNA	NN	O	dna	_	0	SENT_245	[p12l159t1942r311b1990],
4	from	IN	O	from	_	0	SENT_245	[p12l332t1940r467b1991],
5	human	JJ	O	human	amod	7	SENT_245	[p12l486t1940r678b1991],
6	whole	JJ	O	whole	amod	7	SENT_245	[p12l697t1940r868b1991],
7	blood	NN	O	blood	prep_from	3	SENT_245	[p12l888t1940r1050b1991],
8	and	CC	O	and	_	0	SENT_245	[p12l1070t1940r1171b1991],
9	mononuclear	JJ	O	mononuclear	amod	10	SENT_245	[p12l1190t1940r1558b1991],
10	cells	NNS	O	cell	prep_from	3	SENT_245	[p12l1578t1940r1717b1991],
11	.	.	O	.	_	0	SENT_245	[p12l1578t1940r1717b1991],

1	Biotechniques	NNS	O	biotechnique	_	0	SENT_246	[p12l1742t1940r2143b2005],
2	2002	CD	DATE	2002	num	1	SENT_246	[p12l159t2030r678b2089],
3	;	:	O	;	_	0	SENT_246	[p12l159t2030r678b2089],
4	33	CD	NUMBER	33	num	6	SENT_246	[p12l159t2030r678b2089],
5	:	:	O	:	_	0	SENT_246	[p12l159t2030r678b2089],
6	l228	CD	NUMBER	l228	dep	1	SENT_246	[p12l159t2030r678b2089],
7	—	CD	NUMBER	—	number	8	SENT_246	[p12l159t2030r678b2089],
8	30	CD	NUMBER	30	dep	6	SENT_246	[p12l159t2030r678b2089],
9	.	.	O	.	_	0	SENT_246	[p12l159t2030r678b2089],

1	P	NN	O	p	nn	2	SENT_247	[p12l577t2165r599b2188],
2	Staritz	NNP	O	Staritz	_	0	SENT_247	[p12l613t2165r699b2188],
3	et	FW	O	et	nn	4	SENT_247	[p12l711t2169r734b2188],
4	al.	FW	O	al.	dep	2	SENT_247	[p12l745t2164r774b2188],
5	/	:	O	/	punct	2	SENT_247	[p12l788t2164r802b2188],
6	International	NNP	ORGANIZATION	International	nn	7	SENT_247	[p12l808t2164r984b2188],
7	Journal	NNP	ORGANIZATION	Journal	dep	2	SENT_247	[p12l992t2164r1097b2188],
8	of	IN	ORGANIZATION	of	_	0	SENT_247	[p12l1108t2164r1139b2195],
9	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	7	SENT_247	[p12l1146t2164r1293b2195],
10	133	CD	NUMBER	133	number	11	SENT_247	[p12l1306t2165r1352b2188],
11	(	CD	NUMBER	(	num	12	SENT_247	[p12l1367t2164r1451b2195],
12	2009	CD	DATE	2009	dep	9	SENT_247	[p12l1367t2164r1451b2195],
13	)	CD	NUMBER	)	num	15	SENT_247	[p12l1367t2164r1451b2195],
14	34I	NN	O	34us	nn	15	SENT_247	[p12l1464t2165r1579b2188],
15	—	NN	O	—	dep	9	SENT_247	[p12l1464t2165r1579b2188],
16	345	CD	NUMBER	345	number	17	SENT_247	[p12l1464t2165r1579b2188],
17	345	CD	NUMBER	345	dep	15	SENT_247	[p12l2076t2165r2123b2188],

1	adenosine	NN	O	adenosine	_	0	SENT_248	[p12l1201t2270r1331b2294],
2	diphosphate-induced	JJ	O	diphosphate-induced	amod	4	SENT_248	[p12l1350t2270r1624b2300],
3	platelet	NN	O	platelet	nn	4	SENT_248	[p12l1641t2270r1738b2300],
4	aggregation	NN	O	aggregation	dep	1	SENT_248	[p12l1757t2270r1911b2300],
5	after	IN	O	after	_	0	SENT_248	[p12l1930t2270r1989b2294],
6	initiation	NN	O	initiation	prep_after	4	SENT_248	[p12l2008t2270r2125b2294],
7	of	IN	O	of	_	0	SENT_248	[p12l1201t2311r1231b2335],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_248	[p12l1247t2311r1395b2342],
9	therapy	NN	O	therapy	prep_of	6	SENT_248	[p12l1415t2311r1514b2342],
10	with	IN	O	with	_	0	SENT_248	[p12l1533t2311r1591b2335],
11	a	DT	O	a	det	14	SENT_248	[p12l1612t2319r1626b2335],
12	high	JJ	O	high	amod	14	SENT_248	[p12l1645t2311r1704b2342],
13	loading	NN	O	loading	nn	14	SENT_248	[p12l1724t2311r1821b2342],
14	dose	NN	O	dose	prep_with	9	SENT_248	[p12l1842t2311r1908b2335],
15	.	.	O	.	_	0	SENT_248	[p12l1842t2311r1908b2335],

1	Blood	NNP	O	Blood	nn	3	SENT_249	[p12l1930t2311r2010b2335],
2	Coagul	NNP	O	Coagul	nn	3	SENT_249	[p12l2031t2311r2125b2342],
3	Fibrinolysis	NNP	O	Fibrinolysis	_	0	SENT_249	[p12l1200t2352r1356b2383],
4	2005	CD	DATE	2005	num	6	SENT_249	[p12l1367t2353r1481b2381],
5	;	:	O	;	_	0	SENT_249	[p12l1367t2353r1481b2381],
6	l6	CD	NUMBER	l6	dep	3	SENT_249	[p12l1367t2353r1481b2381],
7	:	:	O	:	_	0	SENT_249	[p12l1367t2353r1481b2381],
8	l99	CD	NUMBER	l99	num	9	SENT_249	[p12l1488t2353r1609b2376],
9	—	NN	O	—	dep	3	SENT_249	[p12l1488t2353r1609b2376],
10	204	CD	NUMBER	204	dep	9	SENT_249	[p12l1488t2353r1609b2376],
11	.	.	O	.	_	0	SENT_249	[p12l1488t2353r1609b2376],

1	[	RB	O	[	dep	5	SENT_250	[p12l1131t2394r1181b2424],
2	20	CD	NUMBER	20	num	5	SENT_250	[p12l1131t2394r1181b2424],
3	]	CD	NUMBER	]	num	5	SENT_250	[p12l1131t2394r1181b2424],
4	Serebruany	NNP	O	Serebruany	nn	5	SENT_250	[p12l1201t2393r1349b2424],
5	VL	NNP	O	VL	_	0	SENT_250	[p12l1359t2394r1410b2422],
6	,	,	O	,	_	0	SENT_250	[p12l1359t2394r1410b2422],
7	Midei	NNP	ORGANIZATION	Midei	nn	8	SENT_250	[p12l1422t2393r1499b2417],
8	MG	NN	ORGANIZATION	mg	appos	5	SENT_250	[p12l1510t2394r1570b2422],
9	,	,	O	,	_	0	SENT_250	[p12l1510t2394r1570b2422],
10	Malinin	NNP	PERSON	Malinin	nn	11	SENT_250	[p12l1582t2393r1686b2417],
11	AI	NNP	O	AI	appos	5	SENT_250	[p12l1696t2394r1737b2422],
12	,	,	O	,	_	0	SENT_250	[p12l1696t2394r1737b2422],
13	et	FW	O	et	nn	14	SENT_250	[p12l1750t2397r1772b2417],
14	al.	FW	O	al.	appos	11	SENT_250	[p12l1783t2393r1812b2417],
15	.	.	O	.	_	0	SENT_250	[p12l1783t2393r1812b2417],

1	Absence	NN	O	absence	_	0	SENT_251	[p12l1824t2393r1937b2417],
2	of	IN	O	of	_	0	SENT_251	[p12l1948t2393r1979b2417],
3	interaction	NN	O	interaction	prep_of	1	SENT_251	[p12l1986t2393r2125b2417],
4	between	IN	O	between	_	0	SENT_251	[p12l1200t2435r1309b2459],
5	atorvastatin	NN	O	atorvastatin	nn	8	SENT_251	[p12l1320t2435r1472b2459],
6	or	CC	O	or	_	0	SENT_251	[p12l1483t2443r1510b2459],
7	other	JJ	O	other	nn	8	SENT_251	[p12l1520t2435r1587b2459],
8	statins	NNS	O	statin	prep_between	3	SENT_251	[p12l1598t2435r1679b2459],
9	and	CC	O	and	_	0	SENT_251	[p12l1691t2435r1737b2459],
10	clopidogrel	NN	O	clopidogrel	prep_between	3	SENT_251	[p12l1748t2435r1903b2466],
11	:	:	O	:	_	0	SENT_251	[p12l1748t2435r1903b2466],
12	results	NNS	O	result	dep	1	SENT_251	[p12l1916t2435r2000b2459],
13	from	IN	O	from	_	0	SENT_251	[p12l2012t2435r2075b2459],
14	the	DT	O	the	det	16	SENT_251	[p12l2085t2435r2124b2459],
15	interaction	NN	O	interaction	nn	16	SENT_251	[p12l1201t2476r1339b2500],
16	study	NN	O	study	prep_from	12	SENT_251	[p12l1351t2476r1425b2507],
17	.	.	O	.	_	0	SENT_251	[p12l1351t2476r1425b2507],

1	Arch	NNP	O	Arch	nn	3	SENT_252	[p12l1437t2476r1502b2500],
2	Intem	NNP	O	Intem	nn	3	SENT_252	[p12l1513t2477r1590b2500],
3	Med	NNP	O	Med	_	0	SENT_252	[p12l1601t2476r1661b2500],
4	2004	CD	DATE	2004	num	3	SENT_252	[p12l1671t2477r1913b2505],
5	;	:	O	;	_	0	SENT_252	[p12l1671t2477r1913b2505],
6	l64	CD	NUMBER	l64	num	7	SENT_252	[p12l1671t2477r1913b2505],
7	:2051	CD	NUMBER	:2051	dep	3	SENT_252	[p12l1671t2477r1913b2505],
8	—	NN	O	—	dep	7	SENT_252	[p12l1671t2477r1913b2505],
9	7	CD	NUMBER	7	num	8	SENT_252	[p12l1671t2477r1913b2505],
10	.	.	O	.	_	0	SENT_252	[p12l1671t2477r1913b2505],

1	[	NN	O	[	_	0	SENT_253	[p12l1131t2518r1181b2548],
2	21	CD	NUMBER	21	num	1	SENT_253	[p12l1131t2518r1181b2548],
3	]	CD	NUMBER	]	num	5	SENT_253	[p12l1131t2518r1181b2548],
4	Gorchakova	NNP	PERSON	Gorchakova	nn	5	SENT_253	[p12l1201t2517r1361b2541],
5	o	NN	O	o	dep	1	SENT_253	[p12l1371t2518r1400b2546],
6	,	,	O	,	_	0	SENT_253	[p12l1371t2518r1400b2546],
7	Von	NNP	PERSON	Von	nn	9	SENT_253	[p12l1411t2525r1461b2541],
8	Beckerath	NNP	PERSON	Beckerath	nn	9	SENT_253	[p12l1470t2517r1603b2541],
9	N	NNP	PERSON	N	appos	5	SENT_253	[p12l1612t2518r1643b2546],
10	,	,	O	,	_	0	SENT_253	[p12l1612t2518r1643b2546],
11	Gawaz	NNP	O	Gawaz	nn	12	SENT_253	[p12l1655t2518r1745b2541],
12	M	NNP	O	M	appos	5	SENT_253	[p12l1754t2518r1790b2546],
13	,	,	O	,	_	0	SENT_253	[p12l1754t2518r1790b2546],
14	et	FW	O	et	nn	15	SENT_253	[p12l1802t2521r1825b2541],
15	al.	FW	O	al.	appos	5	SENT_253	[p12l1835t2517r1864b2541],
16	.	.	O	.	_	0	SENT_253	[p12l1835t2517r1864b2541],

1	Antiplatelet	JJ	O	antiplatelet	amod	2	SENT_254	[p12l1875t2517r2029b2548],
2	effects	NNS	O	effect	nsubjpass	13	SENT_254	[p12l2040t2517r2124b2541],
3	of	IN	O	of	_	0	SENT_254	[p12l1201t2559r1231b2583],
4	a	DT	O	a	det	8	SENT_254	[p12l1237t2567r1251b2583],
5	600	CD	NUMBER	600	num	8	SENT_254	[p12l1261t2559r1309b2583],
6	mg	NN	O	mg	nn	8	SENT_254	[p12l1319t2567r1361b2590],
7	loading	NN	O	loading	nn	8	SENT_254	[p12l1372t2559r1469b2590],
8	dose	NN	O	dose	prep_of	2	SENT_254	[p12l1479t2559r1539b2583],
9	of	IN	O	of	_	0	SENT_254	[p12l1549t2559r1579b2583],
10	clopidogrel	NN	O	clopidogrel	prep_of	8	SENT_254	[p12l1586t2559r1734b2590],
11	are	VBP	O	be	auxpass	13	SENT_254	[p12l1745t2567r1783b2583],
12	not	RB	O	not	neg	13	SENT_254	[p12l1793t2563r1835b2583],
13	attenuated	VBN	O	attenuate	_	0	SENT_254	[p12l1845t2559r1979b2583],
14	in	IN	O	in	_	0	SENT_254	[p12l1989t2559r2014b2583],
15	patients	NNS	O	patient	prep_in	13	SENT_254	[p12l2023t2559r2124b2590],
16	receiving	VBG	O	receive	partmod	15	SENT_254	[p12l1200t2600r1321b2631],
17	atorvastatin	NN	O	atorvastatin	dobj	16	SENT_254	[p12l1339t2600r1491b2624],
18	or	CC	O	or	_	0	SENT_254	[p12l1508t2608r1535b2624],
19	simvastatin	NN	O	simvastatin	dobj	16	SENT_254	[p12l1552t2600r1700b2624],
20	for	IN	O	for	_	0	SENT_254	[p12l1718t2600r1755b2624],
21	at	IN	DURATION	at	quantmod	23	SENT_254	[p12l1772t2603r1795b2624],
22	least	JJS	DURATION	least	mwe	21	SENT_254	[p12l1812t2600r1871b2624],
23	4	CD	DURATION	4	num	24	SENT_254	[p12l1888t2601r1903b2624],
24	weeks	NNS	NUMBER	week	prep_for	17	SENT_254	[p12l1921t2600r2002b2624],
25	prior	RB	O	prior	_	0	SENT_254	[p12l2019t2600r2083b2631],
26	to	TO	O	to	_	0	SENT_254	[p12l2099t2603r2124b2624],
27	coronary	JJ	O	coronary	amod	29	SENT_254	[p12l1201t2649r1316b2672],
28	artery	NN	O	artery	nn	29	SENT_254	[p12l1327t2645r1402b2672],
29	stenting	NN	O	stenting	prep_prior_to	16	SENT_254	[p12l1413t2641r1522b2672],
30	.	.	O	.	_	0	SENT_254	[p12l1413t2641r1522b2672],

1	Eur	NNP	O	Eur	nn	3	SENT_255	[p12l1535t2642r1582b2665],
2	Heart	NNP	O	Heart	nn	3	SENT_255	[p12l1592t2642r1664b2665],
3	J	NNP	O	J	_	0	SENT_255	[p12l1674t2642r1687b2665],
4	2004	CD	DATE	2004	num	6	SENT_255	[p12l1697t2642r1956b2670],
5	;	:	O	;	_	0	SENT_255	[p12l1697t2642r1956b2670],
6	25	CD	NUMBER	25	dep	3	SENT_255	[p12l1697t2642r1956b2670],
7	:	:	O	:	_	0	SENT_255	[p12l1697t2642r1956b2670],
8	l898	CD	NUMBER	l898	num	9	SENT_255	[p12l1697t2642r1956b2670],
9	—	NN	O	—	dep	3	SENT_255	[p12l1697t2642r1956b2670],
10	902	CD	NUMBER	902	dep	9	SENT_255	[p12l1697t2642r1956b2670],
11	.	.	O	.	_	0	SENT_255	[p12l1697t2642r1956b2670],

